annal
intens
care
suppl
introduct
mechan
insufflationexsuffl
mie
use
specif
devic
commonli
use
increas
weak
cough
patient
chronic
neuromuscular
weak
intens
care
unit
icu
patient
icuacquir
neuromyopathi
assess
efficaci
mie
devic
commonli
done
measur
peak
cough
flow
pcf
upper
airway
collaps
frequent
associ
neuromuscular
diseas
may
compromis
mie
efficaci
tracheomalacia
anoth
diseas
may
imped
pcf
increas
mie
devic
goal
present
studi
carri
bench
studi
assess
effect
mie
pcf
without
presenc
collaps
tube
hypothesi
pcf
lower
without
collaps
tube
patient
method
use
lung
simul
ttl
michigan
instrument
adjust
complianc
c
resist
r
mie
coughassist
philipsrespiron
attach
without
latex
collaps
tube
flow
pressur
proxim
lung
simul
six
cr
combin
test
without
collaps
tube
cr
combin
set
inspiratori
expiratori
pressur
mie
devic
mie
devic
set
automat
mode
inspiratori
time
expiratori
time
paus
set
record
use
data
logger
biopac
biopac
inc
last
cycl
use
analysi
done
use
acqknowledg
softwar
biopac
inc
peak
expiratori
flow
first
ms
onset
expir
taken
surrog
pcf
correspond
pressur
also
record
result
contrari
hypothesi
peak
expiratori
flow
first
ms
exsuffl
phase
higher
without
collaps
tube
everi
cr
condit
shown
figur
condit
effect
collaps
tube
intercept
cm
signific
offset
signific
increas
slope
l
cm
condit
collaps
tube
significantli
increas
pcf
cm
expiratori
pressur
gap
increas
pressur
slope
increas
collaps
tube
conclus
found
peak
expiratori
higher
without
collaps
tube
vivo
measur
patient
done
confirm
find
annal
intens
care
suppl
introduct
background
current
literatur
french
guidelin
recommend
earli
mobil
intens
care
unit
icu
includ
vertic
walk
vertic
neurolog
patient
icu
challeng
neurolog
impair
risk
fall
clinic
worsen
neuroicu
montpelli
univers
hospit
weight
suspens
system
use
object
studi
feasibl
safeti
walk
weight
suspens
system
neuroicu
feasibl
involv
proport
patient
benefit
suspens
walk
reason
use
physiotherapist
time
requir
safeti
involv
rate
advers
event
chang
vital
paramet
pain
patient
method
design
monocentr
prospect
descript
studi
includ
neurog
patient
hospit
h
icu
initi
mechan
ventil
midfebruari
midseptemb
exclud
deceas
patient
criteria
use
suspens
walk
respiratori
stabil
without
mechan
ventil
tracheostomi
oxygen
therapi
possibl
hemodynam
neurolog
stabil
suffici
respond
command
head
control
test
one
quadricep
two
quadricep
data
includ
gener
descript
patient
clinic
statu
suspens
walk
pain
mrc
test
sit
balanc
rass
hemodynam
respiratori
paramet
medic
equip
pain
hemodynam
respiratori
paramet
session
descript
advers
event
consequ
durat
walk
result
among
patient
includ
see
tabl
characterist
benefit
suspens
walk
stay
patient
suspens
walk
need
hinder
organ
difficulti
timet
challeng
earli
discharg
icu
patient
could
walk
without
suspens
first
vertic
impair
use
suspens
walk
total
suspens
walk
session
perform
five
session
need
interrupt
five
follow
reason
pain
hypotens
dizzi
diarrhea
dysfunct
devic
advers
event
clinic
consequ
beyond
session
pain
score
rais
significantli
one
patient
point
bp
score
mean
delay
extub
tracheotomi
first
suspens
walk
day
mean
delay
first
suspens
walk
first
walk
without
suspens
day
conclus
vertic
suspens
devic
neurolog
icu
feasibl
safe
train
support
team
obstacl
medic
equip
languag
impair
absenc
balanc
heavi
weight
poor
tonic
particip
overcom
use
devic
suspens
could
enabl
sever
neurolog
icu
patient
walk
one
week
earlier
annal
intens
care
suppl
introduct
earli
mobil
recommend
critic
ill
patient
limit
rapid
decreas
muscl
mass
function
sever
method
addit
mobil
use
includ
passiv
activ
inb
cycl
muscl
electrostimul
esm
latter
could
improv
muscl
microcircul
assess
tissu
oxygen
satur
red
blood
cell
rbc
deform
untrain
athlet
rbcnitric
oxid
product
mechan
monocentr
random
trial
investig
critic
ill
patient
effect
passiv
activ
exercis
alon
associ
daili
esm
daili
inb
cycl
session
rbc
deform
patient
method
patient
random
first
h
icu
admiss
three
group
passiv
activ
mobil
twice
day
day
associ
daili
session
leg
passiv
activ
inb
cycl
cycl
day
associ
daili
session
leg
esm
esm
demograph
data
lactat
level
record
session
rbc
deform
assess
ex
vivo
exercis
laserassist
optic
rotat
cell
analyz
lorca
mechatron
instrument
bv
zwaag
netherland
elong
index
ei
relat
shear
stress
pa
appli
rbc
membran
data
express
median
valu
delta
ei
ei
minu
ei
exercis
compar
one
way
test
p
valu
consid
statist
signific
result
patient
group
includ
versu
p
lactat
level
versu
mmoll
l
p
modifi
whatev
type
exercis
esm
group
delta
ei
significantli
decreas
sever
low
shear
stress
pa
compar
two
group
conclus
associ
activ
passiv
mobil
esm
alter
least
low
shear
stress
rbc
deform
critic
ill
patient
effect
long
term
treatment
techniqu
rbc
rheolog
muscl
metabol
need
investig
annal
intens
care
suppl
introduct
neurogen
paraosteoarthropathi
nopo
common
complic
sever
head
trauma
complic
joint
damag
rang
amplitud
limit
ankylosi
complic
frequent
encount
unit
objectivesdetermin
frequenc
nopo
emerg
resuscit
depart
establish
prevent
protocol
establish
physiotherapist
unit
patient
method
expos
work
carri
urc
resuscit
unit
chuoran
prospect
studi
spread
two
year
involv
patient
studi
popul
consist
sever
head
injuri
gct
glasgow
score
less
studi
time
onset
affect
joint
degre
limit
risk
factor
result
tcg
patient
patient
present
nopo
onset
time
averag
day
extrem
rang
day
elbow
affect
joint
knee
involv
case
seri
risk
factor
favor
onset
nopo
sever
neurolog
lesion
periarticular
lymphoedema
arteri
compress
blood
pressur
cuff
durat
sedat
type
drug
use
conclus
nopo
complic
occur
tcg
caus
function
sequela
jeopard
socioprofession
reintegr
prevent
prevent
annal
intens
care
suppl
introduct
stand
icu
patient
becom
routin
care
earli
mobil
program
awak
patient
stand
improv
minut
ventil
awar
undesir
effect
decreas
arteri
pressur
perform
stand
posit
icu
patient
physiotherapist
need
move
icu
bed
recent
stand
posit
perform
directli
bed
ard
patient
posit
one
major
compon
care
upright
prone
posit
show
mani
benefit
prone
decreas
mortal
rate
ard
patient
upright
posit
improv
oxygen
effect
ard
patient
instead
prone
sever
advers
effect
pressur
ulcer
endotrach
tube
obstruct
ventil
acquir
pneumonia
patient
method
order
decreas
advers
effect
prone
posit
propos
evalu
whether
stand
posit
safe
produc
oxygen
effect
prone
posit
stand
perform
directli
dedic
icu
bed
sever
moder
adr
patient
accord
berlin
definit
prevent
hypotens
use
anti
shock
pant
inflat
mmhg
stand
perform
multipl
step
angul
program
base
clinic
patient
respons
min
arteri
blood
sampl
perform
complet
techniqu
static
complianc
calcul
angul
step
result
perform
one
stand
ard
patient
advers
event
occur
techniqu
blood
pressur
remain
stabl
antishock
pant
inflat
heart
rate
rise
bpm
bpm
static
complianc
stabl
begin
end
p
f
ratio
increas
end
manoeuv
discuss
upright
posit
alreadi
evalu
studi
show
benefit
respond
patient
ard
wherea
upright
stand
real
inclin
angl
upright
techniqu
patient
stand
real
feet
postur
similar
human
stand
posit
conclus
techniqu
appear
safe
produc
posit
effect
p
f
ratio
without
chang
static
complianc
ard
volum
control
ventil
patient
need
test
techniqu
prove
real
effect
annal
intens
care
suppl
introduct
clinic
assess
swallow
disord
icu
mani
limit
reliabl
accuraci
refer
standard
imag
techniqu
fluoroscopi
still
reli
analysi
oper
subject
conclus
see
tabl
context
ultrasound
imag
perform
patient
bedsid
noninvas
tool
allow
evalu
main
structur
involv
swallow
phase
may
promis
tool
dysphagia
assess
patient
method
narr
review
interest
ultrasound
imag
swallow
assess
well
perspect
use
physiotherapi
figur
practic
descript
result
author
everyday
use
ultrasound
imag
result
ultrasound
imag
allow
quantit
qualit
examin
major
swallow
structur
tongu
oropharyng
muscl
larynx
upper
esophag
sphincter
ue
assess
tongu
kinet
look
abnorm
movement
contractil
thick
oropharyng
muscl
enabl
assess
potenti
dysfunct
physiotherapist
may
also
follow
larynx
movement
coron
sagitt
plane
evalu
displac
hyoid
bone
decreas
hyoid
bone
displac
contract
tongu
may
explain
dysphagia
final
ultrasound
imag
measur
displac
openingclos
diamet
upper
esophagu
sphincter
ue
allow
detect
dysphagia
relat
ue
disord
conclus
ultrasound
imag
aerodigest
tract
may
improv
quantit
qualit
examin
swallow
structur
use
method
requir
deep
understand
ultrasound
imag
principl
swallow
physiopatholog
order
abl
benefit
potenti
ultrasound
imag
seem
promis
tool
physiotherapi
use
outcom
clinic
research
clinic
practic
order
improv
diagnosi
dysfunct
relat
dysphagia
annal
intens
care
suppl
introduct
mechan
ventil
icu
patient
may
induc
acut
kidney
injuri
aki
aim
describ
effect
mechan
ventil
mv
set
aki
worsen
well
potenti
role
mean
perfus
pressur
mpp
patient
method
includ
mimiciii
databas
adult
patient
admit
first
time
icu
exclud
patient
known
chronic
kidney
diseas
kdigo
inform
suffer
aki
main
outcom
onekdigo
categori
aki
worsen
compar
day
includ
categor
variabl
discharg
aliv
without
aki
worsen
death
aki
worsen
use
multinomi
logist
regress
day
day
accord
landmarkapproach
twoday
slide
perspect
result
patient
met
inclus
criteria
male
median
age
iqr
icu
hospit
mortal
respect
day
day
patient
die
without
aki
worsen
discharg
aliv
suffer
aki
worsen
day
day
patient
suffer
aki
worsen
discharg
aliv
die
multivari
analysi
use
mv
modal
refer
n
mv
day
associ
aki
worsen
day
rel
risk
ratio
rrr
mv
peep
n
peep
n
peep
n
rrr
aki
worsen
mv
peep
n
peep
n
peep
n
day
compar
mv
n
hemodynam
paramet
shown
figur
mpp
significantli
differ
across
mv
group
mmhg
patient
receiv
mv
mv
peep
peep
peep
p
conclus
mechan
ventil
associ
aki
worsen
increas
peep
depend
manner
earli
phase
icu
manag
larg
cohort
patient
interact
mpp
mechan
ventil
explor
annal
intens
care
suppl
introduct
introduct
transven
renal
biopsi
altern
way
obtain
kidney
sampl
patient
bleedingrisk
factor
eg
antiplatelet
therapi
anticoagul
coagul
studi
undertaken
determin
safeti
diagnost
yield
transven
renal
biopsi
critic
ill
patient
patient
method
patient
method
monocent
retrospect
observ
cohort
studi
french
tertiari
icu
patient
undergo
inicu
transven
renal
biopsi
januari
februari
includ
result
result
eighti
patient
male
femal
sex
ratio
mean
sd
age
year
includ
histolog
diagnosi
obtain
patient
acut
tubular
necrosi
frequent
potenti
treatabl
caus
found
patient
number
patient
factor
ie
antiplatelet
therapi
thrombopenia
g
l
prevent
cur
anticoagul
time
biopsi
respect
seven
five
four
two
patient
respect
renal
hematoma
macroscop
hematuria
none
requir
specif
treatment
six
patient
die
inicu
mortal
death
relat
transven
renal
biopsi
median
biopsytodeath
interv
iqr
day
conclus
conclus
base
cohort
icu
patient
acut
renal
failur
transven
renal
biopsi
safe
obtain
high
diagnost
yield
critic
ill
patient
even
presenc
multipl
bleed
risk
factor
annal
intens
care
suppl
introduct
risk
chronic
kidney
diseas
ckd
follow
sever
acut
kidney
injuri
aki
critic
ill
patient
well
document
howev
longterm
risk
ckd
less
sever
aki
critic
ill
patient
never
assess
patient
method
prospect
singlecent
intens
care
unit
icu
observ
followup
studi
carri
bordeaux
franc
patient
sever
kdigo
nonsever
aki
kdigo
stage
enrol
patient
prior
ckd
exclud
primari
outcom
preval
ckd
defin
estim
glomerular
filtrat
rate
lower
mlmin
nonsever
aki
group
secondari
outcom
risk
factor
ckd
renal
surviv
followup
identifi
proport
among
ckd
patient
follow
nephrologist
renal
recoveri
defin
return
creatinin
icu
discharg
l
baselin
result
screen
patient
exclus
prior
ckd
patient
enrol
sever
aki
observ
nonsever
aki
end
followup
exclus
patient
die
patient
remain
nonsever
sever
aki
group
respect
global
preval
ckd
higher
sever
vs
nonsever
aki
group
vs
p
tabl
independ
risk
factor
ckd
diabet
absenc
renal
recoveri
icu
discharg
eleven
ckd
patient
follow
nephrologist
discuss
studi
first
give
preval
ckd
year
nonsever
aki
criticallyil
patient
studi
focus
stage
aki
critic
ill
patient
studi
explor
stage
aki
noncrit
ill
patient
high
preval
ckd
year
limit
amount
ckd
patient
follow
nephrologist
confirm
need
accur
followup
plan
icu
discharg
patient
diagnos
aki
conclus
risk
develop
ckd
year
nonsever
aki
despit
lower
sever
aki
remain
high
underestim
annal
intens
care
suppl
introduct
epidemiolog
experiment
studi
show
link
acut
kidney
injuri
aki
longterm
outcom
mortal
chronic
kidney
diseas
ckd
whether
time
renal
replac
therapi
rrt
aki
eventu
affect
outcom
unknown
studi
analyz
longterm
outcom
patient
includ
artifici
kidney
initi
kidney
injuri
akiki
accord
rrt
initi
strategi
patient
method
akiki
trial
prospect
multicent
openlabel
twoarm
random
control
trial
compar
two
rrt
initi
strategi
patient
receiv
catecholamin
mechan
ventil
present
sever
aki
potenti
lifethreaten
condit
nejm
earli
strategi
rrt
start
within
h
random
criteria
delay
one
rrt
initi
one
follow
criteria
occur
sever
hyperkalemia
sever
acidosi
sever
pulmonari
edema
due
fluid
overload
result
sever
hypoxemia
oligoanuria
h
serum
urea
concentr
mmoll
assess
longterm
year
outcom
patient
surviv
day
random
collect
vital
statu
last
renal
function
valu
healthrel
qualiti
life
use
estim
log
rank
test
analyz
longterm
surviv
accord
random
group
result
median
followup
year
confid
interv
ci
year
earli
strategi
group
initi
includ
patient
aliv
day
random
still
aliv
year
delay
strategi
group
initi
includ
patient
aliv
day
random
still
aliv
year
p
comparison
group
curv
see
figur
superpos
p
valu
analys
longterm
renal
function
health
relat
qualiti
life
still
progress
conclus
although
initi
mortal
aki
critic
ill
patient
high
patient
surviv
acut
episod
good
vital
prognosi
year
addit
death
longterm
death
rate
influenc
initi
rrt
initi
strategi
data
renal
function
health
qualiti
avail
time
present
annal
intens
care
suppl
introduct
superinfect
influenza
pneumonia
staphylococcu
aureu
wellknown
advers
event
convers
publish
data
epidemiolog
superinfect
staphylococcu
aureu
produc
pantonvalentin
leukocidin
sa
pvl
remain
scars
studi
evalu
mortal
epidemiolog
specif
complic
influenza
pneumonia
intens
care
unit
icu
patient
method
conduct
multicent
retrospect
epidemiolog
studi
period
januari
decemb
includ
patient
admit
icu
sa
pvl
co
infect
influenza
pneumonia
primari
endpoint
mortal
icu
secondari
endpoint
includ
demograph
clinic
characterist
popul
descript
complic
icu
stay
microbiolog
therapeut
data
result
particip
centr
patient
admit
icu
influenza
pneumonia
screen
inclus
period
preval
influenza
pneumonia
co
infect
sa
pvl
patient
patient
young
neither
comorbid
risk
factor
sever
influenza
overal
mortal
icu
cohort
patient
admiss
intens
care
patient
leucopen
g
l
present
sever
ard
requir
vvecmo
patient
icu
length
stay
day
survivor
day
nonsurvivor
differ
antivir
antibiot
treatment
two
group
record
conclus
sa
pvl
superinfect
influenza
pneumonia
rare
extrem
sever
complic
high
earli
mortal
patient
often
present
sever
ard
frequent
requir
vvecmo
declar
conflict
interest
work
annal
intens
care
suppl
introduct
studi
show
high
incid
invas
pulmonari
aspergillosi
ipa
patient
sever
influenza
suggest
assess
benefit
antifung
prophylaxi
howev
studi
come
area
lack
extern
valid
aim
measur
incid
invas
pulmonari
aspergillosi
ipa
aspergillosi
colon
patient
sever
influenza
admit
intens
care
unit
icu
patient
method
retrospect
multicent
cohort
studi
recruit
patient
influenza
admit
four
icu
three
french
tertiari
hospit
septemb
april
patient
adult
confirm
influenza
infect
base
posit
airway
pcr
test
patient
aspergillusposit
lower
respiratori
tract
specimen
cultur
patient
aspergillu
diagnos
aspergillu
colon
invas
pulmonari
aspergillosi
put
proven
accord
aspicu
criteria
multivari
logist
regress
perform
determin
factor
associ
invas
pulmonari
aspergillosi
ipa
aspergillosi
colon
result
four
hundr
ninetyon
patient
includ
three
hundr
fiftythre
patient
infect
influenza
patient
influenza
b
mean
simplifi
acut
physiolog
score
ii
sd
patient
die
icu
three
hundr
fiftysix
patient
invas
mechan
ventil
patient
underw
extracorpor
membran
oxygen
twentysix
patient
aspergillusposit
lower
respiratori
tract
specimen
cultur
includ
patient
diagnos
ipa
accord
aspicu
criteria
multivari
analysi
factor
associ
aspergillosisposit
lower
respiratori
tract
specimen
cultur
liver
cirrhosi
haematolog
malign
use
vasopressor
influenza
tabl
mortal
rate
significantli
differ
patient
without
aspergillu
p
conclus
larg
french
cohort
studi
patient
sever
influenza
ipa
diagnos
critic
ill
patient
influenza
infect
prospect
research
warrant
confirm
find
annal
intens
care
suppl
introduct
season
influenza
viru
infect
ivi
associ
high
morbid
frequent
complic
immun
dysregul
secondari
ivi
may
contribut
ard
overmort
increas
risk
secondari
infect
studi
aim
character
immun
profil
icu
patient
admit
ivi
patient
method
prospect
singlecent
observ
studi
immunocompet
adult
admit
icu
ivi
confirm
pcr
nasopharyng
swab
januari
march
immuneprofil
assess
flow
cytometri
peripher
blood
admiss
first
two
week
icu
stay
subset
analyz
includ
immatur
matur
granulocyt
activ
monocyt
hladr
monocyt
hladr
lymphocyt
bacteri
coinfect
defin
presenc
posit
cultur
sampl
acquir
within
standard
care
associ
clinic
evid
infect
result
thirteen
patient
year
old
men
admit
icu
sofa
score
apach
confirm
ivi
influenza
twelv
patient
requir
invas
mechan
ventil
patient
coinfect
admiss
secondari
infect
day
coinfect
pulmonari
origin
commun
acquir
pneumonia
cap
case
relat
pneumococcu
coinfect
isol
relat
ventilatorassoci
pneumonia
vap
staphylococcu
aureu
n
staphylococcu
epidermidi
n
aspergillu
fumigatu
n
four
patient
die
document
coinfect
cap
n
vap
n
patient
show
tlymphopenia
admiss
persist
day
g
l
g
l
figur
activ
monocyt
also
low
admiss
trend
toward
decreas
g
l
g
l
figur
concomitantli
number
myeloid
deriv
suppress
cell
increas
time
hladr
monocyt
g
l
g
l
immatur
granulocyt
g
l
g
l
figur
c
conclus
patient
admit
icu
ivi
immunosuppress
profil
character
decreas
matur
activ
cell
subset
concurr
increas
immatur
suppress
one
immunosuppress
last
first
week
icu
stay
could
explain
increas
risk
secondari
infect
relat
worst
prognosi
annal
intens
care
suppl
introduct
pneumonia
frequent
communityacquir
infect
respons
icu
admiss
multiplex
pcr
enabl
earli
diagnosi
viral
infect
daili
practic
seri
describ
sinc
techniqu
made
avail
routin
object
assess
preval
distribut
virus
among
icu
patient
cap
relationship
sever
outcom
patient
method
retrospect
analysi
consecut
viral
multiplex
pcr
genmark
dx
novemb
octob
french
bed
medic
icu
admit
around
patient
per
year
patient
nasopharynx
sampl
within
h
follow
icu
admiss
select
patient
diagnosi
cap
split
group
accord
causal
agent
none
virus
bacteria
combin
comparison
made
nonparametr
kruskallw
fischer
exact
test
result
patient
sampl
cap
aspir
opportunist
pneumonia
nonpulmonari
infect
pulmonari
edema
exacerb
chronic
lung
diseas
diagnos
patient
cap
follow
characterist
age
male
sex
sap
score
icu
length
stay
lo
mortal
infecti
agent
found
viru
bacteria
viru
bacteria
main
bacteria
pneumonia
h
influenza
main
virus
rhinoviru
enteroviru
influenza
parainfluenza
frequent
virusbacteria
associ
pneumonia
influenza
pneumonia
rhinoviru
enteroviru
sap
score
higher
mix
group
p
iculo
agent
viru
bacteria
mix
day
respect
p
mortal
similar
among
group
conclus
icu
popul
respiratori
virus
present
cap
patient
mix
infect
higher
sever
admiss
longer
iculo
annal
intens
care
suppl
introduct
invas
fungal
infect
remain
associ
high
mortal
rate
among
patient
hematolog
malign
recent
medic
advanc
antifung
prophylaxi
diagnost
criteria
treatment
invas
pulmonari
aspergillosi
ipa
report
sought
assess
whether
advanc
translat
chang
surviv
patient
acut
respiratori
failur
ipa
patient
method
retrospect
multicent
studi
perform
four
center
adult
patient
hematolog
malign
proven
probabl
ipa
acut
respiratori
failur
requir
icu
januari
decemb
includ
result
report
n
median
iqr
cox
regress
model
use
identifi
variabl
independ
associ
month
surviv
result
overal
patient
includ
male
gender
median
age
iqr
acut
myeloid
leukemia
nonhodgkin
lymphoma
frequent
malign
patient
neutropen
studi
inclus
allogen
stem
cell
recipi
includ
suffer
graftversushost
diseas
receiv
antifung
prophylaxi
median
sofa
score
admiss
median
time
introduct
invas
mechan
ventil
day
patient
posit
serum
galactomannan
posit
cultur
icu
mortal
remain
unchang
studi
period
respect
figur
need
invas
mechan
ventil
admiss
follow
failur
noninvas
techniqu
associ
high
mortal
rate
figur
use
voriconazol
hr
focal
radiolog
pulmonari
infiltr
hr
independ
associ
better
surviv
multivari
analysi
adjust
sofa
score
hr
conclus
ipa
still
mostli
affect
patient
neutropenia
bmt
recipi
case
fatal
remain
high
sustain
time
voriconazol
treatment
focal
infiltr
compar
diffus
infiltr
associ
better
surviv
strategi
improv
surviv
highrisk
patient
warrant
annal
intens
care
suppl
introduct
overal
prognosi
critic
ill
patient
thought
improv
last
decad
howev
assumpt
base
upon
unadjust
find
studi
aim
studi
assess
influenc
icu
admiss
year
outcom
criticallyil
cancer
patient
popul
secondari
object
assess
chang
prognosi
prespecifi
subgroup
patient
independ
risk
factor
mortal
patient
method
studi
result
systemat
review
metaanalysi
individu
data
perform
accord
prisma
statement
publicdomain
databas
pubm
cochran
search
use
predefin
keyword
research
restrict
articl
publish
english
studi
focus
critic
ill
adult
patient
may
may
studi
protocol
regist
prospero
databas
select
manuscript
author
contact
individu
data
includ
analysi
result
report
n
median
iqr
adjust
mortal
assess
use
mix
logist
regress
model
take
year
icu
admiss
fix
random
effect
studi
random
effect
result
overal
patient
includ
studi
includ
patient
neutropenia
icu
admiss
median
age
year
iqr
median
sapsii
score
icu
admiss
iqr
mechan
ventil
vasopressor
renal
replac
therapi
requir
n
n
n
includ
patient
median
icu
admiss
year
iqr
rang
hospit
mortal
overal
popul
icu
admiss
year
associ
progress
decreas
hospit
mortal
per
year
ci
adjust
confound
year
icu
admiss
independ
associ
hospit
mortal
hospit
mortal
per
year
ci
find
confirm
subgroup
except
patient
allogen
stem
cell
transplant
per
year
trend
ci
conclus
result
confirm
hospit
mortal
critic
ill
cancer
patient
steadili
decreas
time
adjust
patient
characterist
patient
sever
cluster
effect
find
confirm
predefin
subgroup
except
allogen
stem
cell
transplant
recipi
refer
shimabukurovornhagen
cacanc
icm
annal
intens
care
suppl
introduct
mortal
cancer
patient
remain
high
last
year
new
treatment
target
therapi
improv
outcom
patient
solid
tumor
howev
new
therapi
associ
complic
lead
icu
admiss
incid
sever
advers
event
current
unknown
aim
observ
studi
describ
sever
advers
effect
target
therapi
patient
method
conduct
observ
multicentr
studi
intern
center
belong
research
group
critic
ill
adult
patient
admit
reason
januari
decemb
treat
solid
tumor
target
therapi
prior
icu
admiss
includ
result
patient
age
year
includ
non
smoker
patient
underli
cancer
gastointestin
tract
n
breast
n
kidney
n
lung
n
melanoma
n
patient
metastasi
patient
ps
patient
treat
antiegfr
patient
antivegf
antibraf
target
therapi
start
day
icu
admiss
icu
admiss
median
sofa
score
symptom
icu
admiss
respiratori
failur
n
infecti
diseas
n
cardiac
failur
n
metabol
disord
n
patient
icu
admiss
directli
relat
target
therapi
sideeffect
relat
target
therapi
anaphylaxia
n
cardiac
failur
n
bleed
n
periton
n
metabol
disord
n
lung
injuri
n
encephalopathi
n
sir
without
etiolog
n
die
icu
stay
patient
digest
cancer
treat
antivegf
periton
patient
cardiogen
failur
patient
diagnosi
mostli
acut
respiratori
failur
relat
tumor
progress
pneumonia
n
infecti
diseas
n
cardiac
failur
n
patient
discharg
aliv
icu
median
icu
stay
durat
day
month
surviv
rate
n
conclus
preliminari
studi
ic
icu
admiss
relat
sever
advers
event
target
therapi
intensivist
awar
complic
particularli
anti
patient
would
treat
therapi
year
annal
intens
care
suppl
introduct
cytomegaloviru
cmv
reactiv
occur
frequent
critic
ill
associ
poor
outcom
howev
data
immunocompromis
patient
scarc
primari
object
studi
describ
characterist
outcom
criticallyil
patient
hematolog
malign
cmv
reactiv
secondari
object
includ
descript
cmv
diseas
incid
characterist
associ
whole
blood
viral
load
cmv
diseas
outcom
patient
method
retrospect
singl
center
studi
jan
adult
patient
admit
icu
underli
hematolog
malign
cmv
reactiv
includ
cmv
diseas
defin
accord
recent
guidelin
result
report
median
n
factor
associ
hospit
mortal
cmv
diseas
analyz
use
logist
regress
result
patient
includ
median
age
patient
male
underli
malign
mainli
nonhodgkin
lymphoma
n
acut
leukemia
n
myeloma
n
patient
allogen
stem
cell
transplant
sct
recipi
admiss
median
sofa
score
patient
requir
mechan
ventil
vasopressor
renal
replac
therapi
overal
hospit
mortal
n
median
cmv
load
whole
blood
log
patient
develop
cmv
diseas
includ
probabl
proven
cmv
diseas
pneumonia
enceph
retin
coliti
possibl
cmv
diseas
includ
cytopenia
hepat
pneumonia
mortal
associ
cmv
viral
load
quartil
figur
p
adjust
confound
need
vasopressor
ci
cmv
load
per
log
ci
associ
hospit
mortal
forc
one
one
model
neither
cmv
diseas
cmv
treatment
associ
outcom
sct
ci
mechan
ventil
viral
load
per
log
ci
independ
associ
cmv
diseas
conclus
critic
ill
hematolog
patient
cmv
viral
load
independ
associ
hospit
mortal
convers
neither
cmv
diseas
treatment
associ
outcom
suggest
cmv
reactiv
reflect
immunodefici
rather
caus
poor
outcom
annal
intens
care
suppl
introduct
evalu
patient
inspiratori
effort
help
optim
tailor
ventil
set
diaphragm
electr
activ
propos
valuabl
tool
assess
inspiratori
effort
requir
dedic
tool
name
nava
neural
adjust
ventilatori
assist
cathet
wide
avail
contrast
use
ultrasound
evalu
diaphragm
contractil
activ
grow
icu
howev
relationship
diaphragm
contractil
activ
ie
diaphragm
thicken
fraction
tfdi
diaphragm
electr
activ
eadi
explor
far
hypothesi
tfdi
correl
eadi
present
studi
sought
investig
correl
tfdi
eadi
sever
condit
ventilatori
assist
patient
method
patient
intub
ventil
least
h
elig
inclus
studi
previous
mechan
ventil
nava
mode
nava
cathet
left
place
ultrasound
measur
diaphragm
contractil
activ
made
synchron
measur
maxim
eadi
eadimax
consecut
randomli
assign
ventilatori
condit
nava
pressur
support
level
posit
end
exipartori
pressur
peep
cm
zero
peep
cm
pressur
support
overal
correl
eadimax
tfdi
assess
use
spearman
correl
coeffici
also
sought
determin
correl
eadimax
tfdi
condit
result
twenti
patient
year
old
enrol
studi
median
iqr
period
mechan
ventil
day
overal
correl
tfdi
eadimax
r
p
shown
figur
spearman
correl
coeffici
decreas
level
ventilatori
assist
increas
p
zero
peep
cm
pressur
support
p
p
p
p
level
pressur
support
peep
p
nava
conclus
moder
correl
diaphragm
thicken
fraction
diaphragm
electr
activ
find
suggest
diaphragm
thicken
fraction
behav
relev
surrog
patient
inspiratori
effort
determin
correl
deserv
studi
annal
intens
care
suppl
introduct
esophag
pressur
comput
transpulmonari
pressur
tpp
appeal
techniqu
individu
peep
ard
tpp
comput
differ
airway
esophag
pressur
absolut
measur
plab
product
airway
pressur
ratio
lung
respiratori
system
elast
elastancederiv
measur
plel
aim
studi
evalu
relationship
tpp
measur
comput
tomographi
ct
experiment
model
ard
patient
method
ard
perform
salin
lavag
piglet
recruit
maneuv
perform
follow
mechan
ventil
vt
ml
kg
bodi
weight
peep
set
decreas
piglet
random
peep
group
base
best
complianc
peep
trial
best
endexpiratori
lung
volum
peep
trial
tabl
final
level
vt
rang
ml
kg
appli
optim
peep
tpp
measur
ct
perform
endexpir
endinspir
ard
onset
peep
trial
h
set
optim
peep
variabl
vt
trial
result
plab
rang
plel
rang
plab
plel
significantli
correl
p
bia
plel
plab
amount
limit
agreement
rang
noninfl
compart
significantli
increas
decil
endexpiratori
plab
plel
respect
cf
figur
tabl
provid
diagnost
perform
endexpiratori
plab
plel
detect
noninfl
compart
total
lung
volum
overinfl
compart
significantli
increas
decil
endinspiratori
plab
plel
respect
roc
curv
identifi
endinspiratori
plab
endinspiratori
plel
best
threshold
identifi
overinfl
compart
greater
total
lung
volum
conclus
tpp
measur
techniqu
similar
diagnost
perform
identifi
near
complet
alveolar
recruit
endexpir
hyperinfl
endinspir
near
complet
alveolar
recruit
may
achiev
plab
plel
greater
respect
annal
intens
care
suppl
introduct
prone
posit
pp
venoven
extracorpor
membran
oxygen
ecmo
feasibl
rel
effect
never
thoroughli
describ
object
describ
electr
imped
tomographi
eit
impact
pp
region
ventil
optim
peep
level
deriv
eit
baselin
predict
factor
identifi
pp
respond
ecmo
patient
method
ecmosupport
sever
ard
patient
ventil
pressurecontrol
mode
drive
pressur
eitbas
optim
peep
includ
hpp
session
eit
base
distribut
variat
tidal
imped
centr
graviti
index
endexpiratori
lung
imped
eeli
static
complianc
collect
pp
respond
identifi
patient
increas
static
complianc
ml
h
prone
result
thirteen
studiedpati
consid
pp
respond
ecmo
pp
respond
greater
bodi
mass
index
frequent
viral
pneumonia
shorter
ecmo
durat
compar
pp
nonrespond
p
group
tidal
volum
eeli
redistribut
ventral
dorsal
region
pp
howev
optim
peep
significantli
lower
pp
supin
posit
vs
pp
respond
pp
nonrespond
respect
figur
lastli
baselin
center
graviti
index
lower
pp
respond
p
conclus
eit
allow
monitor
pp
impact
ventil
seem
relev
tool
identifi
patient
like
respond
pp
ecmo
annal
intens
care
suppl
introduct
even
patient
success
pass
ventil
liber
trial
period
extub
risk
complic
present
studi
investig
whether
assess
respiratori
muscl
contract
within
h
extub
could
predict
extub
failur
acut
respiratori
failur
reintub
death
period
follow
extub
patient
method
patient
two
intens
care
unit
intub
sinc
least
h
success
pass
ventil
liber
trial
enrol
studi
within
two
hour
follow
extub
right
hemidiaphragm
tfdi
right
upper
intercost
muscl
thicken
fraction
tfci
obtain
ultrasound
tfdi
tfic
compar
patient
without
extub
failur
unpair
test
receiv
oper
characterist
roc
curv
construct
predict
risk
extub
failur
indic
result
patient
particip
studi
extub
failur
respect
patient
without
extub
failur
tfdi
p
tfic
p
auc
roc
curv
tfdi
tfic
respect
p
valu
tfdi
lower
predict
extub
failur
sensit
specif
valu
tfic
greater
predict
extub
failur
sensit
specif
eventu
tfdi
tfic
ratio
patient
without
extub
failur
respect
p
auc
roc
curv
tfdi
tfic
provid
sensit
specif
predict
extub
failur
cutoff
conclus
assess
respiratori
muscl
contract
within
two
hour
extub
could
use
identifi
patient
risk
extub
failur
potenti
interest
cutoff
could
use
time
consid
prevent
post
extub
ventil
strategi
annal
intens
care
suppl
introduct
current
guidelin
recommend
combin
antibiot
therapi
patient
septic
shock
howev
support
evid
scarc
aim
studi
address
impact
aminoglycosid
combin
therapi
mortal
septic
shock
patient
method
monocent
retrospect
studi
adult
patient
diagnos
septic
shock
within
first
h
includ
septic
shock
defin
microbiolog
proven
clinic
suspect
infect
associ
acut
circulatori
failur
requir
vasopressor
empir
combin
therapi
defin
addit
aminoglycosid
within
h
diagnosi
septic
shock
propens
score
aminoglycosid
administr
built
use
day
demograph
clinic
characterist
determin
mortal
assess
use
propensityadjust
cox
proport
hazard
compet
risk
analysi
result
studi
period
patient
admit
septic
shock
among
male
median
age
year
old
crude
inicu
mortal
rate
antibiot
regimen
base
beta
lactam
therapi
almost
patient
combin
aminoglycosid
patient
firstlin
aminoglycosid
distribut
amikacin
gentamicin
tobramycin
patient
receiv
aminoglycosid
combin
therapi
frequent
immunocompromis
vs
p
posit
blood
cultur
vs
p
higher
creatininemia
admiss
vs
l
p
propens
scorebas
match
patient
receiv
aminoglycosid
combin
therapi
compar
patient
treat
without
aminoglycosid
demograph
clinic
characterist
admiss
similar
two
match
group
mortal
rate
patient
treat
aminoglycosid
combin
therapi
p
univari
analysi
respect
propensityadjust
cox
proport
hazard
multivari
compet
risk
analysi
aminoglycosid
combin
therapi
associ
mortal
csh
ci
p
match
day
creatininemia
similar
group
vs
l
p
wherea
creatininemia
discharg
higher
patient
treat
aminoglycosid
combin
therapi
vs
l
p
conclus
septic
shock
patient
antibiot
combin
aminoglycosid
associ
neither
benefit
harm
annal
intens
care
suppl
introduct
time
appropri
therapi
critic
patient
gramneg
bloodstream
infect
standard
care
blood
cultur
process
oper
hour
laboratori
set
evalu
potenti
impact
realtim
process
h
day
rapid
antimicrobi
suscept
test
ast
antibiot
regimen
intens
care
unit
icu
patient
patient
method
retrospect
review
episod
gramneg
bloodstream
infect
occur
icu
hospit
st
januari
decemb
collect
data
demograph
outcom
timefram
sampl
process
test
antibiot
chang
secondli
three
scenario
simul
dataset
realtim
process
convent
techniqu
gram
stain
standard
ast
standard
process
rapid
ast
realtim
process
rapid
ast
scenario
transport
time
blood
sampl
laboratori
set
h
scenario
time
ast
result
set
h
result
includ
episod
patient
men
median
age
interquartil
rang
median
charlson
score
patient
die
icu
infect
episod
mainli
digest
cathet
relat
frequent
pathogen
e
coli
enterobact
sp
p
aeruginosa
recept
ast
led
chang
antibiot
regimen
episod
deescal
standard
care
median
timefram
blood
collect
gram
stain
h
gram
stain
ast
h
median
timefram
complet
process
blood
sampl
collect
result
definit
ast
h
standard
care
h
scenario
h
scenario
h
scenario
whole
sampl
scenario
potenti
prompt
antibiot
chang
pathogendirect
therapi
averag
h
respect
conclus
realtim
process
rapid
ast
blood
cultur
high
potenti
decreas
time
antibiot
chang
sever
gramneg
bloodstream
infect
effect
must
balanc
cost
diagnost
kit
aroundtheclock
staf
expens
annal
intens
care
suppl
introduct
betalactam
antibiot
effect
timedepend
requir
plasmat
concentr
constantli
minim
inhibit
concentr
mic
target
bacteri
strain
dose
recommend
pharmaceut
compani
base
data
deriv
patient
non
sever
diseas
may
appropri
icu
patient
sepsi
due
variabl
alter
elimin
volum
distribut
object
assess
preval
insuffici
plasma
concentr
betalactam
antibiot
icu
septic
patient
treat
usual
dose
frequenc
patient
method
retrospect
analysi
therapeut
drug
monitor
mass
spectrometri
decemb
novemb
molecul
select
assess
perform
h
iv
administr
amoxicillin
amx
h
cloxacillin
clo
h
piperacillin
pip
h
meropinem
mem
h
cefepim
fep
h
ceftriaxon
cro
eucast
inferior
breakpoint
use
molecul
approach
usual
mic
result
sampl
assess
residu
concentr
amx
clo
pip
mem
fep
cro
patient
age
sap
weight
kg
bodi
mass
index
shock
renal
replac
therapi
lo
icu
day
mortal
plasma
concentr
eucast
inferior
breakpoint
amx
clo
pip
mem
fep
cro
except
mem
cro
plasma
concentr
poorli
correl
time
infus
sampl
patient
insuffici
concentr
younger
versu
p
longer
icu
stay
dosag
vs
day
p
similar
icu
length
stay
dosag
vs
day
p
sex
ratio
sap
score
weight
bmi
shock
rrt
use
mortal
conclus
icu
popul
usual
dose
frequenc
betalactam
antibiot
led
insuffici
plasma
level
concentr
case
particularli
antibiot
short
halfliv
younger
patient
insuffici
concentr
frequent
observ
late
icu
antibiot
treatment
annal
intens
care
suppl
introduct
earli
appropri
antibiot
therapi
reduc
morbid
mortal
sever
hospitalacquir
pneumonia
hap
ventilatorassoci
pneumonia
vap
howev
emerg
bacteri
resist
requir
earli
use
antibiot
narrowest
possibl
spectrumth
unyvero
hospit
pneumonia
hpn
cureti
test
multiplex
pcr
detect
bacteria
resist
gene
respiratori
sampl
within
h
assess
perform
impact
unyvero
hpn
test
icu
patient
patient
method
prospect
singlecent
studi
conduct
icu
perform
unyvero
hpn
test
bronchoalveolar
lavag
bal
plug
telescop
cathet
ptc
sampl
patient
suspect
vap
hap
gramneg
bacilli
cluster
gramposit
cocci
gram
stain
evalu
perform
sensit
specif
test
compar
convent
cultur
method
potenti
impact
choic
antibiot
therapi
result
analyz
sampl
bal
ptc
patient
male
median
age
year
total
bacteria
detect
unyvero
test
sensit
ci
specif
ci
perform
test
shown
tabl
pseudomona
aeruginosa
frequent
isol
pathogen
n
sensit
specif
respect
two
case
relaps
pneumonia
observ
bacteria
detect
unyvero
test
initi
found
convent
cultur
extendedspectrum
betalactamas
esbl
carbapenemas
ndm
detect
unyvero
test
clinic
evalu
episod
pneumonia
show
unyvero
test
would
led
therapeut
chang
correspond
antibiot
therapi
initi
modif
antibiot
treatment
includ
deescal
adequ
improv
antibiot
therapi
less
adapt
therapi
conclus
unyvero
hpn
test
good
perform
use
could
lead
chang
antibiot
therapi
mainli
favor
patient
limit
select
pressur
reduc
antibiot
spectrum
earli
annal
intens
care
suppl
introduct
rhabdomyolysi
common
patholog
intens
care
unit
icu
often
associ
acut
kidney
injuri
aki
high
mortal
rate
date
clinic
cours
prognost
factor
medic
rhabdomyolysi
icu
poorli
document
aim
studi
describ
characterist
evolut
criticallyil
patient
medic
rhabdomyolysi
identifi
prognost
factor
associ
short
longterm
outcom
patient
method
retrospect
studi
conduct
januari
decemb
three
medic
icu
lyon
franc
adult
patient
hospit
sever
medic
rhabdomyolysi
creatin
kinas
ck
iu
l
includ
demograph
featur
comorbid
charlson
score
clinic
laboratori
data
includ
aki
accord
kdigo
classif
organ
failur
support
outcom
oneyear
mortal
collect
result
total
patient
includ
mean
age
year
sex
ratio
common
caus
rhabdomyolysi
immobil
n
sepsi
n
admiss
sofa
score
mean
ck
level
reach
iu
l
icu
stay
patient
develop
aki
requir
renal
replac
therapi
icu
oneyear
mortal
respect
initi
ck
level
significantli
differ
patient
aliv
iu
l
dead
iu
l
day
p
multivari
analysi
charlson
score
organ
failur
cardiovascular
respiratori
neurolog
found
independ
associ
mortal
p
age
charlson
score
highest
sofa
score
icu
stay
independ
factor
associ
oneyear
mortal
p
conclus
result
emphas
poor
outcom
criticallyil
patient
sever
medic
rhabdomyolysi
popul
comorbid
organ
failur
initi
ck
level
appear
major
determin
short
longterm
prognosi
annal
intens
care
suppl
introduct
outofhospit
cardiac
arrest
ohca
geograph
dispar
outcom
may
reflect
baselin
variat
patient
characterist
may
also
result
differ
number
ambul
provid
basic
life
support
bl
advanc
life
support
al
aim
assess
influenc
alloc
ambul
resourc
outcom
ohca
patient
larg
urban
commun
patient
method
may
januari
analyz
prospect
collect
utstein
databas
ohca
adult
case
geocod
accord
neighborhood
number
bl
firefight
perform
cardiopulmonari
resuscit
appli
autom
extern
defibril
al
ambul
medic
team
provid
advanc
care
drug
endotrach
intub
collect
assess
respect
influenc
utstein
paramet
socioeconom
characterist
ambul
resourc
neighborhood
use
mixedeffect
model
success
return
spontan
circul
rosc
primari
endpoint
surviv
hospit
discharg
secondari
endpoint
result
studi
period
nontraumat
ohca
occur
greater
pari
area
overal
rosc
rate
surviv
rate
hospit
discharg
rang
respect
accord
neighborhood
p
patient
sociodemograph
characterist
significantli
differ
neighborhood
p
trend
adjust
higher
densiti
ambul
associ
success
rosc
respect
aor
p
al
ambul
per
neighborhood
aor
p
bl
ambul
per
neighborhood
regard
surviv
discharg
number
al
ambul
per
neighborhood
signific
aor
p
conclus
larg
urban
populationbas
studi
outofhospit
cardiac
arrest
patient
observ
alloc
resourc
emerg
medic
servic
em
associ
outcom
suggest
improv
healthcar
organ
may
attenu
dispar
prognosi
annal
intens
care
suppl
introduct
infecti
diseas
repres
frequent
caus
consult
emerg
depart
ed
biomark
may
help
clinician
diagnos
infect
caus
sever
eosinopenia
may
reflect
level
system
inflamm
aim
studi
evalu
sever
eosinopenia
defin
valu
g
l
marker
infect
patient
method
patient
admit
ed
least
one
complet
blood
count
includ
biomark
infect
evalu
multivari
logist
regress
result
among
patient
screen
patient
final
includ
infect
sever
eosinopenia
present
infect
patient
noninfect
patient
p
sever
eosinopenia
modest
accuraci
diagnosi
infect
sensit
specif
posit
predict
valu
neg
predict
valu
posit
likelihood
ratio
likelihood
ratio
accuraci
lower
biomark
creactiv
protein
fibrinogen
procalcitonin
neutrophil
leukocytosi
mutivari
analysi
sever
eosinopenia
independ
factor
infect
adjust
odd
ratio
confid
interv
lower
biomark
conclus
sever
eosinopenia
reflect
system
inflamm
independ
factor
associ
infect
better
usual
biomark
annal
intens
care
suppl
introduct
assess
quick
sequenti
organ
failur
assess
qsofa
score
predictor
inhospit
mortal
prolong
icu
stay
emerg
depart
ed
patient
suspect
infect
patient
method
measur
qsofa
cohort
ed
patient
suspect
infect
primari
outcom
inhospit
mortal
icu
stay
day
result
qsofa
score
posit
patient
inhospit
mortal
inhospit
mortal
icu
stay
day
respect
qsofa
posit
patient
vs
qsofa
neg
patient
p
predict
inhospit
mortal
posit
qsofa
posit
predict
valu
ppv
ci
neg
predict
valu
npv
ci
predict
inhospit
mortal
icu
stay
day
ppv
npv
posit
qsofa
ci
ci
respect
conclus
among
ed
patient
suspect
infect
posit
qsofa
identifi
much
greater
risk
mortal
longer
icu
stay
annal
intens
care
suppl
introduct
use
spectrum
studi
aim
evalu
whether
hypoxemia
icu
among
obes
patient
differ
caus
manag
compar
nonobes
patient
patient
method
subgroup
analysi
prevalencepointday
conduct
frenchspeak
icu
aim
report
pattern
outcom
hypoxem
patient
defin
p
f
mmhg
obes
defin
bodi
mass
index
bmi
kg
result
among
patient
hospit
icu
day
studi
bmi
data
obes
hypoxem
compar
nonobes
patient
p
exhibit
frequent
obesityhypoventil
syndrom
versu
p
sleep
apnea
versu
p
less
frequent
nonobstruct
chronic
respiratori
diseas
versu
p
interstiti
pulmonari
diseas
versu
p
frequent
home
noninvas
ventil
niv
versu
p
hypoxemia
mild
moder
sever
similar
nonobes
patient
ard
criteria
fulfil
versu
nonobes
patient
requir
high
flow
oxygen
niv
invas
ventil
respect
case
differ
nonobes
patient
peep
higher
iqr
versu
iqr
p
tidal
volum
intub
patient
ml
kg
iqr
obes
patient
versu
p
plateau
pressur
differ
group
versu
cm
well
ph
diagnosi
atelectasi
frequent
group
versu
differ
use
prone
posit
versu
p
icu
mortal
obes
patient
versu
p
multivari
cox
model
confirm
neg
independ
associ
obes
icu
mortal
conclus
obes
patient
repres
patient
hospit
icu
day
studi
hypoxemia
seem
frequent
obes
patient
respiratori
support
hypoxemia
sever
similar
obes
nonobes
patient
peep
higher
obes
patient
obes
associ
lower
mortal
annal
intens
care
suppl
introduct
immunocompromis
patient
acut
respiratori
failur
arf
mortal
remain
high
first
oxygen
strategi
noninvas
ventil
high
flow
nasal
oxygen
clearli
demonstr
accord
patient
statu
assess
assess
outcom
patient
hematolog
malign
acut
respiratori
failur
arf
accord
initi
ventil
strategi
radiolog
lesion
arf
etiolog
patient
method
patient
arf
includ
minimax
trialoh
ivnictu
studi
intub
admiss
includ
post
hoc
analysi
three
multicent
studi
extern
valid
perform
efraim
cohort
result
patient
admit
arf
includ
icu
admiss
radiolog
pattern
subnorm
n
focal
lesion
n
diffus
alveolar
lesion
n
interstiti
lesion
n
diagnosi
arf
mainli
relat
bacteri
viral
pneumonia
diagnosi
arf
found
patient
first
oxygen
strategi
standard
oxygen
n
niv
n
hfno
n
niv
hfnc
n
bilater
alveolar
pattern
p
independ
associ
mortal
adjust
niv
use
within
first
day
p
sofa
score
without
respiratori
item
icu
admiss
p
icu
admiss
p
opportunist
infect
p
identifi
caus
independ
associ
mortal
take
account
niv
use
within
first
day
p
sofa
score
without
respiratori
item
icu
admiss
p
icu
admiss
p
analys
perform
valid
cohort
confirm
result
found
initi
cohort
conclus
niv
use
opportunist
identifi
diagnosi
bilater
alveolar
radiolog
pattern
associ
mortal
take
account
sever
arf
diseas
use
sofa
score
ratio
annal
intens
care
suppl
introduct
highflow
oxygen
therapi
hfnc
shown
benefit
prognosi
patient
hypoxem
acut
respiratori
failur
arf
noninvas
ventil
niv
remain
debat
indic
evalu
effect
hfnc
alveolar
recruit
lung
volum
hypoxem
arf
compar
niv
facial
mask
fm
patient
method
prospect
crossov
physiolog
studi
conduct
elig
patient
present
hypoxem
arf
due
pneumonia
requir
hfnc
niv
accord
icu
physician
cardiogen
pulmonari
oedema
underli
respiratori
diseas
exclud
patient
investig
germani
devic
underw
min
period
hfnc
niv
random
order
interspers
min
period
fm
use
refer
primari
endpoint
comparison
global
region
endexpiratori
electr
lung
imped
eeli
niv
hfnc
secondari
endpoint
comparison
techniqu
lung
volum
global
region
tidal
variat
tv
respiratori
paramet
hemodynam
toler
dyspnea
comfort
result
niv
hfnc
significantli
increas
global
eeli
compar
fm
vs
p
vs
p
respect
global
eeli
differ
found
niv
hfnc
vs
p
fig
global
region
tv
increas
niv
compar
hfnc
p
fm
p
hfnc
modifi
tv
fm
niv
significantli
improv
ratio
compar
hfnc
p
fig
hfnc
significantli
reduc
respiratori
rate
vs
fm
p
niv
differ
found
dyspnea
score
techniqu
patient
comfort
similar
hfnc
fm
decreas
niv
conclus
studi
demonstr
similar
benefit
hfnc
niv
alveolar
recruit
set
use
compar
fm
contrast
hfnc
despit
better
oxygen
niv
also
increas
lung
volum
may
contribut
potenti
deleteri
effect
hypoxem
arf
lead
recent
concept
patient
self
inflict
lung
injuri
psili
brochard
l
et
al
ajrccm
annal
intens
care
suppl
introduct
data
concern
respiratori
mechan
intub
patient
separ
analyz
lung
chest
wall
scare
studi
aim
describ
respiratori
mechan
respiratori
system
complianc
cr
lung
complianc
cl
chest
wall
complianc
ccw
endexpiratori
lung
volum
eelv
intub
patient
admit
intens
care
unit
icu
patient
method
interim
analysi
prospect
singlecent
studi
patient
admit
icu
intub
paralyz
part
routin
care
without
contraind
esophag
pressur
measur
includ
respiratori
mechan
measur
perform
admiss
icu
standard
ventil
set
cl
ccw
measur
use
esophag
pressur
measur
nutriv
cathet
sidam
san
giacomo
roncol
itali
eelv
measur
posit
endexpiratori
pressur
use
nitrogen
washoutwashin
techniqu
crf
inview
gehealthcar
madison
wi
usa
result
present
median
iqr
correl
analyz
use
spearman
test
result
patient
includ
studi
icu
admiss
diagnos
sepsi
pulmonari
patient
pneumonia
patient
cardiac
arrest
patient
acut
cardiac
failur
patient
neurolog
disord
patient
ten
patient
met
acut
respiratori
distress
syndrom
criteria
day
respiratori
mechan
measur
distribut
cr
cl
ccw
present
figur
wide
distribut
ccw
valu
ccw
impair
defin
ccw
ml
observ
patient
clinic
histori
abdomin
hypertens
found
patient
ccw
correl
bodi
mass
index
p
r
cl
well
correl
eelv
p
r
conclus
studi
show
nonselect
popul
intub
patient
admit
icu
variou
reason
distribut
cl
ccw
wide
ccw
impair
rare
predict
patient
medic
histori
morpholog
good
correl
cl
eelv
consist
data
establish
cl
repres
aerat
lung
volum
annal
intens
care
suppl
introduct
ventilatori
acquir
pneumonia
vap
one
main
nosocomi
infect
adult
icu
one
prospect
multicent
studi
perform
six
month
picu
us
prospect
describ
pediatr
vap
design
incipav
studi
report
occurr
vap
european
picu
focus
patient
risk
factor
rf
microorgan
involv
diagnost
tool
antibiot
use
first
aim
studi
calcul
incid
vap
patient
method
multicent
prospect
cohort
studi
includ
patient
mechan
ventil
mv
least
eight
picu
one
netherland
seven
franc
vap
defin
use
cdc
criteria
appli
picu
stay
exclud
h
preceed
follow
picu
patient
describ
admiss
main
rf
ever
test
medic
litteratur
daili
includ
pediatr
intensivist
picu
electron
databas
secur
dedic
websit
ethic
committe
french
societi
intens
care
approv
studi
declar
cnil
record
clinicaltrialsorg
parent
individu
inform
dedic
sheet
descript
data
report
number
median
firstthird
quartil
incid
calcul
number
vap
day
mv
result
result
base
declar
inform
report
incipav
databas
first
open
septemb
clean
one
year
episod
mv
includ
patient
month
male
main
reason
admiss
picu
postop
care
respiratori
neurolog
circulatori
failur
score
observ
mortal
score
patient
ventil
via
uncuf
tube
case
tracheostomi
total
vap
declar
day
mv
incid
vap
day
mv
conclus
incid
vap
incipav
studi
higher
incid
report
recent
gupta
day
mv
new
analys
plan
clean
databas
includ
special
read
case
vap
annal
intens
care
suppl
introduct
pediatr
sepsi
remain
burdensom
public
health
problem
especi
patient
immunodefici
adher
surviv
sepsi
campaign
ssc
would
associ
lower
mortal
howev
correl
never
evalu
children
hematolog
malign
patient
method
retrospect
bicentr
cohort
studi
children
identifi
hematolog
malign
hematopoiet
stem
cell
transplant
requir
intens
care
sever
sepsi
januari
august
detail
descript
sepsi
resuscit
within
six
hour
diagnosi
sepsi
evalu
adher
ssc
recommand
admiss
pediatr
intens
care
unit
picu
accur
analysi
microbiolog
etiolog
assess
mortal
month
sepsi
result
patient
includ
screen
admiss
icu
receiv
oxygen
patient
show
low
blood
pressur
age
without
continu
infus
inotrop
lactic
acid
measur
patient
within
h
picu
admiss
receiv
oxygen
patient
continu
infus
inotrop
ventil
lactic
acid
central
venou
oxygen
satur
measur
obtain
one
third
patient
infecti
organ
isol
patient
common
primari
site
infect
central
venou
cathet
patient
show
fungic
infect
mortal
within
month
evalu
discuss
adher
scc
recommand
hematolog
children
sepsi
appear
inadequ
howev
mortal
lower
studi
previou
data
conclus
higher
adher
ssc
recommand
children
hematolog
malign
better
sensit
medic
nurs
staff
would
potenti
associ
much
better
prognosi
annal
intens
care
suppl
introduct
hfnc
emerg
promis
method
provid
respiratori
support
bronchiol
two
rct
evalu
hfnc
less
sever
bronchiol
admit
gener
ward
fail
demonstr
reduct
length
oxygen
therapi
proport
patient
transfer
picu
kepreot
franklin
therefor
perform
superior
trial
test
hypothesi
hfnc
could
reduc
proport
treatment
failur
requir
noninvas
ventil
among
infant
set
patient
method
inclus
first
episod
bronchiol
infant
less
monthsold
room
air
mwca
score
exclus
urgent
need
niv
mwca
lack
consent
random
standard
oxygen
therapi
l
min
control
hfnc
l
kg
min
experiment
crossov
allow
failur
criteria
nasal
flow
oxygen
min
maintain
target
increas
mwca
score
refractori
apnea
increas
primari
endpoint
proport
patient
treatment
failur
requir
noninvas
within
follow
random
secondari
endpoint
percentag
admit
icu
assess
short
term
respiratori
statu
gener
ward
unit
lo
oxygen
nutrit
support
free
day
result
month
studi
period
patient
admit
bronchiol
ped
network
screen
underw
random
intentiontotreat
analysi
tabl
hfnc
improv
primari
outcom
failur
occur
patient
hfnc
group
control
group
ic
p
hfnc
reduc
risk
admiss
icu
hfnc
group
versu
control
ic
p
patient
intub
main
reason
treatment
failur
worsen
mwca
score
mean
lo
gener
ward
unit
lower
control
group
day
versu
day
p
shortterm
assess
respiratori
statu
shown
differ
except
mwca
score
rr
favor
hfnc
three
pneumothorax
report
hfnc
group
conclus
neither
evid
lower
rate
noninvas
ventil
support
among
patient
receiv
hfnc
therapi
differ
rate
icu
admiss
annal
intens
care
suppl
introduct
acut
chest
syndrom
ac
one
frequent
sever
manifest
sickl
cell
diseas
childhood
physiopatholog
mechan
ac
complex
result
sever
abnorm
ventil
perfus
ratio
hypothesi
noninvas
ventil
niv
could
import
compon
ac
treatment
main
object
studi
describ
toler
niv
pediatr
ac
patient
method
bicentr
prospect
studi
includ
sickl
cell
patient
admit
pediatr
intens
care
unit
picu
ac
main
composit
object
describ
toler
niv
identifi
follow
four
compon
frequenc
use
ii
effect
work
breath
evalu
clinic
respiratori
score
cr
iii
circumst
niv
wean
iv
child
comfort
score
comfort
scale
occurr
complic
result
thirtyseven
children
includ
ventil
niv
hour
durat
stay
picu
day
children
discontinu
ventil
pressur
support
ps
mode
cr
drop
rapidli
p
without
chang
ratio
time
versu
p
comfort
score
without
niv
report
niv
complic
conclus
major
children
admit
picu
ac
broken
niv
ps
mode
niv
well
toler
abl
decreas
respiratori
distress
first
hour
without
modifi
oxygen
requir
annal
intens
care
suppl
introduct
contrast
neurolog
respiratori
failur
place
endotrach
intub
mechan
ventil
detail
guidelin
septic
shock
evidenc
lack
dedic
studi
object
studi
assess
associ
earli
endotrach
intub
follow
vasopressor
initi
outcom
icu
surviv
septic
shock
patient
take
account
presenc
absenc
classic
intub
criteria
ie
neurolog
respiratori
failur
patient
method
prospect
multicent
observ
studi
conduct
may
octob
icu
franc
spain
success
adult
patient
suffer
septic
shock
admit
particip
icu
consid
criteria
defin
three
group
patient
defin
priori
accord
potenti
neurolog
respiratori
motiv
intub
classic
indic
group
cig
presenc
straightforward
indic
endotrach
intub
intermedi
group
ig
presenc
moder
impair
nonclass
motiv
group
ncg
absenc
signific
impair
propens
score
construct
establish
probabl
intub
result
eight
hundr
fiftynin
patient
recruit
two
hundr
twentysix
patient
sort
cig
ig
ncg
earli
intub
perform
cig
ig
ncg
multivari
analysi
show
group
cig
ig
ncg
higher
sap
ii
earli
intub
vs
earli
intub
independ
associ
higher
icu
mortal
propens
score
construct
enter
patient
increas
risk
death
observ
throughout
rang
propens
score
earli
intub
patient
vs
earli
intub
patient
propens
score
increas
p
see
figur
multivari
analysi
delay
intub
show
impact
mortal
vs
earli
intub
p
patient
intub
vs
patient
intub
p
patient
intub
conclus
associ
earli
intub
higher
mortal
observ
multivari
model
use
propens
score
septic
shock
patient
studi
open
way
prospect
intervent
trial
annal
intens
care
suppl
introduct
patient
septic
shock
may
develop
sever
myocardi
dysfunct
refractori
medic
treatment
sever
cohort
casereport
studi
report
salvag
therapi
venoarteri
extracorpor
membran
oxygen
vaecmo
patient
aim
studi
assess
use
vaecmo
rescu
therapi
refractori
myocardi
dysfunct
associ
septic
shock
patient
method
multicent
intern
retrospect
studi
patient
ecmo
center
implant
vaecmo
rescu
therapi
refractori
septic
shock
sever
myocardi
dysfunct
cardiac
index
l
min
left
ventricular
eject
fraction
includ
control
patient
exhibit
sever
myocardi
dysfunct
period
time
receiv
ecmo
isol
larg
septic
shock
databas
includ
first
day
met
criteria
sever
myocardi
dysfunct
ecmo
nonecmo
patient
outcom
compar
match
diseas
sever
primari
end
point
mortal
day
result
mean
sd
n
shown
eightytwo
patient
rescu
vaecmo
includ
patient
exhibit
extrem
sever
myocardi
dysfunct
mean
cardiac
index
l
min
left
ventricular
eject
fraction
despit
high
dose
catecholamin
mean
inotrop
score
kg
min
also
profound
lactic
acidemia
ph
lactatemia
mmoll
sever
multipl
organ
failur
sofa
score
sapsii
score
seventyeight
could
match
nonecmo
patient
base
propens
score
diseas
sever
lactatemia
cardiac
index
sofa
score
mortal
day
dramat
reduc
match
ecmo
patient
compar
control
vs
p
sensit
analysi
patient
cardiac
index
monitor
weight
use
match
weight
ponder
inotrop
score
lactatemia
sofa
score
age
cardiac
index
inclus
mortal
day
remain
significantli
reduc
weight
ecmo
patient
final
survivor
ecmo
group
report
accept
evalu
healthrel
qualiti
life
month
follow
icu
discharg
conclus
retrospect
propensitymatch
studi
rescu
therapi
vaecmo
associ
dramat
reduct
day
mortal
patient
refractori
septic
shock
sever
myocardi
dysfunct
annal
intens
care
suppl
introduct
fluid
expans
first
therapeut
option
patient
present
acut
circulatori
failur
hemodynam
effect
persist
time
maxim
increas
cardiac
output
unknown
sought
describ
time
cours
cardiac
output
period
fluid
expans
object
identifi
pattern
fluid
respons
determin
time
maxim
increas
cardiac
output
fluid
expans
patient
method
prospect
multicentr
observ
studi
conduct
four
intens
care
unit
includ
mechan
ventil
patient
acut
circulatori
failur
infus
norepinephrin
equip
transpulmonari
thermodilut
devic
picco
decis
fluid
expans
ml
salin
standard
period
made
calibr
achiev
two
hour
fluid
expans
transpulmonari
thermodilut
deriv
indic
collect
twohour
period
observ
fluid
respons
defin
increas
cardiac
index
start
fluid
expans
four
pattern
fluid
respons
predefin
never
respond
ultrafast
respond
end
fluid
expans
shortterm
respond
end
fluid
expans
persist
respond
observ
period
chang
drug
dosag
ventilatori
set
allow
studi
result
fiftyeight
patient
case
includ
septic
shock
main
reason
acut
circulatori
failur
pattern
fluid
respons
follow
nonrespond
ultrafast
respond
shortterm
respond
persist
respond
addit
patient
hemodynam
instabl
requir
second
fluid
expans
protocol
signific
differ
found
pattern
term
baselin
hemodynam
characterist
drug
administr
increas
cardiac
output
maxim
second
never
respond
second
ultrafast
respond
second
shortterm
respond
second
persist
respond
conclus
persist
fluid
respons
occur
minor
patient
present
acut
circulatori
failur
maxim
increas
cardiac
output
could
observ
fluid
expans
min
annal
intens
care
suppl
introduct
fluid
compos
molar
sodium
lactat
recent
identifi
benefici
endotoxin
anim
object
work
evalu
effect
molar
sodium
lactat
micro
macrocircul
capillari
leakag
differ
biolog
paramet
sepsi
rat
model
caecal
ligat
punctur
clp
patient
method
realiz
clp
rat
random
group
n
per
group
sham
clpnacl
clplactat
immedi
clp
fluid
infus
intraven
ml
kg
h
h
evalu
mesenter
microcircul
laser
speckl
imag
cardiac
function
echocardiographi
inflamm
uremia
albuminemia
vegfa
assay
capillari
leakag
use
blue
evan
extravas
lung
gut
realiz
addit
rat
n
group
result
express
median
interquartil
comparison
versu
clpnacl
realiz
use
kruskallw
anova
test
result
mesenter
microcircul
lower
clpnacl
vs
sham
vs
pixel
unit
p
clplactat
p
clpnacl
rat
present
lower
cardiac
output
vs
sham
vs
mlmin
g
p
clplactat
p
lower
left
ventricular
shorten
fraction
vs
clplactat
vs
p
differ
concern
albuminemia
left
ventricular
diastol
diamet
central
venou
pressur
e
mitral
flow
ratio
clpnacl
clplactat
suggest
compar
volemia
mean
arteri
pressur
clpnacl
clplactat
similar
end
infus
evan
blue
diffus
reduc
gut
lung
clplactat
vs
vs
ng
eb
mg
tissu
plasma
level
lactat
higher
clplactat
vs
clpnacl
vs
mmoll
p
vs
l
p
differ
plasma
pyruv
acetoacet
inflammatori
respons
reduc
clplactat
vs
pg
ml
p
vs
pg
ml
p
vs
pg
ml
well
vegaa
plasma
level
vs
pg
ml
p
differ
observ
syndecan
plasma
level
conclus
demonstr
first
time
molar
lactat
fluid
perfus
protect
clpinduc
cardiovascular
dysfunct
mesenter
microvascular
alter
capillari
leakag
associ
signific
reduct
inflammatori
process
result
suggest
molar
lactat
fluid
perfus
may
attract
target
treatment
sepsi
annal
intens
care
suppl
introduct
pneumocysti
jiroveci
pneumonia
pcp
one
main
opportunist
complic
patient
infect
human
immunodefici
viru
hiv
also
affect
nonhivinfect
patient
mortal
rate
describ
popul
hivneg
patient
hospit
intens
care
unit
icu
pcp
patient
method
french
multicent
retrospect
studi
perform
icu
arco
associ
de
du
centr
ouest
januari
decemb
discuss
patient
includ
mean
age
year
main
underli
diseas
hematolog
diseas
case
patient
receiv
chemotherapeut
treatment
steroid
patient
undergo
steroid
potenti
elig
pcp
prophylaxi
receiv
patient
dyspnea
main
symptom
biolog
inflammatori
syndrom
present
case
chest
ct
reveal
interstiti
lung
diseas
patient
diagnosi
made
bronchial
fibroscopi
bronchoalveolar
lavag
bal
case
noninvas
method
specif
sputum
pcr
b
glucan
assay
case
mean
diagnost
delay
admiss
day
subject
mechan
ventil
averag
durat
day
patient
develop
septic
shock
vasopressor
support
averag
durat
day
patient
acut
renal
failur
accord
kdigocriteria
averag
length
stay
icu
day
patient
treat
possibl
pcp
upon
admiss
averag
treatment
time
patient
day
receiv
cur
treatment
cotrimoxazol
develop
side
effect
steroid
associ
antiinfect
treatment
patient
impact
evolut
mortal
rate
icu
conclus
pcp
increasingli
infect
immunosuppress
non
hiv
infect
patient
studi
confirm
sever
patholog
main
popul
risk
pcp
mention
case
pulmonari
involv
atrisk
patient
probabilist
treatment
implement
quickli
interest
adjuv
steroid
treatment
remain
demonstr
recommend
prophylact
treatment
wide
distribut
probabl
refin
author
conflict
interest
annal
intens
care
suppl
introduct
candidemia
major
threat
patient
cancer
studi
sought
identifi
outcom
critic
ill
immunocompromis
patient
candidemia
secondari
object
describ
clinic
phenotyp
patient
intens
care
unit
icu
featur
candida
ecolog
factor
associ
hospit
mortal
patient
method
adult
critic
ill
immunocompromis
patient
candidemia
retrospect
includ
icu
immun
defect
defin
underli
solid
tumor
hematolog
malign
autoimmun
diseas
result
overal
among
patient
admit
icu
period
develop
candidemia
underli
immun
defect
ultim
includ
two
third
patient
hematolog
malign
chiefli
nonhodgkin
lymphoma
acut
leukemia
respect
includ
patient
underw
autolog
allogen
stem
cell
transplant
patient
one
risk
factor
candidemia
icu
stay
patient
need
invas
mechan
ventil
patient
need
renal
replac
therapi
patient
need
vasopressor
one
five
patient
consid
emerg
surgeri
patient
candida
albican
predomin
speci
follow
glabrata
tropicali
parapsilosi
krusei
one
third
identifi
candida
resist
fluconazol
echinocandin
icu
mortal
hospit
mortal
candida
speci
suscept
associ
outcom
figur
median
time
featur
candidemia
onset
first
antifung
therapi
day
adjust
confound
need
vasopressor
hr
need
mechan
ventil
hr
allogen
stem
cell
transplant
hr
independ
associ
hospit
mortal
half
patient
develop
candidemia
h
icu
admiss
admit
icu
sever
candidemia
differ
clinic
candida
featur
outcom
two
kind
patient
conclus
candidemia
critic
ill
immunocompromis
patient
associ
high
mortal
rate
despit
high
preval
nonalbican
candida
sever
preexist
allogen
stem
cell
transplant
independ
associ
poor
outcom
last
antifung
therapi
prove
start
late
regard
symptom
develop
strategi
reduc
delay
warrant
annal
intens
care
suppl
introduct
invas
candidiasi
ic
associ
high
incid
mortal
intens
care
unit
icu
delay
antifung
therapi
ic
contribut
poor
outcom
icu
none
predict
publish
risk
score
abl
accur
predict
ic
therefor
new
score
introduc
previou
antiinfect
therapi
elaps
time
admiss
risk
evalu
differenti
candidemia
invas
candidiasi
develop
patient
method
retrospect
analysi
data
outcomerea
prospect
multicent
cohort
critic
ill
patient
icu
length
stay
least
day
includ
multivari
subdistribut
surviv
model
compet
risk
use
day
day
day
use
landmark
method
slide
window
horizon
day
impact
everi
identifi
risk
analys
candidemia
invas
viscer
candidiasi
ivc
candida
periton
pleural
candidiasi
separ
compet
risk
icudeath
icudischarg
predict
probabl
infect
next
day
calcul
day
base
cumul
incid
function
everi
combin
risk
result
patient
includ
candidemia
occur
patient
ivc
patient
antifung
therapi
use
patient
multivari
analysi
risk
factor
candidemia
ivc
identifi
figur
confirm
impact
previous
describ
risk
factor
ie
septic
shock
multifoc
colon
sofa
score
hospit
stay
icu
parenter
nutrit
corticosteroid
blood
transfus
mechan
ventil
surgeri
risk
differ
associ
candidemia
ivc
variabl
corticosteroid
therapi
blood
transfus
mechan
ventil
associ
candidemia
risk
time
depend
impact
earli
state
landmark
time
late
onset
landmark
time
day
antibiotherapi
broad
spectrum
piperacillintazobactam
number
ppi
day
use
medic
histori
cancer
associ
ivc
landmark
time
predict
model
found
maximum
predict
probabl
landmark
respect
candidemia
ivc
shini
app
develop
comput
predict
risk
candidemia
ivc
depend
risk
factor
combin
conclus
risk
factor
candida
infect
differ
candidemia
ivc
must
analys
distinct
diseas
moreov
risk
highli
timerel
earli
late
pattern
icu
stay
annal
intens
care
suppl
introduct
zygomycosi
invas
fungal
infect
increas
incid
especi
patient
hematolog
malign
prognosi
poor
high
invas
power
lead
fungal
dissemin
tissular
necrosi
studi
aim
describ
patient
zygomycosi
admit
intens
care
unit
icu
aim
describ
epidemiolog
zygomycosi
french
icu
evalu
outcom
patient
method
perform
retrospect
multicent
studi
french
icu
universitari
hospit
gener
hospit
period
patient
diagnos
probabl
proven
zygomycosi
report
demograph
baselin
evolut
clinic
data
compar
patient
surviv
icu
patient
patient
patient
univari
multivari
analys
identifi
factor
associ
icu
surviv
also
focu
subgroup
patient
hematolog
malign
result
sixti
patient
admit
icu
zygomycosi
deepli
mildli
immunocompromis
hematolog
malign
solid
malign
solid
organ
transplant
recipi
inflammatori
diseas
longterm
steroid
diabet
malnutrit
among
patient
patient
surviv
icu
stay
median
surviv
day
univari
multivari
analys
survivor
significantli
younger
p
hematolog
malign
less
frequent
p
well
malnutrit
p
trauma
associ
better
surviv
p
univari
analysi
patient
dissemin
infect
noncontigu
infect
organ
die
icu
p
regard
patient
hematolog
malign
median
surviv
n
day
day
wors
day
whole
cohort
multivari
analysi
surgeri
factor
associ
surviv
p
longterm
surviv
observ
subgroup
patient
without
surgic
manag
logrank
p
figur
associ
two
antifung
treatment
demonstr
benefit
surviv
p
conclus
overal
prognosi
zygomycosi
icu
remain
poor
especi
patient
hematolog
malign
despit
increas
frailti
aggress
manag
includ
earli
surgeri
factor
improv
surviv
icu
popul
annal
intens
care
suppl
introduct
adult
onset
still
diseas
aosd
rare
complex
autoinflammatori
disord
sever
system
lifethreaten
manifest
empir
treatment
object
describ
clinic
featur
manag
outcom
aosd
patient
requir
intens
care
support
patient
method
undertook
retrospect
multicent
cohort
studi
french
academ
icu
januari
june
includ
case
icu
admiss
relat
lifethreaten
aosd
patient
older
year
consid
inclus
met
follow
criteria
admiss
icu
relat
system
aosd
flare
accord
yamaguchi
fautrel
criteria
studi
methodolog
data
privaci
polici
french
methodolog
refer
approv
institut
ethic
committe
applic
regist
clinicaltrialsgov
result
fortyf
patient
includ
median
age
quartil
year
men
affect
women
first
aosd
flare
popul
median
sap
ii
cardiocirculatori
shock
pericard
respiratori
acut
respiratori
distress
syndrom
hematolog
reactiv
hemophagocyt
syndrom
disord
frequent
lifethreaten
manifest
multipl
organ
failur
frequent
associ
bad
prognosi
present
admiss
p
nine
patient
die
median
age
year
among
previous
diagnos
aosd
versu
without
previou
diagnosi
p
comparison
survivor
nonsurvivor
icu
stay
shown
tabl
corticosteroid
cs
use
first
line
therapi
patient
efficaci
cs
monotherapi
three
patient
success
treat
anakinra
global
efficaci
four
patient
sever
organ
failur
admiss
die
despit
treatment
anakinra
introduc
sever
line
immunosuppress
agent
cyclosporin
etoposid
intraven
immunoglobulin
conclus
herein
report
largest
cohort
patient
admit
icu
lifethreaten
aosd
lead
lifethreaten
present
miscellan
present
clinic
spectrum
high
mortal
rate
among
young
peopl
previou
diagnosi
aosd
lack
specif
clinic
biolog
sign
frequent
cardiovascular
collaps
key
point
quickli
elimin
septic
diagnosi
add
immunosuppress
treatment
empir
antibiotherapi
annal
intens
care
suppl
introduct
aim
assess
characterist
outcom
associ
cost
septic
shock
complic
system
lupu
erythematosu
sle
patient
method
characterist
sle
patient
experienc
septic
shock
franc
analyz
french
nationwid
medicoadministr
databas
factor
associ
postadmiss
mortal
analyz
crude
surviv
sle
patient
experienc
septic
shock
compar
admit
anoth
reason
compar
outcom
cost
associ
sle
septic
shock
surviv
match
sle
icu
control
popul
result
among
sle
patient
experienc
septic
shock
septic
shock
sever
mean
sapsii
score
patient
invas
mechan
ventil
requir
renal
replac
therapi
mortal
rate
n
hospit
stay
mean
cost
factor
assocait
mortal
tabl
independ
sever
comorbid
acut
ill
associ
syndrom
specif
sle
phenotyp
significantli
associ
mortal
hr
within
one
year
postsept
shock
survivor
n
readmit
time
day
total
cost
unmatch
analysi
show
outcom
patient
admit
icu
septic
shock
poorer
patient
admit
icu
hospit
anoth
diseas
posticu
hospit
outcom
cost
septic
shock
survivor
differ
icu
survivor
match
sever
acut
ill
conclus
associ
syndrom
main
determin
mortal
among
sle
patient
experienc
septic
shock
although
septic
shock
turn
point
sle
histori
survivor
use
healthcar
survivor
anoth
lifethreaten
diseas
annal
intens
care
suppl
introduct
plasma
exchang
pe
often
lead
advers
effect
sepsi
result
impair
immun
caus
remov
antibodi
relat
catheterassoci
infect
repres
sever
complic
studi
evalu
infecti
risk
associ
current
use
pe
identifi
predict
factor
patient
method
major
patient
admit
tertiari
icu
receiv
pe
therapi
includ
patient
develop
secondari
infect
compar
use
univari
multivari
analysi
result
eightyeight
patient
underw
pe
procedur
patient
mechan
ventil
receiv
constrict
drug
renal
replac
therapi
indic
thrombot
thrombocytopen
purpura
neurolog
diseas
vascul
autoimmun
diseas
indic
advers
effect
perprocedur
observ
patient
witch
half
lifethreathen
peassoci
infect
occur
patient
median
time
elaps
icu
admiss
ep
initi
infect
diagnosi
respect
day
infecti
complic
includ
ventilationassoci
pneumonia
nosocomi
pneumonia
viral
reactiv
bacteremia
catheterassoci
infect
urinari
infect
sever
septic
shock
patient
patient
deceas
comparison
univari
analysi
show
patient
associ
infect
significantli
higher
age
need
frequent
mechan
ventil
vasoact
drug
number
pe
icu
inhospit
length
stay
significantli
higher
infecti
group
signific
differ
observ
infecti
infecti
group
regard
sever
score
admiss
corticoid
immunosuppress
therapi
type
substitut
liquid
pe
volum
multivari
analysi
age
p
number
session
ci
p
requir
mechan
ventil
p
predict
infect
occurr
icu
mortal
higher
infecti
group
versu
p
conclus
pe
associ
infect
particular
pneumonia
patient
lead
lifethreaten
condit
age
number
pe
session
requir
mechan
ventil
predict
occurr
infect
annal
intens
care
suppl
introduct
recent
advanc
critic
rheumat
care
may
impact
outcom
patient
system
rheumat
diseas
srd
admit
intens
care
unit
icu
aim
reassess
short
longterm
outcom
prognost
factor
srd
patient
admit
icu
patient
method
conduct
multicent
retrospect
observ
studi
seven
french
icu
srd
patient
admit
includ
inhospit
mortal
oneyear
surviv
discharg
estim
method
prognost
factor
cox
model
compar
surviv
nonsurviv
patient
univari
multivari
analysi
order
identifi
prognost
factor
inhospit
mortal
oneyear
surviv
result
patient
femal
mean
age
year
includ
predomin
srd
vasculitid
rheumatoid
arthriti
system
lupu
erythematosu
main
caus
admiss
shock
acut
respiratori
failur
predomin
diagnos
icu
infect
srd
flareup
admiss
mean
sofa
score
mean
sap
ii
patient
requir
mechan
ventil
vasoact
drug
renal
replac
therapi
extracorpor
membran
oxygen
inhospit
mortal
rate
ci
oneyear
surviv
probabl
ci
figur
prognost
factor
age
hr
ci
p
previou
corticosteroid
treatment
hr
ci
p
sofa
score
hr
ci
p
sap
ii
hr
ci
p
inhospit
mortal
besid
age
hr
ci
p
variabl
associ
oneyear
mortal
discharg
conclus
studi
show
two
third
srd
patient
admit
icu
surviv
hospit
discharg
probabl
oneyear
surviv
patient
satisfactori
surviv
rate
may
relat
recent
improv
critic
care
rheumat
care
also
found
sofa
score
sap
ii
previou
corticosteroid
treatment
predict
factor
inhospit
outcom
annal
intens
care
suppl
introduct
lung
fibroprolifer
ard
patient
associ
mortal
alveolar
procollagen
iii
ntpcpiii
biomark
lung
fibroprolifer
chest
ct
scan
could
use
diagnosi
fibroprolif
radiolog
lesion
main
object
present
studi
therefor
quantifi
chest
ct
scan
lesion
ard
patient
high
alveolar
level
ntpcpiii
indic
activ
fibroprolifer
patient
method
retrospect
cohort
studi
year
januari
includ
ard
least
one
dosag
alveolar
ntpcpiii
obtain
perform
bronchoalveolar
lavag
bal
chest
ct
scan
within
day
bal
accord
previou
studi
alveolar
level
ntpcpiii
l
indic
histolog
lung
fibroprolifer
ct
scan
score
interstiti
honeycomb
alveolar
groundglass
abnorm
crude
score
correct
score
relat
number
score
lobe
case
import
lobar
condens
use
result
one
hundr
ninetytwo
patient
includ
either
coupl
alveolar
ntpcpiii
ct
scan
use
threshold
ntpcpiii
l
crude
correct
fibrosi
score
highest
lung
fibroprolifer
present
valu
lung
fibroprolifer
ct
scan
score
accord
alveolar
ntpcpiii
level
appear
tabl
median
delay
onset
ard
ct
scan
day
onset
ard
bal
day
bal
ct
scan
day
conclus
alveolar
ntpcpiii
use
surrog
lung
fibroprolifer
ct
scan
fibrosi
score
significantli
higher
patient
activ
pulmonari
fibroprolifer
refer
forel
jm
guervilli
c
hraiech
voillet
f
thoma
g
somma
c
et
al
type
iii
procollagen
reliabl
marker
ardsassoci
lung
fibroprolifer
intens
care
med
janv
ea
martinez
fj
flint
jamadar
da
gross
bh
sp
annal
intens
care
suppl
introduct
ultraprotect
ventil
tidal
volum
vt
reduct
ml
kg
predict
bodi
weight
pbw
sever
ard
may
reduc
alveolar
strain
drive
pressur
henc
ventilatorinduc
lung
injuri
main
drawback
worsen
respiratori
acidosi
hypothes
vt
could
reduc
ml
kg
clinic
signific
decreas
drive
pressur
deltap
without
need
extracorpor
remov
maintain
ph
rang
target
recent
ard
trial
patient
method
conduct
nonexperiment
beforeandaft
multicent
studi
ard
patient
mm
hg
within
h
ard
diagnosi
inclus
vt
reduc
ml
kg
pbw
adjust
maintain
ph
respiratori
rate
increas
min
peep
set
use
tabl
favor
high
peep
strategi
appli
posit
peep
wean
trial
primari
judgment
criterion
deltap
day
compar
studi
inclus
result
patient
age
year
sap
ii
amount
patient
pneumonia
ard
risk
factor
sofa
inclus
inclus
mm
hg
peep
inclus
day
deltap
decreas
significantli
vt
decreas
ml
kg
day
studi
tabl
vt
ml
kg
patient
ml
kg
patient
time
vt
ml
kg
averag
day
sedat
drug
significantli
modifi
two
patient
develop
acut
cor
pulmonal
inclus
right
ventricl
left
ventricl
ratio
increas
nonsignificantli
day
eleven
patient
present
sever
respiratori
acidosi
ph
fourteen
patient
die
day
conclus
ultraprotect
ventil
may
appli
approxim
moder
sever
sever
ard
patient
mean
reduct
deltap
approxim
price
sever
respiratori
acidosi
patient
annal
intens
care
suppl
introduct
earli
prolong
repeat
session
prone
posit
pp
proven
substanti
outcom
benefit
ard
patient
sever
form
ard
veno
venou
extracorpor
membran
oxygen
vvecmo
consid
therapeut
option
perform
case
case
patient
treat
vvecmo
previous
turn
prone
howev
studi
evalu
interest
maintain
pp
ecmo
therefor
object
studi
compar
surviv
rate
patient
support
vvecmo
concomit
pp
prone
ecmo
group
turn
prone
ecmo
period
ecmo
alon
group
patient
method
includ
adult
treat
vvecmo
ard
januari
april
univers
teach
hospit
marseil
franc
patient
either
cannul
icu
refer
hospit
transport
ecmo
mobil
team
consid
patient
ecmo
pp
session
systemat
perform
center
feasibl
strongli
encourag
patient
referr
center
criteria
vvecmo
previous
publish
ecmo
patient
consid
prone
posit
case
persist
hypoxemia
defin
mmhg
despit
maxim
ecmo
blood
flow
failur
attempt
wean
ecmo
least
day
ecmo
presenc
lung
consolid
chest
xray
ultrasound
echographi
accord
physician
charg
technic
issu
previous
describ
compar
prone
ecmo
group
ecmo
alon
group
perform
surviv
curv
coxmodel
mortal
result
patient
includ
analysi
prone
group
ecmo
alon
group
prone
group
surviv
rate
compar
surviv
rate
ecmo
alon
group
p
hr
ci
use
ino
ecmo
hr
ci
independ
associ
increas
mortal
wherea
use
pp
ecmo
independ
associ
decreas
mortal
hr
ci
conclus
continu
pp
vvecmo
could
clinic
interest
prospect
control
studi
warrant
annal
intens
care
suppl
introduct
object
report
current
practic
regard
mechan
ventil
use
adjunct
therapi
patient
treat
extracorpor
membran
oxygen
ecmo
sever
acut
respiratori
distress
syndrom
ard
describ
major
ecmorel
complic
outcom
patient
method
intern
multicent
prospect
cohort
studi
patient
undergo
ecmo
ard
oneyear
period
conveni
sampl
intern
intens
care
unit
icu
result
collect
demograph
daili
pre
perecmo
mechan
ventil
set
use
adjunct
therapi
icu
data
patient
median
standard
deviat
age
year
preecmo
mmhg
precannul
use
prone
posit
neuromuscular
blocker
respect
tidal
volum
plateau
pressur
minut
ventil
significantli
reduc
ecmo
drive
pressur
significantli
reduc
cm
median
ecmo
durat
icu
stay
respect
day
sixmonth
surviv
multivari
analys
retain
immunodefici
older
age
extrapulmonari
sepsi
lower
preecmo
ph
higher
preecmo
respiratori
rate
greater
delay
intub
ecmo
start
higher
mean
fluid
balanc
first
ecmo
day
independ
associ
mortal
conclus
preecmo
manag
patient
sever
form
ard
high
casevolum
center
notabl
low
use
prone
posit
suggest
potenti
improv
preecmo
ard
manag
might
impact
number
case
consid
ecmo
receiv
ecmo
use
least
damag
lung
ventil
strategi
larg
adopt
annal
intens
care
suppl
introduct
potenti
benefit
extracorpor
cardiopulmonari
resuscit
ecpr
patient
refractori
cardiac
arrest
ca
remain
unsettl
patient
method
retrospect
analysi
databas
prospect
observ
cohort
ca
patient
includ
consecut
adult
patient
refer
depart
intens
care
ca
januari
decemb
decis
initi
ecpr
depend
attend
physician
initi
ecpr
team
compos
icu
physician
propens
score
deriv
use
logist
regress
model
includ
characterist
vari
group
p
other
potenti
relat
outcom
primari
outcom
surviv
icu
discharg
favor
neurolog
outcom
assess
cerebr
perform
categori
cpc
result
total
ca
patient
admit
studi
period
ecpr
n
patient
ecpr
match
patient
underw
ccpr
median
age
ca
time
arrest
termin
cpr
ie
return
spontan
ecmo
initi
death
min
ecpr
ccpr
group
respect
rosc
rate
two
group
p
surviv
icu
discharg
vs
p
respect
favor
outcom
recept
p
surviv
analysi
show
better
neurolog
outcom
match
ecpr
group
ccpr
group
logrank
p
conclus
ecpr
cardiac
arrest
associ
improv
longterm
neurolog
outcom
annal
intens
care
suppl
introduct
knowledg
studi
map
epidemiolog
inicu
cardiac
arrest
ca
franc
survey
aim
describ
demograph
manag
vital
neurolog
prognosi
patient
concern
patient
method
acir
french
cardiaqu
inattendu
en
prospect
observ
studi
implement
french
icu
throughout
victim
unexpect
ca
resuscit
attempt
chest
compress
adrenalin
electr
shock
admit
icu
includ
inicu
ca
chart
data
collect
compris
medic
histori
circumst
ongo
treatment
time
event
resuscit
maneuv
perform
surviv
rate
cerebr
perform
categori
cpc
score
result
approxim
patient
admit
studi
period
men
year
endur
unexpect
ca
among
hospit
shock
respiratori
distress
outoficu
ca
one
quarter
organ
failur
half
ca
occur
within
first
h
admiss
procedur
deem
risk
mainli
endotrach
intub
dialysi
nurs
care
intrahospit
transport
recogniz
etiolog
identifi
ca
attribut
current
lifesustain
intervent
mechan
ventil
circulatori
assist
drugrel
complic
lifethreaten
condit
mainli
hypoxemia
metabol
disord
hypovolemia
cardio
pulmonari
resuscit
start
without
delay
shockabl
rhythm
ventricular
tachycardia
fibril
diagnos
case
first
shock
deliv
within
minut
case
nonshock
rhythm
asystol
pulseless
bradycardia
first
adrenalin
inject
given
minut
return
spontan
circul
rosc
achiev
patient
discharg
aliv
hospit
number
ca
survivor
cpc
score
consid
satisfactori
hospit
discharg
month
ca
conclus
inicu
ca
occur
sever
ill
patient
first
day
hospit
half
case
atrisk
procedur
onefifth
attribut
lifesustain
intervent
place
despit
high
rate
rosc
victim
discharg
aliv
hospit
howev
survivor
maintain
good
neurolog
statu
time
annal
intens
care
suppl
introduct
emphasi
regard
import
earli
cardiopulmonari
resuscit
cpr
defibril
led
improv
outcom
cardiac
arrest
ca
meanwhil
recent
data
rais
concern
regard
benefit
target
temperatur
manag
ttm
comatos
cardiac
arrest
survivor
may
result
loss
interest
ttm
patient
uncertain
consequ
outcom
use
data
sudden
death
expertis
center
sdec
great
pari
area
assess
relationship
chang
time
use
ttm
patient
outcom
adjust
potenti
confound
patient
method
use
data
prospect
collect
sdec
registri
may
decemb
variabl
collect
accord
utstein
style
nontraumat
ohca
patient
stabl
return
spontan
circul
rosc
includ
analysi
compar
patient
characterist
outcom
accord
ttm
use
perform
multivari
logist
regress
use
surviv
icu
discharg
main
endpoint
result
studi
period
patient
retain
analysi
receiv
ttm
compar
control
patient
ttm
significantli
frequent
male
younger
ca
occur
frequent
public
place
shockabl
rhythm
frequent
proport
patient
short
noflow
min
greater
p
regard
time
trend
gender
age
locat
ca
chang
accord
year
inclus
registri
bystand
cpr
increas
patient
p
rate
shockabl
rhythm
increas
p
rate
patient
noflow
min
decreas
p
figur
ttm
use
decreas
time
p
meanwhil
surviv
rate
icu
discharg
increas
significantli
patient
p
figur
multivari
analysi
year
ca
occurr
associ
outcom
icu
discharg
ttm
use
decreas
year
driven
particular
utstein
criteria
conclus
report
improv
time
icu
surviv
postca
patient
appear
mostli
associ
increas
bystand
cpr
higher
rate
shockabl
rhythm
ttm
use
declin
year
subgroup
ca
patient
evid
consequ
regard
outcom
annal
intens
care
suppl
introduct
postresuscit
shock
high
incid
cardiac
arrest
ca
due
wholebodi
may
complic
multipl
organ
failur
mof
death
mesenter
ischemia
mi
may
occur
set
incid
outcom
poorli
document
patient
method
perform
retrospect
monocentr
studi
aim
describ
characterist
outcom
mi
ca
consecut
patient
admit
tertiari
ca
center
confirm
mi
icu
stay
studi
mi
confirm
endoscopi
abdomin
ctscan
surgic
laparotomi
result
among
ca
postca
patient
mi
clinic
suspect
patient
confirm
patient
median
age
year
median
time
ca
cardiopulmonari
resuscit
cpr
min
time
cpr
return
spontan
circul
min
patient
initi
shockabl
rhythm
receiv
epinephrin
cpr
patient
develop
postresuscit
shock
median
initi
blood
lactat
mmoll
delay
ca
diagnosi
mi
day
mostli
clinic
abdomin
symptom
includ
hemorrhag
feed
intoler
confirm
ct
scan
abnorm
lower
digest
endoscopi
despit
surgic
intestin
resect
perform
patient
icu
mortal
patient
surviv
good
neurolog
outcom
caus
death
mof
postanox
brain
injuri
despit
recoveri
initi
shock
conclus
cohort
observ
mi
ca
uncommon
complic
associ
poor
outcom
effort
made
order
obtain
earlier
recognit
mi
patient
preserv
brain
function
preliminari
result
need
confirm
multicentr
studi
annal
intens
care
suppl
introduct
botul
rare
potenti
sever
neuroparalyt
diseas
caus
neurotoxin
produc
case
clostridium
botulinum
treatment
mainli
consist
life
support
techniqu
specif
medic
antitoxin
franc
guidelin
regard
use
antitoxin
avail
temporari
author
use
primari
goal
studi
describ
evalu
morbid
mortal
sever
adult
botul
icu
franc
secondari
goal
evalu
current
patient
care
french
icu
especi
concern
administr
antitoxin
patient
method
conduct
retrospect
observ
multicent
studi
french
icu
among
adult
icu
unit
agre
particip
patient
data
collect
standardis
crf
includ
patient
age
year
age
admit
icu
januari
june
acut
botul
studi
protocol
approv
srlf
ethic
committe
data
collect
conduct
accord
french
law
cnil
recommend
result
among
particip
unit
identifi
botul
case
unabl
collect
patient
data
twentyeight
icu
identifi
patient
admiss
median
iqr
age
year
patient
male
patient
foodborn
botul
median
sap
ii
clinic
present
ocular
symptom
especi
diplopia
ptosi
oropharyng
symptom
especi
swallow
impair
frequent
usual
first
describ
patient
intub
median
durat
mechan
ventil
day
maximum
day
tracheotomi
perform
patient
median
icu
hospitalis
durat
day
current
botul
episod
associ
sequela
evalu
modifi
rankin
scale
icu
discharg
hospit
discharg
last
followup
patient
respect
score
two
patient
die
hospitalis
icu
stay
twentyf
patient
treat
botul
antitoxin
unabl
show
signific
differ
outcom
patient
treat
treat
antitoxin
conclus
although
botul
rare
caus
death
nowaday
potenti
sever
diseas
high
morbid
possibl
extend
hospitalis
mechan
ventil
recent
studi
favour
use
antitoxin
clear
recommend
need
annal
intens
care
suppl
introduct
nangibotid
peptid
specif
inhibitor
preclin
septic
shock
model
nangibotid
abl
restor
appropri
inflammatori
respons
vascular
function
improv
surviv
phase
nangibotid
found
safe
well
toler
highest
dose
patient
method
intern
multicent
phase
iia
random
doubleblind
twostag
placebocontrol
studi
main
inclus
criteria
septic
shock
accord
sepsi
definit
nangibotid
initi
within
h
shock
onset
patient
random
receiv
either
placebo
mg
kg
h
nangibotid
studi
drug
infus
end
vasopressor
h
day
safeti
data
review
independ
data
safeti
monitor
board
dsmb
primari
endpoint
safeti
toler
patient
followup
period
day
result
patient
random
treat
patient
die
dose
group
well
balanc
term
baselin
characterist
except
apach
ii
score
tend
nonsignificantli
lower
placebo
group
primari
infect
sourc
abdomin
pulmonari
urinari
nangibotid
safe
well
toler
group
dsmb
rais
safeti
concern
number
sae
ae
number
patient
sae
ae
compar
group
frequent
ae
atrial
fibril
anemia
pleural
effus
thrombocytopenia
trend
toward
decreas
circul
level
pharmacodynam
marker
observ
nangibotidetr
patient
allcaus
mortal
pool
nangibotid
group
placebo
group
subgroup
level
median
mortal
calcul
placebo
nangibotid
group
respect
group
high
level
trend
toward
increas
organ
support
free
day
aliv
seen
nangibotidetr
patient
versu
placebo
conclus
nangibotid
shown
safe
well
toler
septic
shock
patient
although
small
exploratori
studi
power
conclud
efficaci
non
signific
lower
mortal
observ
nangibotid
group
result
support
need
larger
studi
demonstr
role
nangibotid
treatment
septic
shock
explor
potenti
efficaci
predict
biomark
nangibotid
annal
intens
care
suppl
introduct
sever
studi
publish
psychiatr
disord
intens
unit
icu
risk
factor
associ
disord
studi
evalu
frequenc
anxieti
depress
disord
icu
stay
patient
method
main
object
prospect
multicentr
observ
studi
assess
rate
patient
anxieti
depress
icu
secondari
object
assess
rate
patient
anxiolyt
antidepress
drug
identifi
factor
associ
anxieti
depress
icu
patient
hospit
sinc
h
icu
studi
day
elig
evalu
patient
anxieti
depress
symptom
perform
bedsid
physician
nurs
care
patient
day
studi
result
french
icu
particip
studi
patient
includ
patient
report
anxieti
depress
caregiv
ci
patient
includ
studi
receiv
drug
treat
anxieti
depress
respect
risk
factor
independ
associ
anxieti
depress
histori
anxieti
depress
syndrom
ci
p
announc
sever
ill
loss
autonomi
icu
stay
ci
p
tracheostomi
perform
icu
stay
ci
p
administr
antipsychot
medic
icu
ci
p
read
book
cargiv
rel
icu
stay
ci
p
organ
failur
independ
associ
less
anxieti
depress
ci
p
conclus
anxieti
depress
symptom
common
critic
ill
patient
icu
stay
histori
anxieti
depress
announc
sever
ill
loss
autonomi
tracheostomi
antipsychot
medic
read
book
caregiv
associ
increas
risk
anxieti
depress
disord
icu
howev
sever
critic
ill
associ
decreas
risk
anxieti
depress
futur
studi
requir
assess
relationship
anxieti
depress
disord
icu
stay
annal
intens
care
suppl
introduct
increas
number
death
occur
icu
set
research
focus
describ
understand
improv
endoflif
care
well
improv
patient
famili
experi
aim
studi
describ
evalu
experi
physician
nurs
involv
endoflif
situat
icu
describ
factor
associ
poor
good
score
patient
method
questionnair
valid
multicent
prospect
studi
conduct
juli
juli
french
icu
icu
consecut
adult
die
least
h
admiss
icu
includ
physician
nurs
charg
patient
time
death
ask
complet
questionnair
within
h
death
psychometr
valid
conduct
use
two
dataset
learn
cohort
valid
cohort
result
among
patient
nurs
score
physician
score
analyz
median
global
caesar
score
nurs
physician
lower
nurs
score
significantli
associ
follow
factor
conflict
physician
pain
manag
nurs
alon
rather
physician
death
disclos
famili
phone
upon
arriv
rather
bedsid
use
invas
treatment
end
life
higher
physician
score
significantli
associ
follow
factor
avail
dedic
inform
room
joint
famili
inform
nurs
total
rather
partial
famili
inform
joint
implement
nurs
decis
withdraw
withhold
therapi
open
visit
polici
higher
score
also
associ
patient
characterist
mccabe
immunocompromis
dementia
liver
failur
haematolog
diseas
use
psychotrop
medic
last
higher
score
associ
end
life
condit
decis
withdraw
withhold
therapi
cardiopulmonari
resuscit
death
disclos
famili
bedsid
rather
phone
upon
arriv
icu
conclus
describ
valid
new
instrument
assess
experi
physician
nurs
involv
endoflif
situat
icu
studi
show
import
area
improv
practic
includ
adapt
level
intens
care
qualiti
teamwork
qualiti
commun
implic
famili
member
annal
intens
care
suppl
introduct
improv
care
older
patient
icu
challeng
term
surviv
qualiti
life
qol
set
prospect
observ
assess
effect
combin
geriatr
intensivist
initi
evalu
determin
cluster
older
patient
oneyear
outcom
cluster
patient
method
patient
age
year
older
admit
icu
western
franc
requir
mechan
ventil
septemb
decemb
includ
proxi
member
consult
icu
admiss
use
predefin
comprehens
geriatr
assess
surviv
assess
one
year
comprehens
geriatr
assess
perform
place
live
survivor
cluster
perform
base
baselin
characterist
icu
admiss
paramet
use
jaccard
similar
measur
result
five
hundr
one
patient
includ
analysi
age
year
male
ninetytwo
percent
patient
live
home
icu
admiss
mean
comorbid
burden
assess
cirsg
score
patient
adl
score
sofa
icu
admiss
cluster
result
three
group
group
n
character
older
age
lower
comorbid
burden
intermedi
acut
sever
group
n
character
lower
age
intermedi
comorbid
higher
acut
sever
group
n
higher
age
higher
comorbid
lower
acut
sever
patient
could
cluster
due
incomplet
data
cluster
experienc
differ
trajectori
throughout
icu
stay
higher
icu
mortal
group
highest
amount
organ
support
moreov
cluster
evolut
differ
hospit
discharg
overal
oneyear
surviv
mortal
higher
group
compar
group
p
see
figur
patient
survivor
underw
oneyear
athom
evalu
moder
decreas
independ
observ
perceiv
qol
remain
satisfactori
patient
indic
happi
happi
differ
oneyear
geriatr
evalu
observ
cluster
conclus
comprehens
geriatr
assess
acut
sever
paramet
use
identifi
three
differ
pattern
patient
differ
outcom
pattern
may
use
design
futur
intervent
studi
long
term
surviv
older
patient
icu
stay
improv
compar
previou
studi
annal
intens
care
suppl
introduct
blood
cultur
bc
remain
firstlin
tool
identif
caus
agent
patient
sever
infect
howev
sever
paramet
affect
diagnost
perform
bc
sensibl
depend
volum
collect
blood
falseposit
bc
may
aris
blood
contamin
venipunctur
object
assess
effect
uniqu
highvolum
blood
cultur
ubc
strategi
rate
bc
contamin
pathogen
detect
patient
method
interrupt
timeseri
studi
conduct
medic
icu
januari
decemb
ubc
protocol
implement
januari
patient
suspect
bacteri
infect
ml
blood
collect
singl
phlebotomi
ten
millilit
blood
inocul
two
bact
alert
fa
aerob
bottl
two
bact
alert
fn
anaerob
bottl
perform
addit
blood
cultur
within
h
strongli
discourag
unless
new
bloodstream
infect
suspect
nurs
physician
knowledg
bc
collect
practic
skill
reinforc
educ
program
decemb
protocol
adher
evalu
month
monitor
bc
volum
result
studi
period
icu
stay
least
one
bc
differ
observ
two
period
regard
sever
sofa
admiss
inicu
death
educ
program
median
volum
blood
cultur
per
bottl
increas
ml
confid
interv
ci
ml
ci
month
decreas
ml
ci
month
p
ubc
period
rate
bloodstream
infect
per
patient
bacteremia
true
pathogen
compar
p
rate
bc
contamin
amongst
posit
bc
decreas
protocol
implement
p
median
number
bc
bottl
collect
per
week
decreas
interquartil
rang
ubc
protocol
implement
correspond
save
per
year
conclus
implement
ubc
protocol
associ
import
decreas
rate
bc
contamin
bcassoci
cost
without
affect
pathogen
detect
rate
annal
intens
care
suppl
introduct
extend
followup
icu
survivor
shown
mani
patient
suffer
longterm
physic
psycholog
sequala
ptsd
increasingli
psychiatr
disord
report
icu
survivor
aim
determin
frequenc
ptsd
predictor
patient
method
mix
method
studi
conduct
medic
icu
januari
januari
data
obtain
medic
record
month
posticu
discharg
patient
contact
phone
complet
impact
event
scale
revis
questionnair
iesr
univari
logist
regress
analys
use
identifi
variabl
independ
associ
iesr
result
patient
admit
studi
period
discharg
aliv
never
success
contact
die
within
month
period
patient
fulfil
inclus
criteria
patient
characterist
mean
age
year
male
median
charlson
comorbid
index
mean
sapsii
invas
mechan
ventil
imv
vasopressor
use
median
durat
imv
length
stay
respect
day
day
patient
met
diagnost
criteria
ptsd
univari
analysi
risk
factor
ptsd
respect
ptsd
group
control
age
vs
p
femal
sex
vs
p
alcohol
vs
p
imv
vs
p
sed
use
vs
p
polyneuromyopathi
vs
p
delirium
vs
p
catheter
vs
p
durat
imv
vs
p
physic
restraint
vs
p
multivari
logist
regress
age
ci
p
femal
sex
ci
p
physic
restraint
ci
p
polyneuromythi
ci
p
identifi
risk
factor
independ
associ
ptsd
conclus
ptsd
common
icu
survivor
physic
restraint
femal
sex
polyneuromyopathi
younger
age
factor
independ
associ
ptsd
annal
intens
care
suppl
introduct
guh
fire
caus
total
evacu
unpreced
event
franc
report
factual
element
first
day
disast
involv
intens
care
unit
icu
activ
specif
propos
impos
respons
sole
icu
guadeloup
island
near
half
million
peopl
patient
method
data
extract
icu
medic
file
experi
report
emerg
depart
softwar
result
fire
start
around
floor
build
icu
floor
oper
room
floor
icu
occupi
bed
includ
ventil
patient
invad
thick
smoke
trigger
fire
alarm
evacu
icu
decid
doctor
activ
offici
evacu
plan
h
absenc
administr
instruct
ventil
patient
reloc
radiolog
level
access
medic
gase
nonventil
patient
evacu
outdoor
car
park
patient
servic
patient
extract
icu
patient
evacu
center
ventil
patient
bass
terr
public
hospit
post
anesthesia
care
unit
ventil
patient
nonventil
patient
privat
hospit
locat
km
unit
ambulatori
surgeri
bed
thu
day
reaffect
icu
patient
per
room
icu
patient
evacu
guh
patient
priorit
medic
evacu
martiniqu
univers
hospit
muh
thank
militari
vector
patient
simultan
casa
militari
aircraft
medic
helicopt
samu
wors
initi
progress
note
except
patient
septic
shock
need
intub
norepinephrin
radiolog
level
icu
activ
heavili
impact
period
difficulti
relat
emerg
servic
medicosurg
servic
support
structur
laboratori
radiolog
pharmaci
rearrang
conclus
disastr
never
experienc
situat
limit
immedi
impact
death
due
fast
manag
patient
transfer
relat
icu
doctor
initi
region
support
muh
militari
vector
help
propos
immedi
respons
sever
icu
patient
mid
longterm
consequ
signific
evacu
patient
well
guadeloup
care
provis
term
icu
hospit
compon
relat
distanc
away
franc
annal
intens
care
suppl
introduct
excess
alarm
intens
care
multipl
consequ
nois
gener
alter
qualiti
patient
stay
particip
genesi
phenomenon
call
alarm
fatigu
alter
qualiti
surveil
directli
impact
patient
safeti
pejor
term
object
project
improv
qualiti
care
work
condit
intens
care
unit
tourco
optim
monitor
patient
collabor
medic
team
compani
provid
monitor
product
patient
method
analysi
alarm
philip
intelivu
monitor
one
month
perform
correct
measur
reduc
number
implement
collabor
dmaic
approach
defin
measur
analyz
improv
control
correct
measur
includ
person
monitor
medic
reflect
alarm
threshold
creation
specif
profil
patient
train
caregiv
good
use
monitor
creation
alarm
cultur
via
train
creation
commun
tool
action
ad
technic
intervent
intens
care
ventil
monitor
impact
alarm
caregiv
patient
present
analysi
period
evalu
use
questionnair
second
alarm
analysi
assess
evalu
effect
implement
measur
result
alarm
equival
alarm
day
patient
includ
vital
alarm
critic
techniqu
found
first
period
analysi
patient
questionnair
contribut
usabl
questionnair
among
respond
major
feel
signific
discomfort
stay
health
questionnair
respons
rate
n
respond
believ
decreas
attent
increas
reaction
time
due
fals
alarm
also
believ
irrelev
alarm
disrupt
qualiti
patient
stay
better
alarm
manag
could
prevent
incid
nearli
caregiv
say
alarm
could
heard
miss
second
period
reduct
total
number
alarm
alarm
equival
alarm
day
patient
p
obtain
conclus
creat
implement
target
correct
measur
dmaic
approach
reduct
number
alarm
achiev
reduct
probabl
enhanc
patient
safeti
improv
healthcar
environ
patient
caregiv
annal
intens
care
suppl
introduct
evid
electron
medic
data
manag
system
emdm
may
help
practition
improv
appropri
red
blood
cell
rbc
transfus
hospitalis
adult
lack
data
support
children
unclear
emdm
use
paediatr
intens
care
unit
picu
survey
aim
document
avail
emdm
british
canadian
picu
characterist
data
record
patient
method
electron
selfadminist
questionnair
sent
thrice
use
survey
monkey
novemb
februari
director
canadian
british
picu
respond
ask
describ
picu
indic
emdm
use
institut
result
among
unit
studi
canadian
british
picu
answer
survey
three
exclud
exclus
took
care
prematur
infant
newborn
emdm
use
remain
picu
tabl
detail
data
collect
emdm
picu
seventeen
picu
use
window
emdm
oper
system
two
type
electron
medic
record
emr
use
document
patient
care
intellispac
critic
care
anesthesia
icca
philip
picu
allscript
profession
picu
total
emr
name
unknown
instanc
electron
medic
data
known
store
structur
queri
languag
sql
server
seven
picu
conclus
data
manag
emdm
common
british
canadian
picu
computer
physician
order
rbc
transfus
report
avail
picu
use
emdm
enabl
electron
medic
decis
support
tool
rbc
transfus
feasibl
picu
may
facilit
effici
data
collect
clinic
trial
annal
intens
care
suppl
introduct
owe
high
mortal
rate
admiss
intens
care
unit
icu
patient
interstiti
lung
diseas
ild
question
system
rheumat
diseas
relat
ild
srdild
seem
associ
better
outcom
data
still
lack
aim
therefor
evalu
short
longterm
outcom
prognost
factor
srd
patient
admit
icu
patient
method
multicent
retrospect
studi
conduct
five
french
icu
includ
patient
srdild
admit
acut
respiratori
failur
inhospit
oneyear
crude
mortal
assess
potenti
prognost
factor
identifi
use
logist
regress
result
seventyon
patient
femal
mean
age
year
median
median
sofa
score
enter
studi
ild
relat
connect
tissu
diseas
vascul
myositi
sarcoidosi
ankylos
spondyl
caus
acut
respiratori
failur
sepsi
pulmonari
flareup
miscellan
fiftyf
patient
requir
mechan
ventil
patient
vasoact
drug
renal
replac
therapi
one
patient
extracorpor
membran
oxygen
occurr
sever
moder
mild
ard
respect
thirtyseven
surviv
hospit
discharg
one
year
later
univari
analysi
follow
factor
significantli
associ
mortal
icu
admiss
sap
ii
p
ratio
p
vasoact
drug
p
mechan
ventil
requir
p
among
factor
multivari
analysi
show
low
ratio
ci
associ
one
year
mortal
conclus
studi
srdild
patient
admit
icu
inhospit
oneyear
crude
mortal
rate
respect
though
mortal
rate
remain
high
discourag
intensivist
admit
patient
found
also
low
ratio
icu
stay
associ
oneyear
mortal
studi
howev
need
best
help
physician
icu
manag
ild
patient
annal
intens
care
suppl
introduct
physician
know
follow
patient
wish
unabl
express
assess
impact
advanc
direct
ad
written
physician
decis
patient
method
multicentr
prospect
intervent
simul
studi
carri
eight
patient
recruit
wrote
ad
receiv
clear
complet
inform
video
interview
one
icu
physician
two
simul
scenario
includ
ten
question
icu
admiss
situat
withhold
withdraw
therapi
use
patient
characterist
submit
icu
physician
french
icu
three
round
r
simul
without
knowledg
patient
ad
ad
ad
knowledg
carri
result
qualit
analysi
ad
highlight
form
live
endoflif
formal
guidelin
medic
care
result
perform
complet
data
physician
figur
variabl
physician
high
among
question
question
agreement
respect
ad
significantli
decreas
number
question
agreement
increas
number
question
agreement
p
differ
round
p
physician
characterist
associ
interindividu
variabl
intraindividu
variabl
high
question
kappa
coeffici
k
ad
significantli
associ
variabl
adjust
characterist
physician
patient
p
relev
notic
knowledg
ad
carri
low
impact
physician
decis
discuss
expect
find
help
ad
patient
diminish
variabl
among
physician
respect
patient
autonomi
variabl
physician
increas
studi
assum
variabl
reflect
differ
interpret
ad
among
physician
conclus
ad
major
impact
physician
decis
admiss
withhold
withdraw
therapi
decis
increas
interindividu
variabl
knowledg
ad
written
might
limit
autonom
model
annal
intens
care
suppl
introduct
recent
year
increas
immunocompromis
patient
admit
intens
care
unit
icu
endof
life
decis
challeng
sever
patient
often
lifethreaten
underli
diseas
main
aim
studi
identifi
patient
organiz
factor
associ
decis
forgo
lifesustain
therapi
dflst
among
immunocompromis
icu
patient
patient
method
secondari
analysi
efraim
studi
includ
immunocompromis
patient
acut
respiratori
failur
enrol
icu
countri
octob
june
perform
multivari
logist
analysi
perform
identifi
independ
predictor
dflst
result
patient
data
dflst
avail
dflst
figur
present
code
statu
icu
admiss
final
decis
dflst
code
statu
follow
variabl
independ
associ
increas
incid
dflst
age
per
one
year
increas
ic
p
sofa
icu
admiss
ic
p
need
orotrach
intub
ic
p
perform
statu
measur
eastern
cooper
oncolog
group
scale
ecog
per
point
ic
p
unit
without
protocol
admiss
criteria
ic
p
palli
care
involv
ic
p
unit
frequent
admiss
transplant
patient
ic
p
two
variabl
independ
associ
decreas
incid
dflst
name
acut
respiratori
failur
easi
aetiolog
identif
ic
p
use
checklist
global
icu
care
ic
p
centr
effect
signific
multivari
analysi
conclus
current
studi
suggest
addit
patientrel
factor
icu
characterist
criticalcar
organ
also
influenc
decis
forgo
life
sustain
therapi
palli
care
involv
frequent
admiss
transplant
patient
protocol
admiss
criteria
admiss
use
checklist
organiz
variabl
associ
dflst
annal
intens
care
suppl
introduct
sinc
kouchner
law
leonetti
claey
law
wwt
decis
becom
essenti
discuss
within
intens
care
unit
intens
care
unit
icu
conduct
work
topic
lead
implement
wwt
procedur
form
followup
assess
practic
year
implement
traceabl
patient
method
patient
limit
record
plr
initi
reassess
weekli
icu
meet
bring
togeth
medic
paramed
staff
also
initi
time
except
meet
plr
initi
request
member
paramed
team
medic
team
patient
entourag
soon
meaning
continu
care
contest
includ
advanc
medic
instruct
estim
patient
qualiti
life
icu
stay
patient
wellb
stay
interview
patient
rel
practition
also
mention
condit
time
applic
limit
analyz
record
extend
period
month
end
june
analysi
period
last
month
septemb
june
result
plr
establish
period
compar
patient
limit
first
ethic
meet
period
limit
life
sustain
treatment
patient
unknown
case
among
patient
whose
known
express
opposit
therapeut
relentless
patient
gener
practition
interview
meet
made
patient
frequent
therapeut
limit
cardiac
arrest
resuscit
renal
replac
therapi
invas
mechan
ventil
limit
case
nutrit
hydrat
never
limit
conclus
ten
year
set
wwt
procedur
icu
limit
frequent
appear
earlier
concern
younger
patient
often
paramed
initi
reflect
stronger
involv
caregiv
end
life
issu
annal
intens
care
suppl
introduct
aim
studi
evalu
psycholog
impact
critic
ill
patient
rel
tunisian
medic
icu
micu
patient
method
studi
includ
patient
admit
micu
januari
decemb
use
impact
event
scale
i
patient
score
i
indic
sever
psycholog
trauma
symptom
individu
score
rang
like
meet
diagnost
criteria
ptsd
burden
minizarit
use
rel
patient
rel
interview
telephon
result
contact
famili
patient
die
patient
particip
rel
studi
sex
ratio
f
mean
age
year
year
averag
length
stay
lo
day
day
patient
mechan
ventil
mean
durat
day
patient
tracheostomi
dementia
diagnos
patient
patient
autonom
main
reason
icu
admiss
respiratori
distress
averag
i
patient
i
significantli
correl
male
gender
p
lo
icu
p
orotrach
intub
oti
p
tracheostomi
p
use
vasopressor
agent
p
averag
minizarit
rel
minizarit
significantli
correl
lo
oti
p
durat
oti
p
tracheostomi
p
durat
tracheostomi
p
use
vasopressor
agent
p
apach
ii
score
p
conclus
patient
recov
critic
ill
left
signific
physic
cognit
problem
deepli
affect
qualiti
life
patient
rel
understand
natur
relationship
critic
ill
ptsd
challeng
demand
attent
particularli
era
mental
health
profession
begin
recogn
profound
cost
associ
psychiatr
syndrom
annal
intens
care
suppl
introduct
elderli
intens
care
patient
intern
multicentr
prospect
studi
endors
european
societi
intens
care
medicin
assess
prognosi
elderli
patient
year
admit
intens
care
unit
icu
studi
subgroup
analysi
french
patient
patient
method
elderli
patient
year
admit
french
icu
includ
studi
octob
may
analyz
post
hoc
subgroup
studi
frailti
defin
clinic
frailti
scale
multivari
analysi
adjust
odd
ratio
aor
confid
interv
ic
perform
determin
factor
associ
inicu
mortal
result
among
patient
admit
french
icu
frail
entir
cohort
compar
nonfrail
patient
frailti
associ
similar
inicu
vs
p
mortal
vs
p
despit
lower
sever
vs
p
lower
use
mechan
ventil
vs
p
lower
use
vasoact
drug
vs
p
howev
withhold
frequent
vs
p
withdraw
vs
p
multivari
analysi
frailti
independ
risk
factor
mortal
contrari
withdraw
aor
withhold
aor
use
mechan
ventil
aor
sofa
admiss
per
one
point
increas
aor
conclus
elderli
patient
admit
french
icu
frail
patient
mortal
nonfrail
patient
despit
lower
initi
sever
higher
frequenc
withhold
decis
annal
intens
care
suppl
introduct
patient
refer
intens
care
unit
icu
refus
intensivist
consid
well
ill
benefit
intens
care
treatment
studi
aim
evalu
factor
associ
decis
refus
icu
admiss
assess
outcom
exclud
patient
patient
method
inpati
refer
icu
februari
august
includ
analysi
patient
evalu
emerg
unit
hospit
area
senior
intensivist
refus
patient
consid
well
inappropri
referr
ir
ill
futil
icu
admiss
main
outcom
surviv
day
first
referr
icu
patient
characterist
number
bed
avail
time
referr
qualiti
life
day
icu
referr
also
assess
result
patient
admit
refus
reason
refus
futil
ill
n
ir
well
n
median
mortal
probabl
model
mpmii
score
ir
group
futil
group
day
admiss
request
came
emerg
unit
n
medic
depart
n
surgeri
depart
n
main
outcom
futil
ir
group
respect
futil
group
modifi
rankin
score
increas
inclus
final
evalu
lack
autonomi
elderli
peopl
dementia
main
caus
refus
futil
group
n
respect
conclus
refus
icu
admiss
occur
case
refus
futil
strongli
invari
associ
death
wherea
patient
consid
well
intens
care
treatment
rare
die
strategi
develop
creat
admiss
criteria
patient
annal
intens
care
suppl
introduct
object
studi
icu
patient
esblproduc
enterobacteriacea
infect
identifi
predictor
deescal
empir
treatment
carbapenem
cp
cpspare
regimen
cp
ii
compar
outcom
patient
deescal
maintain
cp
cpm
patient
method
retrospect
studi
perform
icu
hospit
cp
prescript
review
within
h
antimicrobi
stewardship
team
icu
physician
demograph
clinic
therapeut
data
compar
cp
cpm
patient
unfavor
clinic
outcom
defin
mortal
relaps
evalu
day
followup
result
present
median
iqr
n
result
nineti
patient
includ
cpm
cp
mainli
treat
pneumonia
n
urinari
tract
infect
uti
n
septic
shock
found
cpm
cp
p
main
cpspare
antibiot
piperacillin
tazobactam
n
cefoxitin
n
temocillin
n
median
cp
durat
day
cp
patient
cohort
patient
receiv
total
day
antibiot
cp
day
cp
day
therefor
cp
daili
dose
save
factor
associ
use
cp
older
age
cp
year
cpm
year
p
uti
cp
n
includ
male
uti
cpm
n
p
absenc
immunosuppress
therapi
cp
n
cpm
n
p
total
durat
antibiot
therapi
cp
cpm
p
unfavor
outcom
observ
cp
cpm
respect
p
factor
associ
unfavor
outcom
uti
hazard
ratio
hr
p
respiratori
tract
infect
hr
p
immunosuppress
therapi
hr
p
use
cp
effect
hr
p
conclus
cp
deescal
perform
patient
mainli
immunocompet
treat
uti
strategi
seem
associ
wors
outcom
reduc
cp
exposur
howev
total
durat
antibiot
therapi
longer
cp
high
rate
male
iu
treat
annal
intens
care
suppl
introduct
impact
discuss
bacteriologist
infectiologist
antibiot
therapi
intens
care
unit
auxerr
hospit
patient
method
observ
retrospect
studi
conduct
studi
first
period
weekli
infectiolog
meet
one
hour
compos
intens
care
pratician
bacteriologist
pharmacist
second
period
intervent
infectiologist
primari
outcom
chang
antibiot
consumpt
daili
dose
per
day
hospit
secondari
outcom
chang
number
multiresist
bacteria
bmr
isol
weekli
screen
h
hospit
variou
proport
compar
use
test
result
patient
hospit
intens
care
unit
vs
popul
compar
age
sex
averag
length
stay
simplifi
serious
index
mortal
antibiot
consumpt
differ
two
period
discuss
statist
signific
impact
antibiot
consumpt
fluoroquinolon
amoxicillinclanulan
acid
known
induc
resist
decreas
second
period
prescript
antibiot
improv
cefepim
enterobact
ceftazidim
ciprofloxacin
pseudomona
thu
save
colimycin
imipenem
cilastatin
nonsignific
trend
lower
multiresist
broadspectrum
betalactamaseproduc
bacteria
cephalosorinas
carbapenemas
screen
test
conclus
intervent
infectiologist
servic
allow
effect
adapt
strategi
antibiot
therapi
hope
come
year
select
bmr
decreas
annal
intens
care
suppl
introduct
empir
antimicrobi
therapi
eamt
use
imipenem
colistin
commonli
prescrib
first
line
therapi
critic
ill
patient
sever
sepsi
aim
assess
appropri
prescrib
imipenem
colistin
eamt
icu
patient
patient
method
observ
prospect
studi
includ
icu
patient
requir
imipenem
colistin
eamt
eamt
assess
accord
microbiolog
clinic
outcom
outcom
delay
apyrexia
delay
decreas
biolog
inflammatori
paramet
bip
requir
vasoact
agent
bacteriolog
erad
length
stay
lo
ventil
day
mortal
result
administr
eamt
patient
studi
eamt
appropri
studi
case
icu
stay
day
relat
inappropri
chronic
respiratori
failur
associ
appropri
appropri
eamt
group
show
earlier
apyrexia
shorter
delay
decreas
biolog
inflammatori
paramet
bip
less
signific
vasopressor
requir
attach
fig
furthermor
eamt
improv
surviv
median
gain
day
inappropri
eamt
increas
mortal
risk
six
acquisit
ni
icu
also
independ
factor
mortal
conclus
eamt
use
imipenemcolistin
appropri
half
case
inappropri
associ
increas
icu
mortal
risk
annal
intens
care
suppl
introduct
incid
extendedspectrum
betalactamas
producingenterobacteriacea
esblp
grow
emerg
worldwid
distribut
aim
studi
describ
outcom
patient
hospit
icu
extend
spectrum
betalactamas
produc
enterobacteria
esblp
infect
treat
carbapenem
altern
carbapenemspar
therapi
patient
method
perform
retrospect
descript
monocentr
studi
public
univers
hospit
patient
year
hospit
one
icu
hospit
present
admiss
stay
infect
esblp
januari
march
includ
patient
colon
infect
esblp
includ
primari
studi
outcom
patient
vital
statu
discharg
icu
secondari
outcom
vital
statu
discharg
icu
patient
treat
carbapenem
patient
treat
altern
therapi
relaps
antibiot
chang
recept
antibiot
suscept
test
result
result
studi
patient
includ
among
least
one
risk
factor
esblp
acquisit
mostli
recent
hospit
within
month
use
antibiot
within
month
overal
patient
die
icu
stay
mean
sap
ii
score
admiss
invas
mechan
ventil
requir
patient
catecholamin
use
requir
patient
escherichia
coli
frequent
bacteria
identifi
follow
enterobact
cloaca
complex
klebsiella
pneumonia
distribut
infect
site
summar
figur
relaps
occur
patient
studi
patient
receiv
empir
antimicrobi
treatment
receiv
carbapenem
noncarbapenem
treatment
among
patient
document
treatment
carbapenem
use
patient
noncarbapenem
patient
piperacillin
tazobactam
use
noncarbapenem
treatment
statist
signific
differ
mortal
patient
treat
carbapenem
patient
treat
noncarbapenem
therapi
conclus
infect
esblp
critic
ill
patient
associ
great
mortal
sampl
size
retrospect
studi
differ
group
observ
therefor
larger
studi
drawn
annal
intens
care
suppl
introduct
catheterrel
infect
cri
common
critic
ill
patient
differ
factor
incrimin
develop
cri
studi
aim
identifi
cri
risk
factor
patient
method
conduct
retrospect
studi
includ
patient
admit
intens
care
unit
icu
period
octob
august
cathet
relat
infect
identifi
use
criteria
infecti
diseas
societi
america
patient
valid
bacteriolog
data
includ
result
studi
period
patient
collect
mean
age
year
sex
ratio
median
sofa
score
frequent
caus
admiss
icu
acut
respiratori
failur
coma
septic
shock
diabet
mellitu
main
medic
anteced
median
length
stay
day
overal
mortal
rate
case
among
central
venou
cathet
insert
twentytwo
cathet
relat
infect
diagnos
sofa
score
superior
admiss
relat
higher
risk
develop
cri
ci
p
addit
time
delay
develop
ventilatorassoci
pneumonia
vap
independ
risk
factor
develop
cri
patient
develop
cri
median
time
develop
vap
day
versu
day
patient
develop
cri
p
conclus
sofa
score
admiss
superior
five
predict
factor
develop
catheterrel
infect
annal
intens
care
suppl
introduct
vaecmo
life
support
techniqu
use
patient
cardiac
failur
high
rate
cari
report
patient
support
ecmo
base
evid
cari
prevent
develop
standard
procedur
maxim
steril
barrier
precaut
antisept
skin
prepar
use
isopropyl
alcohol
solut
semiperm
transpar
highli
adhes
chlorhexidin
dress
dress
chang
h
cathet
insert
everi
day
leak
soil
dress
chang
immedi
patient
method
studi
design
retrospect
review
chart
consecut
patient
underw
vaecmo
support
h
januari
decemb
peripher
blood
sampl
collect
cultur
vaecmo
day
insert
site
sampl
dress
press
nutrit
trypticasesoy
agar
plate
counttact
biomerieux
franc
skin
center
plate
insert
site
evalu
criteria
cannularel
bloodstream
infect
carbsi
defin
combin
posit
peripher
blood
cultur
without
infect
explain
posit
blood
cultur
result
cari
defin
local
infect
sign
without
carbsi
skin
colon
defin
neither
carbsi
cari
posit
insertionsit
skin
cultur
cathet
dress
result
studi
period
patient
support
vaecmo
femorofemor
vaecmo
n
femoroaxillari
n
age
male
sap
ii
sofa
cannul
ecmo
durat
correspond
ecmoday
primari
ecmo
indic
postcardiac
surgeri
myocardi
infarct
primari
graft
dysfunct
cardiac
arrest
carbsi
cari
occur
patient
respect
correspond
incid
rate
ecmoday
colon
insert
site
frequent
mainli
relat
coagulaseneg
staphylococci
howev
found
carbsi
cari
relat
microorgan
skin
colon
frequent
cannula
femor
posit
cannula
axillari
posit
conclus
cannularel
infect
insert
site
colon
frequent
despit
standard
procedur
includ
semiperm
transpar
highli
adhes
chlorhexidin
dress
patient
support
vaecmo
annal
intens
care
suppl
introduct
prompt
antibiot
administr
surgic
debrid
infect
tissu
main
modifi
prognost
factor
necrot
skin
soft
tissu
infect
nsti
multidisciplinari
multimod
care
bundl
implement
center
order
standard
patient
manag
aim
work
evalu
impact
patient
recruit
manag
outcom
patient
method
retrospect
cohort
studi
includ
nsti
case
admit
center
multimod
care
bundl
progress
implement
consist
mainli
creation
nsti
multidisciplinari
team
involv
intens
care
infecti
diseas
physician
dermatologist
avail
patient
referr
plastic
surgeon
microbiologist
use
triag
algorithm
includ
multidisciplinari
bedsid
assess
acceler
access
oper
room
prospect
identif
nsti
case
activ
commun
polici
toward
medic
commun
exist
bundl
compar
patient
preimplement
period
patient
postimplement
period
regard
clinic
featur
manag
outcom
primari
endpoint
surviv
result
overal
patient
admit
studi
period
preimplement
n
perimplement
n
postimplement
n
number
yearli
nsti
case
increas
significantli
pre
postimplement
period
median
iqr
vs
p
signific
differ
period
regard
age
comorbid
nsti
locat
potenti
modifi
prognost
factor
includ
time
surgeri
vs
day
p
proport
patient
undergo
surgeri
within
h
admiss
vs
p
antibiot
administr
within
h
vs
p
adequ
antibiotherapi
guidelin
vs
p
inclus
postimplement
period
associ
increas
surviv
univari
analysi
vs
p
logrank
analysi
figur
yet
associ
statist
signific
adjust
patient
comorbid
sever
multivari
cox
model
adjust
hazard
ratio
ci
p
conclus
implement
multidisciplinari
multimod
care
bundl
nsti
associ
higher
patient
recruit
better
censor
surviv
univari
multivari
analysi
annal
intens
care
suppl
introduct
niv
failur
associ
increas
morbimort
icu
niv
failur
predict
could
help
improv
overal
outcom
prompt
earlier
intub
pay
attent
manag
patient
risk
addit
type
diseas
lead
acut
respiratori
failur
technic
consider
might
account
niv
failur
aim
current
studi
test
hypothesi
patient
home
ventil
experi
lower
rate
failur
ventil
noninvas
icu
patient
method
retrospect
studi
prospect
data
collect
includ
patient
admit
januari
decemb
icu
chu
fbourguiba
monastir
acut
hypercapn
respiratori
failur
includ
patient
collect
demograph
clinic
data
detail
diagnosi
workup
ventilatori
support
outcom
success
vs
failur
variabl
usual
consid
impact
ventilatori
outcom
compar
patient
success
niv
cours
niv
failur
continu
variabl
present
mean
sd
p
consid
statist
signific
result
studi
period
patient
admit
icu
hypercapn
respiratori
failur
niv
primari
mode
ventilatori
support
home
ventil
main
caus
decompens
overal
cardiac
dysfunct
icuconduct
niv
fail
patient
similar
rate
patient
prior
home
ventil
n
compar
patient
without
prior
home
ventil
n
tabl
depict
risk
factor
niv
failur
disclos
statist
analysi
conclus
prior
home
ventil
associ
lower
rate
niv
failur
suggest
failur
technic
reason
highli
preval
seri
niv
failur
riskfactor
disclos
pertain
clinic
sever
decompens
caus
annal
intens
care
suppl
introduct
mechan
ventil
exacerb
copd
aecopd
aim
provid
adequ
ga
exchang
reduc
work
breath
wob
extracorpor
remov
valuabl
addit
modal
aecopd
patient
requir
invas
mechan
ventil
imv
improv
ga
exchang
without
deleteri
consequ
term
dynam
hyperinfl
howev
littl
known
quantif
benefit
patient
method
open
phase
iiiii
prospect
crossov
fix
order
studi
perform
deepli
sedat
imv
aecopd
patient
dynam
hyperinfl
ga
exchang
compar
without
hemolung
alung
pittsburgh
usa
adjust
respiratori
rate
carescap
ge
healthcar
adjust
algorithm
either
posit
neg
aim
normal
arteri
ph
valu
base
mainli
nativ
lung
valu
possibl
wob
campbel
method
without
measur
end
wean
process
result
express
median
iqr
nonparametr
test
use
result
patient
includ
center
period
tabl
indic
main
result
obtain
without
use
higher
permit
valu
sweep
ga
flow
adjust
respiratori
rate
wob
measur
joulesmin
joulesl
possibl
patient
indic
nearsignific
higher
valu
stop
sweep
ga
flow
h
period
versu
jmin
p
versu
jl
p
three
patient
die
inicu
patient
success
hospitaldischarg
total
durat
day
tracheal
intub
durat
tracheal
intub
initi
durat
icu
stay
vap
episod
hemorrhag
thrombot
complic
conclus
signific
ph
improv
observ
algorithm
ph
normal
perform
rather
well
without
reduct
respiratori
rate
whole
group
accordingli
improv
dynam
hyperinfl
due
mix
respiratorymetabol
acidosi
patient
ii
intrins
hemolung
properti
low
middl
extracorpor
blood
flow
membran
surfac
area
result
term
wob
line
previou
public
annal
intens
care
suppl
introduct
definit
septic
shock
includ
vasopressor
treatment
maintain
mean
arteri
pressur
mmhg
lactat
concentr
mmoll
impact
hyperoxia
patient
fulfil
criteria
unknown
patient
method
conduct
post
hoc
analysi
trial
includ
patient
requir
vasopressor
therapi
avail
plasma
lactat
valu
studi
inclus
compar
effect
hyperoxia
normoxia
treatment
mortal
patient
hyperlactatemia
mmoll
patient
requir
vasopressor
hypotens
without
hyperlactatemia
result
patient
enrol
analysi
lactat
mmoll
lactat
lower
equal
mmoll
among
patient
lactat
mmoll
hyperoxia
normoxia
treat
respect
patient
lactat
mmoll
significantli
less
coronari
arteri
diseas
cirrhosi
requir
surgeri
frequent
also
higher
ill
sever
sofa
vs
p
requir
renal
replac
therapi
rrt
receiv
vasopressor
mechan
ventil
longer
time
mortal
rate
day
higher
hyperoxia
treat
patient
lactat
mmoll
compar
normoxia
treat
patient
vs
p
despit
similar
rrt
requir
well
vasopressor
mechan
ventilationfre
day
multivari
analysi
show
independ
associ
hyperoxia
mortal
day
patient
lactat
mmoll
hyperoxia
effect
mortal
outcom
conclus
studi
suggest
hyperoxia
may
associ
higher
mortal
rate
patient
septic
shock
use
criteria
patient
hypotens
requir
vasopressor
without
hyperlactatemia
annal
intens
care
suppl
introduct
obesityhypoventil
syndrom
oh
increas
caus
acut
hypercapn
respiratori
failur
ahrf
intens
care
unit
icu
object
describ
epidemiolog
ventilatori
manag
outcom
patient
oh
admit
icu
ahrf
patient
method
retrospect
built
cohort
oh
patient
stay
pneumolog
ward
admit
ahrf
icu
take
part
tertiari
univers
teach
hospit
lyon
franc
januari
septemb
clinic
function
biolog
characterist
patient
time
oh
diagnosi
use
covari
main
endpoint
rate
success
noninvas
ventil
niv
icu
secondari
endpoint
patient
surviv
oh
diagnosi
last
followup
risk
factor
icu
admiss
longterm
surviv
includ
role
icu
stay
data
express
median
quartil
count
percentag
compar
nonparametr
test
surviv
measur
method
differ
restrict
mean
surviv
time
rmst
multivari
logist
regress
analysi
use
assess
risk
factor
icu
admiss
cox
proport
hazard
model
multist
model
use
determin
risk
factor
longterm
surviv
result
onehundr
fifteen
preval
patient
oh
includ
median
followup
period
year
patient
admit
icu
ahrf
frequent
caus
ahrf
congest
heart
failur
fourteen
patient
treat
oh
continu
bilevel
posit
airway
pressur
prior
icu
admiss
niv
use
firstlin
ventilatori
support
patient
success
patient
icu
mortal
low
patient
admit
icu
significantli
higher
age
lower
forc
expiratori
volum
lower
vital
capac
vc
time
oh
diagnosi
differ
rmst
signific
gain
surviv
day
patient
admit
icu
multivari
analysi
show
lower
vc
oh
diagnosi
significantli
associ
higher
risk
icu
admiss
factor
independ
associ
longterm
overal
mortal
multivari
analysi
conclus
ahrf
frequent
oh
diagnosi
gener
respons
niv
lower
vc
associ
higher
risk
icu
admiss
annal
intens
care
suppl
introduct
critic
illnessrel
corticosteroid
insuffici
circi
common
critic
ill
usual
associ
poor
outcom
prolong
durat
mechan
ventil
mv
higher
mortal
circi
may
alter
cardiac
vascular
function
weaninginduc
pulmonari
oedema
wipo
major
mechan
wean
failur
aim
studi
evalu
role
circi
patient
difficult
ventil
wean
possibl
relat
wipo
patient
method
prospect
studi
conduct
intens
care
univers
hospit
franc
patient
mv
h
meet
wean
criteria
fail
first
spontan
breath
trial
sbt
underw
corticotropin
stimul
test
assess
total
blood
cortisol
level
immedi
mg
iv
tetracosactrin
min
afterward
defin
differ
maxim
valu
test
circi
defin
nmoll
nmoll
inadequ
adren
reserv
biomark
natriuret
peptid
protidemia
sampl
echocardiogram
perform
second
sbt
use
diagnos
wipo
defin
accord
two
definit
one
liber
one
conserv
deriv
recent
public
topic
success
extub
defin
patient
aliv
without
reintub
day
extub
result
seventysix
consecut
patient
year
men
difficult
wean
enrol
circi
inadequ
adren
reserv
occur
patient
respect
probabl
success
extub
aliv
significantli
decreas
patient
circi
inadequ
adren
reserv
figur
compar
counterpart
associ
persist
adjust
sever
sofa
score
first
sbt
wipo
occur
patient
accord
liber
conserv
definit
respect
wipo
associ
circi
inadequ
adren
reserv
influenc
wean
outcom
whatev
definit
use
conclus
circi
common
difficult
wean
associ
prolong
find
signific
associ
circi
wipo
annal
intens
care
suppl
introduct
highflow
nasal
cannula
oxygen
therapi
hfnc
recent
techniqu
provid
high
decreas
work
breath
recruit
lung
despit
promis
clinic
result
wean
never
investig
object
describ
factor
associ
success
wean
hfnc
patient
method
retrospect
monocent
studi
period
patient
admit
icu
treat
hfnc
acut
respiratori
failur
includ
patient
never
wean
hfnc
icu
stay
treat
hfnc
associ
niv
receiv
prevent
postextub
hfnc
exclud
primari
outcom
compar
patient
accord
outcom
first
hfnc
wean
attempt
secondari
outcom
compar
evolut
patient
fail
hfnc
wean
first
attempt
success
wean
hfnc
result
patient
includ
success
wean
hfnc
first
attempt
time
first
attempt
success
wean
lower
vs
p
like
correspond
mm
hg
vs
p
higher
rox
index
fail
p
patient
fail
first
attempt
significantli
increas
rox
index
time
success
wean
p
conclus
confirm
studi
rox
index
could
use
noninvas
predictor
success
hfnc
wean
avail
bedsid
annal
intens
care
suppl
introduct
recent
european
american
clinic
practic
guidelin
recommend
firstlin
noninvas
ventil
niv
manag
acut
hypoxem
respiratori
failur
immunocompromis
patient
contrast
nonimmunocompromis
patient
expert
unabl
offer
recommend
given
uncertainti
evid
immunocompromis
patient
particularli
high
mortal
rate
requir
invas
ventil
howev
clear
whether
immunosuppress
statu
risk
factor
niv
failur
aim
assess
influenc
immunosuppress
statu
outcom
patient
treat
niv
acut
respiratori
failur
patient
method
perform
post
hoc
analysi
pool
prospect
studi
acut
hypoxem
respiratori
failur
patient
treat
niv
includ
cardiogen
pulmonari
edema
acuteonchron
respiratori
failur
hypercapnia
exclud
result
among
patient
analyz
immunocompromis
whose
main
reason
cancer
n
immunocompromis
patient
higher
sever
score
upon
icu
admiss
like
bilater
lung
infiltr
receiv
higher
pressuresupport
level
niv
nonimmunocompromis
patient
intub
inicu
mortal
rate
higher
immunocompromis
patient
other
patient
vs
p
patient
vs
p
respect
use
multivari
analysi
immunosuppress
independ
associ
intub
adjust
ci
p
icu
mortal
ci
p
conclus
immunosuppress
statu
influenc
outcom
patient
acut
hypoxem
respiratori
failur
treat
niv
studi
specif
popul
mandatori
annal
intens
care
suppl
introduct
ventilatori
acquir
pneumonia
vap
one
main
nosocomi
infect
adult
icu
date
one
prospect
multicent
studi
perform
six
month
picu
us
prospect
describ
pediatr
vap
design
incipav
studi
report
occurr
vap
european
picu
one
aim
incipav
studi
precis
describ
diagnost
tool
use
pathogen
involv
pediatr
vap
patient
method
multicent
prospect
cohort
studi
includ
patient
mechan
ventil
mv
least
eight
picu
one
netherland
seven
franc
vap
defin
use
cdc
criteria
appli
picu
stay
exclud
h
preceed
follow
picu
patient
describ
admiss
main
risk
factor
ever
test
medic
litteratur
daili
includ
pediatr
intensivist
picu
electron
databas
secur
dedic
websit
ethic
committe
french
societi
intens
care
approv
studi
declar
cnil
record
clinicaltri
parent
legal
repres
individu
inform
dedic
sheet
descript
data
report
number
median
firstthird
quartil
result
result
base
declar
inform
report
incipav
databas
first
open
septemb
clean
total
vap
accord
cdc
criteria
declar
day
mv
least
one
pathogen
identifi
case
vap
one
diagnosi
made
tracheal
aspir
without
quantit
cultur
respect
blind
protect
specimen
brush
without
quantit
cultur
respect
identifi
pathogen
pseudomona
aeruginosa
pa
haemophilu
influenza
hi
staphylococcu
aureu
sa
streptococcu
pneumonia
sp
stenotrophomona
maltophilia
sm
hi
sp
involv
earli
vap
day
pa
sm
sa
report
late
onset
vap
conclus
tracheal
aspir
quantit
cultur
still
method
choic
diagnos
vap
picu
nosocomi
pathogen
mainli
involv
day
mv
precis
analysi
plan
clean
databas
includ
special
read
case
vap
annal
intens
care
suppl
introduct
parapneumon
effus
pleural
empyema
common
complic
communityacquir
bacteri
pneumonia
children
yet
consensu
concern
manag
patholog
expert
recommend
scarc
object
studi
compar
whether
evolut
patient
benefit
drainag
procedur
patient
method
retrospect
singlecent
studi
collect
data
children
treat
pleural
infect
strasbourg
univers
hospit
may
may
group
children
compar
concenr
medic
invas
treatment
receiv
thoracentesi
chest
drain
insert
without
instil
fibrinolyt
agent
surgic
techniqu
result
children
benefit
invas
treatment
strategi
antibiot
alon
aa
epidemiolog
data
group
compar
comorbid
vaccin
statu
signific
differ
durat
oxygen
depend
day
aa
group
versu
day
group
p
time
elaps
obtain
apyrexia
day
aa
group
versu
day
group
p
overal
hospit
stay
durat
intens
care
initi
creactiv
protein
level
measur
mgl
aa
group
versu
mgl
group
p
propos
predict
score
invas
procedur
base
initi
crp
pleural
ultrasound
data
conclus
pneumonia
children
low
moder
volum
effus
may
show
favor
clinic
cours
treat
antibiot
prospect
random
control
trial
need
reassess
indic
invas
procedur
manag
children
pleural
infect
annal
intens
care
suppl
introduct
protect
mechan
ventil
adjuv
therapi
sever
ard
welldefin
adult
pediatr
popul
howev
clearli
identifi
recommend
avail
perform
protect
ventil
pediatr
ecmo
aim
studi
first
describ
potenti
associ
ventilatori
set
ecmo
outcom
ard
patient
secondari
goal
compar
three
period
interest
identifi
signific
modif
potenti
consequ
surviv
rate
patient
method
perform
observ
monocentr
retrospect
studi
januari
decemb
patient
treat
ecmo
refractori
ard
includ
collect
data
day
day
day
day
ecmo
three
period
interest
defin
retrospect
collect
data
local
databas
approv
french
data
protect
author
result
patient
treat
extracorpor
membran
oxygen
includ
identifi
increas
number
ecmo
pediatr
refractori
ard
associ
higher
surviv
rate
throughout
three
period
osi
oxygen
satur
index
preecmo
paramet
significantli
associ
higher
mortal
identifi
signific
modif
adjuv
therapi
illustr
sharp
increas
use
neuromuscular
blocker
prone
posit
ecmo
also
show
evid
strong
modif
ventilatori
paramet
ecmo
exampl
tidal
volum
significantli
lower
throughout
period
cckg
vs
cckg
drive
pressur
vs
cm
contrari
peep
higher
recent
period
final
identifi
improv
surviv
rate
three
period
conclus
recent
modif
ventilatori
paramet
ecmo
pediatr
ard
aim
implement
better
lung
protect
modif
associ
better
surviv
howev
correl
surviv
ventil
set
remain
unclear
multicentr
studi
help
physician
identifi
prognosi
factor
annal
intens
care
suppl
introduct
septic
shock
ss
recent
redefin
adult
lifethreaten
organ
dysfunct
caus
dysregul
host
respons
infect
due
pediatr
specif
adult
definit
transpos
children
toxic
shock
syndrom
tss
particular
entiti
infecti
shock
larg
pediatr
preval
toxin
specif
streptococcu
staphylococcu
aureu
lead
superantigen
activ
tlymphocyt
respons
major
cytokin
storm
multiorgan
failur
immunosuppress
induc
ss
demonstr
adult
children
investig
whether
similar
immun
disord
aris
tss
patient
method
singlecent
prospect
studi
includ
children
yearsold
consecut
admit
pediatr
intens
care
unit
ss
surviv
sepsi
campaign
goldstein
criteria
tss
center
diseas
control
septemb
juli
control
recruit
outpati
admit
elect
benign
surgeri
without
criteria
infect
immun
monitor
realiz
flow
cytometri
includ
hladr
express
monocyt
mhladr
total
lymphocyt
count
lymphocyt
subpopul
proport
cell
regulatori
cell
nk
cell
b
cell
sampl
analyz
day
shock
onset
clinic
data
collect
prospect
well
sever
score
secondari
nosocomi
infect
occurr
result
fortysix
ss
tss
control
recruit
time
point
mhladr
ss
tss
group
decreas
compar
control
fig
moreov
mhladr
significantli
higher
tss
day
ss
lymphocyt
time
cours
also
differ
ss
tss
profound
lymphopenia
occur
day
tss
ss
correct
faster
tss
day
day
ss
differ
observ
concern
regulatori
cell
thirteen
patient
ss
present
secondari
infect
compar
one
tss
group
conclus
studi
show
despit
similar
initi
shock
immun
respons
significantli
differ
ss
tss
tss
induc
persist
immunesuppress
seen
ss
highlight
differ
time
cours
mhladr
lymphocyt
secondari
infect
occurr
one
type
septic
shock
differ
infecti
shock
differ
immun
respons
clinic
outcom
result
reinforc
object
better
character
immun
state
patient
intens
care
order
propos
person
medicin
adapt
immunemodulatori
therapi
annal
intens
care
suppl
introduct
septic
shock
common
patholog
intens
care
unit
respons
high
mortal
rate
extracorpor
life
support
ecl
use
patient
longer
respond
standard
treatment
includ
inotrop
recent
multicent
studi
involv
children
septic
shock
septic
shock
score
sss
prove
highli
reliabl
identifi
patient
risk
death
abl
defin
refractori
septic
shock
object
studi
evalu
two
version
sss
bedsid
sss
bsss
comput
csss
group
patient
hospit
septic
shock
receiv
ecl
support
patient
method
retrospect
studi
includ
patient
age
month
year
hospit
intens
care
unit
necker
enfant
malad
trousseau
hospit
septic
shock
requir
ecl
assist
januari
march
five
data
collect
time
chosen
sepsi
time
ecl
decis
time
ecl
start
time
end
hospit
time
first
collect
clinic
biolog
criteria
collect
calcul
differ
predict
score
septic
shock
group
deceas
patient
group
live
patient
compar
differ
time
result
patient
includ
studi
die
hospit
time
studi
bsss
csss
poor
reliabl
identifi
deceas
children
vasoactiveinotrop
score
significantli
higher
ecl
start
time
deceas
patient
decreas
ecl
decis
time
ecl
start
time
live
patient
conclus
pilot
studi
test
databas
children
septic
shock
receiv
ecl
aphp
intens
care
unit
continu
studi
carri
part
collabor
project
european
societi
pediatr
neonat
intens
care
espnic
extend
pediatr
intens
care
unit
clarifi
ecl
success
criteria
character
evolut
organ
failur
thu
better
defin
ecl
use
children
septic
shock
annal
intens
care
suppl
introduct
sickl
cell
diseas
scd
increas
global
health
problem
approxim
infant
born
everi
year
scd
associ
decreas
life
expect
half
death
occur
icu
preexist
predict
model
built
cooper
studi
scd
show
relationship
exist
earli
clinic
predictor
complic
outcom
co
identif
risk
factor
could
potenti
immedi
effect
prevent
clinic
complic
improv
qualiti
life
hundr
thousand
children
worldwid
aim
identifi
earli
predictor
co
defin
icu
stay
day
need
vital
support
death
children
scd
patient
method
retrospect
observ
cohort
studi
scd
patient
period
conduc
french
territori
america
teach
hospit
scd
referr
center
result
infant
admiss
carabdrepa
cohort
co
death
use
multivari
analysi
found
signific
predictor
co
episod
dactyl
defin
pain
tender
hand
feet
age
one
year
ic
hemoglobin
level
less
g
per
decilit
ic
ic
leukocytosi
ic
respiratori
rate
equal
cycl
min
ic
delay
first
symptom
medic
contact
ic
admiss
sepsi
ic
model
demonstr
good
predict
perform
term
discrimin
cstatist
calibr
conclus
sicklecel
diseas
children
high
risk
life
threaten
complic
episod
dactyl
sustain
drop
hemoglobin
associ
sepsi
context
delay
medic
care
strong
predictor
complic
outcom
annal
intens
care
suppl
introduct
traumatolog
lead
caus
death
young
adult
children
hemorrhag
shock
major
aggrav
factor
trauma
howev
data
avail
pediatr
popul
triss
method
offer
standard
approach
evalu
outcom
trauma
care
enabl
determin
individu
probabl
surviv
ps
patient
accord
trauma
injuri
sever
score
aim
studi
identifi
multipl
trauma
children
admit
hemorrhag
shock
pediatr
trauma
center
analyz
factor
could
influenc
outcom
use
triss
method
patient
method
perform
monocentr
observ
descript
retrospect
studi
medic
record
includ
patient
children
year
age
admit
multipl
trauma
present
hemorrhag
shock
upon
arriv
patient
includ
identifi
mean
computer
databas
intern
servic
primari
outcom
death
result
januari
april
multipl
trauma
children
admit
servic
among
hemorrhag
shock
upon
admiss
includ
studi
median
interquartil
age
weight
year
kg
respect
trauma
profil
similar
polytraumat
children
head
trauma
global
principl
damag
control
resuscit
met
includ
applic
massiv
transfus
protocol
howev
children
actual
correspond
usual
definit
massiv
blood
transfus
ml
kg
h
requir
surgic
hemostasi
procedur
overal
mortal
averag
triss
unexpect
survivor
unexpect
death
accord
triss
method
popul
conclus
studi
multipl
trauma
children
admit
hemorrhag
shock
center
children
heavili
traumat
overal
mortal
rate
howev
triss
method
reveal
observ
mortal
lower
predict
mortal
excess
survivor
check
medic
record
unexpect
survivor
seem
benefici
aggress
prehospit
resuscit
care
refer
boyd
cr
tolson
cope
ws
evalu
trauma
care
triss
method
trauma
score
injuri
sever
score
j
trauma
annal
intens
care
suppl
introduct
electrocardiogram
ecg
essenti
tool
diagnosi
acut
coronari
syndrom
ac
howev
diagnost
perform
postresuscit
ecg
usual
poor
set
outofhospit
cardiac
arrest
ohca
aim
evalu
perform
repeat
ecg
prehospit
period
order
identifi
patient
requir
emerg
percutan
coronari
intervent
pci
ohca
patient
method
includ
consecut
seri
ohca
patient
obviou
extracardiac
caus
immedi
coronari
angiogram
cag
perform
admiss
first
ecg
earli
ecg
return
spontan
circul
rosc
last
ecg
perform
prior
cag
late
ecg
classifi
group
blind
angiograph
result
st
segment
elev
st
left
bundl
branch
block
anomali
st
suspect
ischemia
sign
ischemia
respect
perform
earli
late
ecg
assess
use
need
earli
pci
main
endpoint
result
patient
includ
pci
admiss
chang
classif
earli
late
ecg
observ
patient
pattern
stelev
group
present
late
ecg
predict
need
pci
good
specif
poor
sensit
tabl
multivari
analysi
stelev
pattern
group
late
ecg
stronger
predictor
need
pci
p
compar
pattern
observ
earli
ecg
p
presenc
pattern
ischemia
late
ecg
also
independ
predictor
need
pci
p
good
sensit
low
specif
tabl
absenc
ischem
aspect
late
ecg
perform
min
rosc
independ
predictor
pci
p
conclus
although
perform
better
immedi
postresuscit
ecg
observ
reliabl
late
ecg
insuffici
order
distinguish
patient
requir
earli
pci
earli
cag
avoid
annal
intens
care
suppl
introduct
due
collaps
cardiopulmonari
resuscit
cpr
maneuv
major
traumat
injuri
may
complic
cours
resuscit
outofhospit
cardiac
arrest
patient
ohca
goal
assess
preval
injuri
describ
characterist
identifi
predict
factor
patient
method
conduct
observ
studi
period
french
cardiac
arrest
ca
center
nontraumat
ohca
patient
admit
aliv
icu
studi
major
injuri
identifi
rank
use
function
twolevel
scale
sever
lifethreaten
consequenti
classifi
cprrelat
injuri
collapserel
injuri
depend
predomin
mechan
factor
associ
occurr
cprrelat
injuri
icu
surviv
identifi
use
multivari
logist
regress
result
major
traumat
injuri
follow
ohca
observ
patient
ci
classifi
lifethreaten
injuri
case
traumat
injuri
consid
contribut
death
case
injuri
relat
cpr
maneuv
patient
ci
multivari
analysi
age
ci
p
male
gender
ci
p
ca
occur
home
ci
p
significantli
associ
occurr
cprrelat
injuri
cprrelat
injuri
associ
icu
surviv
ci
p
conclus
major
traumat
injuri
common
cardiopulmonari
resuscit
studi
necessari
evalu
interest
systemat
traumat
checkup
resuscit
ohca
patient
order
detect
injuri
annal
intens
care
suppl
introduct
object
studi
observ
practic
procedur
sedat
analgesia
psa
emerg
depart
ed
evalu
effect
patient
method
januari
juli
conduct
prospect
multicentr
studi
ed
prehospit
set
enrol
adult
patient
need
pain
procedur
would
requir
psa
procedur
divid
group
disloc
b
displac
fractur
c
procedur
abscess
drainag
foreign
bodi
psa
drug
divid
group
sed
drug
propofol
ketamin
midazolam
morphin
absenc
drug
oxygen
nitrousoxyd
premix
use
composit
primari
outcom
defin
success
psa
success
procedur
ep
feel
suffici
sedat
patient
absenc
pain
memori
procedur
result
patient
enrol
psa
success
accord
primari
outcom
criteria
point
reach
point
pain
decreas
measur
numer
rate
scale
nr
median
iqr
number
patient
procedur
group
follow
group
n
group
b
n
group
c
n
drug
group
predomin
n
success
rate
higher
compar
group
group
respect
p
multivari
analysi
psa
success
independ
associ
factor
ramsay
sedat
scale
p
protect
factor
morphin
group
psa
success
p
advers
event
rate
studi
compar
rate
intern
studi
advers
event
easili
treat
seriou
consequ
conclus
prospect
multicentr
studi
patient
show
effici
perfect
case
satisfactori
result
global
effici
posit
link
use
sed
drug
neg
cutan
procedur
abscess
drainag
annal
intens
care
suppl
introduct
retroperiton
hematoma
rph
frequent
observ
case
pelvic
fractur
rph
sign
traumat
pelvic
hemorrhag
studi
valid
quantif
score
rph
traumat
context
aim
studi
test
perform
hrp
quantif
score
predict
outcom
polytraumat
patient
pelvic
fractur
patient
method
retrospect
studi
perform
trauma
center
sever
trauma
patient
pelvic
fractur
underw
ct
scan
admiss
includ
amount
retroperiton
effus
quantifi
use
semiquantit
method
count
number
compart
affect
spread
blood
ten
compart
retroperiton
caviti
consid
preves
space
lateroves
space
laterorect
space
presacr
space
right
left
iliopsoa
space
periaort
psoa
space
right
left
parietocol
space
periren
fascia
extens
rph
categor
compart
absent
moder
larg
bilater
total
score
patient
classifi
group
accord
rph
score
mild
none
moder
abund
compar
term
transfus
requir
pelvic
hemostat
manag
prognost
variabl
result
total
sever
trauma
patient
includ
mean
age
year
mean
iss
averag
rph
score
among
patient
abund
rph
rph
moder
mild
rph
massiv
transfus
requir
import
abund
rph
group
vs
vs
well
pelvic
embol
requir
vs
vs
pelvic
fixat
vs
vs
mortal
vs
vs
p
similarli
day
mechan
ventil
length
stay
significantli
associ
rph
abund
p
predict
valu
moder
abund
hrp
determin
transfus
intervent
need
well
risk
death
present
figur
use
roc
curv
analysi
global
abil
rph
score
robust
predict
transfus
rbc
massiv
transfus
death
conclus
ct
scan
semiquantit
analysi
hrp
admiss
allow
reliabl
predict
transfus
requir
outcom
trauma
patient
pelvic
fractur
annal
intens
care
suppl
introduct
venou
thromboembol
vte
wellestablish
complic
trauma
recent
studi
suggest
pulmonari
embol
pe
may
occur
earli
even
immedi
injuri
aim
studi
analyz
incid
risk
factor
prognosi
earli
pe
among
intens
care
unit
icu
trauma
patient
patient
method
conduct
twenti
month
long
prospect
cohort
includ
trauma
patient
confirm
pe
diagnosi
admit
icu
januari
august
earli
post
traumat
pe
defin
pulmonari
embol
diagnos
within
first
h
injuri
patient
includ
screen
earli
pe
day
factor
associ
earli
pe
identifi
use
univari
multivari
analysi
result
studi
period
patient
posit
diagnosi
pe
includ
accord
analysi
case
patient
present
pe
within
h
trauma
eventsth
patient
earli
pe
group
older
late
pe
group
p
bodymassindex
bmi
thirti
p
high
sequanti
organ
failur
score
sofa
admiss
p
day
pe
diagnosi
earli
group
also
present
higher
sofa
score
p
higher
infect
rate
p
biolog
assess
reveal
lower
platelet
level
p
lower
p
f
ratio
earli
group
p
studi
show
earli
pe
associ
transfus
p
surgic
treatment
measur
p
incid
long
bone
fractur
lower
extrem
higher
earli
pe
compar
patient
p
use
multivari
logist
regress
model
higher
age
p
sofa
score
p
bmi
thirti
p
use
surgic
treatment
measur
p
predict
earli
time
pe
trauma
patient
wherea
pulmonari
infect
independ
associ
late
pe
long
bone
fractur
independ
relat
earli
occurr
pe
conclus
cohort
demonstr
mani
posttraumat
pe
occur
earli
posttraumat
period
best
knowledg
first
prospect
studi
conduct
icu
studi
larger
patient
popul
requir
creat
accur
predict
model
annal
intens
care
suppl
introduct
bag
mask
ventil
spread
technic
ventil
cardio
pulmonari
resuscit
cpr
despit
sever
advers
effect
gastric
ga
insuffl
may
favor
lung
regurgit
result
occurr
aspir
pneumonia
hypothes
continu
chest
compress
cc
may
limit
risk
high
tidal
volum
gastric
inflat
compar
interrupt
cc
strategi
aim
experiment
studi
assess
impact
differ
cc
ventil
strategi
gastric
inflat
ventil
min
prolong
simul
cpr
patient
method
thiel
embalm
cadav
tec
donat
program
du
quebec
troisrivier
ventil
min
recruit
lung
flow
airway
pressur
measur
airway
open
acqknowledg
softwar
surgic
gastrostomi
perform
cm
midlin
laparotomi
introduc
cuf
tracheal
tube
size
stomach
caviti
tube
connect
wright
spiromet
measur
cumul
gastric
inflat
volum
experiment
protocol
strategi
randomli
appli
min
cadav
interrupt
chest
compress
icc
two
success
bag
insuffl
interrupt
cc
everi
cc
continu
chest
compress
ccc
cc
ventil
ratio
first
strategi
without
interrupt
cc
continu
cc
bag
insuffl
everi
ccc
min
strategi
stomach
complet
empti
gastrostomi
tube
order
strategi
experi
random
cadav
result
cadav
analyz
mean
age
year
femal
pbw
kg
expir
bag
tidal
volum
averag
min
long
period
ml
icc
ml
ccc
ml
ccc
min
cumul
gastric
inflat
volum
significantli
higher
icc
compar
ccc
strategi
fig
min
icc
min
ccc
min
ccc
min
p
conclus
compar
recommend
icc
strategi
continu
chest
compress
significantli
reduc
cumul
gastric
inflat
interestingli
ccc
affect
ventil
actual
deliv
cpr
optim
ratio
chest
compress
en
ventil
continu
chest
compress
remain
open
discuss
annal
intens
care
suppl
introduct
cardiac
event
often
seen
acut
cerebr
palsi
would
indic
poor
prognosi
purpos
studi
clarifi
heartbrain
interact
term
incid
repercuss
morbid
mortal
cerebr
palsi
patient
patient
method
prospect
studi
month
includ
consecut
acut
cerebr
palsi
patient
initi
admit
vital
emerg
room
benefit
systemat
cardiac
assess
name
ecg
echocardiogram
troponin
assay
h
patient
transfer
anoth
hospit
cardiac
checkup
h
exclud
epidemiolog
clinic
paraclin
therapeut
evolutionari
paramet
studi
univari
statist
studi
carri
deduc
prognost
factor
earli
mortal
h
among
cardiac
assess
compon
p
result
patient
includ
averag
age
year
sex
ratio
diagnos
relat
cerebroles
ischem
stroke
case
sever
head
trauma
case
hemorrhag
stroke
case
sever
mening
case
cardiac
event
observ
electr
anomali
patient
increas
troponin
patient
echocardiograph
anomali
patient
distribut
cardiac
event
type
brain
injuri
shown
tabl
earli
mortal
rate
h
death
hemorrhag
stroke
ischem
stroke
sever
head
trauma
sever
mening
prognost
valu
variou
cardiac
event
cerebr
palsi
patient
type
aggress
shown
tabl
discuss
studi
show
statist
signific
differ
term
earli
mortal
accord
presenc
absenc
one
cardiac
incid
hand
import
npv
note
brain
lesion
combin
conclus
absenc
cardiac
event
cerebr
palsi
patient
would
favor
better
earli
evolut
find
confirm
broader
studi
recommend
perform
cardiac
checkup
cerebr
palsi
patient
first
h
annal
intens
care
suppl
introduct
dopplerbas
resist
index
ri
semiquantit
evalu
renal
perfus
use
colourdoppl
sqp
suggest
potenti
predictor
aki
occurr
icu
patient
without
renal
dysfunct
result
howev
limit
preliminari
data
studi
aim
evalu
perform
ri
sqp
predict
aki
within
day
criticallyil
patient
without
overt
aki
patient
method
posthoc
analysi
multicentr
prospect
collect
dataset
adult
patient
without
cardiac
arrhythmia
requir
mechan
ventil
includ
patient
sever
chronic
renal
dysfunct
known
renal
arteri
stenosi
exclud
aki
defin
accord
urinari
output
serum
creatinin
criteria
kdigo
definit
renal
doppler
perform
studi
inclus
result
report
n
median
iqr
adjust
factor
associ
aki
develop
assess
use
mix
logist
regress
model
take
centr
random
effect
result
overal
patient
includ
studi
aki
studi
inclus
ultim
includ
post
hoc
analysi
half
patient
male
gender
n
median
age
iqr
addit
mechan
ventil
patient
requir
vasopressor
sepsi
inclus
median
lod
score
iqr
overal
patient
develop
aki
first
day
icu
stay
semiquantit
perfus
score
rang
perfus
perfus
respect
patient
without
aki
day
p
dopplerbas
resist
index
respect
patient
without
aki
day
p
figur
area
roc
curv
predict
aki
within
day
sqp
ri
adjust
confound
neither
sqp
ci
dopplerbas
ri
ci
associ
aki
day
conclus
result
suggest
neither
dopplerbas
resist
index
semiquantit
renal
perfus
accur
predict
occurr
aki
icu
patient
requir
mechan
ventil
annal
intens
care
suppl
introduct
perform
urinari
tissu
inhibitor
insulinlik
growth
factor
bind
predict
renal
recoveri
poorli
studi
preliminari
studi
dopplerbas
renal
resist
index
ri
might
help
differenti
transient
persist
acut
kidney
injuri
aki
aim
studi
compar
perform
ri
predict
shortterm
revers
aki
critic
ill
patient
patient
method
prospect
monocentr
studi
includ
consecut
critic
ill
patient
aki
ri
measur
within
h
admiss
urinari
measur
renal
recoveri
evalu
day
receiveroper
characterist
curv
roc
plot
evalu
diagnost
perform
ri
predict
persist
aki
result
patient
includ
transient
aki
persist
aki
ri
transient
aki
group
persist
aki
group
p
significantli
differ
time
group
perform
poor
respect
area
roc
curv
ci
ci
ci
ci
area
roc
curv
ri
ci
ri
predict
persist
aki
ci
sensit
ci
specif
ri
neither
correl
age
rho
p
mean
arteri
pressur
rho
p
quantiti
fluid
rho
p
logist
regress
found
ri
odd
ratio
step
p
sepsisrel
organ
failur
assess
score
p
predict
persist
aki
conclus
dopplerbas
renal
resist
index
better
perform
predict
revers
aki
critic
ill
patient
urinari
unabl
differenti
transient
persist
aki
studi
need
precis
adequ
factor
influenc
ri
annal
intens
care
suppl
introduct
acut
kidney
injuri
aki
intens
care
unit
icu
carri
high
mortal
morbid
potenti
activ
system
aki
may
play
role
profibrot
pathway
blocker
acei
arb
well
known
benefit
chronic
kidney
diseas
may
potenti
nephrotox
aki
nevertheless
ancillari
studi
frogicu
cohort
icm
may
recent
shown
lower
mortal
year
followup
patient
receiv
acei
arb
episod
aki
kdigo
icu
discharg
vs
p
present
studi
analyz
use
acei
arb
kdigo
aki
potenti
effect
longterm
mortal
patient
method
ancillari
akiki
studi
nejm
patient
discharg
aliv
icu
includ
longterm
prognosi
mortal
assess
accord
treatment
acei
arb
icu
discharg
use
univari
multivari
analys
adjust
potenti
confound
factor
result
among
patient
discharg
aliv
receiv
acei
arb
icu
discharg
tabl
detail
patient
characterist
patient
without
acei
arb
sever
attest
higher
sap
p
higher
rate
catecholamin
infus
p
aki
howev
mortal
significantli
differ
two
group
acei
arb
vs
p
mortal
risk
associ
nonprescript
acei
arb
adjust
prognost
variabl
p
discuss
substanti
proport
patient
receiv
acei
arb
icu
discharg
episod
sever
aki
find
differ
mortal
favor
system
blocker
observ
ancillari
studi
frogicu
includ
patient
acei
arb
wherea
present
studi
includ
could
explain
differ
popul
less
sever
aki
frogicu
lack
power
studi
conclus
studi
confirm
posit
effect
longterm
mortal
random
control
trial
acei
arb
icu
discharg
episod
sever
aki
warrant
annal
intens
care
suppl
introduct
chronic
kidney
diseas
ckd
associ
high
mortal
relat
sepsi
studi
alreadi
shown
urem
toxin
action
vascular
immun
disord
ckd
potenti
role
acut
kidney
injuri
aki
undetermin
kinet
urem
toxin
concentr
consequ
aki
disserv
address
aim
studi
evalu
kinet
three
urem
toxin
concentr
indoxyl
sulfat
sulfat
pc
first
week
kidney
failur
urem
mice
model
consequ
endotoxemia
patient
method
studi
explor
vivo
kinet
three
urem
toxin
concentr
day
control
sham
kidney
injuri
induct
ki
ki
obtain
electrocauter
follow
contralater
nephrectomi
two
week
later
urem
toxin
concentr
determin
sera
sacrific
day
ki
induct
lp
challeng
perform
mg
kg
ip
sham
ki
group
day
surviv
follow
two
group
ki
mice
fed
arabinoxylanoligosaccharid
chelat
pc
group
axo
sevelam
chelat
phosphat
known
decreas
fgf
group
sevelam
expos
lp
day
ki
follow
surviv
result
pc
fgf
concentr
increas
rapidli
kidney
injuri
day
last
ki
group
compar
group
sham
figur
associ
elev
cytokin
concentr
serum
day
ki
mice
expos
lp
die
wherea
sham
lp
anim
surviv
fig
treatment
axo
sevelam
day
preced
lp
challeng
decreas
respect
pc
concentr
axo
group
fgf
concentr
sevelam
group
improv
surviv
ki
anim
conclus
experiment
studi
accumul
urem
toxin
appear
earli
cours
kidney
failur
associ
local
express
proinflammatori
molecul
accumul
toxin
associ
higher
mortal
endotoxemia
decreas
pc
fgf
concentr
associ
improv
surviv
lp
challeng
earli
accumul
urem
toxin
potenti
role
sepsi
mortal
need
confirm
aki
human
annal
intens
care
suppl
introduct
aki
dread
complic
patient
hematolog
malign
associ
increas
morbid
mortal
moreov
aki
may
preclud
abil
receiv
chemotherapi
howev
current
knowledg
kinet
renal
recoveri
persist
renal
dysfunct
limit
patient
method
conduct
retrospect
singlecent
studi
includ
patient
hematolog
malign
admit
intens
care
unit
icu
nant
univers
hospit
januari
decemb
purpos
studi
epidemiolog
aki
occurr
major
advers
kidney
event
make
result
one
hundr
three
patient
includ
among
aki
median
age
year
old
male
common
malign
lymphoma
acut
myeloblast
leukemia
myeloma
patient
newli
diagnos
malign
relaps
diseas
chemotherapi
administ
day
icu
admiss
simplifi
acut
physiolog
score
ii
sap
day
icu
stay
patient
receiv
vasopressor
requir
invas
mechan
ventil
icu
hospit
mortal
respect
accord
kdigo
criteria
aki
stage
aki
stage
aki
stage
requir
renal
replac
therapi
rrt
icu
mortal
rrt
patient
overal
median
durat
aki
day
increas
day
kdigo
stage
patient
day
kdigo
stage
patient
day
kdigo
stage
patient
among
survivor
renal
recoveri
occur
patient
icu
discharg
patient
patient
make
report
patient
icu
discharg
patient
hospit
discharg
day
discharg
conclus
criticallyil
patient
hematolog
malign
high
incid
aki
although
almost
patient
discharg
aliv
icu
make
account
roughli
everi
patient
research
need
identifi
predictor
make
develop
new
therapeut
strategi
might
translat
better
longterm
outcom
annal
intens
care
suppl
introduct
indic
modal
renal
replac
therapi
rrt
intens
care
unit
icu
patient
acut
kidney
injuri
aki
still
debat
akiki
trial
show
delay
rrt
strategi
absenc
lifethreaten
condit
affect
mortal
allow
nearli
patient
escap
rrt
compar
earli
rrt
strategi
patient
aki
obviou
econom
counterpart
evalu
studi
patient
method
financi
cost
rrt
continu
intermitt
assess
patient
seven
french
icu
septemb
august
take
account
cathet
circuit
dialyz
membran
dialys
replac
fluid
price
medic
nurs
work
time
includ
time
venou
catheter
rrt
durat
includ
circuit
prepar
restitut
time
also
record
cost
comput
extrapol
figur
akiki
popul
order
estim
cost
differ
two
strategi
earli
delay
analysi
restrict
first
h
inclus
result
mean
work
time
minut
intermitt
rrt
minut
continu
rrt
mean
financi
cost
first
h
rrt
initi
euro
intermitt
rrt
euro
continu
rrt
p
extrapol
figur
patient
includ
akiki
reveal
earli
strategi
associ
cost
euro
delay
one
cost
euro
first
h
random
conclus
studi
highlight
consider
save
safe
obtain
delay
rrt
strategi
icu
patient
sever
aki
refer
gaudri
hajag
schortgen
f
martinlefevr
l
pon
b
boulet
e
et
al
initi
strategi
renalreplac
therapi
intens
care
unit
n
engl
j
med
jul
annal
intens
care
suppl
introduct
unhealthi
use
alcohol
acut
kidney
aki
injuri
major
public
health
problem
chronic
alcohol
exposur
may
directli
indirectli
associ
kidney
damag
littl
known
impact
current
excess
alcohol
consumpt
kidney
function
nontrauma
critic
ill
patient
aim
determin
whether
unhealthi
use
alcohol
independ
associ
aki
intens
care
unit
icu
worst
kidney
function
hospit
discharg
patient
method
prospect
cohort
studi
noncirrhot
nonliv
transplant
recipi
nonchron
dialyz
patient
admit
bed
polyval
icu
univers
hospit
studi
design
power
detect
differ
incid
aki
atrisk
drinker
atrisk
drinker
twosid
alpha
error
atrisk
dink
defin
accord
nation
institut
alcohol
abus
alcohol
criteria
aki
accord
kidney
diseas
improv
global
outcom
kdigo
criteria
patient
follow
hospit
discharg
day
result
period
calcul
cumul
incid
stage
aki
atrisk
drinker
atrisk
drinker
stage
aki
significantli
frequent
admiss
icu
atrisk
drinker
atrisk
drinker
versu
p
cumul
incid
stage
aki
significantli
higher
atrisk
atrisk
drinker
figur
p
logrank
test
adjust
suscept
predispos
factor
aki
atrisk
drink
significantli
associ
aki
hazard
ratio
hr
p
proport
patient
stage
aki
hospit
discharg
among
survivor
significantli
higher
atrisk
atrisk
drinker
versu
respect
p
atrisk
drink
remain
independ
associ
stage
aki
subgroup
patient
without
stage
aki
admiss
icu
hr
p
conclus
result
suggest
kidney
dysfunct
significantli
frequent
atrisk
atrisk
drinker
believ
systemat
accur
identif
patient
prior
alcohol
misus
may
allow
prevent
aki
annal
intens
care
suppl
introduct
acut
respiratori
failur
remain
main
reason
admiss
intens
care
hivinfect
adult
littl
data
viral
epidemiolog
lower
respiratori
tract
infect
popul
patient
method
case
acut
respiratori
failur
hivinfect
adult
admit
two
intens
care
unit
underw
screen
respiratori
viru
multiplex
polymeras
chain
reaction
retrospect
select
result
total
case
includ
hiv
infect
newli
diagnos
case
popul
take
antiretrovir
therapi
treatment
complianc
almost
case
document
viral
respiratori
infect
found
patient
rhinoviru
main
viru
found
case
n
follow
parainfluenza
n
influenza
n
coinfect
found
patient
case
one
coinfect
overal
neither
level
hivrel
immunodefici
use
arv
admiss
seem
associ
increas
risk
respiratori
viral
infect
nevertheless
subpopul
rhinoviru
infect
associ
low
count
outcom
icu
similar
regardless
whether
respiratori
viral
infect
present
conclus
respiratori
virus
frequent
found
acut
respiratori
failur
hiv
subject
proport
appear
similar
studi
look
proport
respiratori
virus
gener
popul
annal
intens
care
suppl
introduct
human
metapneumoviru
hmpv
may
respons
pulmonari
infect
immunocompromis
patient
sought
assess
clinic
radiolog
characterist
associ
presenc
hmpv
respiratori
tract
critic
ill
immunocompromis
patient
patient
method
singl
center
retrospect
cohort
includ
adult
immunocompromis
patient
admit
intens
care
unit
icu
hmpv
detect
respiratori
tract
septemb
june
result
report
n
median
iqr
comparison
perform
fisher
exact
test
wilcoxon
test
appropri
result
immunocompromis
patient
admit
icu
period
patient
present
hmpv
male
age
iqr
hematolog
malign
includ
allogen
stem
cell
transplant
recipi
addit
respiratori
failur
present
shock
clinic
pictur
includ
fever
patient
cough
wherea
extrapulmonari
symptom
less
common
ctscan
pattern
includ
alveolar
consolid
patient
ground
glass
opac
septa
thicken
one
patient
present
anoth
pathogen
bacteri
infect
patient
viral
infect
fungal
infect
one
invas
aspergillosi
icu
admiss
score
iqr
mechan
ventil
requir
patient
vasopressor
renal
replac
therapi
hospit
mortal
rate
found
associ
hemodynam
failur
renal
replac
therapi
neutropenia
conclus
hmpv
found
respiratori
tract
immunocompromis
patient
acut
respiratori
failur
case
anoth
pathogen
also
identifi
ct
pattern
noth
uniqu
could
ascrib
second
pathogen
whether
posit
hmpv
relev
result
unclear
remain
unaddress
set
data
compar
clinic
radiograph
pictur
outcom
patient
posit
hmpv
match
patient
document
influenza
infect
ongo
display
confer
annal
intens
care
suppl
introduct
rel
lymphopenia
rl
consid
lymphocyt
count
white
blood
cell
report
possibl
marker
influenza
especi
pandem
influenza
infect
aim
studi
assess
rl
incid
patient
hospit
intens
care
unit
icu
influenza
infect
find
whether
relat
sever
ill
patient
method
retrospect
monocentr
studi
conduct
medic
icu
abderrahmen
mami
hospit
tunisia
septemb
septemb
inclus
criteria
icu
patient
admit
influenza
infect
collect
clinic
biolog
outcom
data
compar
initi
sever
outcom
rl
patient
group
normal
lymphocyt
count
patient
group
result
tenyear
studi
period
collect
patient
influenza
infect
strain
detect
pcr
techniqu
n
n
mean
age
year
sexratio
f
seven
women
pregnant
white
blood
cell
wbc
valu
found
normal
high
patient
influenza
infect
leucopenia
seen
patient
thrombocytopenia
platelet
present
patient
rl
present
patient
ratio
lymphocyt
monocyt
notic
patient
admiss
sever
assess
sap
ii
score
apach
ii
score
main
reason
icu
admiss
acut
respiratori
failur
patient
ard
noninvas
ventil
need
patient
intub
mean
durat
mechan
ventil
day
mean
length
stay
icu
day
icu
mortal
rate
comparison
sever
ill
compon
accord
rl
presenc
repres
tabl
conclus
rl
frequent
icu
patient
influenza
infect
significantli
frequent
older
patient
rl
associ
higher
sever
score
respiratori
impair
degre
death
annal
intens
care
suppl
introduct
critic
ill
influenza
patient
mortal
rate
coinfect
especi
invas
aspergillosi
recent
document
amongst
patient
thought
play
major
role
prognosi
patient
nevertheless
need
systemat
microbiolog
document
still
wide
accept
icu
health
worker
moreov
high
incid
cardiovascular
event
acut
coronari
syndrom
stroke
within
first
day
influenza
ill
describ
year
aim
studi
assess
daili
practic
regard
microbiolog
investig
coinfect
assess
cardiovascular
event
rate
patient
method
retrospect
observ
studi
novemb
april
four
french
icu
includ
critic
ill
influenza
patient
conduct
influenza
diagnosi
confirm
polymeras
chain
reaction
rapid
test
coinfect
confirm
use
clinic
standard
microbiolog
criteria
stroke
diagnos
sudden
neurolog
symptom
mri
contrast
tomodensitometri
confirm
acut
coronari
syndrom
diagnos
accord
esc
guidelin
result
patient
includ
patient
classifi
suffer
acut
respiratori
syndrom
patient
receiv
non
invas
ventil
day
patient
receiv
invas
mechan
ventil
day
patient
treat
oseltamivir
day
still
aliv
day
bacteri
sputum
cultur
suffer
bacteri
coinfect
mainli
pneumonia
methicillinsuscept
staphylococcu
aureu
patient
fungal
sputum
cultur
blood
galactomannan
dosag
amongst
patient
exhibit
fungi
sputum
cultur
correspond
aspergillu
spp
candida
spp
viral
coinfect
occur
among
patient
especi
coronaviru
regard
cardiovascular
event
acut
coronari
syndrom
occur
patient
stroke
patient
month
diagnosi
influenza
conclus
critic
ill
influenza
patient
frequent
coinfect
bacteria
also
viru
fungi
fungal
viral
coinfect
seem
still
investig
icu
worker
studi
investig
prophylaxi
manag
coinfect
need
cardiovascular
event
prevent
also
studi
among
critic
ill
influenza
patient
annal
intens
care
suppl
introduct
impact
human
metapneumoviru
hmpv
lower
respiratori
tract
infect
unclear
children
adult
patient
aim
review
evalu
preval
lower
respiratori
tract
infect
lrti
need
intensivecareunit
icu
admiss
hospit
mortal
immunocompromis
adult
previou
detect
hmpv
patient
method
systemat
review
perform
accord
prisma
statement
regist
prospero
databas
studi
report
rate
lrti
icu
admiss
mortal
search
pubm
immunocompromis
patient
preval
confid
interv
ci
plot
public
bia
assess
visual
inspect
funnel
plot
summari
estim
rel
risk
confid
interv
calcul
use
randomeffect
model
result
overal
citat
identifi
studi
report
patient
ultim
includ
cohort
studi
case
seri
median
sampl
size
patient
iqr
median
admiss
year
iqr
diagnosi
hmpv
infect
perform
use
rtpcr
nasopharyng
swab
studi
proport
patient
hematolog
malign
iqr
proport
allogen
stem
cell
transplant
iqr
lrti
preval
ci
icu
admiss
requir
patient
ci
last
hospit
mortal
factor
associ
heterogen
assess
use
metaregress
heterogen
result
partli
explain
studi
design
proport
patient
hematolog
malign
proport
patient
coinfect
conclus
systemat
review
two
third
immunocompromis
patient
hmpv
detect
lrti
mani
requir
icu
admiss
high
heterogen
note
may
explain
studi
design
underli
immun
statu
underli
diseas
rate
coinfect
includ
studi
howev
high
risk
bia
justifi
need
addit
studi
field
annal
intens
care
suppl
introduct
mpcr
multiplex
polymeras
chain
reaction
test
wide
use
clinic
routin
howev
clinic
paraclin
featur
virusassoci
respiratori
tract
infect
adult
poorli
describ
especi
acut
respiratori
failur
requir
critic
care
patient
method
prospect
nonintervent
clinic
studi
adult
patient
admit
intens
care
unit
acut
respiratori
failur
subject
multiplex
pcr
viru
nasopharyng
swab
distal
sampl
first
h
icu
stay
includ
prior
get
mpcr
result
clinician
invit
subject
patient
questionnair
ask
symptom
respiratori
extrarespiratori
code
none
maximum
sourc
may
examin
patient
rel
gener
practition
medic
report
result
decemb
april
patient
includ
men
age
year
intub
final
diagnosi
pneumonia
patient
exacerb
chronic
bronchial
diseas
subject
anoth
diagnosi
subject
least
one
viru
identifi
patient
includ
rhinoviru
influenza
respiratori
syncyti
viru
metapneumoviru
coronaviru
univari
analysi
activ
smoke
close
contact
somebodi
ill
rhinorrhea
bronchorrhea
earach
diarrhea
lymphopenia
thrombocytopenia
elev
cpk
associ
document
respiratori
virus
within
airway
conclus
phenotyp
suggest
virusassoci
respiratori
tract
infect
describ
may
help
ration
use
mpcr
test
annal
intens
care
suppl
introduct
transfus
pack
red
blood
cell
rbc
commonli
indic
septic
patient
improv
tissu
oxygen
deliveri
besid
uncertain
benefit
rbc
transfus
carri
immunomodulatori
properti
like
increas
suscept
icuacquir
infect
mortal
rate
aim
studi
address
impact
rbc
transfus
icuacquir
infect
mortal
septic
shock
patient
patient
method
monocent
retrospect
studi
consecut
adult
patient
diagnos
septic
shock
within
first
h
includ
septic
shock
defin
microbiolog
proven
clinic
suspect
infect
associ
acut
circulatori
failur
requir
vasopressor
number
pack
rbc
transfus
day
record
diagnosi
nosocomi
infect
base
current
intern
guidelin
patient
aliv
day
evalu
risk
icuacquir
infect
determin
icuacquir
infect
mortal
address
multivari
timedepend
cox
regress
analysi
result
among
patient
admit
septic
shock
male
median
age
year
old
crude
mortal
rate
overal
patient
receiv
rbc
transfus
median
unit
multivari
analysi
transfus
independ
associ
prior
immunosuppress
ic
p
chronic
kidney
diseas
ic
p
higher
admiss
sofa
score
ic
p
patient
aliv
day
develop
icuacquir
infect
among
patient
receiv
rbc
prior
episod
icuacquir
infect
multivari
analysi
rbc
transfus
independ
associ
develop
icuacquir
infect
ic
p
mortal
significantli
higher
patient
receiv
rbc
vs
p
multivari
analysi
rbc
transfus
independ
associ
mortal
p
conclus
transfus
rbc
septic
shock
patient
associ
increas
risk
icuacquir
infect
mortal
result
support
restrict
rbc
transfus
polici
septic
shock
patient
annal
intens
care
suppl
introduct
respect
influenc
age
perform
statu
ps
critic
ill
patient
malign
poorli
studi
main
object
studi
analys
impact
age
mortal
popul
patient
method
perform
post
hoc
analysi
prospect
multicentr
data
franc
belgium
identifi
relat
age
mortal
five
class
age
comput
accord
quintil
age
best
threshold
age
determin
use
youden
index
analysi
univari
multivari
cox
analysi
mortal
perform
curv
mortal
accord
age
main
risk
factor
comput
result
patient
includ
age
categori
accord
quintil
repartit
follow
year
old
n
n
n
n
n
next
two
age
group
separ
younger
group
age
older
group
age
median
age
iqr
respect
older
age
significantli
associ
higher
mortal
rate
univari
analysi
hr
p
multivari
cox
analysi
main
risk
factor
mortal
age
hr
p
ps
hr
p
sever
inclus
assess
sequenti
organ
failur
assess
sofa
score
admiss
icu
per
one
unit
increas
hr
p
howev
haematolog
malign
charlson
comorbid
score
index
without
age
reason
icu
admiss
significantli
associ
mortal
figur
show
surviv
analysi
relat
age
ps
mortal
p
conclus
older
age
significantli
associ
higher
mortal
threshold
found
accur
discrimin
dead
aliv
patient
despit
prognost
impact
surviv
meaning
subgroup
oldest
patient
moder
limit
autonomi
studi
may
allow
better
select
oldest
patient
like
benefit
icu
admiss
accord
three
simpl
variabl
age
ps
sofa
score
annal
intens
care
suppl
introduct
hemophagocyt
syndrom
hs
rare
lifethreaten
condit
lead
multi
organ
failur
includ
shock
sever
hs
symptomat
treatment
reli
etoposid
infus
hemodynam
instabl
hs
poorli
studi
object
studi
describ
characterist
hs
patient
shock
prognost
factor
impact
etoposid
inject
hemodynam
paramet
patient
method
adult
critic
ill
patient
hs
manag
multidisciplinari
nation
refer
center
retrospect
includ
patient
without
vasopressor
requir
etoposid
infus
exclud
result
forti
patient
includ
twothird
n
male
gender
median
age
iqr
shock
n
acut
respiratori
failur
n
monitor
n
main
reason
icu
admiss
common
hstrigger
underli
hematolog
diseas
malign
diseas
patient
infecti
diseas
system
rheumat
diseas
median
sofa
score
patient
requir
mechan
ventil
n
median
lactat
level
mmoll
hospit
mortal
n
associ
sever
assess
need
mechan
ventil
vs
p
male
gender
vs
survivor
p
etoposid
infus
follow
increas
norepinephrin
dose
p
trend
toward
higher
lactat
level
p
figur
statist
signific
chang
observ
regard
mean
arteri
pressur
heart
rate
renal
function
assess
serum
creatinin
oliguria
conclus
result
suggest
high
sever
hs
patient
acut
circulatori
failur
high
hospit
mortal
hemodynam
worsen
h
follow
etoposid
infus
chang
hemodynam
icu
stay
comparison
patient
cytopenia
shock
absenc
hs
current
ongo
present
congress
annal
intens
care
suppl
introduct
limit
data
avail
concern
prognosi
primari
malign
brain
tumor
intens
care
unit
icu
among
highgrad
glioma
hgg
frequent
associ
poorest
surviv
wherea
longterm
prognosi
icu
admiss
patient
malign
better
known
data
exist
regard
patient
hgg
aim
studi
analyz
factor
associ
mortal
patient
hgg
admit
icu
assess
function
statu
anticanc
therapi
cours
icu
survivor
patient
method
eightyear
bicentr
retrospect
cohort
studi
consecut
patient
hgg
admit
icu
includ
function
statu
assess
karnofski
perform
statu
kp
mutat
isocitr
dehydrogenas
idh
also
collect
anticanc
therapi
cours
icu
discharg
classifi
continu
without
chang
chang
modifi
stop
icu
discharg
initi
icu
discharg
hgg
diagnos
icu
stay
result
seventyeight
patient
age
yearold
sapsii
includ
glioblastoma
main
reason
admiss
coma
acut
respiratori
failur
respect
mechan
ventil
vasopressor
requir
case
icu
mortal
among
icu
survivor
anticanc
therapi
cours
continu
chang
initi
patient
respect
oneyear
surviv
significantli
higher
patient
anticanc
therapi
continu
compar
other
vs
p
among
icu
survivor
kp
vari
month
year
icu
discharg
vs
p
multivari
analysi
factor
associ
surviv
kp
admiss
ci
p
anticanc
therapi
cours
continu
p
idh
statu
impact
mortal
conclus
despit
high
longterm
mortal
rate
patient
surviv
icu
near
half
continu
plan
anticanc
therapi
cours
aliv
year
icu
discharg
good
function
statu
annal
intens
care
suppl
introduct
sickl
cell
diseas
scd
increas
global
health
problem
better
predict
sever
sickl
cell
diseas
could
lead
precis
treatment
manag
howev
though
sever
predict
model
scd
publish
extern
valid
remain
unclear
object
object
studi
valid
exist
predict
model
scd
patient
risk
complic
outcom
combin
simultan
updat
model
new
socal
metamodel
primari
endpoint
composit
binari
outcom
complic
outcom
defin
intens
care
unit
stay
day
need
vital
support
death
patient
method
januari
decemb
retrospect
cohort
studi
conduct
univers
hospit
guadeloup
french
territori
america
includ
patient
children
adult
admit
institut
combin
exist
predict
model
metamodel
perform
systemat
review
search
pubm
embas
bibliographi
articl
retriev
screen
relev
studi
enrol
sicklecel
diseas
children
adult
patient
predict
model
present
result
patient
admiss
cohort
experienc
complic
outcom
defin
death
patient
acut
respiratori
failur
patient
hemodynam
failur
patient
renal
failur
patient
four
predict
model
combin
predict
patient
risk
complic
outcom
result
metamodel
demonstr
good
predict
perform
term
discrimin
cstatist
calibr
conclus
combin
exist
predict
model
might
help
clinician
obtain
valid
predict
complic
outcom
rapidli
improv
qualiti
care
scd
patient
admit
emerg
depart
annal
intens
care
suppl
introduct
hemophagocyt
syndrom
hs
seriou
condit
lead
patient
intens
care
unit
icu
admiss
diagnosi
may
difficult
patient
may
multipl
organ
failur
hlh
criteria
commonli
use
new
diagnost
score
recent
establish
hscore
main
object
studi
analyz
diagnost
perform
diagnost
score
icu
patient
patient
method
two
conveni
sampl
analyz
includ
sampl
patient
confirm
hs
hs
second
sampl
patient
without
hs
hs
obtain
multicent
cohort
oncohematolog
patient
result
present
median
interquartil
rang
number
area
roc
curv
establish
assess
discrimin
score
diagnos
hs
sensit
analysi
perform
propens
score
ps
match
accord
temperatur
cytopenia
result
overal
patient
includ
studi
hs
patient
younger
median
age
year
vs
p
sever
cytopenia
hemoglobin
gdl
platelet
vs
often
organomegali
hepatomegali
vs
splenomegali
vs
mortal
rate
hemophagocyt
patient
control
patient
median
hscore
sh
patient
sh
patient
number
hlh
criteria
respect
diagnost
perform
score
excel
area
roc
curv
ci
accord
delong
method
ci
hlh
hscore
respect
figur
propens
score
match
n
median
hscore
sh
patient
versu
sh
patient
median
number
hlh
criteria
sh
sh
patient
area
roc
curv
hlh
criteria
hscore
conclus
hscore
hlh
criteria
highli
sensit
specif
icu
patient
studi
unselect
cohort
consecut
icu
patient
suspect
hs
warrant
order
confirm
result
optim
cutoff
score
annal
intens
care
suppl
introduct
thrombocytopenia
common
disord
intens
care
unit
icu
associ
increas
risk
bleed
data
platelet
transfus
icu
obtain
gener
cohort
peripher
thrombocytopenia
ongo
activ
bleed
subject
invas
procedur
patient
hypoprolif
thrombocytopenia
manag
platelet
transfus
remain
somewhat
empir
deriv
studi
perform
hematolog
patient
stabl
clinic
condit
herein
describ
analys
determin
posttransfus
platelet
increment
cancer
patient
hypoprolif
thrombocytopenia
icu
patient
method
singlecent
retrospect
observ
studi
period
patient
malign
hypoprolif
thrombocytopenia
receiv
least
one
platelet
transfus
icu
includ
transfus
episod
poor
platelet
yield
defin
bodi
surfac
areaadjust
correct
count
increment
cci
altern
weightadjust
platelet
transfus
yield
rtp
patient
consid
refractori
platelet
transfus
experienc
poor
platelet
increment
cci
rtp
follow
two
consecut
abocompat
transfus
contain
least
platelet
per
kg
bodyweight
result
patient
receiv
total
platelet
transfus
analyz
indic
platelet
transfus
distribut
prophylact
secur
invas
procedur
therapeut
activ
bleed
transfus
threshold
lower
prophylact
indic
secur
invas
procedur
therapeut
indic
g
l
vs
g
l
vs
g
l
respect
regardless
indic
transfus
episod
associ
cci
rtp
compar
prophylact
indic
transfus
yield
better
secur
invas
procedur
multivari
analysi
factor
associ
poor
posttransfus
increment
lower
bodi
mass
index
bmi
sever
day
transfus
depth
pretransfus
thrombocytopenia
time
platelet
transfus
posttransfus
platelet
count
fever
antibiot
therapi
storag
durat
platelet
concentr
patient
develop
refractori
platelet
transfus
associ
lower
bmi
stem
cell
transplant
spleen
enlarg
conclus
platelet
transfus
often
associ
poor
increment
critic
ill
cancer
patient
hypoprolif
thrombocytopenia
data
suggest
way
improv
effici
platelet
transfus
set
annal
intens
care
suppl
introduct
studi
patient
demograph
clinic
phenotyp
manag
outcom
patient
delirium
hospit
ward
compar
icu
patient
method
cohort
patient
admit
australian
universityaffili
hospit
march
april
code
delirium
use
criteria
result
among
hospit
patient
code
delirium
select
random
sampl
ward
patient
icu
patient
detail
analysi
ward
patient
older
median
age
vs
year
p
like
preexist
neurolog
diseas
vs
icu
patient
p
less
like
surgeri
vs
p
ward
patient
hypoact
delirium
icu
patient
agit
delirium
p
persist
delirium
hospit
discharg
common
among
ward
patient
vs
p
multivari
analysi
age
preexist
neurolog
diseas
predict
persist
delirium
surgeri
predict
recoveri
conclus
delirium
ward
patient
profoundli
differ
delirium
icu
patient
domin
hypoact
clinic
phenotyp
preced
chronic
neurolog
condit
manag
fewer
drug
less
like
recov
hospit
discharg
annal
intens
care
suppl
introduct
trauma
spine
common
patholog
constantli
increas
algeria
mainli
road
accid
potenti
seriou
associ
spinal
cord
injuri
lifethreaten
treat
traumat
cervic
thoracolumbar
spine
patient
spine
unit
chu
oran
patient
method
depart
orthoped
traumatolog
surgeri
spine
unit
chu
oran
period
month
especi
summer
season
secondari
support
ua
middl
age
year
year
result
quadripleg
patient
men
women
age
year
patient
year
old
year
old
year
old
main
caus
traumat
quadriplegia
mainli
due
avp
fall
sport
accid
judo
gymnast
repres
histopatholog
lesion
level
patient
patient
clinic
patient
alreadi
complet
quadriplegia
admiss
patient
incomplet
tetraplegia
neurolog
involv
classifi
accord
frankel
classif
practic
conduct
decompress
arthrodesi
graft
screw
plate
patient
benefit
conserv
treatment
reduct
cranial
traction
cours
mark
recoveri
patient
incomplet
tetraplegia
patient
die
result
complic
discuss
traumat
quadriplegia
major
public
health
problem
injuri
devast
affect
spinal
cord
adult
youth
adolesc
men
highest
preval
suffer
time
perman
deficit
quickli
quadripleg
parapleg
becom
awar
deficit
consequ
hospit
rehabilit
cost
repres
huge
invest
emot
damag
patient
famili
measur
sever
week
treatment
surgeri
resuscit
rehabilit
found
advers
result
treatment
failur
complic
insert
care
famili
conclus
traumat
quadriplegia
especi
aggrav
transport
goal
surgeri
decompress
marrow
stabil
spine
annal
intens
care
suppl
introduct
despit
daili
interrupt
sed
infus
delay
awaken
frequent
observ
critic
ill
patient
requir
invas
mechan
ventil
aim
identifi
prognost
signific
standard
electroencephalographi
find
adult
patient
delay
awaken
intens
care
unit
patient
method
retrospect
studi
includ
consecut
patient
invas
mechan
ventil
intens
care
unit
underw
standard
eeg
delay
awaken
delay
awaken
classifi
group
coma
hypoact
delirium
hyperact
delirium
accord
rass
inclus
primari
endpoint
good
neurolog
outcom
defin
proport
patient
aliv
awak
ie
respond
simpl
command
consecut
day
day
eeg
secondari
endpoint
includ
preval
differ
etiolog
delay
awaken
defin
categori
hypox
metabol
septic
antibiot
sedat
acut
brain
injuri
proport
patient
aliv
awak
icu
discharg
day
data
present
median
interquartil
rang
number
percentag
causespecif
preval
model
use
identifi
independ
paramet
associ
awaken
death
respect
result
patient
age
year
score
rass
inclus
studi
day
patient
awak
aliv
awak
dead
univari
analysi
paramet
associ
awaken
rass
wherea
paramet
associ
mortal
slow
eeg
background
discontinu
eeg
background
unreact
eeg
background
multivari
analysi
reveal
discontinu
eeg
background
associ
mortal
tabl
contrast
background
frequenc
hz
associ
preserv
reactiv
protect
etiolog
delay
awaken
sepsi
hypoxia
sedat
neurotox
antibiot
metabol
caus
patient
multifactori
origin
hypox
encephalopathi
associ
shortterm
mortal
end
icu
stay
patient
awak
aliv
awak
dead
day
awak
awak
dead
conclus
delay
awaken
icu
like
multifactori
origin
character
favor
outcom
case
background
eeg
abnorm
frequenc
continu
reactiv
provid
major
prognost
inform
shortterm
mortal
popul
annal
intens
care
suppl
introduct
cardiac
arrest
ca
among
catastroph
earli
complic
seen
convuls
statu
epilepticu
cse
manag
factor
may
contribut
cserel
ca
cseca
includ
comorbid
sever
system
complic
particularli
event
uncontrol
seizur
activ
injuri
caus
loss
conscious
seizur
treatment
complic
caus
cse
although
cseca
event
consider
concern
studi
assess
characterist
longterm
surviv
function
outcom
object
retrospect
studi
identifi
earli
factor
associ
ca
adult
manag
cse
admit
intens
care
unit
icu
knowledg
factor
might
help
identifi
area
improv
manag
cse
patient
method
retrospect
multicent
studi
includ
consecut
patient
admit
univers
universityaffili
icu
franc
belgium
manag
success
resuscit
outofhospit
cardiac
arrest
complic
initi
manag
cse
patient
compar
control
without
ca
identifi
singlecent
registri
cse
patient
regard
characterist
manag
outcom
result
includ
case
cseca
control
case
median
time
medic
team
arriv
ca
min
iqr
first
record
rhythm
asystol
pulseless
electr
activ
patient
significantli
larger
proport
patient
favor
outcom
glasgow
outcom
scale
score
among
control
among
case
p
multivari
analysi
independ
predictor
ca
puls
oximetri
scene
ci
p
drug
poison
caus
cse
ci
p
complic
earli
manag
ci
p
least
one
comorbid
among
cardiac
respiratori
neurolog
epilepsi
condit
predict
absenc
ca
ci
p
conclus
patient
manag
cse
rel
hypoxemia
onscen
manag
complic
drug
poison
caus
cse
strong
earli
predictor
ca
suggest
area
improv
annal
intens
care
suppl
introduct
postcardiac
arrest
coma
common
caus
brain
injuri
icu
predict
neurolog
outcom
crucial
import
provid
object
inform
love
one
opt
best
therapeut
option
includ
withhold
withdraw
treatment
deem
hopeless
among
prognost
tool
avail
somatosensori
evok
potenti
proven
effici
certain
condit
absenc
cortic
wave
associ
unfavor
neurolog
prognosi
specif
close
tradit
test
requir
expertis
avail
neurophysiologist
assum
techniqu
also
perform
train
intensivist
patient
method
two
physician
icu
receiv
two
day
specif
train
univers
neurophysiolog
laboratori
specialist
interpret
evok
potenti
patient
concern
prolong
postcardiac
arrest
coma
cessat
sedat
record
interpret
sent
neurophysiolog
referr
center
review
specialist
within
h
feasibl
reliabl
test
evalu
retrospect
result
septemb
june
somatosensori
evok
potenti
record
patient
year
old
f
ratio
circulatori
arrest
cardiac
origin
case
respiratori
patient
underw
electroencephalographi
reactiv
stimuli
record
made
interpret
easili
intensivist
similar
conclus
neurophysiologist
one
doubt
could
assess
neurophysiologist
wave
present
patient
absent
patient
two
test
uninterpret
conclus
record
somatosensori
evok
potenti
icu
simpl
reliabl
reproduc
perform
train
critic
care
physician
howev
interpret
must
valid
neurophysiologist
given
implic
term
therapeut
decis
annal
intens
care
suppl
introduct
sodium
disturb
common
probabl
poorli
understood
electrolyt
disord
neurolog
diseas
complic
minim
better
recognit
diagnosi
treatment
sodium
disord
studi
aim
analyz
incid
etiolog
impact
dysnatremia
brain
damag
popul
hypothes
chang
sodium
level
could
indic
recent
neurolog
deterior
patient
method
conduct
six
month
long
prospect
cohort
includ
brain
damag
patient
admit
icu
march
august
minimum
length
stay
lo
day
patient
includ
screen
sodium
disord
first
week
icu
stay
outcom
measur
incid
death
glasgow
outcom
scale
go
discharg
lo
patient
also
monitor
neurolog
deterior
includ
cognit
declin
convuls
seizur
increas
cerebr
edema
brain
herniat
contemporari
sodium
disord
univari
multivari
analysi
use
determin
level
signific
result
studi
period
one
hundr
patient
admit
icu
neurointens
care
among
includ
studi
patient
admit
traumat
brain
injuri
tbi
case
accord
analysi
patient
present
hyponatremia
among
diagnos
syndrom
inappropri
antidiuret
hormon
secret
siadh
corticosteroid
defici
one
case
cerebr
salt
wast
syndrom
siadh
attribut
convuls
seizur
case
mening
case
tbi
case
hyponatremia
found
predict
factor
mortal
icu
p
lo
p
sign
neurolog
deterior
p
day
diagnosi
studi
result
show
incid
hypernatremia
case
among
case
attribut
central
diabet
insipidu
hypernatremia
found
predict
factor
mortal
icu
p
go
p
sign
neurolog
deterior
p
day
diagnosi
conclus
summari
studi
demonstr
sodium
disturb
common
neurointens
care
unit
associ
increas
icu
mortal
besid
indic
chang
sodium
level
could
reveal
seriou
neurolog
complic
annal
intens
care
suppl
introduct
left
ventricular
lv
systol
dysfunct
frequent
septic
shock
patient
prognost
impact
remain
unknown
patient
method
two
publish
databas
differ
icu
includ
echocardiograph
monitor
perform
initi
phase
septic
shock
merg
patient
histori
chronic
heart
failur
atrial
fibril
dobutamin
infus
time
echocardiographi
exclud
analysi
hierarch
cluster
princip
compon
approach
use
defin
five
cardiovascular
phenotyp
use
haemodynam
clinic
echocardiograph
paramet
miss
data
imput
relationship
cluster
mortal
icu
evalu
use
multivari
logist
regress
result
patient
median
age
includ
analysi
five
differ
cluster
individualis
patient
well
resuscit
cluster
n
without
lv
systol
function
right
ventricular
rv
failur
fluid
respons
patient
lv
systol
dysfunct
cluster
n
patient
hyperkinet
profil
cluster
n
patient
rv
failur
cluster
n
patient
persist
hypovolemia
cluster
n
mortal
higher
cluster
other
vs
cluster
respect
p
icu
mortal
differ
across
cluster
multivari
logist
regress
lv
systol
dysfunct
independ
associ
increas
mortal
odd
ratio
confid
interv
conclus
among
five
cardiovascular
phenotyp
individualis
larg
cohort
septic
shock
patient
lv
systol
dysfunct
independ
associ
mortal
annal
intens
care
suppl
introduct
cardiogen
shock
cs
remain
sever
poorli
understood
patholog
mani
predict
death
score
previous
describ
focus
ischem
cs
took
account
data
relat
manag
patient
urgent
need
simpl
object
criteria
assess
shortterm
cs
mortal
regardless
initi
etiolog
patient
method
frenshock
registri
larg
prospect
multicent
registri
cs
patient
admit
intens
cardiac
gener
critic
care
unit
april
octob
franc
patient
prospect
includ
regardless
cs
etiolog
met
least
one
criterion
low
cardiac
output
systol
blood
pressur
sbp
mmhg
need
amin
low
cardiac
index
min
echocardiographi
right
heart
catheter
clinic
radiolog
biolog
ntprobnp
bnp
echocardiograph
invas
hemodynam
overload
sign
clinic
oliguria
marbl
confus
biolog
hypoperfus
lactat
mmoll
hepat
renal
failur
studi
factor
relat
mortal
use
analys
cox
proport
hazard
model
result
patient
includ
male
median
age
nonischem
cs
predomin
n
although
type
infarct
infrequ
n
mortal
n
non
survivor
older
previou
renal
failur
marbl
atrial
fibril
admiss
lower
sbp
dbp
diagnost
test
reveal
higher
arteri
lactat
crp
natriuret
peptid
kaliemia
lower
ph
prothrombin
time
hemoglobin
egfr
also
lvef
multivari
analysi
retain
age
especi
low
systol
blood
pressur
especi
mmhg
high
arteri
lactat
especi
mmoll
low
egfr
especi
low
lvef
especi
signific
predictor
mortal
ischem
etiolog
type
infarct
predict
conclus
multicentr
prospect
design
confirm
heterogen
cs
term
present
prognosi
five
simpl
practic
easi
find
sign
found
signific
predictor
short
term
mortal
could
use
provid
accur
stratifi
definit
cs
patient
order
tailor
addit
therapi
annal
intens
care
suppl
introduct
acut
postop
cardiac
surgeri
poc
right
ventricular
failur
rvf
uncommon
worsen
patient
prognosi
aim
studi
incid
risk
factor
outcom
acut
rvf
cardiac
surgeri
extracorpor
circul
ecc
patient
patient
method
prospect
cohort
studi
one
year
decemb
includ
patient
candid
cardiac
surgeri
cs
extra
corpor
circul
normal
rf
systol
function
transthoracicechocardiographi
tte
doppler
perform
day
day
day
postop
month
taps
mm
swave
veloc
cm
first
postop
week
defin
pocsrvf
thu
patient
divid
two
group
pocsrvf
group
versu
non
pocsrvf
group
compar
outcom
catecholamin
support
septic
event
length
stay
lo
ventil
day
mortal
result
among
patient
includ
pocsrvf
group
n
versu
non
pocsrvf
n
incid
acut
pocsrvf
acut
rvf
occur
post
oper
day
remain
day
attach
fig
mitral
valv
replac
aortic
clamp
time
min
preoper
arrhythmia
bleed
significantli
relat
acut
pocsrvf
respect
ic
ic
ic
ic
acut
pocsrvf
increas
mortal
vs
p
reduc
surviv
time
day
signific
link
show
pocsrvf
death
depend
left
ventricular
lv
systol
function
lv
dysfunct
pocsrvf
patient
increas
death
risk
absenc
improv
surviv
factor
significantli
associ
mortal
bental
coronari
tube
procedur
ecc
time
min
conclus
incid
acut
pocsrvf
neglig
sever
preoper
factor
predispos
phenomenon
lv
failur
worsen
outcom
find
sustain
prevent
measur
limit
myocardi
damag
cardiac
surgeri
annal
intens
care
suppl
introduct
venoarteri
extracorpor
membran
oxygen
vaecmo
life
support
techniqu
associ
major
incid
acut
kidney
injuri
aki
risk
chronic
kidney
diseas
ckd
follow
aki
high
object
studi
describ
renal
natur
histori
within
one
year
follow
vaecmo
identifi
earli
predictor
longterm
renal
impair
patient
method
retrospect
analyz
consecut
adult
patient
without
preexist
endstag
renal
diseas
esrd
receiv
vaecmo
h
medic
icu
univers
hospit
pari
franc
januari
decemb
aki
sever
icu
stay
defin
accord
kdigo
classif
renal
function
year
assess
estim
glomerular
filtrat
rate
egfr
use
mdrd
equat
primari
endpoint
composit
poor
renal
outcom
egfr
mlmin
death
one
year
defin
bad
outcom
factor
associ
bad
outcom
identifi
multivari
logist
regress
analysi
quantit
variabl
report
median
interquartil
rang
iqr
qualit
variabl
number
percentag
result
multivari
analysi
report
oddsratio
confid
interv
result
patient
avail
followup
male
sex
age
year
sap
ii
sofa
time
ecmo
day
includ
studi
patient
die
icu
within
year
patient
develop
aki
icu
stay
requir
renal
replac
therapi
survivor
abnorm
declin
egfr
one
year
median
declin
rate
mlmin
four
patient
esrd
one
year
three
requir
rrt
icu
experienc
recurr
aki
afterward
multivari
analysi
best
baselin
renal
function
protect
bad
renal
outcom
one
year
higher
egfr
p
sever
aki
icu
significantli
associ
one
year
renal
outcom
p
kdigo
stage
conclus
among
survivor
vaecmo
therapi
longterm
renal
impair
major
particularli
previou
ckd
sever
aki
icu
stay
esrd
rare
occur
patient
recurr
aki
annal
intens
care
suppl
introduct
data
avail
concern
impact
levosimendan
patient
refractori
cardiogen
shock
support
peripher
venoarteri
extracorpor
membran
oxygen
vaecmo
aim
studi
evalu
impact
levosimendan
vaecmo
wean
patient
hospit
intens
care
unit
icu
patient
method
retrospect
cohort
studi
conduct
french
univers
hospit
one
icu
patient
hospit
icu
underw
vaecmo
consecut
evalu
result
total
patient
vaecmo
elig
studi
propens
score
match
patient
levosimendan
group
patient
nonlevosimendan
group
patient
treat
levosimendan
h
infus
medic
left
ventricular
eject
fraction
increas
p
aortic
integr
increas
cm
cm
p
match
propens
score
levosimendan
remain
factor
associ
signific
reduct
vaecmo
wean
failur
hazard
ratio
confid
interv
p
surviv
curv
show
surviv
rate
day
levosimendan
group
nonlevosimendan
group
p
howev
signific
differ
found
levosimendan
nonlevosimendan
group
regard
day
mortal
propens
score
analysi
hazard
ratio
confid
interv
p
conclus
studi
suggest
levosimendan
could
associ
benefici
effect
vaecmo
wean
icu
patient
howev
use
levosimendan
tend
decreas
day
mortal
propens
match
analysi
p
annal
intens
care
suppl
introduct
cardiogen
shock
patient
treat
venoarteri
ecmo
vaecmo
may
develop
brain
injuri
ecmo
support
aim
assess
predict
valu
serial
measur
neuron
specif
enolas
nse
identifi
poor
neurolog
outcom
ctdefin
acut
brain
injuri
set
patient
method
conduct
prospect
cohort
studi
consecut
adult
patient
cannul
vaecmo
refractori
cardiogen
shock
medic
icu
univers
hospit
pari
franc
plasma
sampl
predefin
time
point
day
day
day
vaecmo
cannul
ecmo
remov
death
plasma
sampl
collect
store
primari
endpoint
poor
outcom
composit
endpoint
ctdefin
brain
injuri
death
day
vaecmo
cannul
secondari
endpoint
ctdefin
brain
injuri
plasma
nse
level
measur
end
studi
data
present
median
interquartil
rang
number
percentag
associ
nse
level
outcom
explor
multivari
logist
regress
analysi
nse
level
dichotom
accord
median
valu
day
day
result
total
patient
male
n
sofa
score
admiss
includ
underw
cardiopulmonari
resuscit
vaecmo
cannul
vaecmo
cannul
patient
mechan
ventil
sedat
receiv
vasopressor
plasma
nse
level
l
day
l
day
l
day
poor
outcom
occur
patient
ctdefin
brain
injuri
observ
patient
plasma
nse
level
day
day
associ
poor
outcom
crude
analys
multivari
analysi
nse
level
day
remain
independ
associ
poor
outcom
tabl
patient
underw
brain
ct
vaecmo
support
nse
level
day
day
associ
ctdefin
brain
injuri
conclus
cardiogen
shock
patient
treat
vaecmo
plasma
nse
level
measur
day
vaecmo
initi
independ
associ
short
term
acut
brain
injuri
death
irrespect
preecmo
characterist
patient
persist
elev
nse
level
day
vaecmo
initi
may
benefit
advanc
neuromonitor
ecmo
support
annal
intens
care
suppl
introduct
oxygen
therapi
ot
remain
cornerston
acut
heart
failur
ahf
therapi
patient
pulmonari
congest
pc
avoid
hypoxemia
long
goal
critic
care
practition
less
attent
paid
potenti
hazard
relat
excess
oxygen
hyperoxia
recent
studi
highlight
useless
potenti
hazard
hyperoxia
patient
admit
acut
medic
emerg
main
object
evalu
impact
earli
hyperoxia
exposur
among
critic
ill
patient
hospit
ahf
patient
method
observ
retrospect
studi
led
parisian
medic
intens
care
unit
icu
assess
ahf
patient
admit
pc
patient
cardiac
arrest
sever
chronic
obstruct
pulmonari
diseas
longterm
ot
includ
hyperoxia
defin
mmhg
blood
gaz
analysi
hyperoxia
group
defin
least
one
mmhg
first
day
follow
icu
admiss
princip
endpoint
composit
one
combin
allcaus
mortal
unplan
hospit
admiss
secondari
endpoint
occurr
pneumonia
bacteriemia
icu
length
stay
lo
hospit
lo
multivari
analysi
perform
determin
hyperoxia
independ
risk
factor
mortal
result
among
patient
admit
icu
period
studi
patient
pc
due
ahf
includ
fortyon
patient
requir
mechan
ventil
first
h
patient
present
least
one
hyperoxia
abg
hyperoxia
group
h
wherea
patient
control
group
c
baselin
characterist
accord
two
group
differ
tabl
composit
primari
endpoint
differ
two
group
vs
p
mortal
h
versu
c
p
unplan
hospit
admiss
increas
h
compar
c
reach
signific
p
secondari
endpoint
significantli
differ
two
group
tabl
multivari
analysi
hyperoxia
associ
mortal
ci
p
conclus
hyperoxia
use
critic
ill
patient
ahf
benefit
shortterm
outcom
remain
demonstr
annal
intens
care
suppl
introduct
icu
patient
sever
caus
mechan
hypoxemia
present
howev
cumul
effect
multipl
caus
hypoxemia
unknown
use
data
pointprevalenceday
studi
hypoxemia
analyz
relationship
number
hypoxemia
caus
hypoxemia
sever
patient
method
spectrum
studi
conduct
icu
countri
spring
collect
presenc
caus
mechan
hypoxemia
base
investig
judgment
compar
hypoxemia
caus
accord
class
hypoxemia
classifi
patient
group
accord
number
caus
analyz
number
condit
associ
hypoxemia
sever
icumort
use
univari
follow
multivari
analys
result
among
hypoxem
patient
includ
day
studi
could
analyz
median
number
hypoxemia
caus
patient
caus
hypoxemia
record
caus
caus
caus
main
caus
pneumonia
fluid
overload
pleural
effus
atelectasi
acut
chronic
respiratori
failur
repartit
caus
differ
across
class
hypoxemia
sever
patient
hypoxemia
caus
often
chronic
respiratori
heart
renal
failur
higher
often
vasopressor
p
patient
caus
hypoxemia
invas
ventil
p
number
caus
associ
hypoxemia
sever
p
multivari
linear
regress
number
caus
hypoxemia
neg
associ
pf
coeff
ci
p
icumort
across
group
p
multivari
logist
regress
show
addit
age
chronic
heart
failur
admiss
diagnosi
pf
ard
caus
hypoxemia
associ
icumort
ci
wherea
obes
protect
conclus
hypoxem
patient
caus
hypoxemia
number
caus
hypoxemia
independ
associ
lower
pf
ratio
caus
hypoxemia
independ
associ
icumort
prevent
patient
acquir
supplementar
condit
induc
hypoxemia
may
improv
prognosi
annal
intens
care
suppl
introduct
acut
respiratori
distress
syndrom
ard
common
injuri
intens
care
unit
icu
patient
worsen
atelectasi
lung
recruit
maneuv
lrm
aim
open
collaps
alveoli
increas
airway
pressur
short
durat
singl
studi
lrm
use
ard
patient
icu
along
recent
metaanalys
shown
discrep
regard
prognosi
ard
patient
two
recent
rct
publish
entail
around
new
patient
aim
studi
critic
review
literatur
investig
whether
lrm
reduc
mortal
ard
patient
compar
nolrm
strategi
patient
method
perform
systemat
review
metaanalysi
random
control
trial
rct
search
pubm
central
web
scienc
bibliographi
articl
retriev
among
data
screen
relev
studi
enrol
ard
adult
patient
includ
studi
report
mortal
perform
metaanalysi
gener
pool
rel
risk
rr
across
studi
primari
outcom
mortal
secondari
outcom
icu
mortal
mortal
result
eight
rct
total
particip
lrm
group
nolrm
group
includ
analysi
tabl
compar
nolrm
strategi
lrm
reduc
mortal
rr
confid
interv
ci
p
signific
heterogen
observ
p
sensit
analysi
exclud
studi
use
protect
ventil
control
group
show
similar
result
rr
p
signific
differ
found
mortal
icu
studi
patient
rr
p
signific
heterogen
observ
p
sensit
analysi
exclud
studi
use
protect
ventil
control
group
show
similar
result
studi
patient
rr
p
signific
differ
found
mortal
day
studi
patient
rr
p
heterogen
found
outcom
p
conclus
result
suggest
systemat
lrm
provid
signific
benefit
regard
mortal
ard
howev
heterogen
studi
high
remain
explor
annal
intens
care
suppl
introduct
patient
sever
acut
respiratori
distress
syndrom
ard
extracorpor
membran
oxygen
ecmo
ventil
low
tidal
volum
optim
posit
endexpiratori
pressur
peep
combin
best
alveolar
recruit
minim
overdistens
electr
imped
tomographi
eit
provid
noninvas
realtim
bedsid
imag
lung
aim
studi
assess
eit
abil
choos
best
peep
patient
ecmo
receiv
ultraprotect
mechan
ventil
patient
method
ard
patient
venoven
ecmo
includ
written
inform
given
patient
rel
inclus
recruit
maneuv
decrement
peep
trial
step
monitor
eit
lung
imag
divid
four
ventraltodors
horizont
region
interest
drive
pressur
maintain
constant
patient
four
eitbas
peep
defin
peep
odclmin
pressur
lowest
eitassess
collaps
lung
cl
overdistens
od
peep
lowest
pressur
abl
limit
eitassess
collaps
least
overdistens
peep
comp
peep
eitbas
complianc
maximum
peep
gi
peep
eitbas
global
inhomogen
gi
index
minimum
concord
four
eitbas
peep
refer
pulmonari
peep
p
defin
accord
respiratori
clinic
ultrasound
usual
paramet
evalu
cohen
kappa
coeffici
result
fourteen
patient
decrement
peep
trial
induc
decreas
tidal
imped
variat
tiv
depend
region
increas
tiv
nondepend
lung
region
figur
high
peep
level
significantli
associ
overdistens
rho
fewer
collaps
zone
decreas
peep
led
collaps
zone
rho
peep
peep
comp
success
agreement
refer
peep
p
respect
peep
odclmin
medium
agreement
peep
p
peep
gi
disagr
discuss
eit
allow
individu
studi
effect
peep
level
ultraprotect
ventil
ecmo
eitbas
overdistens
collaps
complianc
conclus
eit
may
interest
noninvas
bedsid
tool
provid
realtim
monitor
peep
impact
sever
ard
patient
ecmo
conflict
interest
annal
intens
care
suppl
introduct
toxic
mechan
ventil
acut
respiratori
distress
syndrom
ard
possibl
prevent
use
ultraprotect
ventil
favor
hypercapnia
extracorpor
remov
correct
issu
hypoxemia
remain
prone
posit
pp
known
effect
therefor
studi
pp
feasibl
patient
method
conduct
retrospect
analysi
august
decemb
center
indic
ph
arteri
partial
pressur
mmhg
protect
ventil
indic
pp
ratio
arteri
partial
pressur
fraction
inspir
primari
endpoint
discontinu
h
pp
patient
ard
berlin
criteria
compar
patient
without
fischer
exact
test
result
patient
underw
pp
procedur
whose
last
h
patient
without
underw
pp
procedur
whose
last
h
differ
earli
discontinu
pp
p
discuss
result
accord
scientif
evid
advoc
chang
practic
conclus
possibl
safe
conduct
pp
session
ultraprotect
ventil
ard
annal
intens
care
suppl
introduct
ventil
set
patient
sever
acut
respiratori
distress
syndrom
ard
support
venoven
extracorpor
membran
oxygen
vvecmo
current
set
arbitrarili
studi
aim
evalu
impact
serum
pulmonari
marker
biotrauma
transit
ultraprotect
ventil
set
follow
initi
vvecmo
b
differ
mechan
ventil
strategi
vvecmo
patient
method
monocentr
random
clinic
trial
conduct
period
patient
receiv
vvecmo
refractori
sever
ard
vvecmo
start
patient
switch
aprv
mode
one
second
high
pressur
phigh
low
pressur
plow
h
patient
random
assign
follow
three
experiment
step
accord
computergener
alloc
sequenc
phigh
plow
high
low
drive
pressur
vhpeepvldp
step
phigh
plow
low
drive
pressur
lpeephdp
step
phigh
plow
low
peep
drive
pressur
lpeepldp
step
plasma
bronchoalveolar
solubl
receptor
advanc
glycat
endproduct
srage
serum
cytokin
dose
vvecmo
h
mechan
ventil
strategi
result
sixteen
patient
vvecmo
day
mechan
ventil
includ
ultraprotect
mechan
ventil
set
follow
ecmo
init
associ
signific
reduct
plasma
srage
plasma
cytokin
howev
plasma
srage
cytokin
similar
within
experiment
step
ecmo
nevertheless
bronchoalveolar
level
srage
lowest
drive
pressur
minim
conclus
vvecmo
allow
ultraprotect
ventil
combin
signific
reduct
tidal
volum
drive
pressur
ventil
strategi
significantli
reduc
pulmonari
biotrauma
could
therefor
decreas
ventil
induc
lung
injuri
howev
optim
ultraprotect
ventil
strategi
vvecmo
initi
remain
undetermin
warrant
investig
annal
intens
care
suppl
introduct
prone
posit
pp
shown
use
adjunct
treatment
patient
ard
lack
conclus
studi
concern
efficaci
pp
acut
respiratori
failur
arf
without
ard
criteria
object
evalu
effect
prone
posit
oxygen
surviv
among
patient
receiv
invas
mechan
ventil
mv
sever
persist
hypoxemia
due
anoth
reason
ard
patient
method
prospect
studi
conduct
bed
icu
februari
octob
inclus
criteria
patient
requir
mv
refractori
hypoxemia
exclus
criteria
ard
accord
berlin
criteria
ventil
associ
pneumonia
contraind
pp
decis
withdraw
withhold
therapi
patient
place
pp
least
h
improv
oxygen
defin
increment
mmhg
prone
posit
outcom
measur
improv
oxygen
icu
mortal
ventil
free
day
icu
length
stay
result
studi
mv
use
patient
exclud
patient
patient
met
ard
criteria
patient
hypoxem
thirti
patient
mean
age
year
includ
arf
frequent
reason
admiss
twenti
five
patient
respond
pp
inde
increas
significantli
pp
mmhg
p
decreas
significantli
p
compar
supin
posit
twelv
patient
present
one
complic
relat
pp
common
complic
decubitu
ulcer
case
comparaison
respond
non
respond
pp
show
differ
demograph
characterist
co
morbid
icu
mortal
rate
pp
respond
compar
non
respond
p
post
hoc
analysi
sub
group
patient
accord
degre
hypoxemia
pp
pp
pp
shown
icu
mortal
icu
lo
ventilatorfre
day
similar
group
conclus
present
studi
prone
posit
appli
sever
hypoxem
patient
without
ard
criteria
associ
improv
oxygen
carbon
dioxid
wash
annal
intens
care
suppl
introduct
aim
studi
analyz
cannulaassoci
deep
vein
thrombosi
cadvt
incid
venoven
extracopor
membran
oxygen
vvecmo
use
ctscan
identifi
associ
risk
factor
cadvt
patient
method
retrospect
observ
analysi
conduct
tertiari
referr
univers
teach
hospit
patient
vvecmo
femorofemor
femorojugular
cannul
admit
ard
primari
dysfunct
graft
pulmonari
transplant
includ
diagnosi
cadvt
perform
iodin
ctscan
within
day
decannul
result
patient
screen
includ
bacteri
pneumonia
main
indic
vvecmo
cadvt
found
patient
despit
mean
aptt
specif
femor
cadvt
femorofemor
cannul
induc
cadvt
femorojugular
cannul
vs
respect
p
mean
number
patient
requir
ecmo
circuit
replac
significantli
higher
cadvt
group
vs
p
multivari
logist
regress
analysi
show
thrombocytopenia
g
l
signific
decreas
risk
develop
cadvt
hr
p
conclus
cannula
associ
deep
vein
thrombosi
vvecmo
frequent
event
suggest
systemat
vascular
axe
imag
necessari
vvecmo
thrombocytopenia
associ
reduc
thrombot
event
annal
intens
care
suppl
introduct
overcrowd
emerg
depart
ed
increas
affect
manag
patient
especi
critic
ill
patient
septic
shock
lifethreaten
diseas
mortal
manag
patient
transfer
intens
care
unit
icu
must
prioriti
lengthofstay
lo
septic
shock
patient
ed
increas
mortal
icu
patient
method
perform
monocentr
retrospect
cohort
studi
patient
hospit
icu
septic
shock
admit
via
ed
includ
exclud
resuscit
patient
patient
admit
icu
anoth
ed
compar
lo
ed
aliv
group
dead
group
icu
ig
ii
score
age
delay
antibiot
need
mechan
ventil
use
vasopress
drug
fluid
manag
qsofa
realiz
multivari
analysi
result
patient
includ
icu
septic
shock
median
lo
ed
minut
mortal
rate
icu
aliv
group
lo
ed
minut
vs
minut
dead
group
signific
differ
univari
analysi
qsofa
lactat
ig
ii
score
use
mechan
ventil
ed
signific
multivari
analysi
ig
ii
score
use
mechan
ventil
ed
significantli
associ
mortal
icu
discuss
lo
ed
associ
mortal
icu
studi
dead
group
often
associ
high
comorbid
alter
qsofa
admiss
ed
use
mechan
ventil
ed
associ
poor
prognosi
whatev
origin
septic
shock
import
confirm
result
larg
prospect
studi
conclus
despit
overcrowd
ed
emerg
physician
paramed
seem
remain
vigil
detect
manag
transfer
quickli
septic
shock
patient
annal
intens
care
suppl
introduct
aggress
fluid
resuscit
initi
approach
cardiovascular
instabl
consequ
larg
volum
fluid
given
septic
patient
manag
studi
aim
investig
impact
cumul
fluid
balanc
critic
ill
patient
sepsi
septic
shock
admit
intens
care
unit
icu
patient
method
retrospect
monocentr
studi
conduct
medic
icu
septemb
septemb
patient
septic
shock
requir
dialysi
prior
hospit
includedw
includ
patient
present
sepsi
septic
shock
hospit
studi
relat
fluid
balanc
prognosi
result
enrol
patient
averag
age
year
main
reason
hospit
respiratori
failur
neurolog
disturb
case
median
apach
ii
sofa
score
admiss
respect
sepsi
septic
shock
relat
pulmonari
infect
case
follow
urinari
tract
infect
cathet
relat
infect
frequent
infecti
agent
gram
neg
bacilli
mechan
ventil
requir
patient
vasoact
drug
use
patient
median
durat
mechan
ventil
hospit
stay
respect
day
overal
mortal
multivari
analysi
revel
mortal
associ
posit
cumul
fluid
balanc
sepsi
onset
rel
risk
respect
ic
p
ic
p
conclus
posit
fluid
balanc
associ
poor
prognosi
septic
patient
annal
intens
care
suppl
introduct
venou
thromboembol
vte
common
prevent
complic
among
hospit
patient
intens
care
unit
icu
howev
littl
known
incid
particular
patient
septic
shock
patient
method
prospect
analyt
studi
conduct
icu
habib
bourguiba
univers
hospit
sfax
tunisia
januari
decemb
patient
develop
septic
shock
due
bacteri
infect
studi
period
enrol
thromboprophylaxi
record
patient
diagnosi
tve
confirm
spiral
comput
tomographi
scan
compress
venou
ultrasound
result
sixti
patient
septic
shock
includ
studi
among
develop
vte
hospitalis
incid
vte
vte
associ
increas
length
stay
longer
mechan
ventil
use
tracheotomi
mortal
rate
higher
patient
acut
vte
tabl
conclus
patient
develop
septic
shock
consid
higher
risk
develop
vte
result
multipl
factor
includ
immobl
activ
thromboinflammatori
pathway
dissemin
intravascular
coagul
venou
stasi
central
venou
cathet
insert
thu
effect
vte
prevent
strategi
necessari
patient
sepsi
annal
intens
care
suppl
introduct
microcirculatori
alter
frequent
observ
patient
sepsi
vivo
microdialysi
md
bedsid
techniqu
monitor
tissu
metabol
chang
conduct
studi
aim
assess
perform
muscl
lactat
lactat
pyruv
l
p
ratio
clearanc
predict
mortal
septic
shock
patient
use
microdialysi
patient
method
studi
design
prospect
control
clinic
trial
perform
multidisciplinari
intens
care
unit
septic
shock
patient
enrol
interstiti
tissu
concentr
lactat
pyruv
glucos
glycerol
obtain
baselin
everi
h
day
use
muscl
microdialysi
clearanc
muscl
lactat
l
p
ratio
defin
percentag
chang
muscl
lactat
level
l
p
ratio
compar
baselin
valu
posit
valu
clearanc
mean
decreas
rate
paramet
studi
result
found
associ
muscl
lactat
clearanc
hospit
mortal
statist
signific
differ
p
p
studi
p
also
found
associ
clearanc
muscl
lactat
pyruv
ratio
hospit
mortal
statist
signific
differ
p
p
studi
p
conclus
among
patient
septic
shock
improv
muscl
lactat
lactat
pyruv
ratio
clearanc
hour
may
indic
resolut
global
tissu
hypoxia
associ
decreas
mortal
rate
annal
intens
care
suppl
introduct
sinc
first
public
definit
univers
accept
becom
matter
controversi
clinic
laboratori
paramet
use
develop
definit
deriv
mainli
patient
hospit
unit
state
intens
care
unit
icu
aim
studi
evalu
perform
sepsi
definit
predict
icumort
tunisian
icu
popul
compar
consensu
definit
definit
patient
method
retrospect
descript
studi
perform
medic
surgic
intens
care
unit
tuni
militari
hospit
tunisia
januari
januari
patient
admit
icu
elig
studi
inclus
criteria
follow
age
year
admiss
diagnosi
sepsi
sever
sepsi
septic
shock
defin
accord
surviv
sepsi
campaign
guidelin
consensu
new
definit
secondari
use
primari
outcom
interest
icu
mortal
defin
death
icu
discharg
result
particip
enrol
includ
individu
followup
inform
avail
definit
use
differ
mortal
septic
shock
sepsi
patient
definit
show
mortal
increas
nodysfunctioninfect
patient
patient
qsofa
sepsi
septic
shock
patient
respect
conclus
better
definit
stratifi
mortal
among
septic
patient
admit
icu
emerg
countri
tunisia
annal
intens
care
suppl
introduct
necrot
soft
tissu
infect
nsti
medicalsurg
emerg
relat
sever
bacteri
soft
tissu
infect
hyperbar
oxygen
therapi
hbo
propos
adjuv
therapi
indic
object
studi
assess
prognost
factor
impact
hbo
critic
ill
patient
nsti
patient
method
januari
decemb
patient
nsti
admit
intens
care
unit
tertiari
care
teach
hospit
includ
retrospect
studi
among
one
hundr
twentyeight
patient
receiv
hbo
therapi
prognost
factor
associ
mortal
univari
analysi
includ
logist
regress
model
complic
associ
use
hbo
also
report
result
eightyfour
patient
nsti
limb
patient
perin
nsti
patient
infect
cervicalthorac
region
median
sapsii
score
patient
septic
shock
overal
mortal
day
n
multivari
analysi
factor
significantli
associ
allcaus
mortal
admissionbas
sever
score
sapsii
p
delay
diagnosi
surgeri
p
hyperlactatemia
admiss
p
chronic
renal
diseas
p
protect
factor
streptococc
infect
p
effect
probabilist
antibiot
therapi
p
hbo
associ
decreas
mortal
multivari
analysi
twentythre
patient
suffer
sever
complic
hbo
hbo
complic
favor
use
norepinephrin
p
mechan
ventil
p
combin
two
p
hbo
session
conclus
initi
sever
chronic
renal
diseas
hyperlactatemia
delay
diagnosi
surgeri
independ
risk
factor
mortal
critic
ill
patient
nsti
hbo
therapi
associ
patient
surviv
may
respons
seriou
complic
indic
annal
intens
care
suppl
introduct
mortal
septic
shock
remain
high
undernutrit
septic
shock
respons
signific
morbid
mortalityth
object
studi
evalu
interest
muscl
mass
loss
ultrasound
measur
quadricep
thick
patient
admit
intens
care
septic
shock
prognost
factor
mortal
patient
method
prospect
observ
studi
conduct
medic
intens
care
unit
centr
hospitali
universitair
rouenth
inclus
period
extend
april
octob
main
object
evalu
relationship
variabl
muscl
thick
measur
ultrasound
mortal
secondari
object
assess
differ
variabl
mean
quadricep
thick
live
deceas
patient
result
patient
admit
septic
shock
includedth
median
quadricep
thick
variabl
defin
threshold
valuew
observ
higher
mortal
group
whose
quadricep
thick
decreas
p
ci
sensit
specif
averag
thick
loss
greater
deceas
patient
survivor
p
conclus
earli
loss
quadricep
thick
could
associ
increas
mortal
septic
shock
annal
intens
care
suppl
introduct
ethic
reason
aspect
treatment
pediatr
intens
care
unit
picu
regularli
evalu
take
account
prognosi
patient
particular
situat
lead
multidisciplinari
discuss
continu
withhold
withdraw
life
sustain
treatment
lst
patient
outcom
patient
follow
lst
decis
variabl
poorli
describ
pediatr
literatur
main
purpos
studi
describ
popul
term
mortal
morbid
month
lst
discuss
patient
method
observ
descript
retrospect
monocentr
studi
french
picu
includ
patient
year
age
least
one
meet
lst
taken
place
intens
care
unit
whose
discuss
record
standard
form
provid
purpos
result
patient
includ
median
age
month
major
chronic
condit
main
reason
hospit
picu
neurolog
failur
mortal
rate
month
case
withdraw
lst
vs
case
withhold
lst
vs
case
continu
lst
death
took
place
picu
median
delay
day
discuss
lst
patient
decis
withdraw
lst
taken
younger
higher
predict
mortal
score
frequent
invas
ventil
curar
treatment
among
group
withdraw
lst
patient
extub
deep
continu
sedat
one
third
patient
surviv
month
discuss
lst
despit
decis
withdraw
withhold
lst
major
part
live
home
benefit
rehabilit
care
among
survivor
median
pediatr
overal
perform
categori
popc
pediatr
cerebr
perform
categori
pcpc
score
maximum
conclus
pediatr
patient
ethic
discuss
lst
picu
high
mortal
rate
regardless
decis
taken
survivor
sever
function
neurolog
disabl
need
regular
follow
collabor
picu
team
palli
medicin
team
could
improv
qualiti
care
accompani
process
patient
annal
intens
care
suppl
introduct
agoni
paediatr
intens
care
unit
picu
poorli
describ
literatur
although
never
proven
better
inform
parent
could
reduc
trauma
death
main
object
studi
defin
percept
endoflif
symptom
picu
traumat
parent
determin
wish
inform
would
like
receiv
patient
method
prospect
ongo
studi
conduct
picu
french
univers
hospit
author
robert
hospit
ethic
committe
patient
year
like
die
picu
includ
death
parent
inform
studi
physician
parent
systemat
recal
four
month
death
particip
semistructur
interview
conduct
psychologist
questionnair
concern
shock
percept
symptom
agoni
inform
would
like
receiv
result
month
enrol
patient
includ
among
death
picu
parent
approach
refus
studi
final
parent
could
interview
recal
four
parent
accept
interview
one
mother
describ
chang
skin
colour
bleed
shock
parent
infant
describ
weird
movement
said
help
recogn
death
one
mother
notic
sign
grate
inform
possibl
symptom
call
three
father
wive
refus
interview
coupl
bad
time
discuss
difficulti
encount
expect
parent
refus
inclus
lack
parent
involv
interview
main
problem
partial
due
strong
apprehens
recal
feel
guilt
overtak
benefit
expect
studi
parent
particip
alway
motiv
countergift
caregiv
suffer
desir
avoid
bereav
parent
conclus
ongo
studi
first
prospect
studi
experi
parent
child
endoflif
percept
sign
picu
difficulti
includ
parent
come
caregiv
caregiv
need
remov
taboo
endoflif
research
find
motiv
might
help
parent
testifi
annal
intens
care
suppl
introduct
ifireap
studi
prospect
ongo
studi
percept
endoflif
sign
paediatr
intens
care
unit
picu
ifireap
main
hypothesi
better
inform
parent
percept
endoflif
sign
could
help
live
better
situat
literatur
studi
topic
picu
therefor
first
step
observ
die
children
determin
sign
worsen
appear
endoflif
period
patient
method
studi
ongo
french
picu
patient
like
die
short
term
picu
includ
inform
parent
studi
obtain
nonopposit
caregiv
observ
die
child
death
child
exclud
death
occur
five
next
day
nonexhaust
list
percept
sign
propos
caregiv
fulfil
presenc
absenc
worsen
sign
die
process
result
april
august
patient
includ
exclud
unpredict
death
nonfrench
speaker
parent
oversight
brain
death
median
age
year
chronic
diseas
main
caus
death
respiratori
neurolog
failur
death
follow
limit
withdraw
treatment
patient
frequent
percept
sign
appear
worsen
die
process
concern
child
appear
cyanosi
pallor
marbl
petechia
sometim
respiratori
sign
percept
patient
still
invas
mechan
ventil
time
death
detail
tabl
unsurprisingli
physiolog
paramet
present
die
process
bradycardia
hypotens
desatur
could
notic
parent
monitor
gasp
note
patient
patient
present
digest
neurolog
sign
patient
except
one
receiv
sedoanalgesia
conclus
ifireap
first
prospect
studi
tri
determin
percept
sign
endof
life
picu
frequent
sign
gasp
concern
chang
skin
color
appear
sign
could
hurt
parent
could
easier
support
receiv
inform
onset
next
step
studi
determin
sign
notic
parent
need
explan
impact
inform
experi
annal
intens
care
suppl
introduct
children
suffer
multipl
disabl
frequent
hospitalis
paediatr
intens
care
unit
picu
ill
evolv
burden
treatment
increas
sometim
expens
children
comfort
thu
palli
care
consid
could
improv
qualiti
life
minim
pain
studi
aim
identifi
predict
factor
life
support
withhold
admiss
picu
patient
method
retrospect
studi
conduct
picu
chu
caen
children
year
old
suffer
multipl
disabl
hospit
januari
decemb
includ
studi
alloc
two
group
withhold
group
vs
control
group
depend
notif
medic
file
life
support
withhold
result
patient
includ
life
support
withhold
rate
admiss
withhold
group
younger
control
group
median
age
vs
p
hospitalis
respiratori
issu
n
vs
p
differ
gender
girl
vs
p
hospit
surgic
issu
natur
disabl
predict
factor
life
support
withhold
previou
hospit
picu
p
requir
respiratori
p
feed
support
p
higher
function
statu
score
popc
p
conclus
withhold
life
support
children
suffer
multipl
disabl
appear
limit
paediatr
depart
main
predict
factor
identifi
studi
least
one
admiss
picu
rais
question
role
paediatrician
withhold
life
support
annal
intens
care
suppl
introduct
sedationanalgesia
part
manag
ventil
pediatr
patient
must
adjust
patient
object
evalu
implement
nursingdriven
protocol
sedationanalgesia
durat
mechan
ventil
patient
method
beforeandaft
prospect
observ
studi
pediatr
intens
care
unit
includ
children
age
day
year
receiv
mechan
ventil
longer
h
observ
period
sedationanalgesia
administr
accord
medic
prescript
intervent
period
sedationanalgesia
adjust
nurs
accord
protocolbas
sedationanalgesia
guidelin
includ
evalu
comfortb
scale
result
total
children
includ
protocol
decreas
durat
mechan
ventil
protocol
statist
signific
median
durat
day
vs
day
protocol
p
protocol
mean
comfortb
optim
object
fix
protocol
monitor
comfortb
significantli
frequent
decreas
total
dose
hypnot
opioid
complianc
protocol
nurs
insuffici
median
rate
appear
increas
complic
relat
insuffici
sedationanalgesia
autoextub
low
number
medic
alert
procedur
conclus
implement
nursingdriven
protocol
sedationanalgesia
children
reduc
durat
mechan
ventil
total
dose
sedationanalgesia
protocol
insuffici
appli
howev
ensur
comfort
ventil
children
safe
annal
intens
care
suppl
introduct
withdraw
syndrom
ws
frequent
pediatr
intens
care
unit
picu
incid
could
reach
patient
prolong
sed
drug
give
rise
toler
withdraw
phenomena
scale
specif
tool
diagnos
ws
children
birth
year
old
main
object
work
compar
practic
regard
screen
manag
ws
picu
patient
method
first
consecut
patient
period
includ
ventil
sedat
opioid
benzodiazepin
score
h
three
day
extub
record
patient
cumul
dose
opioid
benzodiazepin
calcul
sed
cotreat
report
use
clonidin
dexmedetomidin
record
result
total
patient
analyz
proport
ws
n
n
pvalu
group
without
ws
patient
evalu
scale
five
day
around
extub
n
n
pvalu
length
sedat
longer
ws
group
versu
day
pvalu
length
mechan
ventil
versu
day
pvalu
higher
global
cumul
dose
sed
treatment
use
ws
group
mg
kg
versu
mg
kg
morphin
pvalu
mg
kg
versu
mg
kg
midazolam
pvalu
treatment
decreas
tent
slower
ws
group
versu
h
pvalu
use
clonidin
import
ws
group
period
ws
group
versu
pvalu
ws
group
versu
pvalu
use
dexmedetomidin
concern
two
patient
could
studi
conclus
studi
accord
literatur
concern
risk
factor
ws
practic
realli
chang
proport
scale
remain
use
systemat
one
way
improv
realiz
common
protocol
unit
annal
intens
care
suppl
introduct
pediatr
intens
care
unit
picu
delirium
preval
probabl
underdiagnos
cornel
assess
pediatr
delirium
capd
valid
scale
detect
delirium
newborn
children
age
year
old
capd
scale
current
translat
french
object
pilot
studi
assess
use
relev
french
version
capd
obtain
revers
translat
singl
picu
patient
method
capd
translat
valid
method
translat
revers
translat
first
step
translat
english
french
health
provid
doctor
nurs
group
doctor
made
translat
back
french
english
third
group
doctor
nurs
compar
two
english
version
valid
french
translat
straightforward
possibl
origin
version
stage
translat
consensu
translat
development
anchor
point
associ
scale
also
carri
two
element
present
caregiv
scale
print
label
stuck
back
care
sheet
children
screen
twice
day
twomonth
period
end
period
caregiv
interview
questionnair
straightforward
use
relev
free
comment
possibl
question
result
studi
period
scale
fill
expect
fill
nurs
alon
eighti
patient
evalu
capd
score
diagnos
delirium
end
period
caregiv
interview
capd
difficult
use
certain
patient
categori
deepli
sedat
patient
caregiv
patient
prior
neurolog
impair
caregiv
infant
caregiv
conclus
first
assess
use
french
version
capd
larg
proport
caregiv
difficulti
use
think
iss
relev
tool
therefor
french
studi
determin
proper
delirium
preval
could
perform
refer
traub
et
al
pediatr
delirium
criticallyil
children
intern
point
preval
studi
crit
care
med
c
et
al
cornel
assess
pediatr
delirium
valid
rapid
observ
tool
screen
deliriumin
picu
crit
care
med
annal
intens
care
suppl
introduct
opioid
overdos
crisi
current
ongo
northamerican
contin
relat
misus
opioid
analges
spread
new
fentanyloid
recreat
scene
data
regard
opioid
overdos
franc
remain
scarc
object
describ
opioid
overdos
admit
intens
care
unit
icu
character
involv
compound
consequ
clinic
featur
result
complic
patient
manag
patient
method
conduct
retrospect
singlecentr
observ
studi
includ
patient
admit
icu
year
period
oipioid
overdos
evidenc
typic
opioid
toxidrom
coma
pinpoint
pupil
bradypnea
associ
compat
blood
urin
toxicolog
screen
result
year
patient
male
femal
age
year
median
percentil
admit
opioid
intox
icu
patient
present
conscious
impair
glasgow
coma
score
respiratori
rate
min
pinpoint
myosi
naloxon
flumazenil
administ
avoid
tracheal
intub
mechan
ventil
request
patient
durat
h
durat
icu
stay
h
observ
complic
includ
aspir
pneumonia
rhabdomyolysi
acut
respiratori
distress
syndrom
cardiovascular
failur
withdraw
syndrom
hospitalacquir
infect
death
toxic
relat
opioid
misus
versu
opioid
overdos
multidrug
exposur
found
case
involv
opioid
follow
morphin
heroin
buprenorphin
methadon
codein
tramadol
dpropoxyphen
fentanyl
oxycodon
preval
differ
opioid
mainli
influenc
ban
propoxyphen
market
consecut
increas
tramadol
prescript
conclus
larg
cohort
opioid
poison
clearli
support
risk
lifethreaten
consequ
case
misus
overdos
mix
opioid
use
combin
legal
illeg
drug
frequent
support
role
interact
onset
toxic
multidrug
poison
annal
intens
care
suppl
introduct
franc
excess
ethanol
use
repres
major
public
health
problem
result
morbid
social
medic
expens
chronic
alcohol
drink
induc
depend
toler
may
thu
respons
withdraw
syndrom
complic
seizur
explain
ethanolinduc
alter
brain
neurotransmitt
includ
gammaaminobutyr
acid
glutamin
balanc
object
describ
patient
characterist
morbid
manag
final
outcom
patient
admit
intens
care
unit
icu
due
ethanol
withdraw
complic
seizur
patient
method
conduct
retrospect
monocentr
observ
studi
includ
presum
chronic
alcohol
patient
admit
icu
ethanol
withdrawalinduc
seizur
diagnosi
consid
physician
charg
base
result
use
clinic
biolog
imag
eeg
data
usual
requir
rule
altern
diagnos
result
fiftythre
patient
male
femal
age
year
median
interquartil
rang
includ
studi
patient
homeless
jobless
previous
present
ethanol
withdraw
syndrom
includ
seizur
patient
develop
statu
epilepticu
associ
delirium
tremen
complic
includ
aspir
pneumonia
cardiovascular
failur
mainli
vasopleg
shock
requir
norepinephrin
infus
neurolog
deficit
skin
compress
lesion
patient
request
mechan
ventil
day
patient
treat
anticonvuls
drug
two
mostli
use
levetiracetam
clonazepam
two
patient
die
readmiss
emerg
depart
rehospit
icu
medic
ward
remark
first
year
follow
icu
admiss
psycholog
addictolog
followup
conclus
ethanol
withdraw
may
respons
chronic
alcohol
seizur
requir
icu
admiss
lifethreaten
complic
death
data
support
absolut
necess
strengthen
fight
excess
ethanol
drink
societi
annal
intens
care
suppl
introduct
sinc
market
franc
prescript
quetiapin
second
gener
antipsychot
drug
exponenti
increas
risk
increas
number
acut
poison
data
regard
acut
quetiapin
overdos
scarc
object
describ
featur
complic
manag
acut
quetiapin
poison
admit
intens
care
unit
icu
evalu
prognost
contribut
plasma
quetiapin
concentr
icu
admiss
model
quetiapin
pharmacokinet
overdos
patient
method
conduct
retrospect
singlecent
observ
studi
quetiapinepoison
patient
evidenc
measur
plasma
concentr
toxic
rang
admit
icu
period
includ
sever
extraneurolog
complic
defin
onset
major
ecg
abnorm
catecholamin
requir
cardiac
arrest
death
plasma
quetiapin
concentr
determin
use
highperform
liquid
chromatographi
coupl
tandem
mass
spectrometri
result
thirtyeight
quetiapinepoison
patient
male
femal
median
age
year
interquartil
rang
presum
ingest
dose
g
includ
poison
result
multidrug
ingest
patient
present
conscious
impair
glasgow
coma
score
request
mechan
ventil
case
seizur
hyperglycemia
hypokalemia
intra
atrioventricular
block
qtc
prolong
ecg
complic
includ
cardiovascular
failur
aspir
pneumonia
cardiac
arrest
one
patient
die
length
icu
stay
h
plasma
quetiapin
concentr
admiss
ng
ml
allow
predict
onset
sever
complic
icu
delay
quetiapin
peak
observ
h
postingest
suggest
prolong
gastrointestin
absorpt
quetiapin
elimin
prolong
comparison
pharmacolog
condit
conclus
quetiapin
poison
rel
rare
may
lead
lifethreaten
cardiovascular
neurolog
featur
plasma
concentr
admiss
help
predict
onset
complic
thu
suggest
mark
interindividu
variabl
annal
intens
care
suppl
introduct
aluminum
phosphid
solid
fumig
pesticid
caus
seriou
potenti
lifethreaten
poison
poison
medic
emerg
requir
earli
adequ
manag
special
resuscit
environ
object
work
determin
profil
aluminum
phosphid
poison
assess
factor
relat
mortal
patient
method
retrospect
studi
patient
admit
intens
care
unit
inclus
criteria
base
anamnest
clinic
data
poison
aluminum
phosphid
result
thirteen
case
aluminum
phosphid
poison
identifi
women
men
averag
age
year
extrem
year
poison
accident
inhal
patient
voluntari
ingest
part
suicid
attempt
patient
delay
intox
admiss
averag
h
glasgow
coma
score
averag
respiratori
sign
forefront
inhal
dyspnea
irrit
cough
wherea
patient
ingest
toxic
shock
stage
abdomin
pain
vomit
present
patient
electr
abnorm
present
patient
conduct
disturb
n
repolar
disord
n
increas
troponin
observ
four
patient
ingest
toxic
mechan
ventil
necessari
case
use
vasoact
amin
patient
use
extraren
cleans
ecmo
perform
one
patient
four
patient
die
highest
mortal
observ
ingest
aluminum
phosphid
factor
significantli
relat
mortal
univari
analysi
oral
poison
p
cardiogen
shock
p
elev
troponin
p
use
ventilatori
support
p
conclus
acut
aluminum
phosphid
poison
remain
graft
heavi
mortal
especi
develop
countri
absenc
antidot
treatment
rapid
hemodynam
manag
may
help
improv
prognosi
includ
use
circulatori
assist
annal
intens
care
suppl
introduct
acut
kidney
injuri
aki
major
complic
rhabdomyolysi
risk
factor
case
poisoningrel
rhabdomyolysi
unknown
object
describ
toxic
involv
poisoningassoci
rhabdomyolysi
result
complic
identifi
predict
factor
aki
set
patient
method
conduct
monocentr
retrospect
observ
cohort
studi
includ
poison
patient
admit
intens
care
unit
icu
presentenc
rhabdomyolysi
defin
elev
phosphocreatinin
kinase
cpk
iu
l
aki
defin
use
kdigo
criteria
factor
associ
aki
onset
identifi
use
multivari
analysi
base
stepbystep
logist
regress
characterist
determin
use
receiv
oper
characterist
roc
curv
result
two
hundr
thirtyseven
patient
male
femal
age
year
includ
main
involv
toxic
benzodiazepin
antipsychot
opioid
serotonin
reuptak
inhibitor
aki
occur
patient
requir
hemodialysi
patient
associ
complic
includ
sepsi
cardiovascular
failur
cardiac
arrest
dissemin
intravascular
coagul
compart
syndrom
overal
mortal
rate
higher
presenc
arf
vs
p
peak
serum
creatinin
peak
serum
cpk
significantli
correl
p
linear
regress
base
multivari
analysi
age
p
femal
gender
p
lithium
intox
p
hypocalcemia
p
hyperphosphoremia
p
elev
serum
lactat
p
creatinin
concentr
p
independ
predict
aki
icu
admiss
area
roc
curv
predict
model
elev
serum
creatinin
concentr
l
best
accuraci
area
curv
sensit
specif
conclus
identifi
predict
factor
aki
poison
patient
admit
icu
present
rhabdomyolysi
may
help
improv
patient
prognosi
intensifi
prevent
select
patient
subgroup
risk
aki
annal
intens
care
suppl
introduct
acut
poison
real
public
health
problem
epidemiolog
profil
vari
region
time
object
studi
studi
epidemiologicalclin
evolutionari
therapeut
profil
acut
intox
admit
camu
resuscit
depart
patient
method
retrospect
studi
conduct
intens
care
unit
januari
decemb
includ
case
acut
intox
hospit
intens
care
result
seven
hundr
sixtytwo
patient
includ
studi
averag
age
year
clear
femal
predomin
sex
ratio
two
hundr
fortythre
addict
psychiatr
histori
alreadi
histori
attempt
suicid
averag
time
treatment
h
four
hundr
seventyon
patient
admit
camu
emerg
intox
voluntari
case
secondari
oral
ingest
toxicolog
analysi
show
drug
rank
first
n
pesticid
second
n
carbon
monoxid
third
n
drug
psychotrop
drug
anticonvuls
cardiotrop
antidiabet
paracetamol
common
caus
drug
poison
frequenc
respect
wherea
pesticid
rodenticid
predomin
n
follow
chloralos
n
organophosphoru
n
illeg
drug
crimin
patient
predomin
toxidrom
respect
anticholinerg
serotoninerg
cholinerg
toxidrom
lactic
acidosi
common
biolog
abnorm
follow
biolog
inflammatori
syndrom
rhabdomyolysi
mechan
ventil
requir
case
use
vasoact
amin
case
antidot
prescrib
case
transit
acceler
patient
evolut
benefici
patient
conclus
gener
epidemiolog
profil
shown
psychotrop
drug
still
predomin
mark
increas
frequenc
cardiotrop
antidiabet
poison
contrast
pesticid
clear
decreas
number
poison
organophosphoru
favor
chloralos
annal
intens
care
suppl
introduct
pesticid
poison
experienc
stabil
year
especi
develop
countri
object
determin
epidemiolog
therapeut
prognost
profil
widespread
pesticid
poison
tunisia
year
patient
method
descript
retrospect
studi
case
acut
intox
pesticid
admit
icu
resuscit
care
result
one
hundr
seventynin
case
pesticid
intox
admit
studi
period
repres
acut
intox
case
admit
intens
care
averag
age
addict
year
sex
ratio
poison
occur
home
case
public
space
poison
voluntari
case
accident
patient
came
directli
emerg
case
transfer
hospit
case
rodenticid
implic
type
pesticid
n
chloralos
leader
n
follow
organophosphoru
n
carbam
n
neurolog
sign
tremor
loss
conscious
predomin
n
follow
tachycardia
n
digest
sign
n
respiratori
distress
present
patient
hemodynam
failur
three
inhal
pneumonia
complic
poison
case
use
mechan
ventil
necessari
case
use
vasoact
drug
use
antibiot
therapi
gastric
lavag
perform
patient
atropin
administ
patient
median
length
stay
day
overal
mortal
n
conclus
pesticid
poison
realiti
tunisia
character
variabl
toxic
substanc
avail
countri
neurolog
sign
foreground
origin
major
fatal
complic
taken
care
due
time
appropri
place
annal
intens
care
suppl
introduct
uncertainti
regard
best
measur
need
red
blood
cell
rbc
transfus
mani
physiolog
marker
advoc
support
assess
addit
common
standard
haemoglobin
level
critic
ill
children
survey
aim
describ
physiolog
marker
measur
avail
british
canadian
paediatr
intens
care
unit
picu
patient
method
prepilot
selfadminist
questionnair
electron
sent
thrice
use
survey
monkey
novemb
februari
director
canadian
british
picu
list
physiolog
marker
includ
survey
develop
group
expert
particip
transfus
anemia
expertis
initi
pediatr
crit
care
med
sept
suppl
respond
ask
indic
marker
list
avail
picu
result
repli
receiv
canadian
british
picu
three
declin
invit
prematur
infant
newborn
admit
unit
result
present
tabl
conclus
mani
physiolog
measur
advoc
paediatr
intensivist
support
rbc
transfus
decis
routin
avail
bedsid
studi
explor
role
physiolog
marker
better
defin
need
rbc
transfus
addit
haemoglobin
concentr
includ
follow
commonli
avail
paramet
puls
oximetri
oxygen
index
oxygen
satur
index
blood
lactat
troponin
level
annal
intens
care
suppl
introduct
resuscit
unit
receiv
children
one
acut
shortterm
lifethreaten
failur
goal
focu
experi
famili
socioprofession
consequ
admit
child
intens
care
unit
patient
method
descript
retrospect
studi
period
month
april
june
pediatr
resuscit
unit
pediatr
eh
pr
boukhrofa
aek
includ
children
age
year
manag
vital
distress
result
children
averag
age
year
year
sex
ratio
parent
low
intellectu
level
averag
socioeconom
level
parent
separ
admiss
night
accompani
whole
famili
case
children
medic
histori
main
reason
admiss
resuscit
respiratori
distress
septic
shock
neurolog
traumat
socioprofession
consequ
parent
admit
abandon
famili
disturb
work
conclus
hospit
children
pediatr
intens
care
extrem
pain
experi
parent
social
profession
consequ
annal
intens
care
suppl
introduct
sever
medic
affect
major
surgic
intervent
children
may
necessit
admiss
pediatr
intens
care
unit
aim
work
evalu
pediatr
mortal
morbid
intens
care
unit
patient
method
retrospect
descript
analyt
studi
done
year
januari
decemb
includ
children
one
month
year
hospit
h
studi
variabl
includ
social
demograph
data
clinic
paraclin
prognost
data
result
studi
period
children
admit
icu
admiss
children
fit
criteria
inclus
femal
popul
present
total
mean
age
patient
patient
homozygot
ss
multipl
transfus
reason
admiss
includ
alter
conscious
fever
without
sever
respiratori
distress
postop
care
main
patholog
record
sever
malaria
bronchopneumopathi
mening
meningoenceph
sever
matern
patholog
repres
admiss
mean
durat
hospit
day
extrem
day
mortal
factor
bad
prognosi
mechan
ventil
p
mening
meningoenceph
conclus
infecti
patholog
form
main
caus
admiss
pediatr
patient
icu
knowledg
main
caus
referr
death
allow
us
better
orient
prevent
strategi
better
manag
patient
icu
annal
intens
care
suppl
introduct
primari
spontan
pneumothorax
psp
idiopath
pneumothorax
without
pulmonari
patholog
psp
preval
rare
children
unit
state
america
intern
consensu
treatment
psp
aim
studi
retrospect
analyz
initi
treatment
psp
young
adult
patient
method
children
psp
came
home
hospit
emerg
elig
sex
kind
pneumothorax
needl
ponction
thorac
ct
scan
realiz
time
limit
psp
diagnosi
thorac
drainag
type
drain
use
durat
drainag
accord
type
drain
eventu
recurr
studi
result
fifteen
children
year
median
year
boy
mostli
psp
period
among
children
need
thorac
drain
simpli
observ
patient
complet
psp
needl
exsuffl
need
thorac
drain
among
children
emphysema
bubbl
thorac
ct
scan
time
limit
psp
diagnosi
drainag
day
ci
durat
drainag
accord
type
drain
day
furhman
drain
day
monod
drain
among
psp
treat
monod
drain
recurr
among
psp
drain
furhman
system
recurr
conclus
studi
show
clearli
exsuffl
larg
psp
pediatr
intens
care
without
vital
life
issu
useless
delay
treatment
thorac
ct
scan
larg
psp
recurr
strongli
recommend
emphysema
bubbl
diagnosi
furhman
drain
mainli
use
icu
instead
monod
drain
mostli
use
surgeon
must
confirm
prospect
studi
nation
intern
pediatr
intens
care
center
annal
intens
care
suppl
introduct
ventil
associ
pneumonia
vap
common
infect
pediatr
intens
care
unit
picu
associ
signific
morbid
mortal
previou
studi
suggest
procalcitonin
pct
followup
vap
may
help
reduc
durat
antibiot
therapi
adult
intens
care
patient
order
lower
risk
select
antibiot
atb
resist
bacteria
patient
method
main
object
studi
impact
monitor
pct
plasma
level
day
day
durat
antibiot
treatment
case
vap
strasbourg
univers
hospit
picu
franc
prospect
includ
hospit
patient
unit
develop
vap
accord
infecti
diseas
societi
amarica
american
thorac
societi
guidelin
durat
pctguid
antibiot
treatment
compar
retrospect
collect
data
patient
treat
vap
result
five
patient
includ
prospect
mean
durat
atb
day
compar
day
control
group
n
found
statist
signific
p
treatment
failur
death
attribut
vap
group
conclus
result
tend
show
pct
followup
vap
diagnosi
could
favor
shortterm
antibiot
durat
picu
annal
intens
care
suppl
introduct
bronchiol
common
lower
respiratori
tract
infect
children
month
age
patient
requir
admiss
pediatr
intens
care
unit
picu
despit
predominantli
viral
etiolog
use
antimicrobi
picu
bronchiol
widespread
pilot
prospect
cohort
studi
aim
compar
level
infect
marker
critic
ill
infant
bronchiol
without
concomit
bacteri
pneumonia
patient
method
pilot
prospect
cohort
studi
includ
patient
year
old
diagnos
first
episod
viral
bronchiol
admit
canadian
picu
novemb
april
collect
data
patient
demograph
sever
score
diagnost
criteria
viral
bronchiol
concomit
bacteri
infect
bacteri
cultur
result
gather
data
follow
infect
biomark
first
day
picu
admiss
temperatur
procalcitonin
crp
white
blood
cell
count
wbc
analyz
preliminari
result
use
descript
statist
result
preliminari
result
includ
analysi
data
collect
patient
particip
mean
age
month
fifteen
patient
posit
respiratori
syncyti
viru
three
patient
bacteri
pneumonia
confirm
cultur
result
bacteri
infect
observ
twenti
patient
receiv
antimicrobi
mean
durat
day
regard
infect
biomark
studi
day
patient
present
fever
hypothermia
mean
level
procalcitonin
crp
ng
ml
mg
l
respect
mean
wbc
cell
l
mean
level
procalcitonin
ng
ml
vs
ng
ml
wbc
cell
l
vs
cell
l
similar
patient
bronchiol
patient
bronchiol
concomit
bacteri
pneumonia
mean
level
crp
higher
patient
bronchiol
concomit
bacteri
pneumonia
mg
l
vs
mg
l
conclus
crp
may
suitabl
biomark
diagnosi
concomit
bacteri
pneumonia
critic
ill
infant
bronchiol
annal
intens
care
suppl
introduct
usual
dose
regimen
meropenem
could
lead
suboptim
exposur
sinc
pharmacokinet
pk
subject
variabl
bsv
particularli
high
critic
ill
children
sepsi
aim
develop
popul
pk
model
simul
dose
regimen
optim
patient
exposur
patient
method
prospect
studi
conduct
pediatr
intens
care
unit
picu
center
necker
hospit
children
age
year
weigh
kg
enrol
meropenem
plasma
concentr
quantifi
high
perform
liquid
chromatographi
meropenem
pk
model
develop
use
non
linear
mixedeffect
model
softwar
monolix
version
estim
glomerular
filtrat
rate
egfr
estim
schwartz
formula
result
forti
patient
median
age
month
median
weight
kg
median
egfr
mlmin
includ
eleven
patient
receiv
continu
replac
renal
therapi
crrt
data
best
describ
two
compart
first
order
elimin
model
bodyweight
bw
allometr
relationship
egfr
crrt
signific
covari
explain
bsv
clearanc
cl
inter
compart
clearanc
q
central
peripher
volum
distribut
x
bw
qi
qpopx
bw
x
bw
cli
clpop
x
bw
x
egfr
patient
crrt
cli
clpop
x
bw
x
popul
cl
q
l
l
mont
carlo
simul
perform
provid
highest
probabl
reach
target
ft
mic
ft
mic
depend
renal
function
continu
infus
mg
kg
per
day
seem
best
dose
regimen
high
mic
valu
mg
l
without
risk
accumul
except
children
sever
renal
failur
without
crrt
usual
dose
regimen
mg
kg
h
min
adequ
patient
sever
renal
failur
regardless
mic
valu
conclus
continu
infus
allow
reach
target
ft
mic
bacteria
high
mic
valu
safeti
children
normal
augment
renal
clearanc
receiv
crrt
usual
dose
regimen
kept
children
sever
renal
failur
regardless
mic
valu
annal
intens
care
suppl
introduct
medic
databas
patient
registri
expand
consider
particularli
pediatr
critic
care
medicin
picanet
anzpic
registri
australia
vp
registri
yet
avail
frenchspeak
countri
aim
studi
develop
frenchspeak
registri
pediatr
pediatr
neonat
picu
p
nicu
franc
determin
structur
personnel
outcom
propos
actual
common
email
directori
patient
method
potenti
french
pediatr
pediatr
neonat
icu
identifi
gfrup
solicit
previous
necessari
variabl
ought
includ
french
pediatr
critic
care
registri
identifi
recher
j
eval
clin
pract
collect
variabl
hospit
servic
characterist
pediatr
neonat
middl
care
unit
icu
activ
characterist
number
bed
personnel
medic
paramed
nurs
number
fulltim
equival
patient
number
patient
outcom
survivor
non
survivor
secur
web
site
creat
head
picu
p
nicu
complet
onlin
data
secur
common
email
directori
result
french
picu
p
npicu
includ
incomplet
datan
picu
n
picu
identifi
mcu
associ
pediatr
number
bed
vari
total
pediatr
bed
pciu
n
picu
neonat
number
bed
vari
total
neonat
bed
n
picu
picu
n
picu
median
nurs
ratio
fte
number
bed
rang
pediatr
patient
admit
picu
n
picu
mean
rang
non
survivor
patient
n
rang
ie
mean
mortal
rate
rang
neonat
admit
n
picu
mean
rang
non
survivor
neonat
n
rang
ie
mean
mortal
rate
rang
mail
directori
complet
physician
n
n
picu
conclus
develop
frenchspeak
pediatr
intens
care
unit
registri
name
picur
provid
larg
descript
almost
french
picu
n
picu
term
structur
mortal
updat
secur
mail
directori
next
stage
implement
collect
patient
data
annal
intens
care
suppl
introduct
pandem
spread
multidrugresist
bacteria
mdrb
pose
threat
healthcar
worldwid
especi
intens
care
unit
icu
aim
studi
investig
relat
posit
mdrb
admiss
infect
well
prognosi
among
patient
admit
medic
icu
patient
method
conduct
retrospect
cohort
studi
includ
patient
admit
medic
intens
care
unit
yasminet
hospit
th
septemb
th
septemb
collect
demograph
characterist
patient
sex
age
igsii
sofa
characterist
infect
number
episod
site
germ
screen
mdrb
admiss
also
analyz
length
stay
mortal
rate
result
enrol
critic
ill
patient
mean
age
popul
year
sex
ratio
f
mean
igsii
sofa
score
respect
seventythre
patient
requir
machan
ventil
averag
durat
mechan
ventil
day
screen
mdrb
admiss
done
case
fourtyfour
patient
posit
mdrb
admiss
univari
analysi
posit
mdrb
admiss
significantli
associ
frequent
incid
infect
case
prolong
length
stay
day
versu
day
higher
rate
mortal
case
respect
p
p
p
multivari
analysi
prolong
length
stay
significantli
associ
posit
mdrb
admiss
conclus
posit
mdrb
admiss
predictor
factor
infect
length
stay
mortal
critic
ill
patient
annal
intens
care
suppl
introduct
burn
patient
risk
multidrug
resist
mdr
infect
burden
high
mortal
rate
aim
studi
establish
followup
digest
colon
carbapenemaseproduc
gram
neg
bacilli
bgnpc
patient
admit
burn
intens
care
unit
patient
method
studi
conduct
period
month
focus
rectal
sampl
taken
burn
search
bgnpc
genexpert
multiplex
realtim
pcr
cepheid
perform
directli
rectal
swab
cepheid
gene
xpert
carbar
allow
detect
preval
carbapenemas
gene
famili
blavim
blandm
blaimp
blakpc
result
studi
period
patient
underw
rectal
swab
carbapenemas
screen
admiss
pcr
case
posit
among
patient
posit
pcr
admiss
transfer
anoth
hospit
mainli
hospit
south
countri
studi
molecular
profil
isol
carbapenemas
show
predomin
posit
result
blavim
blandm
gene
case
ie
case
posit
blandm
gene
case
posit
blavim
gene
case
blavim
blandm
gene
geneposit
case
blavim
gene
blandm
gene
parallel
bmr
research
use
convent
bacteriolog
confirm
presenc
carbapenemresist
bgn
pcrposit
specimen
conclus
patient
explor
carrier
carbapenemas
patient
transfer
anoth
hospit
tunisia
highlight
one
hand
need
isol
polici
care
transfer
patient
hand
need
set
control
strategi
spread
mdr
annal
intens
care
suppl
introduct
use
overus
misus
antibiot
led
emerg
multidrugresist
bacteria
mdrb
witch
real
problem
public
health
fight
real
scourg
screen
best
tool
conduct
studi
evalu
effic
two
mdrb
screen
way
patient
method
studi
retrospect
includ
patient
admit
medic
intens
care
unit
icu
period
septemb
septemb
collect
patient
demograph
characterist
sex
age
igsii
sofa
infect
characterist
episod
site
use
two
way
mdrb
screen
take
sampl
two
site
nasal
rectal
januri
versu
five
site
nasal
buccal
axillari
inguin
rectal
octob
decemb
result
enrol
critic
ill
patient
averag
age
year
sex
ratio
median
igsii
sofa
score
respect
seventythre
patient
requir
mechan
ventil
median
durat
one
day
site
method
screen
mdrb
realis
case
site
method
practic
case
ninetyf
episod
infect
detect
frequent
site
infect
pulmonari
vascular
urinari
multivari
studi
reavel
two
site
method
led
adapt
antibiotherapi
case
versu
five
site
method
p
conclus
conclud
two
site
mdrb
screen
method
effici
detect
nosocomi
infect
adjust
emper
antibiotherapi
help
reduc
manag
cost
annal
intens
care
suppl
introduct
stenotrophomona
maltophilia
sm
nonfer
gramneg
bacterium
nfgnb
caus
seriou
opportunist
infect
repres
major
threat
intens
care
unit
icu
due
multidrug
resist
mdr
outbreak
sm
occur
septemb
januari
icu
gener
hospit
outbreak
control
team
conven
investig
time
epidemiolog
survey
conduct
correct
measur
initi
patient
method
outbreak
investig
combin
clinic
environment
sampl
molecular
type
use
pulsefield
gel
electrophoresi
pfge
patient
infect
colon
sm
period
includ
clinic
data
analyz
result
sixteen
patient
contamin
sm
includ
among
pulmonari
contamin
one
bacteraemia
two
death
probabl
relat
sm
infect
report
admiss
screen
show
outbreak
strain
acquir
icu
median
time
sm
contamin
day
rang
day
thirteen
patient
intub
median
length
day
intub
rang
day
patient
receiv
multiantibiot
treatment
includ
broadspectrum
antibiot
tabl
sm
clinic
strain
genotyp
found
sm
genotyp
patient
environment
sampl
reveal
contamin
almost
sink
icu
sink
icu
contamin
sm
includ
sink
among
patient
room
environment
screen
show
earli
recontamin
siphon
plughol
replac
infect
control
measur
includ
evict
tap
water
patient
care
strengthen
prevent
hygien
measur
made
possibl
control
outbreak
januari
discuss
pfge
result
suggest
outbreak
relat
uniqu
clone
sm
polyclon
colon
icu
water
system
sm
caus
sever
infect
debilit
patient
sourc
inappropri
antibiotherapi
antism
antibiot
integr
probabilist
antibiotherapi
within
icu
contamin
sm
conclus
outbreak
report
highlight
risk
mdr
gramneg
bacterium
contamin
water
system
icu
patient
although
complet
evict
environment
pathogen
imposs
discontinu
outbreak
obtain
infect
control
procedur
pedagogi
reason
evict
annal
intens
care
suppl
introduct
reduc
incid
icu
infect
extendedspectrum
betalactamaseproduc
esbl
extens
drug
resist
xdr
bacteria
routin
screen
faecal
carriag
recommend
patient
specif
contact
precaut
appli
colon
patient
aim
studi
assess
use
repeat
routin
screen
bacteria
icu
patient
patient
method
retrospect
studi
patient
admit
mix
icu
unit
januari
decemb
systemat
screen
done
anal
swab
admiss
weekli
thereaft
target
esbl
enterobacteriacea
xdr
bacteria
carbapenemaseproduc
enterobacteriacea
carbapenemresist
acinetobact
baumannii
pseudomona
aeruginosa
incid
assess
compar
studi
year
trend
test
result
among
studi
patient
screen
posit
multidrug
resist
bacteria
icu
day
incid
icu
day
icu
day
icu
day
p
ns
posit
carriag
acquir
icu
patient
icu
day
patient
day
patient
day
patient
icu
day
studi
year
patient
male
mean
age
tabl
describ
distribut
multidrug
resist
bacteri
faecal
carriag
studi
year
acinetobact
baumannii
found
lone
entiti
patient
pseudomona
aeruginosa
patient
among
esbl
posit
patient
xdr
carriag
diagnos
simultan
patient
later
patient
faecal
carriag
becam
posit
within
week
icu
admiss
none
posit
patient
becam
bacteriafre
subsequ
anal
swab
analysi
diagnosi
faecal
carriag
pursu
weekli
anal
swab
median
swab
total
swab
studi
year
averag
euro
per
anal
swab
analysi
repres
addit
cost
euro
conclus
multidrug
resist
bacteri
faecal
carriag
common
icu
diagnos
screen
may
pursu
contact
precaut
appli
would
probabl
result
signific
cost
reduct
side
effect
annal
intens
care
suppl
introduct
nosocomi
fungal
infect
could
aris
exposur
spore
filament
fungi
exist
hospit
environ
patient
method
present
studi
aim
investig
qualiti
surfac
intens
care
unit
ascertain
potenti
contribut
fungal
infect
rate
hospit
one
morn
punctual
sampl
taken
surfac
moisten
steril
swab
inocul
sabouraud
dextros
malt
extract
agar
qualit
evalu
mould
base
microscop
view
morpholog
featur
coloni
identif
yeast
base
routin
biochem
test
auxacolorbiorad
result
sampl
taken
surfac
posit
fungal
presenc
divid
mould
yeast
identifi
strain
belong
genera
frequent
aspergillu
candida
mucor
cladosporium
penicillium
trichosporon
predomin
fungi
encount
aspergillusnig
conclus
achiev
profession
servic
provid
safe
environ
patient
punctual
fungal
monitor
need
done
consist
annal
intens
care
suppl
introduct
risk
factor
multidrug
resist
mdr
gram
neg
vap
gn
vap
fulli
known
particular
icuresist
rate
increas
risk
known
postul
accord
recent
publish
guidelin
object
investig
risk
factor
mdr
gnvap
patient
method
adult
patient
admit
januari
februari
french
icu
contribut
outcomerea
prospect
databas
includ
diagnosi
requir
posit
cultur
quantit
tracheal
aspir
cfu
ml
plug
telescop
cathet
cfu
ml
bronchoalveolar
lavag
cfu
ml
rate
mdrgn
gn
infect
calcul
icu
use
icuvari
patientbas
variabl
includ
sever
procedur
use
previou
antimicrobi
use
day
use
previou
colon
mdr
gener
mix
model
binomi
distribut
built
assess
risk
factor
mdrgnvap
result
total
vap
episod
studi
includ
gnvap
episod
among
mdrgn
organ
suscept
gn
organ
treatment
frequent
adequ
within
h
suscept
gnvap
vs
p
risk
factor
mdrgn
vap
tabl
rate
mdrgn
infect
icu
independ
associ
mdrgnvap
conclus
larg
cohort
gnvap
patient
chronic
respiratori
diseas
previou
colon
mdr
gnb
previou
antimicrobi
use
independ
risk
factor
mdrgnvap
rate
mdr
gn
infect
icu
also
independ
associ
risk
annal
intens
care
suppl
introduct
carbapenemaseproduc
enterobacteriacea
cpe
repres
grow
problem
worldwid
pathogen
resist
avail
antibiot
therefor
challeng
treat
new
delhi
ndm
hydrolyz
penicillin
cephalosporin
first
isol
patient
travel
india
describ
around
world
intens
care
unit
erasm
hospit
brussel
belgium
epidem
case
month
occur
aim
studi
describ
characterist
evolut
colon
infect
patient
patient
method
screen
patient
colon
infect
cpeproduc
klebsiella
pneumonia
kp
within
rang
month
around
identif
first
case
includ
patient
confirm
ndmkp
genotyp
describ
patient
profil
previou
antibiot
use
infect
type
treatment
outcom
result
five
patient
least
one
sampl
posit
ndmkp
icu
novemb
march
strain
suscept
fosfomycin
also
colistin
chloramphenicol
perform
genotyp
detail
featur
list
tabl
patient
young
mean
age
year
suffer
sever
medic
condit
patient
stay
icu
subunit
patient
present
infect
relat
ndmkp
mediantim
colon
infect
day
patient
receiv
previou
broadspectrum
antibiotherapi
infect
treat
rare
use
antibiot
highli
toxic
observ
microbiolog
success
patient
relaps
infect
patient
die
caus
death
untrackt
infect
comorbid
colon
patient
surviv
mortal
rate
conclus
ndmproduc
enterobacteriacea
emerg
knowledg
seri
first
describ
locallyacquir
case
belgium
worri
reason
first
colon
infect
ratio
high
attest
high
pathogen
power
pathogen
host
frailti
second
infect
patient
die
despit
earli
target
antimicrobi
therapi
well
known
gene
encod
cpe
usual
plasmidtransmit
fact
patient
previou
broadspectrum
antibiot
therapi
support
statement
howev
speci
found
kp
patient
stay
unit
time
proxim
clear
plead
contact
compon
transmiss
hygien
rule
addit
antibiot
stewardship
therefor
crucial
annal
intens
care
suppl
introduct
central
lineassoci
bloodstream
infect
clabsi
remain
signific
sourc
morbid
cost
mortal
pediatr
intens
care
unit
picu
pediatr
intern
recommend
extrapol
adult
guidelin
sought
determin
risk
factor
rf
clabsi
describ
clabsi
incid
compar
evolut
patient
without
central
venou
cathet
cvc
remov
patient
method
monocentr
retrospect
studi
match
sex
age
icu
admiss
date
tertiari
clabsi
defin
accord
cdc
criteria
identifi
prospect
data
collect
posit
hemocultur
picu
prematur
patient
admiss
exclud
control
subject
patient
cvc
without
infect
list
potenti
rf
develop
literatur
review
comparison
characterist
case
patient
control
subject
made
use
wilcoxon
rank
sum
test
test
fisher
exact
test
appropri
univari
multivari
condit
logist
regress
model
use
identifi
independ
rf
clabsi
twosid
p
valu
less
consid
signific
result
case
patient
match
control
subject
independ
rf
clasbi
vein
insert
jugular
p
subclavian
p
congenit
metabol
diseas
p
parenter
nutrit
p
blood
transfus
p
durat
cvc
p
cvc
type
number
lumen
gastrostomi
tube
rate
white
cell
independ
rf
clabsi
case
patient
went
guidewir
exchang
catheter
none
control
subject
incid
clabsi
day
cvc
clabsi
due
extendedspectrum
produc
enterobacteriacea
due
methicillinresist
staphylococcu
aureu
occur
previous
identifi
carrier
conclus
insert
vein
congenit
metabol
disord
parenter
nutrit
blood
transfus
durat
icu
cvc
independ
rf
clabsi
result
must
confirm
prospect
multicent
studi
annal
intens
care
suppl
introduct
acut
chest
syndrom
ac
major
complic
sickl
cell
diseas
main
caus
mortal
adult
patient
current
guidelin
recommend
use
antibiot
treatment
ac
bacteri
infect
document
minor
case
use
procalcitonin
pct
may
allow
shorten
exposur
antibiot
ac
patient
method
prospect
beforeaft
studi
univers
hospit
patient
receiv
antibiot
accord
current
french
guidelin
ac
control
period
clinician
blind
pct
concentr
end
period
measur
use
build
algorithm
fasten
antibiot
cessat
three
day
treatment
bacteri
infect
document
serial
pct
concentr
l
intervent
period
pct
algorithm
use
final
decis
start
stop
antibiot
discret
physician
primari
endpoint
number
day
aliv
without
antibiot
result
control
intervent
period
includ
ac
episod
occur
patient
respect
total
episod
requir
icu
admiss
microbiolog
document
infect
found
episod
number
day
aliv
without
antibiot
longer
intervent
control
period
vs
day
p
patient
short
day
cours
antibiot
intervent
compar
control
period
vs
p
infect
relaps
pulmonari
reinfect
hospit
length
stay
differ
two
group
control
group
vs
intervent
group
day
p
conclus
pctguid
strategi
abl
shorten
durat
antibiot
therapi
appar
advers
outcom
annal
intens
care
suppl
introduct
accur
assess
septic
patient
risk
poor
clinic
outcom
challeng
emerg
physician
patient
experienc
sepsi
develop
organ
dysfunct
whose
intens
durat
link
deleteri
outcom
earli
manag
sepsi
proven
success
accur
triag
patient
key
studi
investig
whether
biomark
could
predict
deterior
patient
admit
ed
suspect
infect
help
emerg
physician
better
triag
manag
patient
method
triag
prospect
multicentr
site
franc
belgium
observ
studi
adult
patient
admit
ed
suspect
infect
least
sir
criteria
includ
blood
sampl
collect
h
admiss
main
outcom
subsequ
deterior
death
intens
care
admiss
increas
sofa
score
within
h
primari
endpoint
assess
independ
adjud
committe
sepsi
expert
biomark
associ
primari
endpoint
prognost
perform
assess
clinic
variabl
age
sex
charlson
score
sofa
score
qsofa
lactat
auc
roc
curv
confid
interv
comput
use
delong
method
predict
perform
assess
use
classif
threshold
optim
high
sensit
result
supar
protein
level
measur
ed
patient
time
point
patient
admiss
patient
worsen
within
studi
period
compar
biomark
supar
protein
combin
differenti
express
worsen
nonworsen
patient
pvalu
test
interestingli
patient
consid
sepsi
patient
enrol
sofa
develop
organ
dysfunct
within
studi
period
combin
supar
protein
level
inclus
best
predictor
worsen
auc
sensit
npv
compar
biomark
crp
auc
lactat
auc
qsofa
auc
pct
auc
moreov
perform
increas
auc
sensit
npv
conclus
express
supar
protein
significantli
predict
worsen
septic
patient
within
h
admiss
ed
biomark
could
enhanc
earli
identif
sever
patient
appropri
rapid
manag
abl
decreas
risk
poor
outcom
annal
intens
care
suppl
introduct
sepsi
frequent
reason
admiss
emerg
depart
ed
assess
septic
patient
risk
poor
clinic
outcom
challeng
clinician
current
valid
prognost
tool
avail
therefor
identif
patient
high
risk
worsen
ed
key
triag
object
assess
prognost
valu
blood
marker
panel
predict
earli
clinic
worsen
patient
admit
ed
suspect
sepsi
patient
method
triag
prospect
multicent
site
franc
belgium
studi
biolog
sampl
adult
patient
admit
ed
suspect
confirm
communityacquir
infect
least
sir
criteria
includ
protocol
includ
clinic
biolog
time
point
main
outcom
subsequ
deterior
defin
follow
death
intens
care
admiss
increas
sofa
score
within
h
patient
divid
group
depend
worsen
evolut
criteria
central
evalu
independ
adjud
committe
sepsi
expert
emerg
physician
intensivist
accuraci
prognost
perform
biomark
assess
patient
follow
day
mortal
result
studi
durat
year
patient
includ
wrongli
includ
n
secondari
exclud
n
patient
analyz
mean
age
charlson
score
adjud
patient
classifi
worsen
patient
without
deterior
admiss
differ
group
sir
criteria
count
wbc
crp
lactat
cf
tabl
central
analysi
progress
select
combin
biomark
best
prognost
perform
conclus
vital
sign
biolog
marker
paramet
predict
worsen
patient
prognost
valu
panel
blood
marker
ed
could
help
identif
septic
patient
risk
worsen
time
admiss
develop
specif
manag
annal
intens
care
suppl
introduct
septic
shock
one
lead
caus
mortal
among
critic
ill
patient
biomark
offer
tool
facilit
earli
diagnosi
identifi
patient
high
risk
complic
monitor
progress
diseas
studi
aim
explor
valu
procalcitonin
pct
creactiv
protein
crp
cholinesteras
activ
schea
kinet
use
predictor
mortal
patient
septic
shock
admit
intens
care
unit
icu
patient
method
conduct
prospect
singleblind
studi
icu
habib
bourguiba
univers
hospit
sfax
tunisia
januari
decemb
includ
patient
year
age
older
confirm
septic
shock
includ
patient
blood
sampl
septic
biomark
pct
schea
crp
obtain
serum
collect
day
icu
admiss
day
septic
shock
day
septic
shock
develop
result
studi
period
patient
includ
mean
age
sd
year
male
femal
patient
mean
sapsii
icu
admiss
median
mean
sofa
score
icu
admiss
median
includ
patient
patient
die
mortal
rate
day
septic
shock
settl
differ
two
group
mean
plasma
concentr
neither
schea
pct
crp
howev
comparison
mean
plasma
concentr
schea
pct
crp
show
signific
differ
survivor
nonsurvivor
tabl
conclus
studi
suggest
group
critic
ill
patient
sever
septic
shock
fall
procalcitonin
crp
level
rise
schea
associ
favor
outcom
studi
need
subject
annal
intens
care
suppl
introduct
recent
randomis
clinic
trial
fail
demonstr
non
inferior
procalcitonin
pct
guid
antibiot
therapi
respect
month
mortal
among
patient
sever
acut
exacerb
chronic
obstruct
pulmonari
diseas
aecopd
need
mechan
ventil
explain
result
assess
capac
pct
distinguish
infecti
non
infecti
caus
sever
aecopd
patient
method
pct
level
patient
time
inclus
h
day
measur
use
sensit
immunoassay
result
regard
cohort
n
time
pct
level
higher
patient
bacteri
infect
n
viral
infect
n
patient
without
document
infect
fig
interestingli
whether
pct
level
tend
higher
patient
bacteri
infect
n
patient
viral
infect
n
pneumon
group
patient
pct
fail
distinguish
bacteri
infect
n
viral
infect
n
non
pneumon
group
patient
conclus
result
underlin
interest
pct
biomark
distinguish
infecti
non
infecti
caus
sever
aecopd
howev
pct
could
fail
distinguish
bacteri
viral
infect
set
annal
intens
care
suppl
introduct
infecti
diseas
repres
frequent
caus
consult
emerg
depart
ed
biomark
may
help
clinician
assess
sever
address
promptli
intens
care
unit
icu
sever
eosinopenia
may
reflect
level
system
inflamm
aim
studi
evalu
sever
eosinopenia
defin
valu
g
l
infect
patient
predict
evolut
toward
admiss
icu
patient
method
infect
patient
admit
ed
least
one
complet
blood
count
includ
factor
explain
admiss
icu
within
day
follow
ed
admiss
evalu
multivari
logist
regress
result
among
patient
screen
infect
patient
final
includ
nearli
half
sever
eosinopenia
admiss
ed
multivari
analysi
sever
eosinopenia
aor
ic
histori
chronic
renal
failur
aor
ic
creactiv
protein
mg
l
aor
ic
pulmonari
infect
aor
ic
independ
factor
associ
icu
admiss
within
follow
week
element
differenti
count
elimin
model
sever
eosinopenia
also
significantli
associ
longer
length
stay
bacteremia
vs
septic
shock
within
day
vs
mortal
vs
p
outcom
conclus
sever
eosinopenia
reflect
system
inflamm
independ
factor
associ
icu
admiss
within
day
also
associ
longer
length
stay
bacteremia
septic
shock
mortal
annal
intens
care
suppl
introduct
emerg
depart
ed
earli
appropri
recognit
infect
crucial
start
antibiot
treatment
time
fashion
tradit
biomark
remain
specif
enough
infect
patient
lymphopenia
known
associ
sepsi
icu
yet
evalu
potenti
infect
biomark
ed
contrari
white
blood
cell
wbc
count
routin
wide
perform
part
admiss
assess
investig
whether
isol
clinic
associ
sever
lymphopenia
ed
could
marker
infect
patient
method
conduct
retrospect
singlecent
studi
yearperiod
adult
patient
admit
ed
sever
lymphopenia
lymphocyt
count
g
l
analyz
patient
hematolog
oncolog
diseas
hiv
infect
hepatocellular
defici
immunosuppress
year
old
exclud
diagnosi
infect
confirm
independ
adjud
committe
correl
lymphopenia
infect
assess
use
univari
analysi
multivari
logist
regress
result
januari
decemb
patient
admit
ed
sever
lymphopenia
elig
men
mean
age
year
infect
confirm
patient
bacteri
viral
initi
patient
refer
ed
suspect
infect
among
biolog
marker
crp
differ
infect
uninfect
group
vs
p
depth
lymphopenia
associ
higher
preval
infect
bacteremia
microbiolog
identif
figur
multivari
analysi
clinic
criteria
independ
associ
infect
sir
criteria
p
fever
p
contrari
classic
biolog
biomark
appear
associ
infect
wbc
count
p
crp
p
conclus
preval
infect
high
patient
sever
lymphopenia
regardless
reason
admiss
ed
tradit
biomark
result
easi
measur
marker
could
use
routin
emerg
physician
assist
earli
diagnosi
infect
annal
intens
care
suppl
introduct
prognosi
infect
acut
chronic
liver
failur
aoclf
depend
rapid
diagnosi
may
difficult
absenc
classic
sign
fever
found
ratio
nlr
plateletlymphocyt
ratio
plr
regard
cheap
simpl
promis
paramet
predict
sepsi
sever
sever
diseas
aim
evalu
role
nlr
plr
diagnosi
infect
aoclf
patient
method
retrospect
followup
studi
case
diagnosi
decompens
cirrhosi
januari
decemb
result
total
case
decompens
cirrhosi
enrol
studi
mean
age
year
gender
diagnosi
sepsi
identifi
case
multivari
logist
regress
analys
show
signific
posit
correl
creactiv
protein
crp
p
procalcitonin
p
plr
p
nlr
p
infect
evalu
abil
nlr
crp
procalcitonin
plr
predict
infect
roc
curv
obtain
evalu
paramet
nlr
show
strong
statist
signific
correl
high
concord
correl
coeffici
conclus
infect
one
lead
caus
hospit
patient
decompens
cirrhosi
associ
consider
mortal
clinician
seek
use
easili
obtain
biomark
studi
shown
plr
nlr
good
marker
predict
infect
aoclf
annal
intens
care
suppl
introduct
evalu
anxieti
depress
posttraumat
stress
disord
preval
ptsd
intens
care
unit
icu
survivor
determin
risk
factor
post
intens
care
unit
psycholog
comorbid
evalu
profession
practic
evolut
patient
method
studi
includ
adult
patient
length
stay
h
icu
came
followup
consult
fill
form
posttraumat
stress
symptom
scale
hospit
anxieti
depress
scale
had
receiv
month
earlier
potenti
risk
factor
pre
per
post
intens
care
unit
collect
preval
psychiatr
comorbid
determin
year
result
among
patient
studi
ci
anxieti
ci
depress
symptom
ci
ptsd
anxieti
depress
ptsd
defin
had
score
predict
factor
age
anxieti
p
risk
factor
psychiatr
comorbid
signific
memori
disord
seem
favor
ptsd
well
sepsi
presenc
favor
anxieti
noninvas
ventil
favor
anxieti
depress
signific
chang
preval
due
profession
practic
evolut
conclus
anxieti
depress
ptsd
critic
ill
common
detect
predictor
allow
earli
multidisciplinari
manag
patient
order
reduc
preval
annal
intens
care
suppl
introduct
last
thirti
year
societi
undergon
sever
socioeconom
demograph
chang
impli
new
challeng
public
health
differ
aspect
critic
care
manag
aim
describ
characterist
mortal
risk
factor
patient
admit
low
incom
countri
micu
medic
intens
care
unit
patient
method
retrospect
analysi
chart
review
patient
admit
tertiari
micu
octob
juli
collect
characterist
evolut
outcom
univari
multivari
regress
analys
perform
identifi
factor
independ
associ
mortal
discuss
patient
admit
studi
period
main
characterist
mean
age
year
male
gender
mean
sap
ii
predict
mortal
median
length
stay
day
common
caus
admiss
acut
respiratori
failur
n
n
chronic
one
multiorgan
dysfunct
n
upon
admiss
occur
diagnos
commun
acquir
pneumonia
septic
shock
voluntari
poison
n
patient
admit
local
emerg
room
rate
acut
renal
failur
n
patient
chronic
kidney
diseas
admiss
patient
requir
renal
replac
therapi
noninvas
ventil
niv
invas
mechan
ventil
mv
indic
n
n
patient
respect
median
durat
niv
mv
day
day
patient
tracheostom
due
difficult
wean
icu
acquir
complic
detail
tabl
mortal
rate
n
multivari
analysi
identifi
two
independ
risk
factor
mortal
sapsii
p
acut
renal
failur
p
conclus
studi
describ
trend
micu
admiss
district
high
incid
icu
acquir
complic
remain
major
problem
tunisia
requir
implement
sever
reform
independ
risk
factor
mortal
sapsii
acut
renal
failur
admiss
annal
intens
care
suppl
introduct
intens
care
unit
elderli
patient
admiss
grow
last
year
mortal
rate
high
loss
autonomi
common
among
survivor
howev
data
regard
impact
critic
ill
caregiv
lack
object
studi
evalu
caregiv
burden
critic
ill
elderli
popul
assess
factor
associ
high
burden
level
patient
method
patient
includ
icecub
clinic
trial
clinic
trial
gouv
nct
inclus
criteria
age
least
critic
condit
preserv
function
statu
defin
activ
daili
live
adl
score
preserv
nutrit
statu
absenc
known
activ
cancer
patient
zarit
burden
interview
zbi
month
avail
select
primari
endpoint
zbi
mild
sever
burden
month
result
one
hundr
nineti
one
patient
median
age
year
includ
median
caregiv
zbi
month
patient
multivari
analysi
factor
significantli
associ
moder
sever
burden
adl
decreas
p
mental
compon
qualiti
life
qol
score
sf
month
p
contrast
age
icu
admiss
length
hospit
stay
associ
moder
sever
load
p
p
p
respect
conclus
function
autonomi
qol
month
associ
mild
sever
caregiv
burden
contrari
age
icu
admiss
length
hospit
stay
advanc
age
obstacl
care
critic
ill
elderli
patient
howev
improv
long
term
autonomi
qol
remain
import
mean
higher
implic
geriatrician
medic
care
annal
intens
care
suppl
introduct
postintens
care
syndrom
sum
cognit
psychiatr
physic
sequela
hospit
intens
care
unit
frequent
sequela
seriou
impact
qualiti
life
autonomi
morbid
mortal
patient
last
sever
year
initi
hospit
although
consensu
intens
care
unit
team
frequent
schedul
visit
assess
physic
mental
statu
patient
discharg
ward
clinic
interest
practic
evidenc
yet
patient
method
sinc
followup
visit
intens
care
unit
discharg
set
intens
ward
tour
univers
hospit
centr
order
detect
potenti
occurr
postintens
care
syndrom
patient
patient
admit
acut
respiratori
distress
syndrom
septic
shock
elig
conduct
descript
studi
cohort
assess
evolut
patient
inform
studi
could
declin
particip
result
thirtyeight
patient
summon
reevalu
followup
visit
month
discharg
among
admit
icu
acut
respiratori
distress
syndrom
septic
shock
acut
respiratori
distress
syndrom
septic
shock
anoth
diagnosi
acut
respiratori
failur
sever
intox
thirteen
patient
still
hospit
rehabilit
followup
visit
day
among
remain
patient
consult
gener
practition
yet
fourteen
patient
present
cognit
alter
patient
psychiatr
troubl
patient
physic
sequela
respiratori
one
patient
two
sequela
least
domain
post
intens
care
syndrom
patient
sequela
figur
fifteen
patient
reevalu
month
discharg
show
global
improv
statu
persist
defici
overal
refer
specialist
modif
treatment
followup
visit
conclus
observ
studi
confirm
frailti
patient
discharg
intens
care
unit
patient
present
troubl
belong
field
post
intens
care
syndrom
highlight
potenti
interest
earli
reevalu
annal
intens
care
suppl
introduct
prolong
lo
length
stay
icu
patient
especi
elderli
welldefin
problem
associ
increas
health
care
cost
resourc
util
delay
icu
admiss
emerg
depart
may
impact
morbid
mortal
predict
icu
lo
may
contribut
effici
resourc
alloc
better
plan
care
aim
determin
incid
predict
factor
prolong
iculo
elderli
patient
admit
tunisian
medic
icu
patient
method
retrospect
analyt
studi
conduct
bed
micu
univers
hospit
year
period
includ
elderli
patient
year
old
icu
stay
consid
prolong
exceed
day
variabl
found
statist
signific
univari
analysi
includ
multivari
regress
model
identifi
factor
independ
associ
prolong
icu
stay
result
review
period
patient
includ
patient
characterist
mean
age
mean
sapsii
mean
apach
ii
mean
sofa
respiratori
disord
admiss
invas
mechan
ventil
vasopressor
use
median
length
icu
stay
day
twentythre
patient
prolong
icu
stay
univari
analysi
identifi
sever
factor
associ
prolong
icu
stay
past
histori
chronic
respiratori
failur
crf
p
admiss
exacerb
crf
p
intub
icu
admiss
p
hyponatremia
admiss
p
invas
mechan
ventil
p
sedat
p
nosocomi
infect
p
shock
p
icuacquir
weak
p
dyskalemia
p
anemia
p
multivari
analysi
three
predictor
independ
associ
prolong
icu
stay
exacerb
chronic
respiratori
failur
ci
p
hyponatremia
admiss
ci
p
nosocomi
infect
ci
p
conclus
exacerb
chronic
respiratori
failur
hyponatremia
admiss
nosocomi
infect
independ
predictor
prolong
icu
stay
research
need
better
identif
patient
prolong
icu
stay
ensur
optim
use
icu
resourc
annal
intens
care
suppl
introduct
place
chest
film
radiographi
manag
critic
care
patient
well
known
howev
sinc
advanc
imag
technolog
last
decad
mani
tool
ad
diagnost
arsen
studi
investig
use
radiolog
procedur
intens
care
unit
icu
aim
determin
use
frequenc
condit
realiz
diagnost
therapeut
impact
specif
cost
differ
radiolog
procedur
icu
patient
method
retrospect
studi
conduct
medic
icu
consecut
radiolog
procedur
realiz
juli
juli
includ
data
collect
medic
file
result
one
hundr
five
radiolog
investig
realiz
among
comput
tomographyscan
ct
scan
five
magnet
reson
imag
mri
echographi
includ
transthorac
echographi
tte
transesophag
echographi
teo
abdomin
echographi
lower
limb
venou
sonographi
forti
one
realiz
patient
bed
realiz
hospit
requir
medic
transport
other
center
sixtyon
examin
realiz
patient
mechan
ventil
patient
sedat
patient
vasopressor
radiolog
procedur
compromis
complic
realiz
occur
n
suspect
diagnosi
confirm
n
exam
five
exam
inconclus
ct
scan
allow
confirm
suspect
diagnosi
echographi
allow
confirm
fortyf
percent
suspect
pulmonari
embol
pe
confirm
pulmonari
comput
tomographi
angiographi
forti
radiolog
examin
direct
therapeut
impact
mean
cost
radiolog
exam
euro
global
cost
euro
conclus
contribut
imag
diagnosi
manag
icu
patient
consider
given
import
therapeut
impact
examin
condit
dissuad
clinician
realiz
radiolog
investig
given
low
rate
incid
complic
annal
intens
care
suppl
introduct
age
popul
increas
demand
critic
care
resourc
elderli
worldwid
data
characterist
outcom
patient
icu
aim
assess
characterist
identifi
predictor
icu
mortal
elderli
patient
patient
method
retrospect
studi
conduct
medic
icu
januari
decemb
includ
patient
age
year
medic
patient
record
review
compil
demograph
characterist
sever
diagnosi
admiss
manag
outcom
univari
multivari
analysi
use
identifi
predictor
icu
mortal
result
studi
period
patient
admit
icu
age
year
patient
characterist
median
age
year
male
median
charlson
score
knauss
c
maccab
median
sapsii
median
apach
median
sofa
invas
mechan
ventil
imv
median
durat
day
vasopressor
use
renal
replac
therapi
main
reason
admiss
respiratori
disord
shock
neurolog
disord
miscellan
median
length
stay
day
mortal
rate
univari
analysi
identifi
respect
death
surviv
apach
ii
vs
p
sofa
vs
p
shock
admiss
vs
p
imv
use
admiss
vs
p
acut
kidney
injuri
vs
p
arrythmia
vs
p
nosocomi
infect
vs
p
multivari
regress
model
identifi
follow
factor
independ
associ
mortal
nosocomi
infect
ci
p
acut
kidney
injuri
ci
p
imv
use
admiss
ci
p
conclus
imv
use
admiss
nosocomi
infect
acut
kidney
injuri
independ
associ
fatal
outcom
elderli
critic
ill
patient
annal
intens
care
suppl
introduct
congress
place
exchang
updat
medic
knowledg
howev
cost
neglig
profit
train
particip
remain
unclear
studi
purpos
studi
identifi
young
intensivit
fund
particip
congress
patient
method
selfquestionnair
french
sent
young
doctor
specialti
mail
list
intern
peopl
survey
characterist
attend
confer
fund
staff
total
contribut
rel
data
anonym
questionnair
regist
cnil
result
total
august
novemb
peopl
includ
intensivist
respond
questionnair
intern
equival
proport
year
internship
young
senior
clinic
leader
specialist
assist
last
congress
host
intensivist
franc
particip
particip
confer
n
receiv
invit
n
receiv
fund
n
scholarship
averag
amount
person
financ
amount
sd
averag
total
amount
sd
figur
reason
particip
simpl
presenc
n
present
congress
n
n
particip
thought
main
interest
convent
n
thought
price
pay
alreadi
barrier
conclus
intensivist
selffinanc
signific
particip
particip
congress
organ
train
object
better
fund
opportun
promot
fellowship
congress
intens
care
annal
intens
care
suppl
introduct
midlin
cathet
mc
peripher
venou
cathet
insert
deeparm
vein
extend
lifespan
day
mc
could
repres
altern
central
venou
cathet
patient
poor
venou
access
requir
prolong
intraven
treatment
antibiot
seek
determin
object
studi
determin
dwell
time
safeti
mc
patient
method
perform
prospect
observ
studi
includ
consecut
mc
insert
academ
hospit
march
septemb
fulli
integr
powerglid
protm
bard
devic
use
mc
insert
use
steril
techniqu
senior
intensivist
experi
ultrasoundguid
cathet
placement
mc
util
period
nurs
physician
receiv
train
mc
manag
mc
team
pharmaci
resid
senior
intensivist
follow
patient
mc
insert
remov
ultrasound
examin
perform
weekli
mc
tip
systemat
cultur
remov
result
fiftyseven
mc
insert
patient
men
age
year
rang
repres
total
mcday
median
rang
cathet
use
per
insert
indic
mc
placement
exclus
extend
antibiotherapi
n
poor
venou
access
n
iter
blood
sampl
n
hydrat
n
median
dwell
time
day
rang
twentynin
mc
remov
without
complic
four
patient
lost
followup
twentythre
mc
retriev
follow
complic
accident
remov
n
suspect
infect
n
confirm
posit
tipcultur
mc
dysfunct
without
vein
thrombosi
n
vein
thrombosi
n
respons
mc
dysfunct
n
clinic
symptom
n
mcrelat
bloodstream
infect
bsi
occur
overal
incid
mcrelat
complic
mcday
discuss
mcinfect
could
overestim
observ
infect
occur
patient
mc
insert
insuffici
diamet
vein
basil
brachial
mc
tip
locat
could
respons
high
rate
vein
thrombosi
conclus
despit
nurs
train
close
monitor
patient
observ
shorter
dwell
time
expect
high
rate
mcassoci
thrombosi
result
question
definit
util
mc
devic
test
howev
longer
devic
axillari
tip
could
safer
durabl
annal
intens
care
suppl
introduct
earli
adequ
fluid
rescuscit
burn
contribut
improv
outcom
severli
burn
patient
lead
less
tissu
oedema
fluid
accumul
reduc
organ
system
dysfunct
aim
studi
evalu
impact
approach
earli
burn
outcom
patient
method
pospect
studi
conduct
intens
burn
care
depart
tunisia
month
januari
may
includ
patient
age
year
total
bodi
surfac
area
admit
within
post
burn
injuri
hospit
durat
h
patient
resuscit
accord
parkland
formula
goal
ressuscit
mean
arteri
pressur
map
mm
hg
hourli
urin
output
huo
mlkgh
bodi
weight
measur
admiss
daili
use
bed
scale
earli
clinic
outcom
burn
patient
design
first
week
post
burninjuri
result
period
studi
patient
admit
burn
icu
patient
includ
mean
age
year
ratio
sex
averag
tbsa
total
bodi
surfac
area
earli
icu
mortal
n
patient
assign
survivor
n
non
survivor
n
compar
studi
group
follow
tabl
tabl
compar
studi
group
conclus
optim
initi
fluid
resuscit
burn
patient
associ
lower
fluid
overload
first
h
improv
earli
outcom
lower
earli
mortal
annal
intens
care
suppl
introduct
reduct
venou
capacit
norepinephrin
increas
mean
system
pressur
pm
increas
cardiac
preload
effect
may
ad
one
fluid
administ
septic
shock
nevertheless
could
imagin
norepinephrin
potenti
synerg
way
efficaci
volum
expans
venou
return
reduc
venou
capacit
reduc
distribut
volum
fluid
enhanc
induc
increas
stress
blood
volum
purpos
studi
test
increas
psm
induc
preload
challeng
enhanc
norepinephrin
ne
patient
method
prospect
compar
studi
includ
septic
shock
adult
revers
reproduc
volum
expans
preload
increas
differ
dose
norepinephrin
mimick
fluid
infus
passiv
leg
rais
plr
patient
decreas
ne
plan
estim
psm
interact
method
use
endinspiratori
endexpiratori
occlus
baselin
plr
test
plrhigh
dose
ne
decreas
psm
estim
second
plr
plrlow
result
ne
dose
decreas
kg
min
p
increas
psm
induc
plrhigh
highest
dose
ne
significantli
greater
induc
plrlow
vs
p
increas
cardiac
index
induc
plrlow
significantli
greater
induc
plrhigh
p
moder
correl
diastol
arteri
pressur
baselinehigh
p
r
neinduc
chang
mean
arteri
pressur
p
r
conclus
norepinephrin
enhanc
increas
psm
induc
plr
mimic
fluid
infus
suggest
may
potenti
effect
fluid
synerget
way
septic
shock
patient
may
decreas
amount
administ
fluid
contribut
decreas
cumul
fluid
balanc
annal
intens
care
suppl
introduct
static
marker
cardiac
preload
central
venou
pressur
cvp
remain
help
variabl
bedsid
guid
hemodynam
manag
criticallyil
patient
sinc
transthorac
echocardiographi
tte
current
firstlin
tool
evalu
hemodynam
condit
criticallyil
patient
aim
assess
abil
tte
estim
track
chang
cvp
patient
method
patient
mechan
ventil
four
atrial
fibril
concomit
cvp
measur
intern
jugular
cathet
tte
examin
perform
passiv
leg
rais
test
infus
salin
calcul
tricuspid
e
wave
ratio
tricuspid
e
e
wave
ratio
right
ventricular
isovolum
time
ivrt
e
ivrt
ratio
wave
ratio
suprahepat
vein
flow
vtisystol
fill
fraction
peak
velocitiessystol
fill
fraction
suprahepat
vein
flow
endexpiratori
diamet
inferior
vena
cava
ivc
respiratori
variat
ivc
diamet
statist
analysi
consid
cvp
threshold
valu
mmhg
clinic
relev
result
chang
cvp
induc
passiv
leg
rais
test
patient
fluid
administr
patient
pool
valu
endexpiratori
ivc
diamet
respiratori
variat
ivc
diamet
correl
cvp
r
r
respect
p
baselin
endexpiratori
ivc
diamet
mm
predict
cvp
mmhg
specif
ci
sensit
ci
endexpiratori
ivc
diamet
mm
predict
cvp
mmhg
specif
ci
sensit
ci
baselin
respiratori
variat
ivc
diamet
could
predict
neither
cvp
mmhg
cvp
mmhg
auc
p
rel
chang
ratio
vtisystol
fill
fraction
correl
rel
chang
cvp
r
r
respect
p
concord
rate
chang
ratio
cvp
concord
rate
chang
vtisystol
fill
fraction
cvp
conclus
criticallyil
patient
tte
reliabl
estim
cvp
track
chang
cvp
induc
chang
cardiac
preload
nevertheless
endexpiratori
ivc
diamet
ou
mm
mm
detect
cvp
ou
mmhg
mmhg
respect
specif
annal
intens
care
suppl
introduct
arteri
elast
ea
ventricular
end
systol
elast
ee
shown
link
way
may
optim
effici
convert
left
ventricular
power
forward
flow
relationship
may
disrupt
sepsi
devis
pilot
studi
investig
feasibl
use
speckl
track
echocardiographi
ste
examin
ea
surrog
convent
equat
base
blood
pressur
stroke
volum
icu
patient
chose
group
septic
patient
group
nonsept
patient
attempt
demonstr
decoupl
ea
ee
use
convent
equat
use
ste
patient
method
septic
nonsept
patient
underw
echocardiograph
carotid
arteri
examin
invas
blood
pressur
measur
echocardiograph
measur
stroke
volum
eject
fraction
use
calcul
ea
ee
convent
mean
carotid
ste
perform
analyz
circumferenti
strain
strainrat
result
studi
ea
feasibl
use
ste
patient
ea
correl
circumferenti
strain
r
p
strainrat
r
p
use
convent
method
demonstr
relationship
ea
ee
r
p
ee
circumferenti
strain
r
p
circumferenti
strain
rate
p
differ
septic
nonsept
patient
regard
ste
ea
ea
ee
conclus
speckl
track
echocardiographi
ste
feasibl
way
examin
elast
great
arteri
icu
patient
differ
observ
septic
nonsept
patient
regard
arteri
elast
assess
use
convent
method
ste
annal
intens
care
suppl
introduct
fluid
infus
one
cornerston
sepsi
resuscit
therapi
howev
paradigm
shift
current
occur
concern
rais
potenti
advers
effect
fluid
therapi
one
major
advers
effect
report
fluid
overload
fo
fo
defin
fluid
accumul
baselin
bodi
weight
object
studi
assess
influenc
fo
sofa
score
chang
day
day
patient
method
studi
retrospect
multicent
epidemiolog
data
analysi
adult
patient
admit
septic
shock
caus
periton
pneumonia
mechan
ventil
enrol
studi
delta
sofa
score
defin
sofa
score
measur
admiss
minu
sofa
score
measur
day
bivari
analysi
perform
parametr
test
nonparametr
test
multivari
analysi
perform
studi
associ
fo
delta
sofa
score
result
patient
met
inclus
criteria
studi
cumul
fluid
balanc
day
greater
fo
group
betweengroup
differ
ml
pvalu
delta
sofa
score
twofold
higher
fo
group
fo
group
differ
two
group
pvalu
patient
without
fo
rapidli
discharg
icu
compar
patient
fo
one
week
less
mechan
ventil
compar
fo
patient
pvalu
stepwis
decreas
delta
sofa
score
durat
fluid
overload
greater
pvalu
linear
model
associ
fluid
overload
statu
delta
sofa
score
confirm
adjust
relativerisk
pvalu
conclus
studi
report
exposit
fluid
overload
frequent
event
occur
patient
cohort
fluid
overload
patient
prolong
multiorgan
failur
septic
shock
annal
intens
care
suppl
introduct
patient
acut
respiratori
failur
arf
bronchoalveolar
lavag
bal
high
risk
intub
oxygen
procedur
could
improv
safeti
set
howev
procedur
usual
associ
discomfort
patient
need
sedat
also
associ
risk
intub
hypnosi
suggest
use
improv
comfort
patient
method
observ
feasibl
studi
perform
patient
arf
requir
bal
hypnosi
induc
train
physician
techniqu
describ
milton
erickson
fiberopt
bronchoscopi
perform
pulmonologist
local
anesthesia
patient
highli
hypoxem
intub
need
noninvas
ventil
within
h
bronchoscopi
record
bronchoscopi
comfort
assess
physician
perform
hypnosi
record
achiev
hypnosi
bronchoscopi
result
nine
patient
admit
icu
arf
need
bal
median
age
year
old
patient
male
underli
immun
defect
relat
hiv
patient
steroid
treatment
patient
allogen
stem
cell
transplant
patient
hematolog
malign
patient
suspect
diagnosi
arf
mainli
pneumocysti
pneumonia
patient
mean
oxygen
level
bronchoscopi
l
min
respiratori
rate
min
patient
need
vasopressor
bronchoscopi
bal
hfnc
mainli
use
tabl
patient
requir
cessat
bronchoscopi
intoler
cough
bal
mechan
invas
ventil
requir
within
h
bronchoscopi
one
patient
comfort
describ
good
patient
quit
good
patient
bearabl
difficult
two
patient
reach
hypnosi
state
bronchoscopi
describ
bronchoscopi
bearabl
patient
difficult
patient
patient
hypnosi
state
achiev
n
almost
achiev
n
one
patient
experi
bal
ask
hypnosi
last
bronchoscopi
pulmonologist
report
felt
bronchoscopi
easier
usual
hypnosi
conclus
hypnosi
seem
feasibl
safe
patient
arf
requir
bal
seem
associ
increas
satisfact
rate
patient
pulmonologist
addit
compar
studi
need
confirm
result
annal
intens
care
suppl
introduct
comatos
patient
antiepilept
drug
a
usual
administ
nasogastr
tube
ngt
popul
often
residu
plasma
concentr
a
outsid
therapeut
rang
object
studi
estim
modal
administr
a
ngt
variou
intens
care
unit
tuni
patient
method
studi
consist
investig
modal
administr
a
ngt
resid
intens
care
four
month
prepar
question
includ
demograph
inform
particip
voluntari
anonym
questionnari
distribut
seven
intens
care
depart
author
head
depart
resid
includ
result
resid
sexratio
mean
age
year
period
ngt
replac
perform
averag
respons
day
resid
thought
a
administ
time
food
account
total
popul
accord
resid
dosag
form
administ
ngt
use
intens
care
unit
tablet
think
crush
administr
introduc
drug
ngt
resid
thought
mix
tap
water
resid
respond
treatment
introduc
dri
ngt
accord
resid
use
a
resuscit
servic
phenobarbit
resid
respond
detect
possibl
overdos
therapeut
drug
monitor
best
way
a
adjust
particular
popul
among
resid
express
need
train
modal
administr
treatment
ngt
improv
knowledg
conclus
manag
comatos
a
requir
control
method
administr
ngt
thu
action
strategi
put
place
improv
knowledg
medic
sector
subject
annal
intens
care
suppl
introduct
myasthenia
gravi
mg
autoimmun
disord
character
gener
weak
gilhu
ne
nejm
treatment
mg
base
immunosuppress
mainli
corticosteroid
annual
incid
mg
rang
case
per
carr
et
al
bmc
neurol
acut
exacerb
mg
character
worsen
muscl
weak
may
result
acut
respiratori
failur
requir
invas
mechan
ventil
upper
airway
viral
infect
may
induc
acut
exacerb
aim
describ
characterist
myasthenia
gravi
exacerb
caus
upper
airway
viral
infect
well
outcom
patient
method
retrospect
cohort
studi
undertaken
medic
icu
tertiari
care
hospit
adult
patient
hospit
myasthenia
gravi
exacerb
due
respiratori
viral
episod
posit
multiplex
pcr
assay
juli
decemb
includ
result
upper
airway
viral
infect
caus
total
hospit
mg
exacerb
year
period
affect
patient
mainli
femal
n
ig
ii
age
year
patient
treat
immunosuppressor
system
glucocorticoid
immunosuppress
month
six
patient
requir
invas
mechan
ventil
vasopressor
requir
patient
icumort
n
bacteri
coinfect
occur
patient
detect
virus
influenza
n
parainfluenza
n
respiratori
syncyti
viru
rsv
n
conclus
upper
respiratori
airway
infect
frequent
caus
myasthenia
gravi
exacerb
despit
popul
immunosuppress
annal
intens
care
suppl
introduct
predict
delirium
intens
care
epredelir
model
develop
recalibr
earli
predict
epredelir
model
test
prove
feasibl
fast
univers
hospit
univers
affili
teach
hospit
would
high
valu
confirm
nonunivers
icu
main
outcom
studi
predict
abil
epredelir
diagnos
delirium
therefor
correl
posit
epredelir
score
icdsc
score
intens
care
delirium
screen
checklist
search
subsequ
analysi
perform
epredeler
use
cardiac
surgeri
vs
patient
also
compar
abil
epredeler
apach
ii
score
predict
delirium
patient
method
studi
approv
medic
ethic
committe
patient
sign
inform
consent
data
patient
collect
secur
electron
system
consecut
patient
age
includ
period
patient
exclud
cognit
dysfunct
known
admiss
chronic
alcohol
epredeler
score
calcul
physician
h
admiss
presenc
delirium
screen
nurs
period
five
day
icdsc
scale
nic
nurs
instrument
commun
sedat
score
result
patient
elig
analysi
overal
incid
delirium
highest
incid
newonset
delirium
day
result
roc
analysi
figur
show
epredelir
score
highli
discrimin
auc
ci
seen
studi
higher
incid
delirium
post
cardiac
surgeri
group
patient
three
time
delirium
group
compar
gener
popul
e
predeler
score
threshold
one
combin
maxim
sensit
specif
maximum
youden
index
apach
ii
score
threshold
would
epredelir
score
discrimin
power
apach
ii
score
auc
ci
conclus
epredelir
delirium
predict
model
reliabl
remain
fast
easi
gener
nonunivers
icu
character
great
turnov
patient
caregiv
rather
low
nursetopati
ratio
allow
earli
prevent
measur
aim
reduc
delirium
incid
high
risk
patient
annal
intens
care
suppl
introduct
post
cardiac
arrest
myoclonu
pcam
occur
patient
admit
cardiac
arrest
ca
associ
outcom
debat
aim
identifi
incid
risk
factor
outcom
pcam
set
also
describ
clinic
characterist
eeg
pattern
patient
method
use
cochin
ca
registri
procat
retrospect
includ
consecut
ca
patient
admit
januari
decemb
icu
patient
treat
target
temperatur
manag
main
outcom
preval
pcam
surviv
icu
discharg
risk
factor
pcam
clinic
characterist
eeg
pattern
also
assess
result
among
patient
male
median
age
year
includ
analysi
develop
pcam
icu
stay
pcam
associ
initi
nonshock
rhythm
p
hypox
caus
p
two
patient
pcam
surviv
one
pcam
patient
good
outcom
cpc
wherea
patient
without
pcam
surviv
icu
discharg
irrevers
brain
damag
lead
caus
death
among
patient
pcam
observ
strong
associ
myoclonu
icu
stay
mortal
icu
discharg
odd
ratio
clinic
characterist
eeg
pattern
also
report
conclus
pcam
observ
nearli
one
third
ca
patient
admit
icu
myoclonu
independ
invari
associ
icu
mortal
syndrom
approach
combin
semiolog
electrophysiolog
could
help
use
myoclonu
tool
prognost
ca
annal
intens
care
suppl
introduct
a
administ
nasogastr
tube
ngt
comatos
patient
evalu
a
efficaci
toxic
may
difficult
therapeut
drug
monitor
tdm
may
use
a
adjust
particular
popul
studi
aim
analyz
trough
plasmat
level
a
administ
ngt
comatos
patient
patient
method
conduct
retrospect
studi
comatos
patient
address
seven
year
measur
a
administ
ngt
includ
sampl
patient
a
measur
autom
chimiluminesc
techniqu
use
pharmacokinet
paramet
dp
dose
per
weight
assess
a
bioavail
includ
patient
result
studi
sexratio
patient
median
age
year
children
year
among
sampl
measur
concern
valproic
acid
vpa
phenobarbit
pnb
carbamazepin
cbz
phenytoin
two
a
associ
patient
a
associ
drug
case
polymed
drug
note
case
a
subtherapeut
case
vpa
subtherapeut
case
among
sampl
correspond
valu
dp
lower
recommand
one
sampl
present
least
one
drug
associ
concern
a
case
drug
associ
nonrespect
ngt
modal
a
administr
patient
conclus
tdm
use
tool
assess
drugdrug
interact
control
modal
a
administr
comatos
patient
annal
intens
care
suppl
introduct
outofhospit
cardiac
arrest
ohca
associ
poor
short
long
term
outcom
determin
outcom
relat
initi
resuscit
process
also
caus
cardiac
arrest
cardiac
caus
ohca
extens
studi
recent
decad
convers
littl
known
noncardiac
caus
present
studi
aim
report
diagnost
pitfal
treatment
issu
larg
seri
patient
select
prospect
populationbas
registri
final
diagnosi
ohca
neurolog
caus
ohcanc
furthermor
also
aim
identifi
factor
associ
use
icag
first
line
investig
initi
diagnost
checkup
patient
method
retrospect
analysi
consecut
patient
pari
sudden
death
expertis
centr
franc
registri
may
septemb
present
sustain
return
spontan
circul
rosc
hospit
admiss
final
diagnosi
ohcanc
descript
earli
diagnost
checkup
perform
identifi
caus
cardiac
arrest
logist
multivari
regress
identifi
factor
associ
immedi
coronari
angiographi
icag
ohcanc
patient
result
among
patient
rosc
final
diagnosi
ohcanc
establish
earli
diagnost
checkup
consist
total
immedi
cranial
ctscan
icag
chest
ctscan
brain
ctscan
allow
identifi
neurovascular
caus
patient
icag
perform
first
line
exam
patient
final
diagnosi
neurovascular
caus
ohcanc
later
identifi
patient
multivari
analysi
decis
icag
independ
associ
stsegment
elev
postrosc
electrocardiogram
ci
p
wherea
obviou
caus
cardiac
arrest
scene
neg
associ
icag
ci
p
conclus
ohcanc
rare
event
mainli
relat
neurovascular
caus
initi
ecg
pattern
may
confound
regard
triag
earli
diagnost
checkup
studi
requir
explor
potenti
harm
associ
decis
perform
icag
popul
annal
intens
care
suppl
introduct
anxieti
depress
unpleas
emot
mani
icu
survivor
experi
psychiatr
disord
impact
neg
qualiti
life
littl
known
factor
associ
anxieti
depress
critic
ill
aim
evalu
incid
anxieti
depress
among
critic
care
survivor
identifi
risk
factor
patient
method
mix
method
studi
conduct
medic
icu
januari
januari
includ
icu
survivor
beyond
month
discharg
data
obtain
medic
record
month
posticu
discharg
patient
contact
phone
complet
hospit
anxieti
depress
scale
had
univari
logist
regress
analys
use
result
patient
admit
studi
period
discharg
aliv
never
success
contact
die
within
month
period
patient
enrol
studi
patient
characterist
mean
age
year
male
mean
sapsii
invas
mechan
ventil
imv
vasopressor
use
anxieti
depress
symptom
found
respect
icu
survivor
median
hadsa
hadsd
score
respect
univari
analysi
factor
associ
anxieti
age
vs
p
femal
sex
vs
p
imv
vs
p
sed
use
vs
p
multivari
logist
regress
sed
use
ci
p
femal
sex
ci
p
age
ci
p
independ
associ
anxieti
age
vs
p
associ
depress
univari
analysi
multivari
logist
regress
sed
use
ci
p
femal
sex
ci
p
independ
associ
depress
conclus
mood
disord
rather
common
icu
survivor
femal
sex
young
age
sed
use
independ
associ
anxieti
depress
icu
discharg
annal
intens
care
suppl
introduct
continu
applic
noninvas
ventil
niv
use
dedic
ventil
high
level
posit
endexpiratori
pressur
peep
expert
center
could
effici
revers
respiratori
failur
perform
systemat
review
random
control
trial
assess
whether
protocol
carri
niv
may
influenc
intub
rate
patient
admit
icu
de
novo
acut
respiratori
failur
patient
method
random
trial
identifi
pubm
embas
incept
april
pediatr
studi
perform
outsid
icu
includ
patient
treat
anoth
reason
de
novo
respiratori
failur
niv
protocol
specifi
exclud
two
author
independ
extract
intub
rate
niv
protocol
especi
continu
applic
intermitt
session
type
ventil
set
peep
level
center
experi
singl
versu
multicent
studi
result
fourteen
studi
includ
icupati
treat
niv
de
novo
respiratori
failur
identifi
overal
intub
rate
influenc
continu
applic
niv
type
ventil
expertis
center
intub
rate
lower
studi
use
higher
peep
level
cm
other
vs
p
inclus
criteria
heterogen
numer
critic
data
niv
lack
conclus
except
high
peep
level
might
associ
lower
intub
rate
protocol
carri
niv
seem
influenc
outcom
patient
de
novo
respiratori
failur
annal
intens
care
suppl
introduct
despit
extens
use
highflow
nasal
oxygen
therapi
hfno
acut
respiratori
failur
arf
daili
clinic
practic
assess
yet
therefor
design
region
survey
evalu
physician
clinic
experi
patient
method
perform
observ
survey
surveymonkey
onlin
softwar
senior
physician
belong
northwest
icu
boreal
studi
group
month
period
thirtyfour
icu
solicit
survey
includ
question
regard
effect
use
hfnc
indic
expect
effici
practic
aspect
use
initi
wean
result
present
median
first
third
quartil
percentag
respons
result
icu
physician
answer
regularli
use
hfno
admiss
arf
icu
bed
indic
expect
result
hfno
present
tabl
hypoxem
arf
consid
best
indic
pneumonia
thorac
trauma
favorit
nevertheless
physician
consid
hfno
effici
ie
avoid
intub
least
case
hypoxem
arf
case
hypercapn
arf
consid
good
indic
physician
expect
success
rate
physician
estim
hfno
indic
convent
oxygen
need
hfno
mainli
use
via
specif
devic
ventil
physician
initi
hfno
progress
increas
flow
regularli
use
hfno
continu
intermitt
niv
practic
hfno
wean
heterogen
depend
situat
consid
necessari
stop
hfno
wherea
flow
lmin
requir
criteria
hfno
failur
ie
need
intub
ventilatori
paus
arrest
persist
hypoxemia
respiratori
acidosi
respiratori
worsen
bronchial
congest
occurr
conclus
hfno
consid
icu
physician
mani
situat
arf
despit
rel
low
expect
success
rate
especi
case
hypercapnia
clinic
practic
appear
heterogen
regard
administr
wean
modal
despit
physiolog
benefit
hfno
result
may
reflect
discrep
current
clinic
studi
prospect
observ
studi
need
hfno
daili
practic
annal
intens
care
suppl
introduct
educ
process
traine
appli
knowledg
treat
patient
intens
care
achiev
full
clinic
compet
moreov
advanc
knowledg
regard
mechan
ventil
particular
lung
protect
ventil
asynchroni
shown
associ
mortal
reason
develop
simul
control
spontan
artifici
ventil
simva
virtual
breath
patient
mathemat
model
resolv
differenti
equat
chest
lung
movement
accord
inspiratori
effort
order
match
clinic
databas
aim
studi
compar
two
teach
modal
mechan
ventil
tradit
lectur
versu
virtual
simul
patient
method
random
control
studi
involv
resid
one
group
particip
attend
didact
lectur
mechan
ventil
h
wherea
simul
group
h
perform
measur
use
pre
posttest
evalu
knowledg
respiratori
set
pressur
flow
time
curv
monitor
retent
test
done
month
question
use
pre
post
retent
test
comparison
individu
group
anova
multipl
comparison
group
p
consid
signific
result
baselin
knowledg
differ
group
posttest
significantli
improv
group
figur
significantli
higher
simul
group
retent
test
significantli
differ
pretest
simul
group
conclus
computerbas
simul
modelis
control
spontan
mechan
ventil
potenti
improv
knowledg
skill
ventil
set
comparison
tradit
didact
lectur
annal
intens
care
suppl
introduct
usual
clinician
measur
respiratori
effort
mechan
ventil
requir
use
esophag
cathet
keep
patient
respiratori
effort
within
normal
rang
pressur
support
ventil
psv
therefor
difficult
achiev
main
aim
studi
describ
relat
respiratori
pattern
respiratori
effort
indic
wide
titrat
pressur
support
level
psl
psv
assess
new
calcul
indic
respiratori
effort
requir
esophag
cathet
patient
method
patient
elig
first
h
switch
control
ventil
psv
psl
decreas
step
flow
airway
esophag
pressur
electr
imped
tomographi
eit
signal
continu
record
titrat
measur
step
indic
respiratori
effort
includ
muscl
pressur
pmu
esophag
product
ptpe
deriv
record
signal
calcul
pmu
pmuscalc
ptpe
comput
use
equat
motion
respiratori
system
respiratori
mechan
previous
collect
patient
control
ventil
result
preliminari
result
involv
first
five
patient
tidal
volum
vt
variat
psl
titrat
depend
basal
level
respiratori
effort
vt
valu
remain
rel
stabl
normal
underassist
effort
ptpe
increas
dramat
case
overassist
ptpe
figur
pmuscalcl
calcul
peak
inspiratori
flow
correl
actual
peak
pmu
r
p
addit
seem
better
correl
pmu
r
p
pmuscalcl
definit
result
includ
eit
assess
present
meet
conclus
preliminari
data
suggest
potenti
interest
analyz
vt
valu
evolut
psl
titrat
furthermor
new
calcul
tool
pmuscalc
may
help
clinician
assess
respiratori
effort
bedsid
person
level
assist
annal
intens
care
suppl
introduct
immunocompromis
intens
care
unit
icu
popul
associ
prognosi
bodi
mass
index
bmi
never
assess
object
studi
determin
influenc
bmi
icu
immunocompromis
patient
mortal
risk
factor
icu
mortal
accord
bmi
patient
method
post
hoc
analysi
prospect
multin
cohort
studi
perform
countri
immunocompromis
acuterespiratoryfailur
arf
patient
conduct
primari
endpoint
icumort
rate
impact
bmi
icumort
risk
factor
accord
bmi
analys
use
multivari
cox
analysi
best
threshold
separ
dead
aliv
patient
determin
use
youden
index
result
patient
bmi
avail
overal
icumort
rate
ninetyon
patient
underweight
icumort
normal
weight
icumort
overweight
icumort
obes
grade
icumort
obes
grade
icumort
obes
grade
icumort
multivari
cox
analysi
includ
initi
oxygen
strategi
sequenti
organ
failur
assess
sofa
score
without
respiratori
item
ratio
icu
admiss
invas
mechan
ventil
pattern
chest
x
ray
etiolog
arf
higher
bmi
significantli
associ
lower
mortal
rate
adjust
hr
ahr
p
centr
effect
observ
two
bmi
group
separ
low
high
bmi
adjust
risk
die
lower
high
bmi
group
compar
low
bmi
group
ahr
p
multivari
cox
analysi
risk
factor
mortal
common
group
sofa
score
without
respiratori
item
niv
use
invas
mechan
ventil
found
low
bmi
group
ratio
mmhg
alveolarinterstiti
radiolog
pattern
figur
conclus
immunocompromis
arf
patient
higher
bmi
associ
lower
mortal
contrari
low
bmi
group
ratio
radiolog
pattern
associ
mortal
high
bmi
group
result
suggest
ratio
radiolog
pattern
reliabl
predict
prognosi
obes
arf
patient
might
one
explan
invers
adjust
associ
observ
icu
mortal
bmi
annal
intens
care
suppl
introduct
mechan
ventil
mv
intend
improv
ga
exchang
offset
work
breath
newtonian
equat
motion
clearli
illustr
respect
restrict
elast
compon
could
imped
ventil
static
dynam
airway
pressur
paw
may
valuabl
assist
wean
process
aim
identifi
discrimin
properti
paw
predict
difficult
wean
patient
method
chart
review
consecut
mv
patient
admit
micu
novemb
februari
perform
patient
characterist
admiss
paw
admiss
day
high
pressur
ratio
hpr
number
day
spent
high
pressur
peak
andor
plateau
andor
drive
andor
autopeep
divid
lo
outcom
record
difficult
wean
express
prolong
durat
mv
day
null
ventilatorfre
day
day
vfd
composit
outcom
death
lo
day
univari
multivari
regress
analys
perform
identifi
factor
independ
associ
difficult
wean
result
includ
mv
patient
main
characterist
mean
age
year
mean
sapsii
ph
mmhg
mmhg
ae
copd
ard
median
mv
durat
day
lo
day
tracheostomi
mortal
mean
paw
respect
peak
plateau
drive
autopeep
admiss
day
median
hpr
multivari
analysi
yield
follow
variabl
independ
associ
studi
endpoint
vfd
plateau
day
ci
p
hpr
ci
p
prolong
durat
mv
hpr
ci
p
composit
outcom
plateau
day
ci
p
hpr
hr
ci
p
conclus
high
plateau
pressur
number
day
spent
high
paw
seem
alter
significantli
wean
annal
intens
care
suppl
introduct
critic
ill
patient
intens
care
unit
icu
acquir
weak
complic
commonli
observ
associ
poor
outcom
increas
length
stay
assess
skelet
muscl
diaphragm
icuassoci
morpholog
chang
usual
appreci
ultrasonographi
shear
wave
elastographi
swe
novel
techniqu
allow
measur
absolut
elast
valu
kpa
soft
tissu
quantifi
mechan
properti
therefor
aim
determin
reliabl
reproduc
ultrasonograph
swe
measur
critic
ill
patient
patient
method
first
phase
two
oper
test
healthi
subject
variou
probe
posit
order
select
reproduc
among
best
probe
posit
use
examin
intra
interoper
reliabl
healthi
subject
second
phase
intra
interoper
reliabl
elastographi
evalu
critic
ill
patient
oper
blind
measur
one
irb
obtain
reliabl
calcul
use
intraclass
correl
coeffici
icc
bootstrap
sampl
method
assess
consist
result
measur
elast
modulu
diaphragm
bicep
brachii
rectu
femori
healthi
subject
critic
ill
patient
lead
record
swe
elastogram
first
group
healthi
subject
interoper
reliabl
favor
longitudin
view
rather
transvers
one
except
diaphragm
respect
icc
vs
vs
vs
second
group
healthi
subject
signific
differ
found
muscl
stiff
measur
oper
result
satisfactori
interoper
intraoper
reliabl
observ
measur
icc
valu
rang
tabl
critic
ill
patient
withinoper
betweenoper
reliabl
swe
measur
also
satisfactori
icc
tabl
probabl
reach
interrat
icc
greater
bootstrap
sampl
respect
conclus
critic
ill
patient
feasibl
reproduc
reliabl
ultrasonograph
swe
measur
limb
muscl
diaphragm
assess
herein
fair
though
result
may
encourag
promot
techniqu
icu
set
applic
understand
manag
icuacquir
weak
need
studi
annal
intens
care
suppl
introduct
acquir
von
willebrand
syndrom
avw
hemostasi
disord
wide
describ
differ
extracorpor
circulatori
assist
convers
data
avail
field
extracorpor
remov
report
result
prospect
monocentr
studi
focus
von
willebrand
disord
induc
devic
patient
method
prospect
studi
perform
consecut
patient
treat
either
ila
devic
biolog
test
includ
platelet
function
diphosph
pfaadp
pfaepi
von
willebrand
factor
antigen
vwf
ag
activ
vwf
rco
multimer
profil
hydrasi
system
measur
perform
prior
initi
min
daili
h
stop
bleed
thrombot
event
record
result
use
patient
ila
januari
juli
indic
acut
exacerb
chronic
obstruct
pulmonari
diseas
n
acut
respiratori
distress
syndrom
n
sever
acut
asthma
n
signific
prolong
pfaadp
median
time
versu
p
pfaepi
versu
p
observ
patient
one
patient
miss
data
normal
respect
among
patient
test
h
stop
vwf
rco
vwf
ag
ratio
decreas
patient
min
median
ratio
versu
figur
ratio
normal
h
cessat
patient
test
loss
high
molecular
weight
multim
occur
patient
test
n
earli
min
median
ratio
versu
associ
increas
low
molecular
weight
multim
figur
fourteen
bleed
event
report
nine
thrombot
event
report
right
intern
jugular
cannul
site
devic
thrombosi
trend
pronounc
decreas
high
molecular
weight
multim
patient
bleed
event
conclus
von
willebrand
disord
observ
patient
may
contribut
least
part
frequenc
sever
bleed
complic
observ
popul
annal
intens
care
suppl
introduct
aim
identifi
characterist
patient
sever
acut
exacerb
chronic
obstruct
pulmonari
diseas
copd
evalu
prognost
copd
patient
patient
method
retrospect
studi
perform
period
icu
habib
bourguiba
univers
hospit
sfax
tunisia
patient
sever
acut
exacerb
copd
includ
result
studi
period
patient
acut
exacerb
copd
admit
icu
emphysema
patient
mean
age
sd
year
sex
ratio
common
comorbid
hypertens
patient
cardiac
failur
situat
diabet
case
mean
sapsii
score
icu
admiss
patient
acut
circulatori
failur
patient
requir
mechan
ventil
mortal
rate
studi
around
length
stay
lo
length
invas
ventil
median
icu
stay
evolut
mark
death
patient
mortal
significantli
higher
patient
cardiac
failur
vs
p
necessit
introduct
catecholamin
admiss
vs
p
high
plasma
urea
plasma
creatinin
concentr
significantli
associ
mortal
p
p
respect
conclus
copd
exacerb
frequent
caus
hospit
icu
sever
form
requir
mechan
ventil
associ
poor
outcom
develop
shock
acut
kidney
injuri
significantli
associ
mortal
annal
intens
care
suppl
introduct
acut
exacerb
chronic
obstruct
pulmonari
diseas
aecopd
import
event
character
respiratori
ill
progress
manag
often
need
intens
care
unit
hospit
ventil
support
either
noninvas
ventil
niv
invas
ventil
iv
object
studi
describ
epidemiolog
clinic
characterist
patient
admit
aecopd
treatment
evolut
icu
order
deduc
factor
predict
iv
patient
method
retrospect
analyt
observ
singlecent
studi
includ
patient
aecopd
statist
analys
perform
spss
result
eighti
nine
patient
enrol
mean
age
year
male
femal
ratio
seventi
nine
percent
smoker
classifi
gold
stage
histori
noninvas
ventil
niv
invas
ventil
iv
found
case
respect
mean
progress
copd
year
mean
exacerb
frequenc
per
year
mean
durat
symptom
hospit
dsbh
day
mean
sap
ii
apach
ii
respect
mean
ph
mmhg
respect
mean
gc
less
case
predomin
precipit
factor
acut
exacerb
ae
respiratori
tract
infect
case
thirti
two
percent
patient
septic
choc
admiss
symptomat
treatment
base
inhal
bronchodil
corticosteroid
mechan
ventil
niv
iv
case
twenti
two
patient
intub
immedi
hospit
niv
failur
mortal
durat
copd
progress
p
exacerb
frequenc
per
year
p
prior
iv
p
dsbh
p
sap
ii
p
gc
p
ph
p
septic
choc
admiss
p
predict
iv
univari
analysi
gc
p
signific
multivari
analysi
conclus
requir
iv
aecopd
depend
sever
underli
respiratori
ill
graviti
ae
qualiti
earli
manag
thu
basic
treatment
improv
earli
appropri
treatment
ae
might
reduc
sever
need
iv
annal
intens
care
suppl
introduct
influenc
respiratori
acidosi
right
ventricular
rv
function
sever
exacerb
chronic
obstruct
pulmonari
diseas
copd
patient
place
invas
mechan
ventil
imv
remain
unclear
previou
studi
report
conflict
result
respiratori
acidosi
might
decreas
contractil
function
cardiomyocyt
venoven
extracorpor
remov
increasingli
use
set
copd
allow
acut
modif
ph
aim
detect
influenc
decreas
rv
systol
function
assess
variat
systol
veloc
wave
tricuspid
annulu
st
patient
method
monocentr
observ
ancillari
studi
rexecor
studi
patient
present
sever
exacerb
copd
implant
hemolung
alung
technolog
pittsburgh
usa
assess
transthorac
echocardiographi
tte
baselin
one
hour
start
imv
ventil
paramet
kept
unmodifi
two
hour
one
hour
begin
tte
data
imv
paramet
arteri
blood
ga
simultan
collect
result
seven
patient
women
median
age
year
median
bodi
mass
index
kg
includ
novemb
februari
median
admiss
respiratori
sofa
regard
tte
find
patient
rv
hypertrophi
rv
free
wall
superior
mm
mm
rv
dysfunct
report
mean
st
cm
mean
taps
mm
induc
signific
variat
mmhg
mmhg
p
ph
p
figur
show
evolut
echo
paramet
differ
wave
valu
signific
reduct
p
wherea
systol
pulmonari
arteri
pressur
spap
decreas
significantli
mmhg
mmhg
p
pulmonari
vascular
resist
pvr
also
significantli
decreas
vs
p
note
paramet
assess
lv
function
chang
flow
variat
conclus
physiolog
studi
decreas
induc
flow
variat
lead
decreas
spap
without
modifi
systol
rv
function
paramet
annal
intens
care
suppl
introduct
comorbidom
correspond
comorbid
frequent
associ
copd
cardiovascular
diseas
diabet
oetoporosi
sarcopenia
carri
signific
impact
mortal
distribut
type
comorbid
vari
studi
agreement
exist
five
phenotyp
comorbiditiesth
current
studi
conduct
determin
associ
specif
comorbid
icu
surviv
acut
exacerb
copd
patient
method
consecut
patient
admit
icu
hypercapn
exacerb
copd
classifi
accord
associ
comorbid
five
cluster
cluster
includ
cardiac
profil
cluster
includ
less
comorbid
cluster
includ
metabol
syndrom
apnea
anxietydepress
cluster
includ
denutrit
sarcopenia
cluster
includ
bronchiectasi
patient
standard
ventilatori
niv
standard
mv
pharmacolog
nebul
agonist
steroid
anticholinerg
manag
discharg
statu
dead
aliv
compar
identifi
comorbid
cluster
result
studi
period
patient
mean
age
year
male
consecut
admit
icu
definit
diagnosi
aecopd
niv
use
primari
ventil
modal
remain
convent
invas
ventil
icu
mortal
occur
follow
mean
icu
ventilatori
support
durat
day
day
respect
figur
depict
rel
mortal
comorbid
cluster
differ
observ
mortal
rate
cluster
statist
signific
conclus
current
studi
show
comorbid
phenotyp
copd
associ
short
term
outcom
icu
mortal
follow
exacerb
annal
intens
care
suppl
introduct
hypercapn
respiratori
failur
frequent
caus
admiss
icu
sever
kind
lung
diseas
design
nosolog
framework
carri
prognost
inform
potenti
impact
clinic
decis
could
made
manag
patient
aim
studi
assess
frequenc
patient
admit
hypercapn
respiratori
failur
without
prior
pulmonari
diagnosi
assign
final
diagnosi
emphasi
morbid
overlap
patient
method
consecut
patient
admit
icu
hypercapn
respiratori
failur
demograph
clinic
data
pertain
current
prior
hospitalis
record
patient
manag
acut
episod
consid
icu
discharg
follow
perform
pulmonari
ct
scan
particular
emphasi
emphysema
fibrosi
pattern
spirometri
diagnosi
obstruct
lung
diseas
transthorac
cardiac
echographi
nocturn
polygraphi
diagnosi
sleep
apnea
syndrom
ahi
result
studi
period
patient
mean
age
year
male
consecut
admit
sever
hypercapn
respiratori
failur
requir
ventilatori
support
niv
start
patient
failur
rate
tabl
report
pulmonari
diseas
eventu
adjud
admiss
icu
discharg
conclus
reliabl
inform
actual
lung
diseas
patient
admit
hypercapn
respiratori
failur
often
lack
icu
admiss
studi
highlight
frequenc
copd
bronchiectasi
obesityhypoventil
syndrom
patient
overlap
frequent
present
patient
need
character
evolutionari
geniu
short
long
term
annal
intens
care
suppl
introduct
despit
wide
spread
use
home
mechan
ventil
hmv
treat
chronic
hypercapn
respiratori
failur
complianc
hmv
among
patient
seldom
systemat
studi
evalu
outcom
icu
survivor
requir
home
mechan
ventil
also
interest
aim
determin
patient
complianc
home
mechan
ventil
indic
discharg
determin
patient
outcom
qualiti
life
within
three
month
discharg
patient
method
retro
pectiv
observ
studi
conduct
medic
icu
consecut
patient
discharg
icu
home
mechan
ventil
januari
decemb
includ
data
collect
involv
patient
demograph
past
histori
underli
diseas
function
state
clinic
paraclin
therapeut
icu
stay
cours
characterist
discharg
data
type
mode
indic
home
mechan
ventil
gather
complianc
report
obtain
provid
one
three
month
use
vital
statu
qualiti
life
assess
st
georg
hospit
respiratori
problem
sgrq
estim
via
phone
call
three
month
discharg
result
among
tal
icu
admit
patient
requir
mechan
ventil
patient
discharg
hmv
via
noninvas
ventil
tracheostomi
tppv
mean
age
predominantli
chronic
respiratori
failur
copd
mmrc
score
iii
iv
alreadi
hmv
patient
least
two
comorbid
charlson
comorbid
index
admiss
mean
sapsii
median
icu
stay
day
discharg
complianc
report
obtain
patient
respect
mean
percentag
daili
use
home
niv
tppv
h
per
day
respect
twelv
patient
readmit
mortal
three
month
estim
health
relat
qualiti
life
assess
sgqr
show
signific
impair
mean
total
score
symptom
score
activ
score
impact
score
compar
popul
norm
total
score
symptom
score
activ
score
impact
score
conclus
present
studi
show
rather
poor
vital
function
outcom
three
month
discharg
hmv
albeit
satisfi
hmv
complianc
annal
intens
care
suppl
introduct
simul
intens
care
innov
method
teach
respiratori
set
respons
asynchroni
may
increas
mortal
patient
reason
develop
simul
spontan
artifici
ventil
simva
virtual
breath
patient
mathemat
model
resolv
differenti
equat
chest
lung
movement
accord
inspiratori
effort
order
match
clinic
databas
goal
studi
evalu
asynchroni
index
ai
virtual
copd
patient
accord
pressur
support
ps
level
inspiratori
time
ti
compar
result
studi
thill
et
al
patient
method
virtual
case
copd
defin
thorac
pulmonar
complianc
total
resist
lung
volum
inspiratori
adapt
muscl
pressur
asynchroni
index
patient
ineffect
effort
ie
ie
ventil
respiratori
rate
ventilatori
protocol
baselinep
optimalp
optimalti
optim
meant
decreas
ps
ti
order
reduc
ai
describ
thill
et
al
virtual
case
titrat
protocol
ai
record
compar
result
thill
et
al
result
optim
protocol
titrat
ps
ti
order
reduc
ai
softwar
simul
correspond
valu
tidal
volum
respiratori
frequenc
effect
intrins
peep
ga
trap
differ
set
respiratori
mechan
virtual
case
patient
signific
tabl
conclus
ai
abl
chang
accord
ps
ti
set
within
rang
studi
thill
et
al
simul
softwar
simva
realist
may
help
teach
interact
ventilatori
set
asynchroni
copd
patient
pressur
support
ventil
anywher
without
risk
patient
refer
intens
care
med
care
med
annal
intens
care
suppl
introduct
aim
determin
incid
prognost
impact
mortal
length
intens
care
unit
icu
stay
lo
pulmonari
embol
pe
critic
ill
patient
sever
acut
exacerb
chronic
obstruct
pulmonari
diseas
copd
patient
method
retrospect
studi
perform
period
icu
habib
bourguiba
univers
hospit
sfax
tunisia
patient
sever
acut
exacerb
copd
includ
diagnosi
pe
confirm
spiral
comput
tomographi
scan
show
one
fill
defect
obstruct
pulmonari
arteri
branch
result
studi
period
patient
acut
exacerb
copd
admit
icu
mean
age
standard
deviat
year
icu
stay
patient
develop
pe
diagnosi
confirm
within
h
icu
admiss
case
comparison
two
group
without
pe
show
baselin
characterist
howev
patient
pe
group
develop
shock
icu
admiss
icu
stay
icu
mortal
significantli
higher
pe
group
vs
p
addit
icu
lo
significantli
higher
pe
group
pefre
group
p
conclus
studi
show
pe
common
patient
sever
copd
exacerb
requir
icu
admiss
moreov
pe
significantli
associ
higher
mortal
icu
lo
critic
ill
patient
sever
copd
exacerb
annal
intens
care
suppl
introduct
impact
home
ventil
surviv
patient
chronic
respiratori
failur
still
debat
studi
includ
patient
chronic
hypercapnia
away
hospitalis
show
posit
effect
frequenc
exacerb
impact
home
ventil
surviv
patient
discharg
icu
well
proven
current
studi
report
long
term
surviv
accord
use
home
ventil
patient
method
patient
surviv
icu
stay
hypercapn
respiratori
failur
consid
home
ventil
follow
basi
frequent
exacerb
longterm
oxygenotherapi
obstruct
lung
diseas
sign
nocturn
hypoventil
restrict
lung
diseas
vital
statu
check
januari
surviv
curv
drawn
log
rank
statist
test
result
studyperiod
patient
fulfil
inclus
criteria
includ
studi
mean
age
year
male
major
copd
home
ventil
administ
patient
remain
mean
followup
month
patient
home
ventil
significantli
longer
surviv
patient
without
home
ventil
log
rank
figur
conclus
home
ventil
associ
prolong
surviv
icu
patient
surviv
hypercapn
respiratori
failur
annal
intens
care
suppl
introduct
fragil
index
fi
repres
number
patient
respons
statist
signific
find
suggest
aid
interpret
robust
result
clinic
trial
small
fi
indic
statist
signific
trial
depend
event
object
calcul
fi
statist
signific
result
random
control
trial
rct
anesthesia
critic
care
intervent
determin
frequenc
distort
present
result
spin
patient
method
systemat
search
medlin
januari
februari
identifi
rct
explor
effect
critic
care
medicin
anesthesia
intervent
studi
includ
random
patient
two
parallel
arm
report
least
one
statist
signific
p
binari
outcom
primari
secondari
two
review
independ
assess
elig
extract
data
fi
determin
chosen
outcom
assess
level
spin
neg
trial
presenc
recommend
clinic
practic
posit
trial
result
identifi
elig
rct
median
sampl
size
patient
interquartil
rang
iqr
median
fi
iqr
mean
ad
three
event
one
trial
treatment
arm
elimin
statist
signific
trial
fi
zero
statist
signific
outcom
found
nonsignific
recalcul
pvalu
use
fisher
exact
test
high
spin
identifi
n
neg
rct
n
posit
rct
provid
recommend
lower
level
spin
recommend
associ
public
journal
high
impact
factor
p
conclus
statist
signific
result
anesthesia
critic
care
rct
often
fragil
studi
conclus
frequent
affect
spin
routin
calcul
fi
medic
literatur
may
allow
better
understand
trial
therefor
enhanc
qualiti
report
annal
intens
care
suppl
introduct
risk
admit
icu
patient
end
life
increas
age
popul
yet
usual
easi
discern
priori
hospit
presag
fatal
outcom
signific
potenti
recoveri
limit
lifesupport
therapi
llst
becom
current
practic
icu
mani
countri
includ
tunisia
lack
legal
framework
practic
aim
studi
evalu
magnitud
llst
among
intensivist
practic
differ
healthcar
facil
patient
method
questionnair
address
icu
physician
practic
univers
nonunivers
hospit
tunisia
invit
particip
respond
anonym
questionnair
limit
activ
cessat
care
questionnair
includ
descript
particip
workplac
characterist
frequenc
end
life
situat
daili
practic
insight
way
handl
situat
without
extern
help
health
worker
result
intensivist
year
experi
practic
princip
icu
belong
univers
hospit
answer
questionnair
particip
found
limit
lifesupport
therapi
ethic
accept
activ
shorten
die
process
major
comfort
withhold
withdraw
lifesupport
therapi
declar
practic
llst
addit
said
awar
practic
icu
estim
icu
death
preced
llst
around
formal
written
llst
polici
present
unwritten
polici
declar
polici
one
senior
icu
doctor
usual
take
part
decisionmak
regard
llst
singl
senior
icu
doctor
icu
nurs
care
patient
consid
request
limit
lifesustain
therapi
patient
famili
surrog
rare
comfort
talk
llst
famili
strongli
agre
principl
give
analges
painkil
llst
ensur
absenc
pain
termin
stage
even
death
may
hasten
use
regret
lack
ethic
consult
committe
conclus
limit
lifesupport
therapi
frequent
practic
tunisian
icu
although
formal
legisl
academ
frame
lack
intensivist
claim
legal
framework
practic
annal
intens
care
suppl
introduct
evalu
impact
decis
forgo
lifesupportingtherapi
dflst
surviv
patient
admit
intens
care
unit
icu
infect
patient
method
retrospect
monocentr
observ
studi
conduct
medic
icu
includ
patient
admit
infect
classifi
accord
classif
dflst
separ
two
group
withhold
withdraw
lifesupportingtherapi
perform
logist
regress
identifi
predict
factor
hospit
mortal
result
patient
includ
dflst
global
mortal
predict
factor
hospit
mortal
multivari
analysi
dflst
odd
ratio
interv
confid
ic
p
admiss
sepsisrel
organ
failur
assess
sofa
score
ic
p
admiss
lactatemia
ic
p
moder
sever
chronic
kidney
diseas
ic
p
chronic
steroid
ic
p
chronic
hepatopathi
ic
p
accord
subtyp
dflst
withhold
withdraw
subtyp
infect
sepsi
septic
shock
signif
statist
differ
hospit
mortal
sepsi
patient
without
dflst
patient
withhold
patient
withdraw
p
septic
shock
patient
without
dflst
patient
withhold
patient
withdraw
p
figur
earli
predict
factor
dflst
multivari
analysi
age
ic
p
metastat
cancer
ic
p
respiratori
ic
p
renal
ic
p
neurolog
ic
p
item
initi
sofa
score
fungal
infect
ic
p
conclus
dflst
independ
factor
mortal
patient
sepsi
septic
shock
icu
result
may
influenc
clinic
practic
show
necess
collect
dflst
studi
annal
intens
care
suppl
introduct
sinc
medic
decis
withhold
withdraw
treatment
patient
unabl
express
wish
legal
frame
leonetti
law
resolut
adopt
socal
collegi
reflect
procedur
regard
deliber
preced
decis
medic
societi
ethic
reflect
committe
issu
recommend
term
standard
train
transpar
studi
aim
evalu
delib
member
percept
collegi
procedur
implement
french
medic
intens
care
unit
main
object
survey
assess
role
collegi
procedur
within
decisionmak
process
core
issu
deliber
perceiv
approv
decis
alreadi
taken
ethic
discuss
lie
heart
decisionmak
patient
method
percept
nurs
nurs
aid
resid
doctor
assess
use
fivesect
questionnair
openend
multipl
answer
question
characterist
patient
admit
icu
well
collegi
procedur
undertaken
period
collect
result
formal
collegi
procedur
patient
admit
regist
attend
least
resid
nurs
doctor
analysi
questionnair
fill
doctor
resid
nurs
nurs
aid
show
global
satisfact
regard
organ
durat
exchang
consider
particip
opinion
nurs
aid
often
absent
deliber
show
moder
implic
decis
make
contribut
specif
aspect
individu
care
desir
healthcar
profession
caregiv
also
deplor
limit
involv
extern
consult
whose
role
would
provid
neutral
expertis
patient
condit
base
examin
respons
openend
question
seem
necessari
reposit
collegi
procedur
within
complex
delib
process
gradual
lead
throughout
hospit
stay
conting
revoc
decis
forego
certain
treatment
deem
useless
disproportion
object
artifici
preserv
life
conclus
despit
limit
number
particip
singlecent
studi
suggest
sever
refin
improv
collegi
reflect
procedur
term
legal
ethic
knowledg
organ
attend
annal
intens
care
suppl
introduct
organ
donat
transplant
remain
requir
morocco
year
see
number
patient
need
organ
transplant
od
get
bigger
face
real
shortag
od
moroccan
student
repres
young
gener
could
key
futur
improv
organ
transplant
lead
studi
order
determin
knowledg
aspir
concern
life
save
therapi
patient
method
descript
prospect
studi
survey
lead
eight
higher
educ
institut
use
preestablish
questionnair
analyz
main
theme
knowledg
assess
opinion
toward
od
caus
way
improv
countri
data
analyz
use
spss
softwar
result
question
student
alreadi
heard
od
awar
possibl
practic
morocco
idea
lethal
diseas
requir
use
transplant
abl
identifi
transplant
organ
tissu
underestim
number
peopl
wait
transplant
thought
act
organ
remov
transplant
done
privat
clinic
awar
law
govern
od
morocco
trust
law
ignor
registr
step
donat
accept
regist
convinc
perfect
compat
od
muslim
religion
major
student
favor
od
among
group
respond
refus
donat
organ
right
refus
religi
obstruct
top
list
determin
refus
respect
preval
student
express
opinion
rel
conclus
studi
show
young
moroccan
support
od
despit
limit
knowledg
subject
develop
therapi
must
go
inform
regular
motiv
peopl
gener
confer
seminar
repres
solut
spread
awar
among
gener
order
establish
strong
polici
organ
donat
earli
futur
annal
intens
care
suppl
introduct
encephal
death
organ
donat
wide
debatedth
promot
organ
donat
includ
brain
dead
donor
requir
us
explor
concept
among
populationw
aim
evalu
knowledg
attitud
consult
nonunivers
hospit
center
concern
organ
donat
concept
brain
death
patient
method
carri
descript
studi
one
year
moroccan
nonunivers
hospit
center
target
popul
consult
hospit
center
questionnair
fill
anonym
aim
evalu
organ
donat
knowledg
concept
brain
death
organ
transplant
braindead
patient
wear
voluntari
organ
donor
card
discuss
donat
famili
organ
famili
consent
case
cadaver
donor
receiv
organ
live
donor
donat
organ
religion
result
peopl
includ
averag
age
year
male
predomin
valu
associ
organ
donat
save
live
gestur
chariti
gestur
altruism
know
encephal
death
know
donat
organ
patient
state
brain
death
know
contraind
organ
donat
patient
state
encephal
death
agre
donat
one
organ
organ
donat
purpos
treat
patient
without
opinion
refus
carri
voluntari
organ
donor
card
agre
receiv
organ
live
donor
receiv
organ
deceas
donor
never
report
posit
love
one
favor
organ
donat
death
repli
muslim
religion
allow
live
organ
donat
live
repli
author
donat
organ
live
organ
patient
state
encephal
death
live
conclus
clear
dispar
found
concept
brain
death
organ
donat
despit
inform
campaign
media
coverag
popul
studi
sociodemograph
cultur
characterist
requir
adapt
inform
tool
cultur
approach
annal
intens
care
suppl
introduct
recreat
use
mdma
becom
common
sinc
end
number
poison
significantli
increas
last
year
mdma
respons
serotoninerg
toxic
lead
onset
hyperthermia
multiorgan
failur
object
describ
time
cours
bodi
temperatur
serotoninerg
sign
biolog
paramet
sever
mdmapoison
patient
order
understand
evolut
paramet
relat
plasma
concentr
mdma
main
metabolit
methylenedioxyamphetamin
mda
patient
method
conduct
retrospect
singlecentr
observ
studi
includ
mdmapoison
patient
admit
intens
care
unit
icu
develop
fever
bodi
temperatur
symptom
sign
serotoninerg
syndrom
accord
sternbach
criteria
plasma
mdma
mda
concentr
determin
use
liquid
chromatographi
coupl
mass
spectrometri
result
sixteen
mdmapoison
patient
mdmaexpos
patient
admit
icu
period
present
serotoninerg
syndrom
fever
attribut
mdma
exposur
treat
support
care
extern
cool
cyproheptadin
nonspecif
serotonin
receptor
antagonist
includ
studi
patient
femal
et
male
old
median
percentil
use
recreat
mdma
found
nightclub
street
home
bodi
temperatur
reach
present
complic
cardiac
arrest
cardiovascular
failur
aspir
pneumonia
hospitalacquir
infect
fatal
four
patient
worsen
clinic
heart
rate
pyramid
syndrom
eeg
encephalopathi
biolog
paramet
transaminas
prothrombin
index
creatinin
phosphokinas
includ
serotoninerg
syndrom
surprisingli
observ
parallel
increas
bodi
temperatur
due
concomit
infecti
inflammatori
nontox
event
observ
worsen
occur
absenc
increas
plasma
mdma
mda
concentr
n
even
presenc
undetect
concentr
n
conclus
mdma
use
result
serotonin
syndrom
possibl
lead
onset
hyperthermia
organ
failur
death
despit
optim
care
worsen
serotonin
syndrom
icu
stay
sever
mdmapoison
patient
without
increas
plasma
mdma
concentr
observ
patient
exact
molecular
mechan
involv
serotoninerg
memori
remain
clarifi
annal
intens
care
suppl
introduct
carbon
monoxid
co
lead
caus
poison
relat
lethal
franc
moreov
survivor
may
develop
sever
neurocognit
sequela
studi
sought
determin
prognost
factor
relat
co
induc
coma
primari
object
studi
determin
prognost
factor
icumort
follow
co
induc
coma
secondari
object
determin
prognost
factor
co
relat
cognit
sequela
time
intens
care
unit
icu
discharg
patient
method
retrospect
observ
studi
januari
decemb
comatos
patient
glasgow
coma
score
due
carbon
monoxid
poison
treat
hyperbar
oxygen
therapi
tertiari
hospit
greater
pari
area
includ
current
studi
clinic
biolog
iconograph
electrophysiolog
data
collect
medic
file
result
patient
includ
median
iqr
age
year
patient
male
caus
poison
mainli
co
exposur
n
smoke
inhal
n
patient
die
icu
stay
present
cognit
sequela
icu
discharg
multivari
analysi
found
cardiac
arrest
p
eeg
anomali
p
simplifi
acut
physiolog
score
sap
ii
p
associ
icumort
neuroimag
anomali
p
associ
cognit
sequela
icu
discharg
neither
lactat
carboxyhemoglobin
level
associ
cognit
sequela
mortal
cohort
conclus
studi
predict
factor
icumort
co
induc
comatos
patient
cardiac
arrest
eeg
anomali
sap
ii
score
neuroimag
anomali
predict
cognit
sequela
icu
discharg
annal
intens
care
suppl
introduct
recreat
use
popper
increas
franc
sinc
last
judgment
nation
council
june
reauthor
market
popper
contain
variou
alkyl
nitrit
highli
oxid
compound
abl
induc
methemoglobinemia
methb
deleteri
even
lifethreaten
consequ
human
object
describ
circumst
complic
outcom
patient
admit
intens
care
unit
icu
methb
onset
attribut
exposur
popper
investig
relationship
serum
lactat
concentr
methb
treatment
patient
method
conduct
retrospect
monocentr
observ
studi
includ
patient
admit
icu
increas
blood
methb
follow
exposur
popper
investig
relationship
serum
lactat
concentr
methb
icu
admiss
calcul
pearson
coeffici
use
bartlett
test
spheric
result
twentysix
patient
male
femal
age
year
median
percentil
includ
popper
snort
ingest
snort
ingest
recreat
multidrug
exposur
mostli
accompani
gammahydroxybutyr
use
admiss
methb
patient
receiv
methylen
blue
infus
mechan
ventil
catecholamin
infus
exsanguinotransfus
admiss
weakli
correl
methb
p
serum
lactat
concentr
mmoll
highli
correl
mehb
p
plasma
lactat
concentr
mmoll
highli
predict
methb
sensit
specif
posit
predict
valu
neg
predict
valu
conclus
use
popper
respons
lifethreaten
consequ
attribut
methb
data
clearli
support
recommend
intern
french
guidelin
administ
methylen
blue
patient
develop
methb
evidenc
tissu
hypoxia
almost
consist
present
threshold
annal
intens
care
suppl
introduct
cardiocirculatori
failur
one
lead
caus
death
acut
poison
aim
work
analyz
hemodynam
profil
intox
noncardiotrop
product
identifi
prognost
factor
patient
method
prospect
studi
includ
patient
age
year
primari
admiss
vital
emerg
room
noncardiotrop
drug
intox
also
nondrug
analyz
paramet
clinic
examin
electr
abnorm
echocardiograph
data
troponin
level
evalu
perform
intak
statist
analysi
univari
p
result
patient
includ
averag
age
sex
ratio
toxic
product
found
organophosphoru
benzodiazepin
aluminum
phosphid
cocain
carbon
monoxid
tricycl
antidepress
cardiocirculatori
insuffici
observ
patient
electr
abnorm
patient
elev
troponin
patient
echocardiograph
abnorm
patient
incid
particularli
high
aluminum
phosphid
tricycl
antidepressantsth
overal
mortal
rate
death
depend
offend
product
aluminum
phosphid
tricycl
antidepress
cocain
organophosphoru
compound
benzodiazepin
figur
correl
clinic
paraclin
abnorm
occurr
death
shown
tabl
discuss
toxicolog
rang
cardiotox
product
much
wider
class
cardiotrop
drug
inde
mani
product
origin
cardiovascular
toxic
mechan
failur
variabl
membran
stabil
effect
antidepress
betablock
calcium
channel
blocker
organophosphoru
diastol
dysfunct
rhythm
disord
toxic
myocard
myocardi
necrosi
phostoxin
cocain
co
vasodilat
antihypertens
conclus
difficulti
accur
assess
incid
preval
cardiocirculatori
failur
due
toxic
caus
due
among
thing
lack
valid
studi
propos
better
diagnost
therapeut
techniqu
studi
main
factor
poor
prognosi
cardiocirculatori
insuffici
echocardiograph
abnorm
annal
intens
care
suppl
introduct
cocain
frequent
use
psychostimul
illicit
drug
worldwid
franc
use
significantli
increas
last
ten
year
two
main
modal
recreat
snort
cocain
hydrochlorid
inhal
smoke
crack
freebas
form
cocain
obtain
cocain
salif
use
common
bake
soda
ammoniac
highli
depend
dissoci
user
neurolog
cardiovascular
respiratori
metabol
complic
cocain
rel
wellknown
howev
differ
cocain
hydrochlorid
crackrel
toxic
poorli
investig
object
describ
compar
circumst
result
complic
cocain
use
patient
admit
intens
care
unit
icu
relat
rout
exposur
ie
snort
versu
inhal
patient
method
conduct
retrospect
singlecentr
observ
studi
includ
cocainepoison
patient
admit
intens
care
unit
period
comparison
two
rout
cocain
exposur
perform
use
univari
analysi
test
request
result
seventytwo
patient
age
year
median
percentil
includ
toxic
mainli
result
multidrug
use
benzodiazepin
ethanol
methadon
tetrahydrocannabinol
amphetamin
glasgow
coma
score
admiss
complic
includ
cardiac
arrest
n
aspir
pneumonia
n
acut
renal
failur
n
malign
hypertens
n
ischemia
thrombosi
event
n
seizur
n
hyperthermia
n
myocardi
infarct
n
death
n
user
snort
n
present
significantli
sever
symptom
user
inhal
n
lower
glasgow
coma
score
p
intens
adrenerg
syndrom
p
tachycardia
elev
plasma
lactat
concentr
p
lower
platelet
count
p
mark
rhabdomyolysi
p
snort
cocain
less
frequent
associ
methadon
use
p
cocain
snort
patient
frequent
develop
cardiac
arrest
p
aspir
pneumonia
p
request
mechan
ventil
p
conclus
cocain
use
may
lead
sever
complic
requir
icu
admiss
find
suggest
complic
attribut
cocain
hydrochlorid
snort
sever
complic
attribut
crack
inhal
experiment
investig
may
interestingli
complement
studi
allow
better
understand
mechanist
reason
support
observ
differ
annal
intens
care
suppl
introduct
bromazepam
commonli
use
frequent
involv
benzodiazepin
acut
drug
poison
franc
object
report
complic
manag
bromazepampoison
patient
admit
icu
investig
bromazepam
pharmacokinet
overdos
relationship
coma
depth
plasma
bromazepam
concentr
admiss
patient
method
conduct
retrospect
singlecentr
observ
studi
includ
bromazepampoison
patient
admit
evidenc
least
one
plasma
bromazepam
concentr
toxic
rang
stay
studi
correl
presum
ingest
dose
bromazepam
plasma
concentr
bromazepam
coma
depth
determin
glasgow
coma
score
calcul
pearson
coeffici
use
bartlett
test
spheric
result
onehundr
sixtyfour
patient
femal
male
age
year
median
percentil
includ
toxic
result
multidrug
ingest
presum
bromazepam
ingest
dose
mg
plasma
bromazepam
concentr
admiss
mg
l
conscious
impair
mark
glasgow
coma
score
hypoton
coma
decreas
loss
tendon
reflex
complic
includ
aspir
pneumonia
increas
liver
enzym
cardiovascular
renal
failur
sino
atrioventricular
block
found
case
flumazenil
bolu
dose
mg
follow
infus
rate
mg
h
h
administ
patient
patient
intub
mechan
ventil
subgroup
monointox
bromazepam
signific
correl
coma
depth
plasma
bromazepam
concentr
observ
bartlett
test
p
factor
associ
requir
tracheal
intub
vs
flumazenil
use
includ
lower
glasgow
coma
score
p
elev
serum
lactat
concentr
p
signific
relationship
evidenc
ingest
dose
plasma
concentr
bromazepam
admiss
conclus
acut
bromazepam
poison
frequent
may
respons
lifethreaten
consequ
ingest
dose
plasma
concentr
bromazepam
correl
coma
depth
predict
necess
tracheal
intub
thu
suggest
high
interindividu
variabl
drug
toxic
optim
manag
annal
intens
care
suppl
introduct
mdma
also
known
ecstasi
recreat
drug
popular
among
youth
europ
america
sinc
last
decad
remarqu
increas
case
mdma
poison
admit
icu
present
studi
aim
better
know
epidemiolog
clinic
therapeut
characterist
poison
order
improv
prognosi
patient
method
observ
retrospect
studi
spread
nine
year
januari
septemb
toxicolog
icu
includ
patient
admit
acut
mdma
poison
result
studi
period
mdma
poison
account
n
acut
poison
requir
hospit
intens
care
unit
mean
age
year
sexratio
eight
patient
drugaddict
exposur
singledrug
case
case
ecstasi
coingest
alcohol
case
benzodiazepin
case
trihexyphenidyl
case
cannabi
heroin
one
case
suppos
ingest
dose
sid
unknown
case
one
median
sid
pill
half
consult
delay
h
ingest
main
symptom
mydriasi
agit
tachycardia
averag
bpm
hallucin
hypertens
five
coma
patient
intub
requir
sedat
midazolam
one
patient
requir
curar
malign
hyperthermia
eleven
patient
develop
rhabdomyolysi
averag
rate
creatin
phosphokinas
lactat
deshydrogenas
respect
ui
ui
two
patient
develop
dissemin
intravascular
coagul
fulmin
hepat
high
rate
alanin
aminotransferas
ui
ui
aspart
aminotransferas
ui
low
factorv
receiv
nacetylcystein
one
patient
receiv
cyproheptadin
antidot
mg
day
thirteen
patient
discharg
icu
mean
length
stay
three
day
one
patient
die
hepat
encephalopathi
cerebr
herniat
conclus
shown
mdma
poison
present
vital
risk
due
serotonin
syndrom
clinician
must
warn
recogn
better
symptom
sever
order
improv
manag
annal
intens
care
suppl
introduct
incid
import
sever
malaria
sm
increas
patient
characterist
prognosi
chang
sinc
earli
object
analyz
chang
clinic
present
outcom
sinc
artesun
becam
firstchoic
treatment
sm
patient
method
retrospect
observ
singlecent
studi
medic
icu
referr
univers
hospit
conduct
patient
admit
sm
period
demograph
variabl
sever
score
who
sever
criteria
admiss
icu
hospit
length
stay
collect
patient
characterist
outcom
compar
two
period
name
artesun
becom
firstchoic
treatment
poor
outcom
defin
composit
endpoint
death
icu
length
stay
day
requir
vasopressor
invas
mechan
ventil
renal
replac
therapi
start
first
day
icu
univari
analysi
stepwis
multivari
logist
regress
stratifi
period
perform
identifi
factor
associ
poor
outcom
result
patient
includ
main
epidemiolog
clinic
characterist
tabl
even
number
criteria
sm
compar
group
sap
ii
sofa
icu
length
stay
significantli
higher
patient
visit
friend
rel
vfr
home
countri
live
endem
area
seem
frequent
p
poor
outcom
occur
case
case
p
risk
factor
poor
outcom
impair
conscious
adjor
ci
p
shock
adjor
ci
p
creatinin
l
adjor
ci
p
patient
vfr
live
endem
area
associ
better
outcom
adjor
ci
p
final
model
artesun
therapi
significantli
improv
outcom
compar
quininebas
therapi
adjor
ci
p
conclus
patient
sm
admit
icu
less
sever
trend
could
partial
explain
increas
proport
immun
patient
vfr
live
endem
area
adjust
sever
stratif
period
artesun
significantli
associ
better
outcom
iv
quinin
annal
intens
care
suppl
introduct
clostridium
speci
import
agent
anaerob
infect
may
associ
wide
rang
sever
clinic
diseas
requir
icu
admiss
data
focus
non
difficil
clostridium
speci
bacteriemia
icu
scarc
reli
mainli
case
report
sought
defin
clinic
biolog
characterist
risk
factor
acquisit
clostridium
ecolog
outcom
non
difficil
clostridium
speci
bacteriemia
critic
ill
patient
patient
method
multicentr
retrospect
cohort
studi
icu
includ
patient
diagnos
nondifficil
clostridium
bacteriemia
januari
june
result
fifti
patient
includ
median
age
year
old
patient
clostridium
bacteriemia
occur
day
icu
admiss
median
charlson
score
underli
condit
includ
oncohaematolog
malign
chronic
alcohol
abus
diabet
chronic
cardiac
failur
obes
cirrhosi
chronic
kidney
injuri
first
symptom
start
day
icu
admiss
median
day
symptom
icu
admiss
patient
present
fever
case
hypothermia
shock
coma
acut
respiratori
failur
cardiac
arrest
digest
symptom
present
case
icu
admiss
median
sap
ii
score
median
sofa
score
overal
patient
requir
vasopressor
invas
mechan
ventil
renal
replac
therapi
twentyfour
percent
patient
experienc
massiv
hemolysi
median
serum
lactat
level
mm
infect
due
c
perfringen
follow
c
ramosum
c
septicum
c
tertium
digest
infect
diagnos
case
skin
infect
case
ga
gangren
present
patient
surgeri
necessari
speci
sensit
penicillin
two
third
patient
die
icu
hospit
mortal
non
survivor
median
time
icu
admiss
hospit
death
day
conclus
alcohol
consumpt
diabet
underli
malign
main
risk
factor
clostridium
bacteriemia
clinic
manifest
non
specif
digest
symptom
hemolysi
alert
physician
consid
risk
fulmin
cours
high
lethal
infect
adequ
antibiot
start
soon
diagnosi
suspect
annal
intens
care
suppl
introduct
tetanu
infect
nonimmun
diseas
still
endem
mani
develop
countri
respons
high
mortal
aim
work
describ
manag
patient
admit
icu
tetanu
patient
method
descript
studi
base
retrospect
analysi
done
year
period
januari
decemb
intens
care
unit
includ
patient
admit
tetanu
studi
variabl
sociodemograph
characterist
clinic
therapeut
prognost
data
result
patient
admit
tetanu
mean
nage
patient
year
show
male
predomin
sex
ratio
trismu
associ
generalis
contractur
spasm
present
patient
port
entri
found
patient
mean
score
dakar
struggl
spasm
contractur
combin
magnesium
sulfat
diazepam
administ
patient
mechan
ventil
need
patient
mean
length
hospitalis
day
lethal
conclus
tetanu
patholog
still
met
unit
lethal
remain
high
intensif
vaccin
campaign
necessari
erad
diseas
annal
intens
care
suppl
introduct
pneumocysti
jirovecii
pneumonia
pjp
associ
higher
rate
intub
mortal
nonhiv
immunocompromis
host
object
studi
establish
earli
risk
factor
sever
pjp
mortal
nonhiv
patient
focu
impact
broncho
alveolar
lavag
bal
cytolog
patient
method
prospect
enrol
patient
pjp
admit
nant
univers
hospit
januari
januari
sever
defin
acut
hypoxem
respiratori
failur
arf
highflow
oxygen
use
factor
associ
sever
pjp
specif
death
analys
nonparametr
test
logist
regress
univari
multivari
whole
popul
nonhiv
patient
result
among
patient
pneumocysti
identif
patient
met
criteria
pjp
met
criteria
sever
patient
requir
icu
admiss
requir
mechan
ventil
death
within
day
postadmiss
occur
sever
vs
nonsever
case
p
earli
risk
factor
associ
sever
age
year
odd
ratio
confid
interv
ci
p
albuminemia
g
l
ci
p
blood
neutrophil
l
ci
p
bronchoalveolar
lavag
bal
neutrophil
p
bal
pj
posit
direct
examin
p
overal
cohort
contrast
hiv
posit
statu
ci
p
alveol
bal
p
protect
factor
sever
multivari
analysi
among
non
hiv
patient
lymphocyt
alveol
hr
ci
p
associ
improv
prognosi
wherea
sofa
score
admiss
hr
ci
p
associ
pneumocystosisspecif
mortal
conclus
initi
sever
pneumocystosi
evalu
sofa
score
major
prognost
factor
predict
global
specif
mortal
pneumocystosi
age
albuminemia
bronchoalveolar
lavag
bal
neutrophil
bal
pj
posit
direct
examin
sofa
score
associ
sever
pneumocystosi
worst
prognosi
annal
intens
care
suppl
introduct
candiduria
increasingli
frequent
among
patient
admit
intens
care
unit
clear
discrimin
threshold
predict
occurr
invas
candidiasi
purpos
identifi
interest
yeast
numer
urin
earli
diagnosi
invas
candidiasi
patient
method
prospect
studi
carri
sfaxtunisia
intens
care
unit
period
month
select
criteria
patient
includ
least
one
major
risk
factor
two
minor
risk
factor
develop
ic
tabl
includ
studi
search
candida
urin
perform
day
hospit
week
patient
candiduria
carri
multipl
mycolog
sampl
bodi
site
blood
cultur
pittet
index
calcul
well
candida
score
diagnosi
invas
candidiasi
made
basi
presenc
candidemia
expert
advic
daili
visit
patient
least
one
follow
symptom
fever
hypothermia
unexplain
hypotens
absenc
respons
adequ
antibiot
treatment
suspect
bacteri
infect
result
heighti
height
patient
includ
candiduria
found
patient
patient
candiduria
densiti
cfuml
c
albican
found
patient
mean
interv
admiss
onset
candiduria
day
seven
patient
develop
candidemia
concomit
candiduria
diagnosi
invas
candidiasi
made
patient
risk
factor
develop
invas
candidiasi
patient
candiduria
renal
failur
p
candida
score
point
p
pittet
index
p
logist
regress
renal
failur
independ
factor
associ
invas
candidiasi
patient
candiduria
p
ci
associ
candiduria
cfu
ml
pittet
index
significantli
associ
invas
candidiasi
p
mortal
rate
conclus
candiduria
cfu
ml
intens
care
patient
sever
risk
factor
predict
invas
candidiasi
perman
mycolog
surveil
wide
recommend
order
make
earli
diagnosi
start
appropri
antifung
therapi
annal
intens
care
suppl
introduct
fungal
infect
fi
risen
caus
signific
morbid
mortal
critic
ill
patient
aim
describ
epidemiolog
fungal
colon
infect
patient
admit
medic
intens
care
unit
icu
determin
risk
factor
patient
method
retrospect
studi
carri
icu
octob
septemb
demograph
characterist
patient
risk
factor
fungal
infect
colon
evalu
data
epidemiolog
patient
signific
clinic
data
surgeri
mechan
ventil
dialysi
central
venou
cathet
urinari
cathet
arteri
cathet
total
parenter
nutrit
leucopenia
neutropenia
previou
antimicrobi
therapi
prophylaxi
collect
result
twentythre
per
cent
patient
enrol
studi
fungal
infect
case
fungal
colon
patient
median
score
candida
albican
isol
infect
case
colon
case
candiduria
detect
candidaemia
observ
patient
patient
develop
fungal
infect
central
line
insert
prolong
length
stay
prolong
antibiot
therapi
use
corticosteroid
neutropenia
fluconazol
first
line
use
antifung
treatment
n
amphotericin
b
use
three
patient
median
hospit
stay
day
multivari
analysi
reveal
catecholamin
use
associ
fungal
infect
colon
p
conclus
fungal
infect
colon
frequent
popul
use
catecholamin
appear
risk
factor
annal
intens
care
suppl
introduct
invas
fungal
infect
increasingli
observ
icu
concern
specif
nonneutropen
patient
absenc
simpl
access
techniqu
earli
microbiolog
diagnosi
use
antifung
steadili
increas
frequent
use
echinocandin
littl
known
extent
problem
typolog
antifung
prescript
tunisian
icu
bicentr
studi
describ
prescript
circumst
antifung
tunisian
icu
patient
method
studi
period
prescript
antifung
analys
analysi
concern
demograph
clinic
circumst
histori
acut
diseas
procedur
previou
drug
lifethreaten
condit
time
antifung
therapi
well
basi
antifung
prescrib
target
vs
preemptiv
empir
result
patient
enrol
studi
men
mean
age
year
admit
leuconeutropenia
present
steroid
administ
major
patient
mechan
ventil
central
venou
line
either
sever
sepsi
septic
shock
largespectrum
antibiotherapi
day
antifung
treatment
start
often
preemptiv
empir
basi
consist
often
echinocandin
prescript
azol
often
target
therapi
antifung
deescal
perform
infect
resolv
overal
mortal
conclus
antifung
prescript
except
tunisian
icu
preemptiv
empir
prescript
base
primarili
echinocandin
reflect
lack
effici
laboratori
support
prompt
physician
reli
clinic
inform
annal
intens
care
suppl
introduct
critic
ill
patient
type
diabet
increas
risk
infect
proinsulin
connect
peptid
cpeptid
protect
immunomodulatori
featur
level
may
affect
presenc
sepsi
exogen
insulin
treatment
aim
assess
sepsi
exogen
insulin
administr
affect
cpeptid
level
cpeptid
insulin
ratio
critic
ill
diabet
patient
patient
method
studi
critic
ill
adult
type
diabet
measur
serum
insulin
cpeptid
level
first
day
icu
stay
record
daili
exogen
insulin
dose
obtain
control
data
eight
volunt
patient
unexpos
exogen
insulin
therapi
first
compar
sepsi
without
compar
septic
patient
unexpos
insulin
therapi
sepsi
treat
insulin
determin
paramet
associ
cpeptid
level
cpeptid
insulin
ratio
use
multivari
linear
regress
result
sepsi
diagnos
patient
diabet
patient
sepsi
significantli
higher
cpeptid
level
compar
healthi
control
vs
nmoll
p
diabet
patient
sepsi
higher
cpeptid
insulin
ratio
compar
control
vs
p
increas
compar
nonsept
patient
p
expos
insulin
therapi
septic
patient
mark
decreas
cpeptid
insulin
ratio
compar
septic
patient
unexpos
insulin
p
multivari
analysi
cpeptid
level
significantli
neg
associ
exogen
insulin
therapi
posit
associ
serum
insulin
level
glucos
intak
cpeptid
insulin
ratio
significantli
posit
associ
sepsi
neg
exogen
insulin
therapi
p
p
respect
conclus
type
diabet
critic
ill
patient
sepsi
associ
mark
increas
cpeptid
cpeptid
insulin
ratio
impli
uncoupl
rel
secret
clearanc
uncoupl
howev
markedli
inhibit
administr
exogen
insulin
annal
intens
care
suppl
introduct
adjunct
corticosteroid
therapi
proven
effect
hivpati
pneumocysti
pneumonia
pcp
data
remain
unclear
controversi
concern
nonhiv
relatedpati
evalu
effect
mortal
earli
adjunct
corticosteroid
therapi
nonhiv
pcprelat
patient
patient
method
retrospect
cohort
studi
includ
patient
without
hiv
pcp
diagnosi
admit
institut
paoli
calmett
cancer
referr
centr
compar
mortal
rate
chang
respiratori
item
sequenti
organ
failur
assess
score
delta
sofaresp
chang
global
sofa
score
sofaaggrav
use
intub
antipneumocysti
therapi
occurr
coinfect
earli
adjunct
corticosteroid
recipi
within
h
landmark
analysi
late
corticosteroid
recipi
use
invers
probabl
weight
surviv
analysi
ipw
result
hivneg
patient
pcp
includ
earli
corticosteroid
n
late
corticosteroid
n
main
underli
condit
haematolog
malign
n
solid
tumor
n
stem
cell
transplant
n
overal
mortal
respect
ipw
analysi
found
differ
hr
ci
p
hr
ci
p
mortal
rate
group
way
differ
deltasofaresp
sofaaggrav
use
intub
occurr
coinfect
found
group
conclus
addit
earli
adjunct
corticosteroid
antipneumocysti
therapi
nonhiv
patient
pcp
associ
improv
outcom
concern
mortal
respiratori
evolut
studi
need
evalu
therapeut
strategi
annal
intens
care
suppl
introduct
accuraci
test
depend
intrins
characterist
sensit
specif
diseas
preval
paramet
uncommonli
taken
account
assess
diagnost
accuraci
illustr
relationship
nonhiv
patient
pneumocysti
pneumonia
whose
preval
low
avail
diagnost
test
high
intrins
perform
studi
aim
assess
posttest
probabl
pneumocysti
pneumonia
accord
result
pcr
bdg
test
nonhiv
patient
arf
patient
method
systemat
review
perform
assess
diagnost
perform
pcr
betadglucan
bdg
preval
pneumocysti
pneumonia
assess
dataset
immunocompromis
patient
arf
use
supervis
classif
tree
preval
pneumocysti
pneumonia
simul
use
r
softwar
assum
normal
distribut
subject
basi
previous
observ
preval
posttest
probabl
assess
use
bay
theorem
analys
perform
use
r
softwar
result
preval
pneumocysti
pneumonia
arf
patient
ci
supervis
classif
identifi
subgroup
patient
without
ground
glass
opac
preval
ci
ground
glass
opac
prophylaxi
preval
ci
b
without
prophylaxi
preval
ci
c
without
prophylaxi
lymphoid
malign
stem
cell
transplant
preval
ci
overal
popul
posit
predict
valu
ppv
ci
ci
pcr
bdg
respect
neg
predict
valu
low
ci
ci
pcr
bdg
respect
highest
risk
subgroup
ppv
ci
ci
pcr
bdg
respect
conclus
although
pcr
bdg
yield
high
intrins
perform
low
incid
pneumocysti
pneumonia
translat
limit
ppv
even
highest
risk
group
result
underlin
need
adequ
pretest
probabl
assess
suggest
method
illustr
pre
posttest
probabl
relationship
may
improv
percept
diagnost
test
perform
patient
predefin
clinic
vignett
annal
intens
care
suppl
introduct
sever
communityacquir
pneumonia
scap
requir
urgent
specif
antimicrobi
therapi
howev
diagnost
tool
avail
diagnos
respons
pathogen
antiinfect
therapeut
must
initi
final
question
abil
predict
microbi
etiolog
scap
within
first
hour
hospit
emerg
evid
recent
suggest
artifici
intelligencederiv
method
could
effici
assist
medic
decis
process
wonder
mathemat
model
diagnost
predict
could
effici
evalu
made
experi
physician
object
studi
compar
abil
panel
expert
mathemat
model
predict
microbi
etiolog
scap
patient
method
conduct
prospect
nonintervent
studi
first
includ
patient
hospit
scap
icu
record
clinic
paraclin
data
avail
three
first
hour
care
final
microbi
diagnosi
establish
microbiolog
examin
includ
bacteri
cultur
multiplex
pcr
respiratori
fluid
scap
mix
etiolog
without
microbiolog
document
exclud
second
built
mathemat
model
predict
random
forest
method
loocv
use
data
initi
collect
final
independ
sampl
studi
popul
use
test
perform
pathogen
predict
panel
expert
ii
mathemat
algorithm
blind
regard
microbi
diagnosi
posit
likelihood
ratio
lr
neg
lr
consid
clinic
relev
result
includ
patient
scap
men
mean
age
year
mean
sapsii
respons
pathogen
viral
bacteri
mix
etiolog
unidentifi
datadriven
approach
defin
five
item
creat
final
mathemat
model
bmi
systol
blood
pressur
symptomtohospit
time
procalcitonin
neither
expert
algorithm
abl
predict
respons
pathogen
pneumonia
discrimin
abil
algorithm
moder
low
lr
viral
bacteri
pneumonia
discrimin
abil
expert
low
low
lr
viral
bacteri
pneumonia
conclus
studi
show
neither
expert
mathemat
algorithm
predict
microbi
etiolog
scap
within
first
hour
hospit
urg
defin
antiinfect
therapeut
strategi
result
highlight
need
develop
pointofcar
test
rapid
microbi
diagnosi
annal
intens
care
suppl
introduct
urinari
tract
ut
infect
frequent
diagnosi
emerg
depart
ed
staphylococcu
aureu
sa
uncommon
isol
urin
cultur
posit
urin
cultur
frequent
popul
risk
factor
ut
colon
absenc
urolog
invas
procedur
risk
factor
sa
colon
communityacquir
sa
bacteriuria
may
relat
deepseat
sa
infect
septic
embol
could
consid
trigger
symptom
cohort
studi
aim
assess
preval
infect
endocard
ie
patient
communityacquir
sa
bacteriuria
ed
patient
method
conduct
prospect
singlecent
studi
april
juli
patient
admit
ed
sa
bacteriuria
cfu
ml
sa
isol
singl
urin
sampl
without
risk
factor
ut
colon
ie
month
ut
surgeri
ut
catheter
includ
blood
cultur
collect
patient
clinic
symptom
infect
sir
criteria
concomit
bacteremia
h
case
transthorac
echocardiographi
tte
transesophag
echocardiographi
tee
perform
diagnosi
ie
base
duke
criteria
result
studi
period
patient
sa
bacteriuria
identifi
ed
exclud
patient
risk
factor
ut
colon
ut
catheter
n
ut
surgeri
n
patient
includ
men
iqr
yearsold
twentytwo
patient
clinic
symptom
infect
ut
infect
eleven
patient
concomit
sa
bacteremia
tte
tee
perform
patient
confirm
ie
patient
ie
affect
essenti
left
heart
mitral
aortic
valv
involv
sa
bacteriuria
identifi
significantli
earlier
ie
diagnosi
mean
differ
day
among
duke
minor
criteria
patient
septic
emboli
fever
predispos
heart
condit
mortal
conclus
absenc
risk
factor
communityacquir
sa
bacteriuria
interpret
isol
ut
infect
earli
warn
ie
requir
explor
accur
time
begin
antibiot
treatment
annal
intens
care
suppl
introduct
spontan
communityacquir
bacteri
mening
cabm
rare
poor
prognosi
cabm
epidemiolog
never
studi
french
west
indi
thu
assess
clinic
microbiolog
characterist
outcom
spontan
cabm
adult
requir
admiss
intens
care
unit
icu
french
west
indi
patient
method
chart
consecut
patient
year
old
requir
admiss
icu
cabm
guadeloup
martiniqu
januari
decemb
retrospect
analyz
patient
mening
clinic
sign
posit
bacteri
cerebrospin
fluid
cultur
includ
data
given
absolut
valu
percentag
median
valu
test
use
requir
studi
protocol
approv
local
ethic
committe
result
studi
period
case
cabm
identifi
due
streptococcu
pneumonia
n
klebsiella
pneumonia
n
staphylococcu
aureu
n
escherichia
coli
n
neisseria
meningitidi
b
n
streptococcu
spp
n
pseudomona
aeruginosa
n
escherichia
coli
streptococcu
spp
n
strain
wildtyp
phenotyp
antibiot
resist
patient
febril
neurolog
sign
headach
stroke
nuchal
stiff
glasgow
coma
scale
alter
median
ig
score
hospit
mortal
rate
patient
stay
icu
day
requir
mechan
ventil
case
interestingli
staphylococcu
aureu
cabm
associ
endocard
whatev
bacteria
bacteraemia
occur
frequent
ie
case
associ
case
abscess
initi
therapeut
regimen
thirdgener
cephalosporin
n
alon
n
combin
aminoglycosid
n
aminopenicillin
n
aminopenicillin
alon
n
comparison
cabm
staphylococcu
aureu
endocard
exclud
klebsiella
pneumonia
cabm
n
specif
clinic
present
p
ns
conclus
convers
epidemiolog
cabm
europ
north
america
found
high
incid
klebsiella
pneumonia
caus
microorgan
cabm
among
french
west
indi
popul
epidemiolog
could
relat
specif
bacteri
ecolog
caribbean
area
clinic
present
outcom
seem
similar
whatev
involv
bacteria
annal
intens
care
suppl
introduct
clinic
present
pleural
empyema
depend
upon
mani
factor
includ
caus
infecti
agent
patient
pleural
empyema
admit
icu
often
present
life
threaten
complic
like
respiratori
failur
septic
shock
aim
work
studi
bacteriolog
profil
clinic
present
caus
pleural
empyema
micu
effect
patient
outcom
patient
method
conduc
retrospect
monocentr
observ
studi
eight
year
period
april
juli
case
note
patient
diagnos
pleural
empyema
review
follow
data
collect
clinic
inform
sever
upon
admiss
microorgan
treatment
outcom
result
total
case
includ
sex
ratio
median
age
year
old
median
sever
score
apach
ii
sap
ii
patient
acut
respiratori
failur
time
admiss
n
quit
n
associ
pneumonia
nine
patient
present
septic
shock
median
rate
lactat
pleural
empyema
case
suspect
ultrasound
n
x
chest
ray
n
ct
scan
n
macroscop
presenc
pu
note
patient
found
neg
pleuralfluid
cultur
patient
n
alphahemolyt
streptococcu
ten
patient
klebsiella
pneumonia
two
anaerob
bacteria
three
drainag
pleural
content
perform
patient
chest
drain
three
thoracentesi
ten
median
durat
drainag
five
day
eleven
patient
requir
invas
mechan
ventil
case
treat
clavulan
acid
amoxicillin
n
intrapleur
fibrinolyt
therapi
perform
case
patient
n
fulli
recov
pleural
empyema
median
durat
stay
icu
nine
day
conclus
pneumonia
main
caus
pleural
empyema
high
sap
score
bilater
pneumonia
presenc
septic
shock
correl
high
mortal
lung
abscess
durat
stay
icu
correl
mortal
annal
intens
care
suppl
introduct
spontan
bacteri
periton
sbp
seriou
complic
cirrhosi
despit
standard
treatment
mortal
remain
high
aim
evalu
predictor
mortal
patient
sbp
patient
method
retrospect
work
carri
year
consecut
patient
approv
sbp
admit
depart
includ
clinic
biolog
data
collect
medic
record
univari
multivari
analysi
use
identifi
associ
factor
death
result
total
patient
diagnos
sbp
cirrhosi
enrol
studi
mean
age
sex
ratio
hcv
main
etiolog
cirrhosi
least
one
complic
occur
evolut
septic
shock
found
six
patient
die
sbp
signific
differ
sex
aetiolog
cirrhosi
ascit
abund
receiv
prophylact
antibiot
surviv
group
patient
die
howev
statist
signific
associ
mortal
onset
complic
p
low
systol
p
diastol
blood
p
pressur
tachycardia
p
admiss
empir
antibiot
therapi
static
prevent
factor
p
conclus
sbp
seriou
event
histori
cirrhot
diseas
particular
caution
must
exercis
regard
state
hemodynam
instabl
present
admiss
adequ
empir
treatment
would
improv
prognosi
annal
intens
care
suppl
introduct
intraabdomin
infect
iai
common
caus
hospit
intens
care
unit
icu
epidemiolog
microorgan
depend
mainli
patient
bacteri
flora
caus
risk
factor
multidrugresist
organ
mdro
difficult
identifi
french
expert
advis
publish
french
studi
investig
epidemiolog
commun
nosocomialacquir
iai
specif
incid
mdro
patient
method
perform
prospect
epidemiolog
multicent
studi
includ
consecut
hospit
adult
patient
iai
requir
hospit
icu
cultur
perform
blood
simpl
intraop
sampl
periton
fluid
purul
exud
discret
abscess
evalu
epidemiolog
factor
associ
isol
mdro
enrol
patient
result
among
patient
includ
studi
total
microorgan
isol
intraperiton
fluid
blood
sampl
cultur
two
pathogen
identifi
candida
spp
identifi
mdro
repres
total
isol
microorgan
among
patient
mdro
colon
found
surgeri
acquir
hospit
mdro
frequent
isol
patient
healthcareassoci
iai
uninomin
logist
regress
analysi
risk
factor
demonstr
statist
signific
risk
factor
independ
associ
occurr
mdro
iai
previou
know
carri
mdro
antimicrobi
therapi
administ
within
month
oper
conclus
studi
show
mdro
repres
tenth
iai
knowledg
previou
colon
mdro
previou
antibiotherapi
within
month
might
guid
identifi
patient
iai
caus
mdro
therefor
permit
introduc
adequ
empir
antimicrobi
therapi
annal
intens
care
suppl
introduct
toxic
epiderm
necrolysi
ten
rare
cutan
diseas
case
per
million
per
year
worldwid
potenti
fatal
morbid
also
high
persist
longterm
sequela
ophthalmolog
psycholog
mainli
novemb
auvergnerhonealp
refer
center
implement
order
central
optim
care
patient
ultim
goal
initi
improv
patient
outcom
aim
studi
assess
impact
implement
central
network
patient
outcom
patient
method
two
group
patient
compar
first
one
novemb
octob
implement
central
network
care
second
one
central
care
novemb
decemb
patient
suffer
ten
auvergnerhonealp
area
includ
primari
endpoint
procedur
pain
assess
visual
analogu
scale
va
secondari
endpoint
patient
recruit
need
gener
anesthesia
wound
treatment
treatment
durat
icu
hospit
length
stay
secondari
infect
rate
mortal
rate
day
proport
patient
lost
followup
three
month
report
sequela
observ
mortal
compar
predict
scorten
tool
statist
analysi
student
wilcoxon
test
perform
continu
variabl
fisher
test
perform
qualit
variabl
p
valu
consid
statist
signific
result
patient
enrol
patient
central
demograph
characterist
similar
group
result
present
tabl
fatal
occur
aftercar
central
wherea
expect
mortal
accord
scorten
tool
discuss
central
care
ten
refer
center
led
signific
reduct
procedur
pain
seem
decreas
treatment
durat
icu
hospit
length
stay
morbid
mortal
result
like
due
optim
patient
cours
grow
experi
caregiv
opinion
increas
number
report
sequela
may
highlight
underdiagnosi
complic
precentr
period
conclus
implement
central
medic
care
ten
referr
center
lead
signific
decreas
procedur
pain
patient
improv
comfort
thank
experienc
team
annal
intens
care
suppl
introduct
acut
kidney
injuri
aki
rapidli
evolv
condit
requir
earli
identif
urin
output
serum
creatinin
level
convent
marker
renal
function
could
help
improv
aki
detect
measur
frequent
aki
earli
identif
may
also
enhanc
measur
urinari
tissu
inhibitor
insulinlik
growth
factor
bind
aim
assess
perform
convent
novel
biomark
predict
aki
gener
icu
popul
patient
method
prospect
studi
enrol
critic
ill
adult
risk
develop
aki
exclud
patient
stage
aki
enrol
report
urin
output
chang
serum
creatinin
measur
h
preced
inclus
urinari
level
measur
inclus
comput
composit
risk
score
ratio
log
aki
defin
presenc
kdigo
stage
aki
occur
within
h
inclus
biomark
perform
express
use
area
receiv
oper
characterist
auroc
confid
interv
result
aki
occur
patient
inclus
significantli
lower
significantli
higher
patient
aki
compar
nonaki
patient
interquartil
rang
mlkgh
vs
mlkg
h
l
vs
l
aki
risk
predict
fair
poor
use
auroc
significantli
higher
patient
aki
compar
without
ng
ml
vs
ng
ml
auroc
predict
aki
composit
risk
score
show
best
aki
risk
predict
perform
auroc
conclus
combin
shortterm
urin
output
chang
serum
creatinin
show
good
perform
predict
aki
gener
icu
popul
preliminari
result
suggest
convent
indic
renal
function
measur
equival
recent
aki
biomark
annal
intens
care
suppl
introduct
acut
kidney
injuri
aki
frequent
seriou
complic
intens
care
unit
icu
patient
mani
studi
alreadi
demonstr
sepsi
septic
shock
import
caus
aki
critic
ill
patient
strong
evid
aki
septic
shock
associ
import
disord
hemodynam
paramet
despit
extens
research
field
studi
identifi
target
hemodynam
statu
patient
septic
shock
improv
kidney
function
object
determin
valu
mean
arteri
blood
pressur
lead
acut
kidney
failur
earli
septic
shock
factor
associ
mortal
patient
method
conduct
prospect
studi
month
januari
august
includ
patient
present
septic
shock
patient
cardiogen
hypovolem
shock
exclud
analyz
demograph
characterist
comorbid
sapsii
score
respiratori
hemodynam
neurolog
paramet
use
noninvas
invas
ventil
impact
hemodynam
statu
kidney
function
length
stay
mortal
result
includ
patient
sex
ratio
sapsii
admiss
averag
point
thirtyseven
percent
case
admit
respiratori
distress
aki
develop
multivari
logist
regress
analysi
reveal
develop
septic
aki
associ
older
age
preexist
chronic
kidney
diseas
low
mean
arteri
pressur
map
septic
shock
day
h
later
roc
curv
show
aki
develop
patient
map
septicshockday
mmhg
mmhg
h
later
studi
incid
aki
higher
patient
receiv
fluid
resuscit
vs
p
mortal
rate
higher
aki
group
p
coexist
aki
septic
myocard
septic
cholestasi
associ
low
outcom
conclus
develop
septic
aki
associ
poor
clinic
outcom
prevent
attenu
septic
aki
need
good
fluid
manag
hemodynam
statu
adjust
despit
larg
research
incid
mortal
septic
aki
high
extens
studi
best
histopatholog
inform
may
need
better
manag
kidney
dysfunct
patient
septic
shock
annal
intens
care
suppl
introduct
acut
kidney
injuri
aki
requir
renal
replac
therapi
rrt
occur
critic
ill
patient
associ
high
mortal
higher
sodium
na
dialys
concentr
mmoll
recommend
order
improv
intradialyt
hemodynam
toler
may
lead
sodium
load
patient
fluid
overload
associ
advers
icu
outcom
aim
therefor
evalu
flux
sodium
accord
na
dialysat
concentr
mmoll
hemodialysi
hd
hemodiafiltr
hdf
session
icu
aki
patient
patient
method
aki
patient
requir
rrt
includ
prospect
studi
patient
underw
consecut
hd
hdf
session
na
dialys
concentr
mmoll
sodium
concentr
measur
plasma
session
affluent
effluent
fluid
flux
sodium
rrt
session
estim
use
mean
sodium
logarithm
concentr
includ
diffus
convect
influx
compar
flux
sodium
hd
hdf
mmoll
na
concentr
dialys
result
fourteen
patient
enter
studi
aki
mostli
septic
origin
almost
patient
requir
need
vasopressor
drug
mechan
ventil
underw
rrt
session
hdf
neg
na
gradient
dialys
replac
fluid
patient
observ
techniqu
dialys
sodium
concentr
induc
fluid
overload
comparison
hd
hd
hdf
hdf
show
higher
na
dialysat
induc
signific
higher
flux
na
patient
consequ
fluid
overload
tabl
icu
mortal
rate
around
surviv
patient
mean
creatinin
clairanc
icu
discharg
conclus
studi
show
rrt
substanti
na
load
occur
na
load
increas
significantli
elev
na
dialys
concentr
mmoll
clinic
intradialyt
hemodynam
toler
increas
na
dialys
need
howev
studi
analyz
annal
intens
care
suppl
introduct
sodium
disord
frequent
among
intens
care
unit
patient
aim
determin
characterist
prognost
factor
patient
develop
sodium
disord
intens
care
patient
method
conduct
retrospect
studi
one
year
medic
intens
care
unit
ibn
rushd
hospit
casablancamoroccoth
epidemiolog
clinic
therapeut
data
collect
studi
two
categori
patient
present
hyponatremia
hypernatremia
intens
care
unit
result
incid
hyponatremia
averag
age
patient
year
admit
respiratori
diseas
mean
apach
ii
sap
ii
mean
charlson
comorbid
index
patient
experienc
earli
hyponatremia
day
patient
mechan
ventil
receiv
antibiot
use
vasoact
drug
necessari
case
patient
receiv
diuret
receiv
corticoid
patient
receiv
sodium
supplement
outcom
favor
incid
hypernatremia
averag
age
patient
year
endocrin
patholog
main
reason
hospit
mean
apach
ii
sap
ii
osf
mean
charlson
comorbid
index
patient
experienc
earli
hypernatremia
day
patient
mechan
ventil
receiv
antibiot
vasoact
drug
necessari
patient
receiv
diuret
outcom
favor
patient
present
hyponatremia
factor
associ
mortal
apach
ii
score
reason
admiss
oxygen
satur
degre
sever
hyponatremia
hepat
function
low
serum
albumin
hyperfibrinigenemia
mechan
ventil
antibiot
vasoact
drug
blood
transfus
sedat
length
stay
nosocomi
infect
patient
hypernatremia
prognosi
factor
sex
gender
apach
ii
score
oxygen
satur
length
stay
sever
hypernatremia
hepat
dysfunct
anemia
low
serum
albumin
sedat
antibiot
vasoact
drug
blood
transfus
conclus
sodium
disord
associ
high
mortal
risk
among
patient
present
hyponatremia
apach
ii
sap
ii
score
earli
hyponatremia
mechan
ventil
antibiot
vasoact
drug
corticoid
blood
transfus
sedat
length
stay
nosocomi
infect
sepsi
predict
factor
mortal
hand
low
serum
albumin
sedat
apach
ii
score
associ
mortal
among
patient
hypernatremia
annal
intens
care
suppl
introduct
sled
hybrid
techniqu
use
intermitt
hemodialysi
ihd
equip
lower
blood
dialys
flow
along
longer
dialysi
session
ds
gain
popular
may
allow
effici
ultrafiltr
uf
enhanc
hemodynam
toler
set
major
fluid
overload
region
citrat
anticoagul
ca
emerg
prefer
anticoagul
techniqu
continu
replac
therapi
thank
decreas
bleed
risk
increas
extracorpor
circuit
ecc
lifetim
expens
augment
risk
metabol
disord
herein
describ
modifi
protocol
use
dialys
sourc
ca
patient
method
patient
hospit
singl
center
nephrolog
intens
care
requir
prolong
ds
uf
includ
month
period
patient
treat
cur
anticoagul
exclud
clinic
biolog
metabol
characterist
coagul
score
collect
patient
altern
ihd
h
sled
h
ihd
prescrib
mlmin
blood
flow
mlmin
dialys
flow
sled
use
respect
mlmin
mlmin
uf
left
physician
discret
dialys
composit
potassium
mmoll
sodium
mmoll
magnesium
mmoll
calcium
mmoll
citrat
mmoll
glucos
g
l
calcium
magnesium
infus
rate
base
ionic
dialys
follow
chart
previous
devis
standard
ihd
session
result
ds
prescrib
patient
analys
ihd
sled
weight
loss
h
significantli
increas
sled
compar
ihd
p
concern
safeti
differ
ioniz
calcium
ica
measur
everi
hour
session
without
citrat
overload
tabl
level
sodium
magnesium
potassium
phosphat
bicarbon
anion
gap
session
differ
differ
regard
pressur
profil
evolut
earli
interrupt
dialysi
uf
despit
higher
uf
sled
ica
measur
dialyz
outlet
consist
predefin
threshold
mmoll
observ
higher
score
membran
clot
ecc
clot
sled
bleed
event
observ
conclus
sled
use
modifi
dialys
sourc
ca
appear
safe
effici
techniqu
provid
uf
may
repres
use
renal
replac
therapi
patient
major
fluid
overload
high
bleed
risk
annal
intens
care
suppl
introduct
acut
renal
failur
rare
complic
sever
malaria
children
aim
studi
evalu
therapeut
manag
context
patient
method
realiz
observ
transvers
descript
studi
month
januari
septemb
pediatr
emerg
depart
intens
care
unit
centr
hospitali
universitair
de
librevil
patient
acut
renal
failur
posit
thick
film
includ
studi
studi
variabl
includ
social
demograph
data
clinic
paraclin
therapeut
prognost
data
result
studi
period
patient
admit
manag
malaria
among
patient
boy
girl
present
acut
renal
failur
due
malaria
mean
age
month
renal
replac
therapi
indic
patient
effect
patient
hemodialysi
techniqu
use
mean
durat
hospit
day
mortal
conclus
studi
shown
acut
renal
failur
complic
sever
malaria
children
realli
rare
renal
replac
therapi
feasibl
older
children
essenti
improv
facil
manag
children
annal
intens
care
suppl
introduct
cardio
renal
syndrom
cr
group
disord
result
patholog
interact
heart
kidney
studi
preval
cr
patient
admit
ae
copd
limit
set
discoveri
renal
dysfunct
rare
import
therapeut
implic
particularli
cr
impact
mortal
prognost
valu
group
patient
deserv
special
emphasi
aim
evalu
preval
cr
well
impact
mortal
patient
admit
ae
copd
patient
method
retrospect
review
chart
consecut
patient
admit
ae
copd
medic
icu
novemb
februari
collect
clinic
featur
admiss
sever
ill
icu
cours
occurr
cr
univari
multivari
regress
analys
perform
identifi
factor
independ
associ
cr
determin
risk
mortal
secondari
cr
result
total
patient
admit
ae
copd
main
characterist
mean
age
year
male
copd
gold
mean
apach
ii
ph
mmhg
mm
hg
initi
invas
mechan
ventil
mean
durat
mechan
ventil
day
mean
length
stay
day
mortal
eight
patient
develop
cr
among
patient
type
cr
patient
type
cr
patient
type
cr
underli
cardiac
diseas
patient
cr
hypertens
cardiomyopathi
case
ischem
cardiomyopathi
case
pulmonari
arteri
hypertens
found
patient
cr
mean
systol
pap
mmhg
patient
cr
septicemia
univari
analysi
show
signific
associ
cr
acut
circulatori
failur
admiss
p
occurr
cr
associ
increas
risk
mortal
p
conclus
cr
frequent
patient
admit
ae
copd
significantli
associ
circulatori
failur
admiss
well
signific
risk
death
annal
intens
care
suppl
introduct
time
renal
replac
therapi
rrt
sever
acut
kidney
injuri
aki
highli
debat
three
multicent
trial
assess
question
akiki
idealicu
show
mortal
differ
earli
delay
rrt
strategi
pend
result
starrtaki
ongo
bulk
evid
suggest
absenc
sever
complic
aki
delay
rrt
safe
durat
anuria
serum
urea
concentr
among
criteria
mandat
rrt
delay
strategi
akiki
valid
criteria
open
debat
design
studi
compar
akiki
delay
strategi
delay
one
patient
method
akiki
prospect
multicent
openlabel
random
trial
random
preced
observ
stage
patient
receiv
receiv
catecholamin
mechan
ventil
sever
aki
potenti
lifethreaten
condit
sever
hyperkalemia
sever
acidosi
pulmonari
edema
result
sever
hypoxemia
observ
one
follow
criteria
occur
serum
urea
concentr
mmoll
oliguria
anuria
h
patient
randomli
alloc
one
two
arm
delay
strategi
rrt
initi
within
h
document
random
delay
strategi
rrt
initi
one
lifethreateningcondit
see
occur
serum
urea
concentr
reach
mmoll
primari
outcom
number
rrtfree
day
day
random
consid
mean
rrtfree
day
day
day
delay
strategi
data
deriv
akiki
total
sampl
size
patient
requir
random
stage
demonstr
increas
day
delay
strategi
approxim
one
third
patient
observ
stage
elig
random
stage
expect
patient
includ
observ
stage
result
five
month
studi
begin
center
activ
plan
open
patient
includ
random
inclus
complet
decemb
conclus
akiki
allow
precis
descript
natur
histori
aki
expand
result
previou
larg
random
control
trial
show
whether
possibl
delay
rrt
initi
popul
annal
intens
care
suppl
introduct
social
network
analysi
seek
understand
network
particip
two
main
focus
actor
relationship
specif
social
context
applic
health
sector
remain
underutil
sought
use
social
network
analysi
sna
describ
pattern
commun
teamwork
acut
medic
unit
amu
patient
method
network
analysi
conduct
examin
network
structur
teamwork
profession
commun
amu
univers
hospit
elig
personnel
n
includ
sna
survey
team
member
report
frequenc
time
profession
discuss
everi
cowork
last
examin
structur
network
densiti
degre
between
central
degre
between
central
calcul
score
rang
higher
valu
indic
dens
central
network
central
team
member
network
respect
examin
homophili
network
use
ei
index
commun
staff
differ
function
commun
staff
similar
function
pvalu
obtain
base
quadrat
assign
procedur
qap
permut
network
network
analysi
use
construct
network
map
use
multidiment
scale
gener
visual
represent
network
network
diagram
result
mean
age
particip
year
densiti
whole
network
moder
degre
central
lowerbetwe
central
seven
team
member
central
central
degre
network
includ
three
senior
physician
head
nurs
physiotherapist
medic
secretari
archivist
evid
regard
homophili
network
indic
high
level
ei
index
valu
p
qap
indic
low
degre
commun
among
differ
function
team
member
conclus
sna
reveal
moder
team
member
connected
network
measur
densiti
amu
network
show
moder
degre
central
low
between
central
suppos
team
connect
well
posit
member
support
interteam
commun
greater
number
gatekeep
domin
network
member
network
effect
five
function
profil
central
role
bridg
commun
howev
analysi
also
show
possibl
point
weak
medic
unit
repres
low
degre
commun
among
differ
function
team
member
annal
intens
care
suppl
introduct
advers
event
ae
common
recogn
report
ae
crucial
step
caregiv
implement
adequ
strategi
improv
patient
safeti
aim
evalu
rate
risk
factor
ae
impact
patient
method
prospect
studi
conduct
octob
june
medic
icu
includ
patient
monitor
ae
variabl
found
statist
signific
univari
analysi
introduc
multivari
regress
model
identifi
factor
independ
associ
ae
result
patient
includ
patient
characterist
median
age
year
femal
median
sapsii
invas
mechan
ventil
imv
vasopressor
use
respiratori
disord
main
reason
admiss
patient
ae
occur
patient
median
length
stay
lo
frequent
ae
ventil
acquir
pneumonia
remov
gastric
tube
pressur
sore
remov
central
peripher
line
remov
bladder
cathet
accident
extub
fall
cathet
relat
bloodstream
infect
acut
renal
failur
venou
thromboembol
event
patient
present
ae
significantli
longer
durat
imv
vs
day
p
longer
lo
vs
day
p
higher
mortal
rate
vs
p
univari
analysi
reveal
follow
factor
associ
ae
respect
age
year
vs
p
sapsii
vs
p
imv
use
vs
p
vasopressor
use
vs
p
corticosteroid
use
vs
p
sed
agent
use
vs
p
delirium
vs
p
multivari
regress
model
identifi
two
factor
independ
associ
ae
delirium
ci
p
imv
durat
ci
p
conclus
studi
highlight
seriou
problem
ae
icu
delirium
imv
durat
identifi
independ
associ
ae
annal
intens
care
suppl
introduct
earli
icu
admiss
propos
mean
limit
risk
clinic
worsen
improv
outcom
icu
patient
aim
review
investig
impact
earli
icu
admiss
gener
icu
popul
criticallyil
cancer
patient
cicp
patient
method
systemat
review
perform
accord
prisma
statement
protocol
regist
prospero
databas
studi
report
impact
delay
icu
outcom
search
pubm
adult
patient
without
cancer
differ
term
mortal
report
risk
ratio
ci
public
bia
assess
visual
inspect
funnel
plot
summari
estim
rel
risk
confid
interv
calcul
use
fix
randomeffect
model
result
overal
icu
popul
among
citat
identifi
gener
icu
popul
studi
report
patient
includ
includ
patient
earli
admiss
group
earli
icu
admiss
associ
decreas
mortal
use
random
effect
model
rr
confid
interv
figur
cicp
among
citat
identifi
studi
report
patient
includ
earli
icu
admiss
includ
earli
icu
admiss
associ
decreas
mortal
use
random
effect
model
rr
confid
interv
explor
heterogen
metaregress
perform
characterist
trial
prospect
vs
retrospect
monocent
vs
multicent
impact
find
public
median
public
period
associ
lower
treatment
effect
estim
ci
p
gener
icu
popul
signific
public
bia
observ
sever
sensit
analys
perform
use
trim
fill
method
copa
method
take
account
outcom
report
bia
confirm
find
robust
gener
icu
popul
cicp
conclus
result
suggest
earli
icu
admiss
associ
decreas
mortal
gener
icu
popul
cicp
result
howev
obtain
high
risk
bia
studi
high
heterogen
note
addit
studi
requir
confirm
potenti
benefit
earli
icu
admiss
along
ratio
annal
intens
care
suppl
introduct
icu
heath
care
worker
icu
hcw
use
expens
devic
care
patient
unfortun
lifetim
multi
user
devic
often
shorter
could
wait
singl
user
util
aim
survey
evalu
icu
hcw
knowledg
cost
devic
regularli
use
icu
patient
care
patient
method
hcw
three
icu
medic
medico
surgic
univers
affili
propos
answer
anonym
questionnair
aim
measur
estim
cost
devic
system
use
daili
patient
care
includ
cathet
ultrasound
devic
renal
replac
therapi
devic
cost
estim
express
percentag
real
cost
cost
estim
compar
use
median
quartil
accord
hcw
statu
magnitud
cost
devic
correct
estim
defin
estim
cost
equival
real
cost
result
hcw
accept
take
part
survey
provid
cost
estim
median
global
cost
estim
devic
decreas
real
cost
devic
real
cost
real
cost
real
cost
devic
cost
accuraci
cost
estim
real
cost
estim
cost
estim
cost
senior
physician
perform
better
junior
physician
conclus
hcw
unawar
real
cost
devic
use
icu
patient
care
case
annal
intens
care
suppl
introduct
clinic
assess
sever
ill
essenti
compon
medic
practic
especi
intens
care
unit
icu
multipl
score
system
develop
icu
risk
stratifi
patient
predict
outcom
help
care
provid
decis
make
guid
alloc
resourc
aim
studi
compar
perform
local
valid
clinic
sever
score
css
sever
score
system
physiolog
chronic
health
evalu
apach
system
ii
simplifi
acut
physiolog
score
ii
sap
ii
sequenti
organ
failur
assess
score
sofa
patient
method
retrospect
studi
perform
micu
januari
decemb
data
collect
review
medic
patient
chart
score
system
calcul
base
worst
valu
record
first
h
admiss
discrimin
evalu
use
receiv
oper
characterist
roc
curv
result
total
patient
enrol
studi
mean
age
n
male
common
reason
admiss
acut
respiratori
failur
patient
neurolog
cardiovascular
disord
respect
patient
patient
intub
need
vasopressor
mean
length
icu
stay
day
mean
sapsii
apach
ii
sofa
css
respect
overal
mortal
rate
best
perform
icu
score
system
studi
css
area
roc
curv
auc
ci
p
sofa
sapsii
apach
ii
respect
auc
ci
p
ci
p
ci
p
figur
conclus
find
present
studi
show
sofa
sap
ii
apach
ii
good
accuraci
predict
mortal
icu
howev
partial
perfect
emphas
import
repeat
valid
score
css
interest
timeconsum
costless
minim
invas
tool
predict
mortal
icu
annal
intens
care
suppl
introduct
elimin
unnecessari
health
care
may
reduc
cost
improv
qualiti
healthcar
studi
aim
measur
appropri
hospit
identifi
patient
hospit
characterist
associ
appropri
hospit
acut
medic
unit
univers
hospit
patient
method
prospect
data
includ
patient
admit
acut
medic
unit
collect
month
appropri
hospit
day
contribut
patient
assess
mean
appropri
evalu
protocol
assess
equiti
distribut
hospit
resourc
among
patient
cumul
appropri
hospit
mean
gini
coeffici
gini
index
rang
zero
repres
perfect
equal
distribut
predictor
variabl
includ
patient
anthropometr
characterist
hospit
characterist
associ
patientrel
variabl
inappropri
hospit
day
relat
variabl
studi
use
gener
estim
equat
univari
multivari
logist
regress
analysi
result
overal
hospit
admiss
hospit
day
rate
inappropri
univari
analysi
inapproprit
hospit
day
frequent
among
patient
whose
admiss
inappropri
factor
significantli
relat
inappropri
stay
hospit
singl
room
absenc
previou
hospit
p
transfer
request
anoth
depart
p
transfer
done
anoth
depart
p
diagnosi
hematolog
diseas
p
multivari
analysi
diagnosi
hematolog
diseas
remain
significantli
relat
inappropri
stay
ci
p
day
inappropri
hospit
less
evenli
distribut
appropri
day
gini
coeffici
respect
conclus
studi
show
inappropri
hospit
acut
medic
unit
frequent
admiss
one
bed
ten
could
free
one
patient
twenti
could
shorter
stay
consid
emerg
depart
chronic
satur
limit
fund
inadequ
hospit
result
unnecessari
cost
less
effici
qualiti
care
acut
medic
unit
annal
intens
care
suppl
introduct
increas
life
expect
elderli
patient
requir
intens
care
unit
icu
admiss
frequent
age
thought
strongli
associ
icu
mortal
clinic
variabl
may
incrimin
earli
recognit
patient
high
risk
mortal
help
outcom
predict
better
care
plan
health
care
cost
contain
strategi
develop
aim
studi
describ
characterist
tunisian
elderli
patient
admit
icu
identifi
predict
factor
icu
mortal
patient
method
prognost
studi
type
surviv
analysi
conduct
medic
icu
univers
hospit
period
includ
patient
year
baselin
characterist
clinic
laboratori
paramet
treatment
outcom
record
univari
multivari
analysi
perform
use
surviv
analysi
result
studi
period
patient
admit
n
includ
mean
age
year
overal
icu
mortal
acut
respiratori
failur
common
reason
hospit
communityacquir
pneumonia
main
etiolog
mean
apach
ii
sap
ii
sofa
score
fiftythre
per
cent
requir
invas
mechan
ventil
requir
vasoact
drug
common
complic
hemodynam
disord
follow
nosocomi
infect
renal
failur
mean
lo
day
univari
analysi
factor
associ
mortal
past
histori
chronic
renal
failur
p
shock
p
ard
p
resuscit
cardiac
arrest
p
sever
score
sofa
p
apach
ii
p
sap
ii
p
acut
renal
failur
admiss
p
vasoact
drug
p
sedat
p
multivari
analysi
independ
predict
factor
mortal
sever
score
sap
ii
hr
ci
p
apach
ii
hr
ci
p
conclus
even
though
old
age
link
high
risk
death
age
alon
appear
strong
predictor
mortal
sever
ill
icu
admiss
main
predict
factor
death
longitudin
studi
longterm
surviv
elderli
need
annal
intens
care
suppl
introduct
mani
studi
focus
work
hospit
doctor
littl
known
work
intens
care
unit
icu
physician
especi
concern
medic
time
spent
outsid
unit
workload
never
evalu
date
main
object
studi
evalu
time
spent
icu
doctor
outsid
unit
manag
patient
intrahospit
transport
iht
care
patient
depart
vital
emerg
advic
medic
care
ethic
discuss
secondari
object
describ
organ
distribut
medic
time
outsid
icu
patient
method
prospect
observ
studi
took
place
year
januari
decemb
two
academ
medic
icu
strasbourg
dijon
intervent
outsid
icu
intensivist
doctor
time
intervent
everi
day
morn
medic
staff
anonym
data
collect
regist
result
five
year
studi
h
spent
intensivist
outsid
icu
strasbourg
dijon
correspond
averag
h
min
per
year
min
per
day
strasbourg
averag
h
per
year
min
per
day
dijon
five
year
shift
correspond
averag
shift
per
year
strasbourg
shift
dijon
correspond
averag
shift
per
year
one
third
time
spent
emerg
depart
one
third
intrahospit
medic
ward
last
third
iht
icu
patient
requir
computer
tomographi
scan
cardiac
catheter
discuss
better
understand
differ
activ
respect
part
occupi
daili
life
intensivist
essenti
order
optim
care
hospit
patient
conclus
prospect
french
bicentr
studi
highlight
fact
intensivist
medic
activ
outsid
unit
timeconsum
part
intensivist
activ
often
unrecogn
hospit
administr
taken
account
concern
routin
activ
icu
well
care
given
patient
bedsid
time
devot
recept
famili
time
devot
meet
annal
intens
care
suppl
introduct
bacteraemia
induc
high
rate
morbimort
blood
cultur
bc
standard
method
diagnosi
bacteraemia
franc
practic
recommend
exist
concern
bc
updat
avoid
inadequ
sampl
result
fals
diagnosi
inadequ
antibiotherapi
prolong
hospit
length
stay
appropri
train
nurs
student
could
promot
good
clinic
practic
sinc
franc
bc
mainli
taken
nurs
aim
studi
evalu
theoret
practic
train
receiv
french
nurs
student
school
hospit
bc
execut
well
relat
hygien
practic
patient
method
perform
crosssect
studi
evalu
theoret
practic
train
receiv
french
nurs
student
hygien
practic
concern
bc
studi
base
electron
survey
use
questionnair
sent
french
nurs
student
octob
januari
survey
encompass
short
answer
multiplechoic
question
result
one
thousand
thirtysix
nurs
student
fill
survey
femal
mean
age
year
nurs
school
nurs
student
declar
receiv
theoret
train
bc
execut
receiv
practic
train
theoret
practic
train
internship
declar
receiv
practic
train
theoret
train
declar
train
among
bc
execut
recommend
peripher
stick
first
aerob
well
known
among
nurs
student
respect
similarli
practic
wash
hand
clean
venepunctur
site
prior
bc
execut
known
among
student
contrast
practic
wear
glove
facial
mask
rel
lower
conclus
discrep
knowledg
base
nurs
student
good
practic
recommend
blood
cultur
execut
relat
hygien
practic
strengthen
teach
practic
like
improv
student
knowledg
base
reduc
blood
cultur
contamin
improv
qualiti
care
annal
intens
care
suppl
introduct
epidemiolog
data
cardiogen
shock
cs
still
poor
focus
ischem
cs
forget
part
cs
encount
clinic
practic
patient
method
frenshock
registri
larg
prospect
multicent
registri
nonselect
cs
patient
admit
critic
care
unit
realiz
april
octob
franc
patient
includ
met
follow
three
criteria
low
cardiac
output
defin
sbp
mmhg
need
amin
low
cardiac
output
defin
ci
tte
swanganz
elev
left
right
heart
pressur
defin
clinic
radiolog
biolog
echocardiographi
swanganz
clinic
biolog
hypoperfus
result
patient
includ
center
male
mean
age
comorbid
classic
previou
coronari
revascular
histori
extra
cardiac
arteri
diseas
previou
renal
failur
copd
cardiovascular
risk
factor
includ
diabet
activ
tobacco
dyslipidemia
hypertens
known
previou
cardiomyopathi
especiali
ischem
origin
cs
etiolog
often
associ
sever
trigger
ischem
retain
n
patient
type
infarct
n
nonischem
trigger
factor
predomin
n
supra
ventricular
ventricular
arrythmia
infect
iatrogen
conduct
disord
nonobserv
other
admiss
median
sbp
mmhg
sinus
rhythm
present
right
heart
failur
sign
present
left
sign
killip
iv
biolog
analysi
found
sign
hypoperfus
high
lactat
ci
renal
egfr
hepat
alter
asat
ui
ml
ic
prothrombin
time
biventricular
failur
frequent
lvef
taps
mm
realiz
n
coronarographi
patholog
n
monotroncular
bitroncular
tritroncular
culprit
lesion
found
concern
lva
rca
left
main
conclus
larg
multicentr
prospect
registri
confirm
heterogen
cs
term
etiolog
present
prognosi
predomin
nonischem
cs
practic
annal
intens
care
suppl
introduct
expert
propos
defin
rv
failur
state
rv
unabl
meet
demand
blood
flow
without
excess
dilat
taps
tricuspid
annular
plan
systol
excurs
frequent
report
pertin
paramet
studi
rv
function
still
question
goal
report
incid
rv
dilat
sever
distribut
shock
ii
report
distribut
taps
differ
group
accord
rv
size
serum
lactat
level
patient
method
retrospect
analysi
observ
prospect
multicent
studi
includ
patient
admit
icu
shock
mechan
ventil
echocardiographi
transthorac
transesophag
systemat
perform
exclus
cardiogen
hypovolem
obstruct
shock
patient
screen
combin
lactat
level
enddiastol
ratio
right
left
ventricl
rv
lv
eda
group
defin
group
without
rv
dilat
rv
lv
eda
group
moder
rv
dilat
rv
lv
eda
without
increas
lactat
level
mmoll
group
sever
rv
dilat
rv
lv
eda
result
patient
analyz
median
age
iqr
iqr
sofa
score
iqr
caus
shock
septic
case
overal
inicu
mortal
patient
group
group
group
group
patient
ventil
ard
median
rv
lv
eda
iqr
iqr
iqr
iqr
group
respect
intergroup
differ
observ
taps
median
valu
mm
p
central
venou
pressur
significantli
higher
group
mmhg
compar
group
conclus
rv
dilat
observ
moder
sever
taps
discrimin
normal
valu
group
annal
intens
care
suppl
introduct
inhospit
admiss
elderli
patient
resuscit
outofhospit
cardiac
arrest
ohca
increas
author
report
favour
outcom
other
report
increas
risk
death
surviv
loss
autonomi
addit
benefit
intervent
ie
transport
percutan
coronari
intervent
pci
time
resourc
associ
evalu
consequ
conduct
studi
evalu
prognosi
elderli
ohca
patient
region
one
pci
center
patient
method
retrospect
includ
patient
age
older
admit
intens
care
unit
univers
non
univers
hospit
ohca
januari
decemb
cardiac
arrest
patient
characterist
collect
cardiac
arrest
hospit
prognosi
cahp
score
calcul
primari
outcom
neurocognit
function
assess
cerebr
perform
categori
hospit
discharg
result
studi
period
patient
includ
median
age
male
patient
present
signific
comorbid
condit
median
charlson
index
sixtyeight
patient
initi
shockabl
rhythm
hundr
sixtysix
patient
present
without
obviou
extracardiac
caus
pci
perform
patient
number
nonneurolog
organ
failur
admiss
lower
patient
favor
outcom
patient
receiv
renal
replac
therapi
unfavour
outcom
rate
favor
neurolog
outcom
hospit
discharg
patient
includ
patient
initi
first
shockabl
rhythm
month
rate
decreas
patient
includ
patient
initi
first
shockabl
rhythm
accord
cahp
score
patient
low
risk
poor
neurolog
outcom
intermedi
risk
high
risk
base
cahp
score
stratif
patient
low
risk
group
patient
intermedi
risk
group
patient
highrisk
group
underw
earli
pci
conclus
surviv
elderli
patient
low
ohca
especi
patient
first
non
shockabl
rhythm
howev
patient
first
shockabl
rhythm
low
risk
death
may
favor
long
term
outcom
level
organ
failur
seem
strongli
associ
prognosi
stratif
cahp
score
suggest
use
pci
coud
improv
better
select
patient
like
benefit
annal
intens
care
suppl
introduct
manag
outofhospit
cardiac
arrest
ohca
patient
requir
coordin
prehospit
inhospit
postdischarg
team
data
report
comprehens
analysi
cost
associ
treat
ohca
scarc
patient
method
perform
analysi
merg
databas
toronto
region
rescunet
epistri
databas
prehospit
data
administr
populationbas
databas
ontario
nontraumat
ohca
patient
year
age
treat
em
januari
march
includ
studi
primari
outcom
per
patient
longitudin
cumul
healthcar
cost
time
collaps
maximum
follow
death
day
event
includ
avail
cost
sector
perspect
health
system
payer
use
multivari
gener
linear
model
logarithm
link
gamma
distribut
determin
predictor
healthcar
cost
result
patient
treat
em
servic
ohca
mostli
male
mean
age
pronounc
dead
scene
die
emerg
depart
admit
hospit
die
still
aliv
total
cost
interquartil
rang
iqr
per
patient
rang
iqr
patient
pronounc
scene
iqr
patient
still
aliv
inhospit
cost
account
total
cost
adjust
age
gender
rate
patient
surviv
main
driver
total
cost
rate
ratio
confid
interv
patient
die
ed
patient
die
ed
within
day
patient
still
aliv
compar
patient
pronounc
dead
scene
respect
factor
independ
associ
cost
number
prehospit
team
need
hospit
transfer
coronari
angiographi
target
temperatur
manag
conclus
clinic
outcom
main
driver
total
cost
treat
ohca
patient
larg
canadian
health
system
potenti
modifi
factor
includ
number
prehospit
team
arriv
scene
arrest
need
betweenhospit
transfer
success
resuscit
annal
intens
care
suppl
introduct
low
ph
acidemia
histor
describ
one
major
factor
associ
hyperkalemia
older
studi
suggest
context
elev
anion
gap
metabol
acidosi
acidemia
link
hyperkalemia
consequ
administr
sodium
bicarbon
long
consid
firstlin
therapi
acut
hyperkalemia
recent
reassess
treatment
either
hyperkalemia
regard
high
preval
hyperkalemia
acidemia
resuscit
outofhospit
cardiac
arrest
ohca
patient
share
experi
sever
acut
type
lactic
acidosi
frequent
caus
metabol
acidosi
set
patient
method
retrospect
analyz
first
arteri
blood
ga
result
success
resuscit
ohca
patient
admit
tertiari
parisian
intens
care
unit
baselin
characterist
compar
accord
presenc
hyperkalemia
factor
associ
kalemia
identifi
use
multivari
linear
regress
sensit
analysi
repeat
subgroup
patient
without
chronic
respiratori
diseas
crd
without
acut
kidney
injuri
aki
result
admiss
blood
lactat
mmoll
patient
potassium
level
mmoll
patient
hyperkalemia
present
frequent
initi
nonshock
rhythm
experienc
longer
collaps
resuscit
icu
admiss
patient
hyperkalemia
present
deeper
acidemia
vs
p
higher
lactatemia
vs
p
higher
serum
creatinin
level
vs
p
follow
multivari
linear
regress
kalemia
associ
initi
nonshock
rhythm
ci
higher
creatininemia
ci
elev
ci
elev
lactat
level
inde
statist
neg
trend
potassium
blood
level
lactatemia
observ
p
sensit
analys
perform
patient
without
aki
crd
show
similar
result
conclus
studi
demonstr
absenc
associ
blood
lactat
potassium
level
acidosi
sever
acidemia
success
resuscit
ohca
patient
set
phenomenon
appear
independ
aki
result
suggest
kaliemia
fact
strongli
link
arteri
annal
intens
care
suppl
introduct
venoven
vvecmo
venoarteri
vaecmo
extracorpor
membran
oxygen
increasingli
use
treatment
refractori
acut
respiratori
distress
syndrom
cardiac
arrest
refractori
cardiogen
shock
respect
aim
describ
preval
vascular
complic
follow
ecmo
wean
identifi
associ
risk
factor
patient
method
januari
decemb
patient
manag
ecmo
unit
rangueil
univers
hospit
toulous
among
wean
patient
benefit
postdecannul
venou
arteri
doppler
ultrasound
assess
vascular
complic
includ
retrospect
studi
result
thirtyon
patient
show
vascular
complic
ecmo
cannula
withdraw
twentytwo
patient
arteri
complic
venou
complic
case
vascular
complic
asymptomat
patient
vascular
complic
younger
vs
respect
p
patient
deep
vein
thrombosi
dvt
longer
ecmo
durat
vs
day
p
prolong
icu
length
stay
vs
day
p
compar
patient
without
dvt
final
preval
dvt
higher
patient
vv
ecmo
compar
patient
va
ecmo
p
vascular
complic
occurr
tend
associ
increas
mortal
month
versu
p
conclus
vv
va
ecmo
associ
elev
preval
vascular
complic
systemat
doppler
ultrasound
evalu
wean
could
optim
manag
specif
patient
annal
intens
care
suppl
introduct
mitral
veloc
e
wave
veloc
wave
veloc
earli
diastol
mitral
annulu
veloc
e
assess
transthorac
echocardiographi
tte
tissu
doppler
imag
tdi
correl
pulmonari
arteri
occlus
pressur
paop
cardiolog
patient
paramet
depend
load
condit
modifi
mechan
ventil
use
catecholamin
icu
ventil
patient
receiv
catecholamin
e
ratio
e
veloc
evalu
patient
method
observ
prospect
studi
includ
consecut
patient
mean
age
year
septic
shock
ard
patient
treat
catecholamin
mean
dose
mg
h
ventil
mean
mean
tidal
volum
ml
kg
volum
expans
perform
ringer
lactat
solut
discret
clinician
echocardiograph
doppler
examin
hemodynam
measur
repeat
volum
expans
obtain
measur
doppler
mitral
inflow
tdi
mitral
annulu
veloc
determin
compar
paop
measur
swanganz
cathet
tte
paramet
analyz
offlin
independ
oper
blind
clinic
histori
paop
valu
result
fluid
challeng
increas
paop
mmhg
howev
differ
cardiac
index
l
min
signific
correl
paop
e
wave
beta
ic
p
e
ratio
beta
ic
p
e
e
ratio
beta
p
conclus
preliminari
studi
signific
correl
found
e
wave
e
ratio
e
e
ratio
paop
ventil
patient
receiv
catecholamin
inclus
need
confirm
refut
result
annal
intens
care
suppl
introduct
central
venou
cathet
cvc
allow
infus
sever
drug
simultan
intens
care
unit
thank
use
yset
infus
line
mani
constraint
encount
manag
pediatr
popul
limit
infus
rate
accord
age
children
maximum
infus
volum
relat
weight
inde
limit
water
suppli
perform
hyperpermeabil
vessel
popul
optim
infus
set
therefor
essenti
improv
secur
support
main
object
evalu
infus
practic
identifi
optim
suggest
patient
method
observ
infus
line
cvc
conduct
month
decemb
march
pediatr
resuscit
depart
restitut
observ
carri
unit
form
work
group
optim
infus
setup
sever
propos
perfus
set
discuss
result
conduct
interview
nurs
last
approxim
min
accord
grid
compos
multiplechoic
question
openend
question
infus
line
observ
nurs
interview
nurs
staff
observ
concern
children
year
old
children
year
old
children
year
old
cvc
place
jugular
vein
femor
subclavian
trilumen
bilumen
monolumen
cvc
avail
port
use
infus
line
cvc
dress
chang
everi
day
soil
unstuck
nurs
declar
problem
dress
dress
big
younger
inadapt
burn
children
yet
sticki
drool
nurs
encount
drug
incompat
infus
cvc
survey
nurs
knew
exist
unit
drug
incompat
tabl
conclus
evalu
nurs
practic
highlight
good
knowledg
type
infus
line
compar
recommend
howev
effort
must
made
ration
number
line
avail
infus
set
integr
infus
devic
optim
geometri
limit
drug
incompat
discuss
medic
team
size
cathet
accord
child
weight
engag
smaller
dress
referenc
unit
modif
dess
chang
frequenc
consid
day
annal
intens
care
suppl
introduct
malnutrit
preval
children
admit
pediatr
intens
care
unit
picu
inadequaci
energi
intak
known
risk
factor
morbid
mortal
critic
children
sfar
et
de
publish
european
nutrit
guidelin
studi
aim
evalu
nutrit
practic
french
picu
compar
energi
protein
intak
use
sfar
recommend
american
recommend
identifi
risk
factor
inadequ
energi
intak
use
sfar
recommend
patient
method
studi
retrospect
one
picu
univers
hospit
children
age
one
month
eighteen
year
old
receiv
exclus
enter
nutrit
en
includ
patient
hospit
less
h
patient
fed
exclus
oral
parenter
rout
exclud
individu
energi
protein
intak
calcul
day
compar
sfar
recommend
satisfactori
energi
intak
consid
follow
equal
greater
sfar
recommend
intak
two
group
constitut
compar
identifi
risk
factor
patient
follow
sfar
recommend
optim
en
group
children
receiv
energi
recommend
maintain
least
half
icu
stay
optim
en
children
result
patient
involv
studi
malnutrit
admiss
occur
patient
averag
energi
intak
kcal
kg
day
repres
energi
estim
intak
sfar
recommend
schofield
equat
respect
energi
intak
receiv
closer
intak
estim
use
schofield
equat
recommend
sfar
figur
sfar
recommend
respect
patient
american
recommend
taken
board
patient
averag
protein
intak
g
kg
day
repres
intak
recommend
sfar
patient
optim
en
median
time
initi
en
longer
optim
en
group
vasopressor
identifi
risk
factor
meet
sfar
recommend
p
conclus
patient
respect
sfar
recommend
vasopressor
risk
factor
meet
sfar
recommend
american
recommend
use
schofield
equat
respect
patient
enter
feed
protocol
could
reduc
median
time
initi
en
support
annal
intens
care
suppl
introduct
fluid
overload
fo
common
pediatr
icu
particularli
septic
shock
cardiac
surgeri
respons
acut
kidney
injuri
decreas
ventilationfre
day
increas
length
stay
icu
gener
morbimort
predictor
hemodynam
intoler
hi
deplet
children
exist
knowledg
anoth
studi
show
calibr
abdomin
compress
cac
abl
predict
fluid
respons
children
acut
circulatori
failur
patient
method
primari
object
studi
determin
variat
stroke
volum
index
svi
cac
test
index
predict
hi
deplet
defin
decreas
cardiac
output
deplet
least
ml
kg
children
fo
conduct
prospect
nonintervent
studi
french
teach
hospit
cardiolog
icu
patient
eight
year
old
might
suffer
fo
need
deplet
diuret
select
includ
urin
ml
kg
less
two
hour
assess
svi
aortic
flow
veloc
integr
transthorac
echocardiographi
deplet
cac
deplet
record
hemodynam
paramet
consid
secondari
outcom
result
patient
includ
cardiac
surgeri
six
decreas
cardiac
output
deplet
area
curv
receiv
oper
curv
rocauc
test
index
ci
figur
median
valu
specif
sensit
posit
neg
predict
valu
respect
significantli
correl
deplet
r
ci
p
howev
respiratori
variat
aortic
blood
flow
peak
veloc
variat
central
venou
pressur
cvp
cac
appear
good
predictor
hi
deplet
rocauc
ci
ci
respect
figur
surprisingli
patient
shown
hi
deplet
profil
right
ventricular
failur
instead
expect
profil
hypovolemia
conclus
test
index
inconclus
predict
hi
deplet
children
admit
icu
variabl
like
chang
cvp
cac
seem
superior
annal
intens
care
suppl
introduct
intern
task
forc
chang
definit
sepsi
septic
shock
adult
use
organ
failur
score
name
sequenti
organ
failur
assess
sofa
concept
new
progress
multipl
organ
dysfunct
syndrom
npmod
correspond
organ
dysfunct
aggrav
propos
proxi
mortal
critic
diseas
mani
criteria
exist
defin
organ
dysfunct
proulx
criteria
goldstein
criteria
pediatr
logist
organ
score
pediatr
sofa
score
aim
studi
compar
four
definit
find
best
definit
npmod
could
use
surrog
outcom
pediatr
septic
shock
therapeut
trial
patient
method
retrospect
observ
studi
januari
decemb
singl
picu
inclus
criteria
age
year
hospit
picu
septic
shock
definit
primari
outcom
measur
picu
mortal
secondari
outcom
evalu
morbiditymort
use
evolut
pediatr
overal
perform
categori
popc
result
patient
includ
mean
age
year
year
patient
less
day
old
patient
die
fatal
rate
patient
signific
worsen
deltapopc
common
caus
septic
shock
mening
meningoenceph
purpura
fulminan
intraabdomin
infect
patient
develop
npmod
accord
proulx
criteria
accord
goldstein
criteria
psofa
four
definit
use
defin
npmod
significantli
associ
mortal
deltapopc
p
deceas
patient
score
worsen
first
five
day
score
improv
contrari
score
survivor
improv
within
first
day
whatev
definit
use
conclus
npmod
definit
could
surrog
outcom
mortal
usabl
pediatr
septic
shock
therapeut
trial
whether
use
proulx
goldstein
psofa
criteria
howev
definit
consid
onset
aggrav
organ
dysfunct
studi
would
need
creat
valid
altern
definit
incorpor
notion
nonimprov
organ
dysfunct
time
would
better
reflect
natur
cours
sever
patient
pediatr
septic
shock
annal
intens
care
suppl
introduct
electr
velocimetri
ev
noninvas
method
continu
left
cardiac
output
monitor
main
object
valid
ev
investig
agreement
cardiac
output
measur
perform
ev
transthorac
echocardiographi
patient
method
conduct
prospect
singlecent
pilot
studi
bed
pediatr
intens
care
unit
picu
includ
children
day
year
hemodynam
instabl
circulatori
failur
exclud
children
congenit
heart
diseas
imposs
chest
access
imposs
simultan
measur
cardiac
output
ev
echocardiographi
agreement
bia
precis
measur
analyz
method
bia
percentag
error
consid
clinic
accept
paramet
contractil
icon
ev
left
ventricular
eject
fraction
preload
depend
stroke
volum
variat
svv
ev
variat
aortic
blood
flow
veloc
echocardiographi
compar
result
patient
includ
median
age
year
median
weight
kg
measur
perform
analyz
bia
percentag
error
cardiac
output
measur
respect
correl
paramet
assess
contractil
left
ventricular
eject
fraction
echocardiographi
contractil
index
ev
r
p
evalu
preload
depend
variat
aortic
blood
flow
veloc
echocardiographi
svv
ev
r
p
conclus
ev
appear
reliabl
method
continu
co
monitor
compar
transthorac
echocardiographi
limit
contractil
preload
depend
paramet
cardioreap
studi
follow
pilot
studi
start
novemb
focu
children
annal
intens
care
suppl
introduct
kawasaki
diseas
kd
rare
acut
system
vascul
occur
mainli
children
year
age
major
challeng
cardiac
involv
may
requir
admiss
intens
care
unit
icu
lifethreaten
common
patient
requier
icu
meet
american
heart
associ
aha
criteria
vascular
damag
often
begin
complic
differenti
diagnosi
especi
infecti
challeng
risk
delay
treatment
case
intraven
immunoglobulin
ivig
patient
method
aim
studi
specifi
caracterist
outcom
patient
admit
icu
potenti
kd
complic
compar
patient
met
aha
criteria
aha
patient
aha
end
collect
nation
retrospect
case
et
follow
call
scholarli
associ
sofremip
gfup
collect
clinic
biolog
echocardiographi
data
comparison
base
fisher
exact
test
categor
variabl
student
ttest
continu
variabl
statist
analys
perform
use
prism
medcalc
test
twotail
p
consid
signific
result
patient
yet
kd
diagnos
admiss
icu
present
either
sepsi
includ
toxic
shock
syndrom
acut
abdomen
nearli
half
patient
receiv
vasoact
drug
patient
except
two
receiv
broadspectrum
antibiot
patient
receiv
least
one
ivig
infus
resist
first
ivig
infus
observ
patient
second
ivig
infus
chosen
third
treatment
line
need
iv
corticoid
infus
chosen
associ
antiinterleukin
anakinra
patient
kdicu
present
aha
criteria
compar
patient
aha
younger
lower
heamoglobin
concentr
intub
mechan
ventil
conclus
kdicu
patient
initi
evolut
differ
whether
complet
incomplet
aha
criteria
strong
suspicion
kd
icu
therefor
enough
initi
specif
therapeut
ivig
analysi
defin
phenotyp
patient
kdicu
target
earlier
compar
kd
need
icu
transfer
via
kawanet
french
databas
annal
intens
care
suppl
introduct
bronchiol
first
caus
hospit
infant
six
admit
pediatr
intens
care
unit
picu
develop
complic
relat
respiratori
distress
like
seizur
hyponatremia
aim
studi
describ
occurr
hyponatremia
bronchiol
infant
age
three
month
admit
picu
associ
morbid
patient
method
conduct
retrospect
studi
includ
infant
younger
month
admit
lyonfranc
picu
diagnosi
bronchiol
januari
april
children
previou
histori
signific
heart
diseas
neurolog
impair
exclud
studi
approv
ethic
committe
french
societi
intens
care
hyponatremia
defin
plasma
sodium
level
mmoll
time
picu
stay
test
use
compar
hyponatremia
group
nohyponatremia
group
pvalu
consid
signific
result
total
infant
includ
among
least
one
avail
natremia
valu
hyponatremia
occur
n
children
n
natremia
mmoll
age
vs
day
hyponatremia
group
p
weight
g
vs
g
p
similar
two
group
comparison
sever
factor
group
present
tabl
conclus
hyponatremia
occur
one
third
infant
younger
month
year
old
admit
picu
bronchiol
hyponatremia
associ
sever
factor
bronchiol
frequent
seizur
longer
length
picu
stay
hyponatremia
need
monitor
prevent
treat
accur
infant
sever
bronchiol
annal
intens
care
suppl
introduct
hyponatremia
common
fluid
electrolyt
disord
incid
estim
oper
children
hyponatraemia
occur
postop
period
object
determin
circumst
occurr
hyponatremia
patient
method
retrospect
studi
carri
pediatr
surgeri
multipurpos
resuscit
depart
chu
includ
acut
hyponatraemia
without
neurolog
symptomatolog
follow
control
surgeri
healthi
children
patholog
lead
fluid
electrolyt
disturb
result
hyponatraemia
identifi
studi
regardless
mechan
children
present
iatrogen
acut
hyponatremia
children
oper
circumcis
fractur
reduct
orthoped
surgeri
clubfoot
lch
thyrogloss
cyst
serum
sodium
rang
mmoll
mmo
l
patient
present
vomit
three
children
gener
seizur
brain
ct
found
diffus
cerebr
edema
evolut
favor
case
one
death
addit
anticonvuls
therapi
patient
treatment
hyponatremia
involv
administr
sodium
salt
rate
mmol
hour
pe
h
control
clinic
statu
ionogram
discuss
children
present
iatrogen
acut
hyponatremia
underw
simpl
surgeri
one
except
children
class
perfus
periop
period
hypoton
highthroughput
fluid
blood
glucos
moder
high
children
hypovolem
arriv
circumst
occurr
explain
bya
dilut
relat
infus
hypoton
solut
abund
flow
monitor
nurs
due
lack
personnel
prolong
preoper
fast
h
seri
may
accompani
hypovolemia
respons
secret
adh
compon
ad
iatrogen
factor
conclus
followup
good
practic
periop
pediatr
perfus
use
adapt
equip
precis
infus
pump
volumetr
pump
strict
control
infus
rate
educ
nurs
staff
perman
abandon
pseudo
prescript
type
keep
vein
fundament
avoid
type
ionic
disord
children
postop
annal
intens
care
suppl
introduct
traumatolog
triag
dynam
process
start
trauma
scene
includ
prehospit
care
continu
trauma
team
activ
trauma
center
requir
end
patient
admiss
adequ
unit
hospit
referr
sever
injur
children
level
pediatr
trauma
center
ptc
like
femm
enfant
hfme
lyon
franc
reduc
mortal
hfme
local
guidelin
establish
trauma
team
activ
prehospit
carrier
trauma
scene
emerg
physician
emerg
depart
level
criteria
vital
distress
level
criteria
vital
distress
stabil
prehospit
care
level
criteria
vital
distress
mechan
injuri
criteria
patient
method
conduct
retrospect
studi
patient
admit
hfme
trauma
team
activ
criteria
accord
local
guidelin
level
patient
level
patient
present
injuri
sever
score
iss
consid
sever
injur
four
type
undertriag
defin
differ
stage
support
prehospit
undertriag
transport
prehospit
undertriag
orient
emerg
depart
undertriag
final
undertriag
consid
main
undertriag
figur
result
eighti
eight
patient
sever
injur
rate
undertriag
respect
prehospit
undertriag
transport
prehospit
undertriag
orient
emerg
undertriag
final
undertriag
factor
associ
final
undertriag
firefight
prehospit
care
transport
without
medic
transport
team
intervent
median
iss
lower
final
undertriag
subgroup
versu
p
final
undertriag
associ
higher
death
rate
longer
hospit
stay
howev
patient
subgroup
requir
critic
care
within
h
admiss
conclus
rate
undertriag
ptc
recommend
less
prehospit
triag
seem
strongli
impact
cours
patient
care
evalu
traumat
child
complic
even
profession
firstaid
high
rate
emerg
depart
undertriag
show
triag
also
need
improv
emerg
depart
annal
intens
care
suppl
introduct
diaphragm
dysfunct
wean
induc
pulmonari
edema
wipe
two
main
caus
wean
failur
sinc
spontan
breathingincreas
venou
return
key
determin
wipe
hypothes
diaphragm
dysfunct
could
provid
thorac
depress
enabl
occurr
wipe
therefor
object
studi
determin
preval
wipe
diaphragm
dysfunct
coexist
patient
method
patient
intub
sinc
h
elig
fail
first
spontan
breath
trial
sbt
follow
sbt
diaphragm
function
evalu
refer
method
drop
tracheal
pressur
induc
bilater
phrenic
nerv
stimul
cardiac
echo
earli
e
late
peak
diastol
veloc
ratio
tissu
doppler
imag
mitral
annulu
veloc
includ
earli
ea
peak
diastol
veloc
wave
ratio
biolog
hemoconcentr
marker
wipe
search
diaphragm
dysfunct
defin
ptr
stim
wipe
defin
fail
sbt
associ
either
combin
e
e
ea
end
sbt
increas
plasma
protein
concentr
hemoglobin
sbt
result
among
patient
includ
twentyon
fail
sbt
wipe
present
patient
fail
diaphragm
dysfunct
found
patient
fail
mechan
present
patient
except
one
patient
patient
wipe
occur
diaphragm
dysfunct
found
figur
conclus
coexist
diaphragm
dysfunct
wipe
frequent
time
liber
mechan
ventil
difficult
wean
patient
presenc
diaphragm
dysfunct
reduc
risk
wipe
annal
intens
care
suppl
introduct
use
extracorpor
membran
oxygen
ecmo
adult
cancer
patient
controversi
studi
design
report
outcom
adult
cancer
patient
treat
ecmo
sever
acut
respiratori
distress
syndrom
ard
failur
optim
convent
therapi
also
identifi
preecmo
predictor
icu
mortal
patient
method
chart
cancer
patient
admit
oncolog
icu
receiv
ecmo
support
ard
retrospect
review
case
record
use
pmsi
data
analysi
computer
record
keyword
systemat
detect
placement
cannula
patient
transfer
hospit
special
icu
ecmo
therapi
result
fourteen
patient
receiv
ecmo
studi
period
tabl
one
patient
receiv
venoarterialven
ecmo
acut
circulatori
failur
addit
ard
patient
receiv
venoven
ecmo
ecmorel
major
bleed
ventilatorassoci
pneumonia
frequent
respect
respect
median
ecmo
durat
icu
stay
day
icu
surviv
four
survivor
significantli
shorter
time
interv
icu
admiss
start
ecmo
therapi
vs
day
lower
baselin
vs
mmhg
ecmo
initi
lower
health
careassoci
infect
vs
episod
shorter
ecmo
durat
vs
day
discuss
limit
studi
retrospect
design
small
number
case
involv
obviou
select
bia
induc
patient
treat
ecmo
includ
systemat
computer
analysi
ensur
lack
miss
data
despit
high
rate
icu
mortal
studi
show
survivor
still
aliv
month
later
earli
begin
ecmo
avoid
ventilatorinduc
lung
injuri
associ
better
prognosi
find
encourag
identifi
soon
possibl
patient
favor
prognosi
malign
isol
respiratori
failur
order
optim
chanc
recoveri
ard
close
cooper
intensivist
oncologist
warrant
conclus
ecmo
therapi
may
benefici
select
cancer
patient
ongo
investig
need
better
select
patient
like
benefit
determin
optim
time
initi
ecmo
annal
intens
care
suppl
introduct
dyspnea
frequent
potenti
intens
symptom
mechan
ventil
patient
whether
presenc
intens
dyspnea
could
interfer
result
spontan
breath
trial
sbt
unknown
altern
use
visual
assess
scale
dyspnea
challeng
critic
ill
patient
fiveitem
mechan
ventil
respiratori
distress
observ
scale
mvrdo
propos
reliabl
surrog
dyspnea
noncommun
intub
patient
present
studi
sought
describ
preval
chang
mvrdo
sbt
evalu
perform
mvrdo
predict
sbt
failur
patient
method
patient
singl
center
intub
sinc
h
elig
fail
first
spontan
breath
trial
sbt
dyspnea
assess
mvrdo
begin
end
sbt
dyspnea
defin
mvrdo
area
receiv
oper
characterist
roc
curv
mvrdo
measur
onset
sbt
comput
predict
risk
sbt
failur
result
thirtyf
patient
sbt
age
sap
ii
med
iqr
includ
total
sbt
analyz
patient
deem
readi
wean
criteria
posit
end
expiratori
pressur
respiratori
rate
cycl
min
dyspnea
present
begin
sbt
twentythre
sbt
lead
failur
consid
success
chang
mvrdo
patient
succeed
fail
sbt
depict
figur
proport
sbt
failur
higher
patient
present
dyspnea
begin
sbt
vs
p
mvrdo
valu
begin
sbt
predict
sbt
failur
sensit
specif
auc
ci
conclus
despit
patient
met
classic
readi
wean
criteria
dyspnea
frequent
begin
sbt
increas
patient
fail
sbt
mvrdo
could
predict
sbt
failur
good
perform
refer
gay
f
persichini
r
mayaux
j
c
similowski
demoul
mechan
distress
observ
scale
surrog
selfreport
dyspnoea
intub
patient
eur
respir
j
annal
intens
care
suppl
introduct
system
lupu
erythematosu
chronic
autoimmun
diseas
characteris
frequent
skin
joint
haematolog
renal
involv
acut
interstiti
pneumonia
aip
infrequ
poorli
investig
diseas
aim
studi
describ
clinic
characterist
cours
outcom
aip
sle
patient
method
conduct
monocentr
retrospect
observ
cohort
studi
novemb
septemb
includ
patient
sle
defin
use
american
colleg
rheumatolog
criterion
aip
defin
acut
respiratori
manifest
diffus
pulmonari
opac
chest
radiographi
lung
tomographi
exclus
altern
diagnosi
includ
acut
respiratori
infect
result
fourteen
patient
male
femal
sex
ratio
mean
sd
age
year
present
episod
includ
aip
present
diseas
onset
first
year
sle
diagnosi
respect
patient
eleven
episod
requir
icu
admiss
respiratori
failur
episod
requir
mechan
ventil
vvecmo
median
iqr
sapsii
sofa
score
icu
admiss
respect
frequenc
associ
slerel
organ
involv
kidney
arthriti
fever
seros
skin
haematolog
manifest
neurolog
manifest
median
iqr
k
bronchoalveolar
lavag
avail
episod
reveal
alveolar
haemorrhag
chest
tomographi
reveal
bilater
consolid
predomin
lower
part
lung
patient
sle
treatment
follow
corticosteroid
puls
cyclophosphamid
plasmapheresi
evolut
favour
patient
surviv
followup
one
patient
asymptomat
residu
lung
interstiti
opac
patient
normal
lung
ctscan
conclus
aip
rare
manifest
sle
occur
first
year
sle
onset
young
patient
aip
sle
sever
requir
mechan
ventil
even
ecmo
patient
usual
exhibit
multipl
slerel
organ
involv
mortal
cohort
low
patient
recov
complet
without
chronic
interstiti
lung
diseas
followup
annal
intens
care
suppl
introduct
sever
pneumonia
frequent
associ
acut
respiratori
distress
syndrom
ard
uncontrol
inflammatori
respons
lung
key
factor
transit
pneumonia
ard
howev
underli
mechan
still
poorli
understood
assess
heterogen
popul
lymphocyt
call
unconvent
cell
utc
deserv
greater
attent
cell
compris
natur
killer
nkt
cell
mucosalassoci
invari
cell
mait
gamma
delta
cell
preclin
studi
shown
versatil
properti
key
role
immun
respons
invad
pathogen
thu
hypothes
tight
regul
function
mandatori
finetun
host
inflammatori
respons
infect
lung
subsequ
prevent
emerg
aberr
respons
lead
tissu
damag
despit
strong
rational
human
data
howev
lack
patient
method
singlecent
prospect
studi
patient
hospit
intens
care
sever
pneumonia
blood
respiratori
sampl
perform
flow
cytometrybas
analysi
cell
order
determin
frequenc
differ
timepoint
hospit
presenc
activ
regul
marker
abil
produc
cytokin
involv
ard
pathogenesi
cytotox
capac
result
patient
includ
date
compar
healthi
control
half
patient
present
ard
median
sapsii
patient
sever
pneumonia
observ
strike
decreas
circul
mait
cell
compar
healthi
control
fig
nkt
gamma
delta
cell
observ
may
suggest
recruit
cell
inflammatori
site
sinc
high
proport
mait
cell
detect
respiratori
fluid
patient
ard
addit
circul
mait
cell
patient
express
high
level
fig
interestingli
proport
mait
cell
decreas
clinic
improv
proport
remain
stabl
upon
ex
vivo
stimul
proport
ifngammaproduc
mait
cell
significantli
decreas
patient
compar
healthi
control
fig
proport
tnfalphaproduc
mait
cell
similar
conclus
mait
cell
recruit
activ
alter
cytokin
profil
secret
sever
pneumonia
preliminari
data
justifi
pursu
indepth
analysi
mait
cell
function
patient
correl
clinic
condit
annal
intens
care
suppl
introduct
cancer
patient
present
arf
use
mechan
ventil
mv
frequent
associ
high
mortal
prevent
endotrach
intub
appear
crucial
step
therapeut
strategi
therapi
use
hfnc
offer
altern
patient
object
studi
determin
predict
factor
endotrach
intub
cancer
patient
present
de
novo
arf
firstli
treat
hfnc
intens
care
unit
icu
patient
method
retrospect
studi
conduct
cancer
referr
center
januari
end
data
record
consecut
critic
ill
cancer
patient
present
arf
treat
hfnc
two
group
compar
use
non
parametr
test
intub
patient
versu
independ
predict
factor
tracheal
intub
determin
use
logist
regress
result
two
hundr
nine
patient
present
de
novo
arf
final
select
analysi
icu
mortal
n
hospit
mortal
n
intub
rate
n
median
iqr
age
male
n
haematolog
diseas
present
n
case
multivari
analysi
factor
associ
tracheal
intub
pulmonari
infect
ic
viral
infect
ci
multidrug
resist
bacteria
infect
sap
ii
score
ci
nb
patholog
xchest
quadrant
hfnc
initi
ci
well
cardiolog
sofa
start
hfnc
ci
greater
start
hfnc
level
min
start
hnfc
ic
conclus
specif
popul
intub
rate
studi
intub
predictor
clinic
paramet
easili
collect
bedsid
order
improv
outcom
paramet
use
categor
high
risk
patient
annal
intens
care
suppl
introduct
venoarteri
ecmotr
patient
present
mani
risk
factor
breath
failur
associ
heart
failur
seem
essenti
optim
ventilatori
paramet
order
limit
lung
injuri
aim
studi
evalu
abil
electr
imped
tomographi
set
optim
level
posit
end
expiratori
pressur
peep
patient
method
perform
alveolar
recruit
maneuv
follow
decrement
peep
trial
decrement
thank
clinic
ultrasonograph
paramet
heart
lung
defin
optim
pep
accord
respiratori
criteria
peeplung
adjust
accord
hemodynam
cardiac
toler
defin
pepheart
lung
eit
data
region
distribut
ventil
zcomplianc
overdistens
collapsu
odcl
global
inhomogen
index
gi
record
procedur
analyz
retrospect
defin
optim
peep
peepcomp
peepodcl
peepgi
friedman
test
compar
differ
optim
peep
well
region
ventil
distribut
pep
level
agreement
peeplung
measur
peep
analyz
cohen
kappa
coeffici
result
patient
includ
analyz
month
period
peep
decreas
increment
ventil
ventral
region
correspond
overdistens
decreas
dorsal
region
reflect
collaps
collaps
cl
maximum
distens
maximum
signific
differ
differ
optim
peep
agreement
averag
peeplung
optim
peep
calcul
eit
paramet
kappa
choic
peeplung
question
base
global
static
respiratori
complianc
paramet
measur
singl
respiratori
cycl
measur
transpulmonari
pressur
could
precis
measur
peplung
statist
higher
pepheart
lung
p
reflect
bad
hemodynam
toler
high
level
peep
due
complex
phenomenon
interact
conclus
eit
help
find
best
compromis
overdistens
lung
collaps
detect
region
distribut
mechan
ventil
effect
howev
evalu
chosen
peep
hemodynam
toler
necessari
associ
eitechocardiographi
seem
effici
tool
provid
monitor
peep
effect
annal
intens
care
suppl
introduct
airway
pressur
ms
airway
occlus
assess
respiratori
drive
intens
measur
mouth
pulmonari
function
test
lab
icu
ventil
may
reflect
mouth
due
complianc
circuit
aim
compar
measur
evita
xl
icu
ventil
evita
airway
aw
esophag
es
pressur
icu
patient
spontan
breath
trial
patient
method
compar
pressur
support
ps
peep
treatment
ps
peep
automat
tube
compens
treatment
b
appli
min
treatment
baselin
ps
appli
min
paw
flow
measur
proxim
tip
endotrach
tube
pe
obtain
esophag
balloon
whose
right
posit
optim
volum
check
properli
three
ten
measur
perform
builtin
function
avail
evita
xl
ventil
separ
breath
condit
patient
evita
read
ventil
screen
paw
pe
flow
signal
record
valu
express
mean
sd
data
assess
use
bland
altman
represent
linear
mix
effect
model
use
assess
role
evita
valu
method
measur
rank
measur
condit
fix
variabl
patient
taken
random
variabl
result
eighteen
patient
includ
total
measur
es
discard
instanc
differ
patient
inaccuraci
evita
averag
aw
es
bia
limit
agreement
evita
aw
evita
es
respect
neither
method
use
rank
measur
condit
signific
effect
evita
tabl
conclus
evita
provid
reason
estim
measur
near
patient
annal
intens
care
suppl
introduct
classic
definit
cardiogen
shock
cs
combin
systol
blood
pressur
sbp
mmhg
low
cardiac
output
tissu
hypoperfus
contrast
practic
spectrum
present
far
complex
compar
present
prognosi
hypotens
normotens
low
cardiac
output
patient
patient
method
frenshock
multicent
prospect
observ
survey
realiz
center
franc
patient
includ
met
criteria
low
cardiac
output
sbp
mmhg
need
amin
low
cardiac
index
min
tte
swanganz
clinic
radiolog
biolog
ntprobnp
bnp
echocardiographi
invas
hemodynam
overload
sign
clinic
biolog
hypoperfus
lactat
mmoll
hepat
renal
failur
result
patient
includ
male
median
age
sbp
mmhg
group
proven
low
cardiac
output
without
hypotens
group
b
group
b
patient
chronic
renal
failur
idiopath
dilat
cardiomyopathi
previou
treatment
furosemid
cs
frequent
caus
drug
inobserv
less
marbl
lower
lvef
mitral
insuffici
higher
ph
without
signific
differ
lactat
treat
furosemid
vs
p
less
dobutamin
vs
p
norepinephrin
vs
p
epinephrin
vs
p
invas
mechan
ventil
vs
p
renal
replac
therapi
vs
p
circulatori
support
vs
p
differ
mortal
heart
transplant
vad
implant
observ
conclus
normotens
patient
low
cardiac
output
overload
hypoperfus
sign
present
similar
prognosi
classic
cs
current
definit
cs
could
challeng
avoid
underestim
patient
annal
intens
care
suppl
introduct
passiv
leg
rais
plr
routin
use
predict
preload
respons
critic
ill
patient
howev
realtim
measur
cardiac
output
requir
assess
effect
author
suggest
fluid
nonrespond
central
venou
pressur
cvp
increas
markedli
analog
cvp
rule
propos
weill
et
al
assess
fluid
challeng
hypothes
increas
cvp
mmhg
plr
predict
preload
unrespons
absenc
increas
integr
vti
flow
left
ventricular
outflow
tract
patient
method
critic
ill
patient
central
venou
cathet
place
physician
decid
test
preload
respons
plr
prospect
includ
transthorac
echocardiographi
perform
obtain
vti
cvp
vti
measur
plr
result
fortyseven
measur
perform
patient
mean
age
mean
sapsii
baselin
blood
lactat
level
mmoll
map
mmhg
cvp
mmhg
vti
cm
thirtynin
patient
receiv
norepinephrin
mean
dose
posit
respons
plr
found
case
increas
cvp
mmhg
measur
five
neg
respons
plr
found
case
increas
cvp
mmhg
measur
four
chang
cvp
plr
respond
nonrespond
differ
mmhg
mmhg
p
respect
correl
chang
cvp
chang
vti
r
p
found
neither
baselin
cvp
chang
plr
predict
preload
unrespons
area
receiv
oper
characterist
curv
ci
respect
fig
conclus
chang
cvp
plr
use
bedsid
predict
preload
unrespons
critic
ill
patient
refer
de
backer
vincent
jl
crit
care
mh
hen
rj
anesth
analg
annal
intens
care
suppl
introduct
adequ
tissu
perfus
postop
period
prioriti
cardiac
surgeri
insur
optim
cardiac
output
requir
obtain
among
other
volum
expans
howev
crucial
distinguish
patient
respond
fluid
challeng
improv
cardiac
output
inferior
vena
cava
ivc
diamet
variat
one
sever
indic
propos
predict
fluid
respons
howev
efficaci
indic
remain
controversi
studi
test
hypothesi
respiratori
variat
ivc
crosssect
surfac
could
better
predictor
fluid
respons
ivc
diamet
variat
patient
method
prospect
studi
mechan
ventil
patient
cardiac
surgeri
crystalloid
fluid
challeng
administ
period
time
collect
data
includ
puls
pressur
variat
respiratori
variat
ivc
diamet
respiratori
variat
ivc
crosssect
surfac
ivc
studi
subxyphoid
view
fluid
respons
defin
increas
cardiac
output
obtain
swanganz
cathet
continu
thermodilut
analys
perform
use
parametr
nonparametr
test
accord
variabl
distribut
abil
paramet
predict
fluid
respons
assess
use
roc
curv
result
popul
studi
consist
consecut
patient
age
year
male
main
type
surgeri
coronari
arteri
bypass
graft
valvular
surgeri
statist
differ
respond
nonrespond
static
paramet
includ
heart
rate
central
venou
pressur
minim
maxim
ivc
diamet
respiratori
variat
ivc
diamet
ivc
distens
index
unabl
predict
fluid
respons
show
area
roc
curv
auc
indic
discrimin
power
puls
pressur
variat
fair
auc
studi
best
predictor
fluid
respons
respiratori
variat
ivc
crosssect
surfac
auc
figur
conclus
novel
dynam
index
obtain
cyclic
variat
ivc
crosssect
surfac
could
candid
predict
fluid
respons
consist
previou
studi
ivc
diamet
fail
distinguish
fluid
respond
nonrespond
studi
fair
abil
puls
pressur
variat
predict
fluid
respons
could
explain
rapid
chang
patient
hemodynam
shown
signific
drop
system
vascular
resist
observ
fluid
challeng
annal
intens
care
suppl
introduct
tobacco
smoke
import
caus
prevent
death
worldwid
predispos
infect
alter
immun
system
object
investig
whether
smoke
statu
impact
morbid
mortal
patient
septic
shock
patient
method
retrospect
studi
conduct
medic
intens
care
unit
teach
hospit
mahdia
period
year
immunocompet
adult
septic
shock
includ
adopt
center
diseas
control
prevent
definit
current
smoker
smoke
cigarett
still
smoke
daili
quit
within
year
former
smoker
smoke
cigarett
quit
smoke
year
never
smoker
never
smoke
smoke
cigarett
lifetim
defin
two
group
tobacco
group
current
smoker
former
smoker
nonsmok
group
never
smoker
record
demograph
characterist
co
morbid
sapssii
score
smoke
statu
site
infect
length
stay
durat
mechan
ventil
mortal
result
total
patient
includ
mean
age
year
mean
sapsii
score
septic
shock
caus
communityacquir
infect
patient
sofa
score
first
day
shock
current
smoker
account
patient
former
smoker
repres
patient
patient
never
smoker
mortal
current
smoker
former
smoker
never
smoker
respect
patient
tobacco
group
older
versu
p
pulmonari
infect
common
tobacco
versu
p
nosocomi
acquir
infect
frequent
tobacco
group
versu
p
durat
mechan
ventil
length
stay
longer
tobacco
group
respect
day
versu
day
p
day
versu
day
p
signific
differ
mortal
tobacco
nonsmok
group
vs
p
multivari
analysi
factor
associ
mortal
age
ci
p
use
ventil
assist
ci
p
conclus
studi
smoke
statu
associ
mortal
patient
septic
shock
annal
intens
care
suppl
introduct
acut
respiratori
distress
syndrom
ard
prone
posit
pp
increas
cardiac
preload
effect
determin
system
venou
return
mean
system
pressur
pm
resist
venou
return
rvr
unknown
patient
method
includ
nineteen
patient
ard
decid
perform
pp
prior
pp
preload
reserv
assess
passiv
leg
rais
test
endexpiratori
occlus
test
hemodynam
measur
includ
cardiac
index
ci
central
venou
pressur
cvp
pm
rvr
interact
method
intraabdomin
pressur
iap
measur
semirecumb
supin
horizont
patient
min
start
pp
result
pp
significantli
increas
iap
mmhg
pm
mmhg
rvr
patient
ci
increas
pp
patient
preload
reserv
pmscvp
gradient
increas
rvr
patient
ci
increas
pp
ten
patient
preload
reserv
pp
pmscvp
gradient
chang
pp
three
patient
preloaddepend
baselin
pmscvp
gradient
increas
rvr
increas
transit
semirecumb
supin
horizont
posit
studi
patient
result
increas
pm
without
significantli
modifi
rvr
patient
preload
reserv
accompani
increas
pmscvp
gradient
ci
unlik
patient
without
preload
reserv
conclus
pp
increas
pm
cvp
rvr
iap
ci
increas
patient
preload
reserv
increas
rvr
less
increas
pmscvp
gradient
hemodynam
effect
pp
relat
increas
iap
transit
pp
also
increas
pm
transfer
semirecumb
posit
supin
horizont
posit
annal
intens
care
suppl
introduct
major
intens
care
unit
icu
usual
insert
central
venou
cathet
cvc
jugular
femor
site
use
ultrasound
guid
techniqu
sinc
recent
public
describ
benefit
use
ultrasoundguid
techniqu
subclavianvein
catheter
reduct
bloodstream
infect
subclavian
site
compar
jugular
femor
site
modifi
central
venou
cathet
insert
protocol
instead
privileg
femor
jugular
site
decid
implement
new
protocol
oper
consid
three
site
insert
femor
jugular
subclavian
take
account
clinic
paramet
coagul
disturb
result
ultrasound
first
look
visual
diamet
vein
object
studi
compar
number
cathet
place
subclavian
posit
two
period
rate
mechan
complic
patient
method
carri
observ
retrospect
monocentr
studi
intens
care
unit
amien
univers
hospit
may
novemb
first
period
jugular
femor
last
may
januari
second
period
jugular
femor
subclavian
februari
juli
procedur
cvc
adult
patient
includ
icu
cvc
procedur
report
patient
record
subclavian
vein
catheter
done
ultrasoundguid
longitudin
axi
jugular
femor
short
axi
result
three
hundr
forti
six
procedur
includ
first
period
protocol
modif
number
cathet
place
subclavian
site
greater
second
period
n
vs
p
reduct
jugular
vein
catheter
vs
p
choic
femor
site
stabl
vs
p
subclavian
vein
catheter
associ
increas
number
mechan
complic
hematoma
pneumothorax
arteri
punctur
number
malposit
significantli
greater
subclavian
group
n
vs
n
p
two
main
reason
choos
subclavian
site
coagul
disord
n
poor
visual
vessel
n
conclus
implement
ultrasoundguid
subclavian
catheter
possibl
associ
increas
mechan
complic
annal
intens
care
suppl
introduct
examin
characterist
prognost
valu
hypoproteinemia
icu
admiss
discharg
elderli
critic
ill
patient
patient
method
retrospect
studi
conduct
patient
year
januari
decemb
admit
sahloul
medic
icu
patient
divid
normal
moder
sever
hypoproteinemia
group
accord
serum
protein
level
analysi
includ
patient
characterist
age
gender
apacheii
sofa
score
characterist
pulmonari
infect
onset
pathogen
nutrit
support
length
stay
mortal
icu
discharg
analyz
result
fourtysix
patient
age
year
sex
ratio
f
investig
main
caus
admiss
acut
respiratori
failur
septic
shock
coma
mean
apach
ii
sofa
score
respect
twenti
patient
mechan
ventil
day
four
patient
tracheostomi
day
enter
nutrit
support
frequent
method
feed
day
discharg
patient
still
moder
sever
hyporoteinemia
p
highest
apach
ii
score
record
patient
moder
sever
hypoproteinemia
admiss
p
patient
moder
n
sever
n
hypoproteinemia
contract
pulmonari
infect
p
within
day
type
pathogen
signific
relat
level
hypoproteinemia
p
howev
trend
fungal
infect
observ
patient
candida
albican
candida
tropicali
candida
glabrata
mean
icu
lo
day
longer
among
patient
moder
sever
hypoproteinemia
day
versu
day
compar
patient
without
hypoproteidemia
day
p
mortal
icu
nine
patient
die
icu
moder
sever
hypoproteinemia
survivor
normal
serum
protein
level
p
mortal
icu
discharg
n
relat
patient
die
posticu
hypoproteinemia
discharg
statist
signific
p
conclus
hypoproteinemia
discharg
predictor
mortal
elderli
patient
admit
icu
serum
protein
level
admiss
use
index
observ
ill
sever
determin
prognosi
critic
ill
age
patient
annal
intens
care
suppl
introduct
fluid
administr
corner
stone
earli
sepsi
septic
shock
manag
normal
salin
may
induc
hyperchloraemia
howev
remain
controversi
whether
hyperchloraemia
associ
wors
outcom
set
patient
method
studi
prospect
multicent
observ
studi
adult
admit
one
particip
intens
care
unit
icu
septic
shock
receiv
vasopressor
infus
nonintub
includ
patient
chronic
dialysi
exclud
cumul
chlorid
dose
administ
within
first
h
septic
shock
manag
calcul
associ
high
dose
chlorid
administr
gram
chlorid
kidney
injuri
defin
increas
renal
sofa
score
first
day
rrt
renal
replac
therapi
requir
icu
intens
care
unit
stay
studi
betweengroup
differ
test
parametr
test
student
test
continu
variabl
chi
squar
test
categor
variabl
multivari
analysi
iptw
invers
probabl
treatment
weight
methodolog
perform
take
account
main
confound
result
total
patient
includ
one
year
studi
period
icu
admiss
mean
sofa
score
sd
mortal
n
consid
cumul
chlorid
infus
within
first
h
patient
receiv
gram
chlorid
iptw
signific
differ
use
rrt
patient
receiv
high
load
chlorid
versu
low
load
vs
rr
ci
p
differ
persist
kidney
injuri
group
vs
ci
p
univari
analysi
icu
length
stay
day
vs
day
p
mortal
vs
p
differ
group
conclus
cohort
patient
septic
shock
high
dose
chlorid
administ
within
first
h
manag
associ
renal
failur
rrt
requir
high
dose
chlorid
infus
also
associ
outcom
includ
mortal
therefor
resuscit
normal
salin
could
use
safe
set
annal
intens
care
suppl
introduct
baclofen
gabab
receptor
agonist
increasingli
use
manag
alcohol
depend
lead
increas
poison
preclin
clinic
studi
point
onset
withdraw
syndrom
follow
baclofen
cessat
baclofenpoison
patient
admit
intens
care
unit
withdraw
syndrom
rapidli
follow
toxic
intric
featur
difficult
diagnosi
object
character
baclofen
withdraw
rat
studi
revers
use
differ
common
drug
patient
method
studi
conduct
rat
model
pretreat
repeat
increas
dose
baclofen
mg
kg
time
daili
day
use
neurobehavior
locomot
anxieti
memori
test
electroencephalographi
eeg
use
markand
scale
investig
evid
withdraw
syndrom
effect
differ
treatment
topiram
diazepam
gammahydroxybutyr
ghb
baclofen
daili
administ
pharmacolog
dose
day
evidenc
peak
withdraw
syndrom
use
revers
deleteri
effect
result
baclofen
withdraw
result
mark
encephalographi
peak
grade
markand
scale
anxieti
p
signific
effect
locomot
memori
observ
topiram
diazepam
administr
led
revers
baclofen
withdrawalinduc
encephalopathi
ghb
administr
test
dose
result
addit
sign
toxic
conclus
baclofen
withdraw
respons
rat
mark
encephalopathi
possibl
benefici
revers
use
topiram
diazepam
howev
exact
molecular
mechan
involv
remain
investig
refer
markand
electroencephalographi
diffus
encephalopathi
j
clin
annal
intens
care
suppl
introduct
acut
ethanol
poison
repres
frequent
caus
admiss
emerg
depart
intens
care
unit
icu
franc
ethanol
theoret
abl
increas
serum
lactat
concentr
howev
hyperlactatemia
acut
ethanolpoison
patient
rare
report
exact
mechan
still
debat
aim
determin
preval
describ
etiolog
lactat
elev
follow
excess
ethanol
ingest
patient
method
conduct
retrospect
singlecentr
observ
studi
includ
patient
admit
icu
year
acut
drunken
defin
ethanol
concentr
g
l
absenc
signific
drug
coingest
present
hyperlactatemia
defin
lactat
concentr
mmoll
result
fiftyfour
patient
femal
male
median
age
year
interquartil
interv
past
histori
chronic
alcohol
includ
repres
patient
admit
acut
drunken
icu
period
patient
comatos
glasgow
coma
score
request
tracheal
intub
complic
includ
aspir
pneumonia
sepsi
cardiovascular
failur
vomit
seizur
hospitalacquir
infect
death
blood
ethanol
concentr
g
l
admiss
plasma
lactat
concentr
mmoll
admiss
peak
mmoll
signific
correl
paramet
respect
main
reason
increas
lactat
concentr
sepsi
hypovolemia
trauma
exist
underli
alcohol
cirrhosi
explain
hyperlactatemia
case
case
etiolog
except
ethanol
found
explain
hyperlactatemia
onset
patient
subset
peak
lactat
concentr
significantli
less
elev
mmoll
vs
mmoll
p
decreas
serum
bicarbon
limit
mmoll
vs
mmoll
p
conclus
acut
drunken
complic
hyperlactatemia
case
elev
serum
lactat
attribut
presenc
ethanol
bodi
metabol
investig
conduct
better
character
involv
mechan
one
hypothesi
disequilibrium
induc
ethanol
intracellular
nadh
nad
ratio
annal
intens
care
suppl
introduct
acut
poison
flecainid
antiarrhythm
drug
vaughanwilliam
classif
rare
may
respons
lifethreaten
consequ
object
report
featur
complic
manag
flecainid
poison
admit
intens
care
unit
icu
investig
prognost
contribut
plasma
flecainid
concentr
measur
admiss
patient
method
conduct
retrospect
singlecentr
observ
studi
includ
al
flecainid
poisonedpati
admit
icu
period
evidenc
least
one
plasma
flecainid
concentr
toxic
rang
plasma
flecainid
concentr
measur
use
liquid
chromatographi
coupl
mass
spectrometri
identif
predict
factor
death
perform
use
univari
analysi
test
requir
result
fortyeight
flecainidepoison
patient
male
femal
age
year
median
percentil
includ
patient
ingest
g
flecainid
includ
slowreleas
formul
admit
h
postingest
develop
cardiovascular
failur
membran
stabil
effect
ecg
plasma
flecainid
concentr
mg
l
icu
admiss
manag
includ
mechan
ventil
catecholamin
sodium
bicarbon
activ
charcoal
defibril
venoarteri
ecmo
ten
patient
die
base
univari
analysi
nonsurvivor
present
mark
hypotens
p
bradycardia
p
elev
plasma
lactat
concentr
p
elev
transaminas
p
decreas
serum
bicarbon
concentr
p
survivor
presum
ingest
dose
p
plasma
concentr
flecainid
admiss
p
significantli
correl
onset
death
conclus
flecainid
poison
respons
acut
cardiovascular
failur
due
membran
stabil
effect
lead
high
mortal
rate
plasma
flecainid
concentr
admiss
highli
predict
onset
death
bedsid
avail
strongli
encourag
identif
clinic
prognost
help
decid
implement
ecmo
flecainidepoison
patient
annal
intens
care
suppl
introduct
valproic
acid
vpa
overdos
caus
lifethreaten
disord
includ
hyperammonemia
hyperlactatemia
lcarnitin
use
sever
year
antidot
revers
vpa
toxic
without
evid
effect
aim
describ
featur
outcom
vpapoison
patient
admit
icu
investig
effect
lcarnitin
treatment
vpa
pharmacokinet
pk
contribut
patient
prognosi
patient
method
conduct
retrospect
singlecent
cohort
studi
consecut
patient
admit
icu
acut
vpa
intox
defin
presenc
compat
symptom
plasma
vpa
concentr
mg
l
februari
decemb
includ
lcarnithin
administ
accord
physician
charg
vpa
elimin
halfliv
determin
use
noncompartment
approach
populationbas
model
vpa
pk
individu
pharmacodynam
pd
obtain
effect
lcarnitin
investig
use
multivari
analysi
propens
score
match
studi
result
sixtynin
patient
includ
frequent
present
conscious
impair
multiorgan
failur
sofa
score
median
percentil
frequent
biolog
impair
increas
lactat
concentr
mmoll
patient
treat
lcarnithin
present
significantli
higher
peak
lactat
concentr
mmoll
vs
p
sever
neurolog
disord
vs
p
significantli
differ
vpa
concentr
howev
base
propens
score
approach
differ
associ
lcarnithin
administr
plasma
lactat
admiss
p
compar
match
lcarnithinetr
nontreat
patient
signific
benefit
lcarnithin
demonstr
use
differ
wors
admiss
valu
sofa
score
delay
plasma
lactat
normal
vpa
halflif
pharmacokinet
paramet
wellfit
populationbas
model
vpa
pk
overdos
ka
ke
halfliv
h
conclus
vpa
poison
respons
lifethreaten
featur
includ
hyperlactatemia
treatment
use
lcarnithin
alter
neither
vpa
elimin
patient
outcom
icu
pk
pd
model
appear
help
improv
manag
vpapoison
patient
allow
identif
condit
interindividu
variabl
annal
intens
care
suppl
introduct
acut
intox
common
reason
admiss
emerg
care
resuscit
servic
object
studi
determin
prognost
factor
relat
acut
intox
young
popul
patient
method
retrospect
studi
includ
acut
intox
admiss
intens
care
unit
year
epidemiolog
biolog
therapeut
paramet
collect
uni
follow
multivari
analysi
perform
determin
independ
factor
mortal
result
studi
period
patient
admit
intens
care
acut
intox
averag
age
year
old
intox
voluntari
order
commit
suicid
incrimin
toxic
drug
n
especi
psychotrop
drug
n
pesticid
n
chloralos
leader
n
accident
poison
carbon
monoxid
co
rank
first
n
clinic
pictur
domin
coma
n
digest
disord
n
igsii
apach
ii
admiss
sever
score
respect
stay
main
complic
inhal
pneumonia
case
rodenticid
poison
shock
case
drug
poison
rhabdomyolysi
case
co
poison
nosocomi
infect
observ
patient
therapeut
manag
mainli
symptomat
use
mechan
ventil
case
antibiot
case
vasoact
amin
case
overal
mortal
acut
poison
n
independ
mortal
factor
greater
score
p
apach
ii
occurr
hepat
cytolysi
p
acut
renal
failur
p
recov
cardiorespiratori
arrest
p
length
stay
day
p
conclus
although
mortal
acut
intox
low
essenti
rais
awar
danger
poison
certain
cardiotox
drug
also
legisl
sale
insecticid
product
annal
intens
care
suppl
introduct
minoxidil
commonli
use
treatment
androgen
alopecia
wrongli
consid
safe
sever
poison
case
mainli
pediatr
prove
ingest
millilit
lead
signific
intox
perspect
carri
illustr
differ
characterist
poison
order
emphas
graviti
wrongli
use
improv
manag
patient
method
observ
retrospect
studi
spread
nine
year
januari
septemb
toxicolog
icu
includ
patient
admit
acut
minoxidil
poison
result
studi
period
patient
elig
minoxidil
poison
account
acut
poison
requir
hospit
intens
care
unit
patient
age
year
one
patient
male
exposur
singledrug
accident
suppos
ingest
dose
unknown
case
delay
consult
h
ingest
gastrointestin
decontamin
perform
tachycardia
constant
averag
beat
per
minut
vomit
present
patient
nine
patient
present
hypotens
requir
crystalloid
resuscit
averag
ml
nine
patient
requir
vasopressor
support
norepinephrin
averag
mg
h
wean
delay
day
five
present
myocardi
suffer
decreas
st
segment
case
neg
wave
two
time
three
cardiogen
pulmonari
edema
averag
propnb
level
pg
ml
one
coronari
angiographi
immedi
one
antiischem
treatment
patient
perform
favor
discharg
icu
mean
length
stay
two
day
three
patient
suffer
cardiogen
edema
refer
cardiolog
depart
explor
conclus
shown
minoxidil
unsaf
product
vasodil
action
may
respons
prolong
tachycardia
profound
hypotens
requir
vasopressor
support
manufactur
enhanc
packag
secur
overthecount
avail
must
question
annal
intens
care
suppl
introduct
gammahydroxybutyr
acid
ghb
gammabutyrolacton
gbl
poison
report
increas
month
franc
ghb
anesthet
compound
classifi
schedul
iii
control
substanc
due
recreat
abus
potenti
use
sexual
assault
gbl
ghb
precursor
legal
market
solvent
although
respons
neurolog
toxic
abus
liabil
object
describ
clinic
featur
acut
ghb
gbl
poison
investig
predict
valu
plasma
ghb
concentr
admiss
studi
relationship
plasma
ghb
concentr
coma
depth
patient
method
conduct
retrospect
monocentr
observ
studi
includ
ghb
gblpoison
patient
admit
intens
care
unit
icu
year
januari
juli
plasma
ghb
concentr
measur
use
liquid
chromatographi
coupl
mass
spectrometri
determin
ghb
pharmacokinet
paramet
studi
correl
plasma
gb
concentr
coma
depth
admiss
model
relationship
plasma
gb
concentr
glasgow
coma
score
gc
poison
patient
possibl
result
one
hundr
thirteen
ghb
gblpoison
patient
femal
male
age
year
median
interquartil
interv
includ
increas
trend
observ
number
ghb
gbl
mainli
gbl
poison
icu
admiss
patient
present
deep
conscious
impair
gc
mark
hypotonia
osteotendin
reflex
abolit
myosi
mark
hypothermia
increas
plasma
creatinin
phosphokinas
ui
l
treatment
support
includ
mechan
ventil
outcom
favor
rapid
wakeup
short
hospit
h
three
major
complic
note
includ
aspir
pneumonia
rhabdomyolysi
withdraw
syndrom
signific
correl
coma
depth
plasma
ghb
concentr
observ
admiss
individu
model
gc
plasma
ghb
concentr
relationship
allow
recogn
role
ethanol
coingest
toler
acquisit
ghb
due
chronic
use
conclus
ghb
gbl
poison
increas
icu
lifethreaten
present
despit
wellfit
sigmoid
relationship
gc
ghb
concentr
individu
level
interindividu
variabl
express
ghbinduc
neurotox
exist
mainli
relat
ethanol
coingest
toler
acquisit
annal
intens
care
suppl
introduct
analgesia
essenti
compon
chest
trauma
manag
prevent
medic
complic
particularli
respiratori
one
serratu
plane
block
spb
recent
ultrasoundguid
region
anesthet
techniqu
prove
capabl
provid
effect
analgesia
chest
trauma
main
object
studi
assess
feasibl
spb
nonanesthesiologist
physician
patient
method
cadaver
feasibl
studi
conduct
anatomi
lab
faculti
medicin
lyon
est
particip
physician
voluntari
special
emerg
medicin
perform
one
spb
corps
inject
methylen
blue
solut
pleura
previous
fill
eosin
red
solut
primari
endpoint
success
block
composit
item
correct
identif
anatomi
respect
safeti
rule
pleural
punctur
aspir
red
solut
valid
procedur
check
ultrasound
anatom
dissect
presenc
methylen
blue
solut
anatom
space
latissimu
dorsi
serratu
anterior
result
twelv
emerg
physician
particip
studi
militari
one
doctor
realiz
one
spb
spb
success
obtain
result
summar
tabl
pleural
punctur
conclus
studi
show
spb
achiev
emerg
physician
easi
safe
anesthet
block
provid
effect
analgesia
chest
trauma
dissemin
emerg
depart
prehospit
set
would
improv
earli
multimod
analgesia
includ
absenc
avail
anesthetist
annal
intens
care
suppl
introduct
eclampsia
seriou
complic
preeclampsia
obstetr
emerg
signific
morbid
mortal
occur
childbirth
studi
aim
describ
epidemiolog
clinic
profil
women
eclampsia
gynecolog
obstetr
depart
oran
ehu
patient
method
carri
singlecentr
prospect
studi
includ
women
treat
eclampsia
obstetr
gynecolog
depart
oran
ehu
level
matern
period
one
year
januari
decemb
result
case
eclampsia
record
period
incid
eclampsia
occur
antepartum
case
postpartum
postpartum
eclampsia
convuls
first
h
other
occur
late
day
day
even
day
epidemiolog
profil
young
woman
year
old
primipara
follow
patient
develop
complic
mostli
hellp
syndrom
patient
variou
treatment
put
place
magnesium
sulphat
nicardipin
alpha
methyl
dopa
nifedipin
main
rout
deliveri
caesarean
section
gener
anesthesia
studi
deplor
matern
death
perinat
death
discuss
eclampsia
becom
rare
complic
develop
countri
thank
earli
manag
one
main
sign
preeclampsia
hand
surveil
pregnanc
qualifi
health
staff
screen
pregnanc
risk
inform
patient
made
possibl
make
patholog
regress
howev
remain
common
develop
countri
seri
preval
almost
constant
subsaharan
africa
conclus
improv
prognosi
eclampsia
rest
mainli
detect
earli
diagnosi
sever
form
earli
adequ
care
well
avail
multidisciplinari
team
annal
intens
care
suppl
introduct
cerebr
venou
sinu
thrombosi
cvst
follow
cranial
trauma
constitut
rare
seriou
clinicopatholog
entiti
describ
literatur
along
lack
consensu
regard
diagnosi
manag
aim
studi
point
incid
cvst
head
trauma
clinic
present
cours
patient
method
retrospect
descript
studi
conduct
intens
care
unit
icu
habibbourguiba
univers
hospit
sfax
tunisia
januari
decemb
patient
victim
polytrauma
studi
period
enrol
underw
fullbodi
comput
tomographi
ct
addit
ct
mri
angiographi
perform
patient
present
radiolog
suspicion
cvst
result
studi
period
patient
admit
icu
depart
polytrauma
among
patient
includ
patient
diagnosi
post
traumat
cvst
sex
ratio
mean
age
icu
admiss
mean
sapsii
mean
sofa
score
caus
trauma
domin
traffic
injuri
patient
mean
glasgow
coma
scale
score
median
extracrani
injuri
found
patient
brain
ct
scan
present
subarachnoid
hemorrhag
patient
basilar
skull
fractur
patient
cranial
vault
fractur
patient
cerebr
contus
patient
subdur
hematoma
patient
extradur
hematoma
patient
diffus
axon
injuri
patient
cstv
diagnos
fortuit
fullbodi
ct
patient
case
diagnos
mri
control
ct
angiographi
csvt
locat
transvers
sinus
patient
intern
jugular
vein
patient
superior
sagitt
sinu
patient
cavern
sinu
patient
intraven
unfraction
heparin
use
patient
mean
dose
mg
mg
per
day
rang
mg
low
molecular
weight
heparin
use
patient
delay
anticoagul
day
rang
day
outcom
favor
patient
conclus
although
head
trauma
rare
caus
cvst
consid
head
traumat
patient
develop
symptom
increas
intracrani
pressur
date
initi
anticoagul
still
matter
debat
risk
worsen
traumat
haemorrhag
annal
intens
care
suppl
introduct
hyponatremia
defin
serum
sodium
meq
l
common
electrolyt
abnorm
traumat
brain
injuri
tbi
also
independ
predictor
poor
neurolog
outcom
encount
hyponatremia
frequent
practic
therefor
decid
review
data
center
estim
incid
hyponatremia
analys
incid
impact
outcam
patient
admit
tbi
intens
care
unit
patient
method
retrospect
studi
conduct
period
year
januari
decemb
polyval
reanim
set
bed
patient
postraumat
head
injuri
develop
hyponatremia
serum
sodium
mmoll
first
h
stay
includ
hyponatremia
devid
mild
na
moder
na
sever
hyponatremia
na
epidemiolog
clinic
evolutionari
data
collect
descript
analyt
statist
studi
conduct
result
two
hundr
twenti
one
patient
includ
came
road
accid
averag
age
year
male
sex
predomin
percentag
eighti
seven
percent
patient
present
mild
hyponatremia
wherea
moder
hyponatremia
develop
sever
hyponatremia
patient
moder
hyponatremia
experienc
longer
ventilatorfre
day
vs
longer
intens
care
unit
stay
vs
less
favor
outcom
compar
patient
mild
hyponatremia
howev
differ
signific
conclus
studi
show
elev
frequenc
hyponatremia
patient
brain
injuri
icu
demand
effect
approach
accur
time
diagnosi
electrolyt
disord
studi
need
determin
optim
manag
strategi
tbiassoci
hyponatremia
intens
care
unit
set
annal
intens
care
suppl
introduct
terrorist
threat
franc
real
differ
form
attack
challeng
train
numer
nonspeci
caregiv
differ
background
damag
control
dc
strategi
purpos
work
propos
specif
train
program
provid
standard
care
ambiti
goal
zero
avoid
death
patient
method
task
forc
civilian
militari
physician
expert
tactic
medicin
medic
train
met
h
session
propos
construct
dc
train
program
nonspeci
caregiv
result
dc
train
program
exist
alreadi
heterogen
mainli
theoret
almost
physician
task
forc
identifi
hole
exist
train
program
name
damag
control
terrorist
attack
victim
dctav
propos
identifi
train
target
caregiv
physician
nurs
nurs
assist
prehospit
hospit
staff
trauma
experi
train
object
improv
individu
collect
skill
dc
strategi
manag
terrorist
attack
casualti
tool
select
train
concern
elearn
dedic
digit
teach
platform
includ
core
section
modul
type
mechan
injuri
basic
dc
techniqu
triag
organ
emerg
medic
respons
complementari
modul
doctor
dc
resuscit
dc
surgeri
handson
workshop
procedur
simul
full
scale
simul
exercis
technic
tourniquet
hemostat
gauz
needl
thoracostomi
chest
tube
drainag
manag
airway
coniotomi
nontechn
leadership
commun
coordin
triag
decisionmak
appropri
use
resourc
skill
feasibl
pilot
studi
propos
rural
area
trauma
center
univers
hospit
final
evalu
dctav
plan
use
tool
use
train
conclus
dctav
program
ambiti
civilianmilitari
nation
longterm
program
base
harmon
standard
care
includ
multidimension
train
annal
intens
care
suppl
introduct
despit
increas
organ
donat
hundr
patient
die
wait
list
everi
year
one
solut
suggest
agenc
de
la
abm
develop
organ
donat
nonheart
beat
donor
nhbd
particularli
nhbd
categori
iii
maastricht
classif
nhbd
allow
sinc
chang
french
law
program
launch
abm
want
initi
organ
donat
nhbd
miii
hospit
chu
besancon
order
increas
graft
pool
patient
die
brain
death
patient
organ
donor
dbd
hospit
patient
method
perform
retrospect
analysi
death
follow
withdraw
life
sustain
support
treatment
wlst
intens
care
unit
icu
use
data
medic
record
primari
endpoint
identifi
mani
patient
could
nhbd
elig
criteria
death
icu
wlst
age
year
major
brain
damag
hope
recoveri
exclud
patient
present
contraind
organ
donat
result
patient
die
wlst
year
old
less
exclud
patient
patient
cancer
patient
multipl
organ
failur
patient
die
wlst
patient
brain
injur
patient
could
nhbd
median
age
men
caus
brain
damag
patient
post
anox
encephalopathi
subarachnoid
hemorrhag
patient
brain
trauma
examin
medic
record
suggest
patient
could
donat
kidney
patient
could
donat
liver
base
data
day
death
patient
die
h
wlst
patient
uncontrol
infect
left
potenti
kidney
donor
potenti
liver
donor
conclus
patient
identifi
potenti
nhbd
chu
besancon
addit
dbd
data
show
patient
young
good
health
suggest
great
qualiti
graft
despit
potenti
warm
ischem
injuri
due
nhbd
posit
experi
hospit
sinc
encourag
us
initi
program
annal
intens
care
suppl
introduct
transcrani
doppler
tcd
noninvas
examin
allow
velocimetr
studi
intracrani
vessel
via
ultrasound
beam
author
propos
studi
statist
therapeut
impact
tcd
trauma
coma
databank
tcdb
data
coupl
moder
cranial
trauma
ed
patient
method
prospect
studi
includ
patient
year
old
moder
head
injuri
gc
initi
admit
vital
emerg
room
immedi
benefit
craniocerebr
ct
dtc
within
h
postadmiss
without
respiratori
hemodynam
distress
without
gasometr
anomali
normal
absenc
anemia
tdm
allow
distinguish
class
trauma
coma
databank
measur
dtp
consid
stabl
pattern
ten
cardiac
cycl
paramet
measur
systol
velocimetri
sv
mean
velocimetri
mv
diastol
velocimetri
dv
well
pulsatil
index
pi
cerebr
perfus
pressur
deduc
equat
map
x
dv
mv
data
collect
concern
demograph
data
vital
paramet
neurolog
deterior
statist
analysi
univari
p
result
patient
includ
studi
divid
two
group
group
n
without
neurolog
deterior
group
n
neurolog
deterior
mean
age
two
group
year
sex
ratio
group
group
averag
initi
gc
group
group
patient
group
tcdb
tcdb
group
patient
tcdb
patient
tcdb
pi
group
pi
group
statist
perform
dtc
ctdb
dtc
ctdb
coupl
occurr
neurolog
worsen
illustr
follow
tabl
conclus
coupl
dtc
tcdb
data
would
increas
statist
predict
perform
earli
neurolog
deterior
high
sensit
specif
vpn
would
also
guid
intens
neuroresuscit
result
confirm
larger
cohort
annal
intens
care
suppl
introduct
immun
system
play
central
role
surveil
neoplasm
develop
develop
research
project
investig
impact
sepsisinduc
immun
dysfunct
malign
tumor
growth
sepsisthencanc
model
like
sepsisinduc
immun
suppress
promot
tumor
growth
cancerthensepsi
model
sepsi
may
rather
inhibit
tumor
growth
herein
investig
sepsi
tolllik
receptor
tlr
signal
may
promot
antitumor
function
cytotox
natur
killer
nk
cell
lymphocyt
patient
method
use
j
wildtyp
wt
mice
mice
first
subcutan
inocul
fibrosarcoma
cell
fourteen
day
later
mice
subject
septic
challeng
polymicrobi
sepsi
induc
cecal
ligat
punctur
clp
endotoxin
shock
induc
intraperiton
lipopolysaccharid
lp
inject
main
function
tumorassoci
cytotox
nk
cell
assess
flow
cytometri
intracellular
express
interferongamma
ifn
cytotox
molecul
perforin
granzym
well
outer
membran
express
degranul
marker
order
address
cytotox
function
vitro
nk
cell
isol
septic
control
mice
expos
tumor
cell
result
polymicrobi
sepsi
dampen
tumor
growth
wt
mice
neither
counterpart
similar
tumor
growth
inhibit
observ
follow
lp
challeng
wt
mice
distribut
tumorinfiltr
nk
cell
weakli
affect
sepsi
undergo
signific
function
chang
among
nk
cell
lp
induc
expans
cytotox
subset
along
increas
express
activ
marker
tumorinfiltr
nk
cell
obtain
septic
mice
exhibit
enhanc
antitumor
properti
nk
cell
obtain
clpoper
mice
display
increas
express
ifn
behaviour
nk
cell
obtain
lpschalleng
mice
consist
activ
degranul
process
suggest
increas
membran
express
along
decreas
intracellular
express
perforin
granzym
express
low
cell
similar
cell
antitumor
properti
nk
cell
obtain
septic
mice
exacerb
cultur
cell
conclus
sepsi
promot
main
antitumor
function
nk
cell
cancer
mice
result
point
critic
regulatori
role
set
annal
intens
care
suppl
introduct
date
maintain
fibrinogen
level
g
l
recommend
therapeut
target
postpartum
hemorrhag
howev
time
fibrinogen
supplement
still
controversi
purpos
retrospect
studi
describ
experi
earli
administr
fibrinogen
concentr
sever
pph
patient
method
analyz
databas
patient
need
fibrinogen
concentr
transfus
treatment
sever
postpartum
hemorrhag
cesarean
deliveri
treat
coagulopathi
plasmat
fibrinogen
gl
massiv
transfus
earlier
result
plasmat
concentr
fibrinogen
patient
divid
two
group
group
e
earli
receiv
fibrinogen
concentr
within
first
hour
deliveri
group
l
late
receiv
fibrinogen
transfus
later
h
assess
blood
loss
transfus
requir
result
demograph
paramet
age
weight
patient
height
gestiti
pariti
preoper
hemostat
statu
compar
group
blood
loss
correl
delay
fibrinogen
administr
fig
pearson
correl
coeffici
mean
blood
loss
ml
group
e
n
versu
ml
group
l
n
p
red
blood
cell
transfus
requir
unit
patient
group
e
versu
group
l
p
need
fresh
frozen
plasma
unit
patient
group
e
versu
group
l
p
discuss
fidel
studi
prospect
multi
centric
french
studi
whose
result
yet
publish
may
give
answer
best
time
fibrinogen
concentr
infus
sever
pph
conclus
earli
administr
fibrinogen
within
first
hour
follow
deliveri
may
reduc
bleed
sever
postpartum
hemorrhag
transfus
requir
annal
intens
care
suppl
introduct
venou
thromboembol
event
vte
often
silent
complic
burn
patient
strongli
associ
poor
outcom
previou
research
shown
burn
injuri
size
tbsa
weight
affect
enoxaparin
dose
burn
aim
studi
assess
hypotheti
burn
treat
enoxaparin
vte
prophylaxi
achiev
adequ
anti
factor
xa
level
antixa
initi
dose
impact
reduc
vte
patient
method
studi
conduct
burn
center
tuni
februari
septemb
acut
burn
patient
admit
burn
center
anticip
nonambulatori
greater
h
includ
exclud
patient
contraind
use
enoxaparin
includ
intracrani
bleed
hemorrhag
stroke
within
h
neurotrauma
suspect
proven
bleed
creatinin
clearanc
ml
mn
creat
mgdl
enrol
patient
receiv
enoxaparin
follow
enoxaparin
dose
mg
x
tbsa
x
weight
kg
peak
antixa
obtain
h
third
enoxaparin
dose
dose
enoxaparin
titrat
achiev
recommend
antixa
ml
result
burn
patient
includ
mean
age
year
ratio
sex
averag
tbsa
bodi
weight
kg
fourteen
patient
reach
antixa
target
initi
patient
antixa
target
patient
antixa
targetth
median
final
enoxaparin
dose
mg
rang
mg
patient
antixa
target
compar
studi
group
patient
antixa
target
initi
target
follow
tabl
episod
hemorrhag
thrombocytopenia
heparinassoci
allergi
document
studi
patientsvt
occur
patient
among
case
patient
antixa
target
initi
conclus
enoxaparin
dose
equat
burn
allow
reach
prophylact
initi
antixa
level
associ
low
incid
vte
event
bleed
complic
enoxaparin
dose
correl
strongli
burn
size
patient
weight
clearanc
creatinin
thu
standard
dose
adult
acut
burn
patient
recommend
refer
farakla
al
j
trauma
annal
intens
care
suppl
introduct
thrombot
thrombocytopen
purpura
ttp
element
thrombot
microangiopathi
tma
syndrom
caus
sever
defici
activ
lead
spontan
format
thrombi
microcircul
earli
ttp
recognit
critic
diseas
almost
alway
lethal
treat
promptli
plasma
exchang
dosag
unavail
routin
score
develop
help
differenti
ttp
tma
aim
work
studi
accuraci
diagnost
score
icu
set
patient
method
perform
coppo
plasmic
score
studi
cohort
tma
patient
admit
univers
hospit
icu
result
present
median
interquartil
rang
number
ttp
nonttp
group
compar
use
nonparametr
test
roc
curv
establish
score
confid
interv
auc
determin
use
delong
bootstrap
method
multivari
logist
regress
analysi
perform
result
studi
period
patient
tma
requir
icu
admiss
includ
ttp
nonttp
patient
hematolog
sign
pronounc
ttp
group
hemoglobin
rate
gdl
vs
gdl
p
platelet
rate
l
vs
l
p
ttp
patient
renal
involv
less
sever
creatinin
l
vs
l
p
neurolog
involv
preval
vs
p
nonttp
patient
mortal
rate
ttp
patient
versu
nonttp
patient
p
auc
roc
curv
predict
ttp
coppo
score
plasmic
score
thrombocytopenia
alon
figur
result
confirm
adjust
confound
use
multivari
logist
regress
compar
calibr
varianc
explain
model
conclus
cohort
sever
tma
patient
requir
icu
admiss
plasmic
score
limit
perform
diagnosi
ttp
perform
coppo
score
good
similar
singl
highli
discrimin
item
platelet
count
annal
intens
care
suppl
introduct
new
definit
sepsi
septic
shock
base
sofa
score
qsofa
score
emerg
studi
conduct
gener
popul
demonstr
sofa
score
accur
sir
score
predict
hospit
mortal
infect
patient
requir
intens
care
howev
nowaday
oncolog
popul
one
studi
shown
new
definit
predict
hospit
mortal
reliabl
gener
popul
patient
method
analyz
record
cancer
patient
admit
infect
oncolog
icu
calcul
sofa
qsofa
sir
score
tri
determin
accur
score
predict
hospit
mortal
also
compar
new
old
definit
septic
shock
final
analyz
prognost
factor
hospit
mortal
result
studi
includ
patient
solid
tumor
metastasi
hematolog
malign
allograft
hospit
mortal
rate
patient
septic
shock
accord
new
definit
accord
old
definit
patient
sofa
score
increas
point
sinc
admiss
icu
qsofa
sir
score
sofa
score
reach
best
diagnost
perform
predict
hospit
mortal
area
roc
curv
auc
compar
auc
qsofa
sir
score
multivari
analysi
higher
sofa
score
higher
qsofa
score
predict
poor
prognosi
odd
ratio
per
onepoint
increas
ci
ci
respect
complet
remiss
cancer
good
prognost
factor
hospit
mortal
ci
conclus
new
definit
sepsi
septic
shock
usabl
icu
oncolog
popul
reliabl
similar
report
gener
popul
oncolog
patient
admit
icu
suspect
infect
sofa
score
accur
qsofa
sir
score
predict
hospit
mortal
annal
intens
care
suppl
introduct
due
evolut
demographi
surgic
manag
elderli
oncolog
patient
evolv
steadili
popul
preoper
benefitrisk
balanc
remain
difficult
establish
main
object
studi
evalu
longterm
mortal
associ
risk
factor
cancer
patient
year
undergo
major
abdomin
pelvic
surgeri
systemat
admit
intermedi
care
unit
imc
intens
care
unit
icu
patient
method
perform
observ
retrospect
monocentr
cohort
studi
imc
icu
paoli
calmett
institut
marseil
march
april
cancer
patient
age
undergo
abdomin
pelvic
surgeri
includ
univari
multivari
cox
analysi
mortal
perform
result
patient
met
inclus
criteria
analyz
median
age
year
colorect
surgeri
account
n
intervent
splenic
pancreat
surgeri
n
hepat
surgeri
n
urolog
surgeri
n
gynecolog
surgeri
n
gastric
surgeri
n
median
durat
followup
month
ci
mortal
observ
period
n
ci
univari
analysi
risk
factor
associ
mortal
score
asa
p
preoper
malnutrit
p
preoper
cognit
disord
p
emerg
surgeri
p
intraop
vasopressor
p
cur
surgeri
associ
better
longterm
surviv
p
type
cancer
type
surgeri
metastat
diseas
influenc
longterm
mortal
use
multivari
analysi
five
factor
associ
prognosi
histori
diabet
p
cognit
disord
p
preoper
malnutrit
p
intraop
vasopressor
p
cur
natur
surgeri
associ
better
surviv
p
conclus
longterm
surviv
major
oncolog
surgeri
may
consid
patient
year
even
though
cur
natur
surgeri
remain
determin
factor
work
strongli
highlight
import
comorbid
context
view
data
preoper
optim
within
framework
specif
prehabilit
protocol
must
evalu
prospect
preoper
optim
within
framework
specif
prehabilit
protocol
must
prospect
evalu
annal
intens
care
suppl
introduct
incid
cancer
constantli
increas
surviv
critic
ill
cancer
patient
improv
past
decad
data
scarc
regard
biliari
sepsi
septic
shock
ohp
bssohp
main
object
studi
evalu
hospit
mortal
well
associ
factor
context
bssohp
patient
method
observ
retrospect
monocentr
studi
includ
patient
novemb
octob
describ
two
group
patient
group
consist
ohp
control
group
noncanc
patient
present
bssohp
icu
admiss
periop
paramet
collect
well
performan
statu
ps
karnofski
score
stage
malign
hospit
discharg
year
statist
univari
multivari
analysi
use
logist
regress
p
consid
signific
result
ohp
hospit
mortal
n
mortal
n
control
group
n
n
respect
ohp
use
multivari
analysi
factor
independ
associ
hospit
mortal
sapsii
ci
renal
replac
treatment
ci
biliari
esbl
endoscopi
ci
presenc
duoden
stenosi
ci
factor
associ
mortal
presenc
metastasi
ci
ps
ci
sapsii
ci
biliari
procedur
p
ci
surgeri
biliari
drainag
ci
associ
good
prognosi
year
n
survivor
continu
receiv
chemotherapi
n
radiotherapi
n
remiss
diseas
physic
statu
quiet
conserv
karnofski
score
iqr
ps
n
year
survivor
final
n
palli
care
conclus
hospit
mortal
low
organ
failur
esbl
document
difficulti
biliari
drainag
major
factor
shortterm
outcom
malign
seem
affect
longterm
mortal
annal
intens
care
suppl
introduct
acut
respiratori
failur
arf
sever
lifethreaten
complic
oncohematolog
patient
arf
frequent
mix
associ
lesion
cardiogen
edema
surviv
benefit
niv
could
harder
demonstr
may
balanc
chang
ventil
strategi
select
strategi
differ
accord
arf
etiolog
sever
niv
valid
acut
cardiac
pulmonari
edema
acut
exacerb
chronic
obstruct
pulmonari
diseas
decreas
intub
mortal
rate
opposit
highflow
oxygen
nasal
cannula
hfnc
valid
context
de
novo
arf
data
niv
cancer
patient
mix
arf
lack
aim
studi
assess
prognost
factor
includ
ventil
strategi
associ
intens
care
unit
icu
mortal
patient
method
conduct
observ
retrospect
studi
institut
paolicalmett
cancerreferr
center
critic
ill
cancer
patient
mix
arf
analyz
factor
associ
icu
mortal
use
univari
multivari
match
propens
score
analysi
evalu
result
icu
hospit
mortal
initi
ventil
strategi
icu
admiss
consist
mechan
ventil
mv
other
patient
receiv
noninvas
ventil
niv
associ
oxygen
high
flow
nasal
oxygen
hfno
hfno
alon
standard
oxygen
icu
stay
patient
requir
intub
multivari
analysi
identifi
independ
factor
associ
icu
mortal
sapsii
admiss
point
ci
p
invas
fungal
infect
ci
p
initi
ventil
strategi
p
compar
niv
hfno
alon
standard
oxygen
alon
associ
increas
icu
mortal
respect
p
p
subsequ
realiz
propens
score
analysi
includ
match
patient
niv
arm
receiv
ventil
strategi
exclud
initi
mv
patient
icu
mortal
rate
significantli
lower
patient
treat
niv
versu
patient
receiv
ventil
strategi
p
conclus
oncohematolog
patient
present
mix
arf
sever
icu
admiss
invas
fungal
infect
initi
ventil
strategi
independ
associ
icu
mortal
niv
protect
factor
icu
mortal
niv
evalu
mix
arf
cancer
patient
annal
intens
care
suppl
introduct
defin
prognost
factor
mortal
critic
ill
patient
admit
intens
care
unit
acut
pancreat
patient
method
retrospect
singlecent
studi
two
intens
care
unit
caen
univers
hospit
januari
decemb
patient
admit
acut
pancreat
includ
patient
isol
high
level
lipasemia
extrapancreat
diseas
respons
acut
ill
cardiopulmonari
arrest
polytrauma
secondarili
exclud
demograph
clinic
biolog
data
well
differ
characterist
pancreat
defin
accord
revis
atlanta
classif
pancreat
inducedcompl
icu
stay
collect
result
one
hundr
two
patient
includ
among
medic
intens
care
surgic
intens
care
unit
respect
overal
mortal
deceas
patient
pancreat
classifi
sever
sofa
score
admiss
significantli
lower
survivor
nonsurvivor
respect
iq
p
ig
ii
score
also
significantli
lower
among
survivor
among
nonsurvivor
mortal
rate
similar
patient
without
necrosi
infect
univari
analysi
sofa
score
admiss
multipl
organ
failur
renal
dysfunct
metabol
acidosi
hypoxemia
haemoconcentr
associ
death
well
need
renal
replac
therapi
mesenter
ischemia
icu
stay
differ
model
multivari
analysi
sofa
score
icu
admiss
ci
p
need
renal
replac
therapi
p
bacteremia
p
mesenter
ischemia
p
icu
stay
identifi
independ
risk
factor
mortal
convers
enter
nutrit
independ
associ
surviv
p
conclus
sofa
score
admiss
need
renal
replac
therapi
complic
bacteremia
mesenter
ischemia
icu
stay
identifi
independ
predictor
mortal
patient
admit
intens
care
unit
acut
pancreat
enter
nutrit
independ
factor
surviv
annal
intens
care
suppl
introduct
recent
guidelin
advoc
stepup
approach
manag
infect
pancreat
necrosi
ipn
nearli
half
patient
requir
secondari
necrosectomi
drainag
previou
studi
holleman
et
al
identifi
risk
factor
cathet
drainag
failur
male
gender
multipl
organ
failur
percentag
necrosi
heterogen
collect
construct
nomogram
area
receiv
oper
characterist
roc
curv
primari
object
valid
de
construct
nomogram
secondari
goal
explor
other
possibl
predictor
cathet
drainag
failur
patient
method
retrospect
studi
consecut
patient
admit
suspect
ipn
requir
intervent
cathet
drainag
first
admit
univers
hospit
comput
tomographi
ct
prior
first
drainag
procedur
review
singl
blind
radiologist
result
cathet
drainag
procedur
success
patient
nomogram
predict
cathet
drainag
failur
area
roc
curv
score
result
success
chanc
primari
cathet
drainag
similarli
unfavor
score
point
result
failur
primari
cathet
drainag
multivari
analysi
cathet
drainag
failur
independ
associ
bodi
mass
index
bmi
ci
p
heterogen
collect
ci
p
respiratori
failur
h
prior
cathet
drainag
ci
p
conclus
half
patient
requir
necrosectomi
primari
cathet
drainag
nomogram
use
predict
cathet
drainag
failur
especi
extrem
rang
heterogen
collect
ct
respiratori
failur
h
prior
drainag
strongli
associ
cathet
drainag
failur
earli
identif
patient
risk
drainag
failur
alon
could
improv
manag
reduc
antibiot
durat
annal
intens
care
suppl
introduct
recent
guidelin
rule
prophylact
antibiot
prevent
infect
pancreat
necrosi
ipn
advoc
stepup
approach
manag
ipn
emerg
drug
resist
bacteria
rise
problem
among
sap
icu
patient
primari
object
determin
impact
antibiotherapi
sampl
cultur
collect
intervent
ipn
among
patient
admit
sever
acut
pancreat
sap
descript
microbiolog
speci
pattern
resist
secondari
goal
patient
method
retrospect
studi
consecut
patient
admit
icu
suspect
ipn
requir
intervent
collect
data
microbiolog
sampl
well
antimicrobi
therapi
classifi
speci
accord
definit
propos
magiorako
et
al
result
ipn
confirm
patient
sampl
collect
intervent
posit
cultur
levi
effici
antibiotherapi
h
previou
antibiotherapi
influenc
cultur
result
p
sampl
polymicrobi
gram
stain
sensit
specif
posit
predict
valu
ppv
neg
predict
valu
pnv
half
patient
develop
multi
extens
drug
resist
bacteria
prolong
antibiot
steril
collect
necrot
tissu
discuss
previou
antibiotherapi
influenc
microbiolog
cultur
result
prolong
adapt
broadspectrum
antibiot
allow
steril
necrot
tissu
fluid
collect
result
show
preval
drug
resist
bacteria
gram
stain
use
invalid
ipn
diagnosi
neg
cultur
among
patient
antibiot
question
diagnosi
ipn
antibiot
discontinu
conclus
prolong
broad
spectrum
antibiot
permit
steril
ipn
preval
drug
resist
bacteria
rais
studi
strategi
reduc
antimicrobi
therapi
use
exposur
cours
sap
need
futur
prospect
studi
need
determin
optim
antimicrobi
therapi
durat
annal
intens
care
suppl
introduct
sever
acut
liver
injuri
character
acut
liver
damag
without
underli
chronic
liver
diseas
critic
condit
may
lead
acut
liver
failur
aim
work
provid
epidemiolog
prognost
featur
condit
patient
method
retrospect
studi
januari
decemb
includ
patient
admit
sever
acut
liver
injuri
ali
result
fortysix
patient
includ
sexratio
mean
age
year
main
comorbid
diabet
mellitu
hypertens
princip
etiolog
ali
hepat
drug
hepat
type
b
incrimin
patient
type
patient
type
e
patient
acut
liver
failur
alf
occur
patient
alf
classifi
hyperacut
patient
acut
patient
subacut
patient
six
patient
die
alf
patient
unfavor
outcom
death
alf
demograph
characterist
similar
patient
favor
outcom
lower
platelet
count
ml
vs
ml
p
lower
prothrombin
time
ratio
vs
p
higher
inr
level
vs
p
lower
hemoglobin
amount
gdl
vs
gdl
p
lower
diastol
blood
pressur
mmhg
vs
mmhg
p
lower
mean
blood
pressur
mmhg
vs
mmhg
p
result
logist
regress
analysi
show
diastol
blood
pressur
level
significantli
relat
unfavor
outcom
roc
curv
analysi
show
diastol
blood
pressur
level
mmhg
predict
factor
unfavor
outcom
sensibl
specif
aur
ic
conclus
ali
associ
nonneglig
mortal
mainli
due
alf
diastol
blood
pressur
level
less
mmhg
may
help
predict
unfavor
outcom
annal
intens
care
suppl
introduct
hepat
dysfunct
common
intens
care
howev
data
avail
hepat
dysfonct
critic
ill
patient
remain
signific
problem
purpos
studi
evalu
incid
time
onset
characterist
possibl
etiolog
liver
function
abnorm
intens
care
unit
icu
patient
method
retrospect
cohort
studi
conduct
patient
admit
icu
januari
septemb
includ
patient
present
stay
elev
hepat
transaminas
asat
alat
elev
gammaglutamyl
transpeptidas
ggt
twice
normal
level
alkalin
phosphatas
alp
one
half
time
normal
level
bilirubin
two
half
time
normal
level
patient
previou
liver
dysfunct
new
episod
defin
increas
one
variabl
fifti
per
cent
admit
patient
develop
liver
disturb
defin
group
control
result
period
studi
patient
admit
present
liver
dysfunct
median
age
year
mean
apach
ii
sofa
score
respect
acquir
liver
dysfunct
occur
median
delay
one
day
thirtyeight
patient
hepat
cytolysi
ggt
elev
bilirubin
elev
nine
alp
elev
twelv
patient
hepatobiliari
imag
diagnosi
cholecyst
retain
one
case
patient
serolog
hepat
virus
allneg
except
one
fiftynin
episod
collect
median
number
hepat
dysfunct
episod
per
patient
one
ten
patient
two
episod
retain
etiolog
multifactori
forti
case
sepsi
hypoxia
drug
toxic
sepsi
seven
case
drug
toxic
two
case
compar
group
control
patient
mortal
higher
vs
p
length
stay
prolong
vs
day
p
differ
signific
conclus
liver
abnorm
common
intens
care
multifactori
liver
dysfunct
frequent
popul
drug
toxic
commonli
suspect
difficult
retain
incrimin
factor
annal
intens
care
suppl
introduct
encephalopathi
common
complic
liver
diseas
andor
portosystem
shunt
pathophysiolog
complet
understood
mechan
includ
role
elev
ammonia
level
associ
system
inflamm
impair
barrier
bbb
permeabl
also
hypothetis
metabolom
enabl
detect
wide
rang
metabolit
without
priori
recent
metabolom
studi
includ
patient
underw
cerebrospin
fluid
csf
collect
group
outlin
xenobioticsdrug
usual
cross
bbb
retriev
csf
suggest
potenti
neurolog
toxic
drug
csf
collect
invas
henc
aim
describ
xenobiot
present
plasma
cirrhot
patient
use
metabolom
approach
patient
method
conduct
retrospect
studi
plasma
sampl
hepatolog
icu
plasma
sampl
cirrhot
patient
display
encephalopathi
compar
plasma
cirrhot
patient
without
neurolog
symptom
plasma
healthi
control
liquid
chromatographi
coupl
highresolut
mass
spectrometri
perform
metabol
fingerprint
compar
databas
differ
group
result
plasma
sampl
obtain
cirrhot
patient
encephalopathi
age
meld
alcohol
cirrhot
patient
without
encephalopathi
age
meld
alcohol
healthi
control
among
identifi
metabolit
correspond
xenobiot
deriv
fluoxetin
detect
fold
increas
aminosalicyl
acid
fold
increas
benzyl
alcohol
present
cough
pill
antisept
fold
increas
cirrhot
patient
encephalopathi
compar
cirrhot
patient
cirrhot
patient
without
encephalopathi
propranolol
detect
fold
increas
acetaminophen
fold
increas
penicillamin
ampicillin
fold
increas
compar
healthi
control
interestingli
sever
substanc
expect
system
diffus
detect
cirrhot
patient
healthi
control
eugenol
isoeugenol
use
mouth
bath
solut
triethanolamin
trolamin
use
cutan
cream
resorcinol
monoacet
use
mouth
bath
solut
cutan
cream
conclus
cirrhot
patient
especi
neurolog
symptom
display
dramat
increas
level
sever
xenobiot
plasma
result
confirm
pk
pd
paramet
commonli
use
drug
highli
modifi
patient
suggest
potenti
role
xenobiot
pathophysiolog
encephalopathi
patient
liver
diseas
annal
intens
care
suppl
introduct
differ
score
model
use
predict
sever
acuteonchron
liver
failur
aoclf
differ
score
model
use
predict
sever
acut
chronic
liver
failur
aoclf
model
endstag
liver
diseas
meld
clif
sofa
previou
studi
shown
neutrophillymphocytr
ratio
nlr
plateletlymphocyt
plr
use
prognost
marker
variou
diseas
process
aim
evalu
role
nlr
predict
mortal
patient
aoclf
patient
method
retrospect
follow
studi
includ
patient
decompens
cirrhosi
januari
decemb
result
total
case
decompens
cirrhosi
aoclf
enrol
present
studi
mean
age
year
sex
ratio
mean
child
meld
respect
chronic
hepat
c
infect
remain
major
case
cirrhosi
studi
lead
caus
hospit
oedematoascit
decompens
diagnosi
sepsi
identifi
case
find
indic
month
mortal
interset
patient
univari
logist
regress
analys
show
signific
posit
correl
nlr
month
mortal
p
also
high
meld
score
p
child
score
p
clif
sofa
p
multivari
logist
regress
analys
prove
high
nlr
addit
independ
risk
factor
mortal
p
well
child
score
p
evalu
abil
nlr
child
score
predict
mortal
roc
curv
obtainedth
auc
valu
child
score
nlr
p
conclus
studi
nlr
seem
good
marker
easili
achiev
assess
prognosi
immedi
admiss
decompens
cirrhosi
annal
intens
care
suppl
introduct
combin
increas
antibiot
resist
decreas
discoveri
new
antibiot
molecul
seriou
concern
intens
care
unit
howev
link
bacteri
resist
prognosi
remain
controversi
predomin
pathogen
caus
ventilatorassoci
pneumonia
vap
pseudomona
aeruginosa
pa
increasingli
becom
multidrug
resist
mdr
aim
studi
therefor
evalu
relationship
mdr
vap
pa
episod
mortal
patient
method
longitudin
prospect
french
multicent
databas
pavap
onset
physiolog
data
record
mdr
defin
nonsuscept
least
one
agent
three
antimicrobi
categori
analyz
mdr
episod
associ
higher
inhospit
mortal
perform
multivari
surviv
analysi
use
multivari
nonlinear
frailti
model
result
total
patient
present
pavap
maximum
episod
per
patient
observ
episod
mdr
suscept
multivari
model
factor
independ
associ
mortal
includ
age
hr
ci
p
hospit
month
preced
first
episod
hr
ci
p
chronic
renal
failur
hr
ci
p
vap
pa
recurr
hr
ci
p
final
mdr
pavap
associ
death
hr
ci
p
conclus
studi
identifi
relationship
resist
profil
pseudomona
aeruginosa
mortal
annal
intens
care
suppl
introduct
octob
march
nosocomi
outbreak
corynebacterium
striatum
occur
icu
tertiari
hospit
aim
character
popul
affect
defin
risk
factor
match
equival
control
help
avoid
futur
outbreak
patient
method
retrospect
identifi
patient
posit
cultur
corynebaterium
striatum
regardless
infecti
sign
includ
control
posit
patient
match
icu
length
stay
unit
hospit
presenc
mechan
ventil
tri
identifi
risk
factor
c
striatum
acquisit
result
wherea
respect
patient
c
striatum
posit
specimen
first
month
identifi
patient
c
striatum
cultur
oct
march
isol
identifi
use
malditof
share
suscept
resist
antibiomicrobi
except
vancomycin
genotyp
perform
cohort
includ
male
mean
age
year
median
icu
stay
day
iqr
main
comorbid
cancer
diabet
patient
follow
immunodepress
copd
cirrhosi
chronic
kidney
diseas
n
medic
admiss
one
case
elect
postop
admiss
surviv
rate
patient
one
intub
median
ventil
length
day
patient
one
posit
respiratori
specimen
either
tracheobronchi
aspir
bronchoalveolar
lavag
c
striatum
one
patient
periton
liquid
first
posit
cultur
one
soft
tissu
colon
case
consid
actual
infect
accordingli
treat
vancomycin
case
show
clinic
recoveri
despit
microbiolog
failur
niv
high
flow
oxygen
therapi
patient
infect
treat
antibiot
corynebacterium
posit
cultur
among
treat
broad
spectrum
antibiot
characterist
control
patient
current
record
data
comparison
case
control
shown
congress
conclus
c
striatum
caus
microepidem
icu
mechan
ventil
comorbid
patient
high
lo
virul
seem
low
infect
patient
infectionrel
mortal
annal
intens
care
suppl
introduct
multidrugresist
gramneg
bacilli
mdrgnb
infect
frequent
seriou
intens
care
unit
icu
patient
intestin
microbiota
reservoir
mdrgnb
besid
alter
intestin
microbiota
relat
antibiot
intak
could
associ
nosocomi
infect
includ
involv
mdrgnb
poor
outcom
main
object
assess
link
intestin
colon
mdrgnb
composit
microbiota
rich
divers
patient
method
perform
prospect
monocentr
cohort
studi
medic
icu
bichat
hospit
pari
patient
ventil
day
spontan
pass
fece
includ
patient
fecal
sampl
collect
day
inclus
twice
week
mdrgnb
defin
third
gener
cephalosporin
resist
enterobacteriacea
also
enterococcu
faecium
search
cultur
method
mdrgnb
rel
abund
ra
calcul
defin
concentr
mdrgnb
concentr
total
enterobacteriacea
composit
intestin
microbiota
assess
profil
calcul
rich
number
oper
taxonom
unit
divers
shannon
index
result
collect
stool
sampl
patient
includ
fece
mdrgnb
includ
extendedspectrum
betalactamaseproduc
enterobacteriacea
cephalosporinas
overproduc
enterobacteriacea
differ
patient
averag
ra
mdrgnb
twentytwo
stool
sampl
posit
e
faecium
observ
link
divers
rich
intestin
microbiota
mdrgnb
intestin
ra
convers
intestin
divers
rich
decreas
along
rel
abund
read
assign
enterococcu
sp
p
figur
enterococcu
faecium
intestin
carriag
detect
p
detect
mdrgnb
nosocomi
infect
includ
ventil
associ
pneumonia
within
day
posit
mdrgnb
stool
sampl
mdrgnb
intestin
ra
associ
occurr
infect
caus
mdrgnb
conclus
intestin
mdrgnb
rel
abund
associ
divers
rich
intestin
microbiota
enterococcu
sp
rel
abund
enterococcu
faecium
intestin
carriag
annal
intens
care
suppl
introduct
perform
air
handl
unit
ahu
reduc
airborn
particl
transmiss
wide
demonstr
literatur
term
decreas
bacteri
fungal
concentr
air
surfac
studi
aim
evalu
effici
ahu
reduc
incid
infect
intens
care
unit
icu
patient
method
annual
mainten
ahu
perform
icu
januari
conduct
retrospect
compar
studi
includ
two
group
patient
admit
h
group
patient
admit
octob
octob
group
patient
admit
januari
august
clinic
bacteriolog
data
patient
record
identifi
develop
nosocomi
infect
icu
stay
incid
rate
adjust
patienttim
differ
analyz
use
chi
squar
test
result
total
patient
includ
studi
belong
group
mean
age
year
sex
ratio
main
etiolog
admiss
acut
respiratori
failur
coma
shock
overal
incid
nosocomi
infect
patient
day
ventil
acquir
pneumonia
vap
overal
incid
patientventilationday
result
summar
tabl
catheterrel
infect
account
overal
incid
patient
day
differ
two
incid
rate
within
two
group
statist
signific
prevent
fraction
ahu
amount
tabl
median
time
onset
vap
also
significantli
longer
patient
admit
ahu
median
day
prior
ahu
vs
day
ahu
p
conclus
studi
shown
ahu
appear
reduc
significantli
incid
cathet
relat
infect
also
shown
slow
develop
vap
intub
impact
overal
incid
nosocomi
infect
annal
intens
care
suppl
introduct
acinetobact
baumanii
opportunist
nosocomi
pathogen
import
multidrugresist
microorgan
associ
high
mortal
rate
studi
aim
evalu
perform
dual
flow
air
handl
unit
ahu
annual
mainten
use
new
surfac
aerial
disinfect
reduc
risk
acinetobact
baumanii
infect
intens
care
unit
icu
patient
method
perform
annual
mainten
ahu
chang
surfac
aerial
disinfect
januari
conduct
retrospect
compar
studi
includ
two
group
patient
group
patient
admit
h
octob
octob
group
patient
admit
h
januari
august
identifi
patient
develop
acinetobact
baumanii
infect
result
studi
period
patient
collect
mean
age
year
sex
ratio
median
caus
admiss
icu
acut
respiratori
failur
coma
septic
shock
global
mortal
rate
icu
case
record
case
acinetobact
baumanii
infect
ventil
associ
pneumonia
n
cathet
relat
infect
n
urinari
tract
infect
n
global
mortal
rate
among
case
record
mainten
ahu
use
new
surfac
aerial
disinfect
result
statist
signific
p
conclus
use
new
surfac
aerial
disinfect
mainten
ahu
reduc
significantli
acinetobact
baumanii
infect
annal
intens
care
suppl
introduct
ventilatorassoci
pneumonia
vap
common
nosocomi
infect
critic
ill
patient
reach
high
mortal
rate
acinetobact
baumannii
ab
emerg
pathogen
frequent
incrimin
vap
tunisia
aim
studi
describ
epidemiolog
characterist
acinetobact
baumannii
ventilatorassoci
pneumonia
identifi
risk
factor
predictor
poor
outcom
vap
ab
patient
method
retrospect
studi
conduct
intens
care
unit
militari
hospit
tuni
januari
decemb
patient
vap
document
infect
includ
vap
patient
ab
vs
vap
patient
due
pathogen
result
seventi
patient
develop
vap
incid
vap
ab
previou
antibiot
therapi
identifi
risk
factor
acinetobact
baumaniiinduc
pneumonia
unlik
underli
diseas
ab
resist
ceftazidim
imipenem
sensit
colistin
case
multidrugresist
ab
account
highli
resist
ab
account
patient
ab
pneumonia
frequent
complic
acut
respiratori
distress
syndrom
compar
patient
versu
p
lead
higher
mortal
versu
p
conclus
increas
incid
vap
multidrugresist
highli
resist
ab
predict
high
morbid
mortal
henc
risk
factor
relat
poor
outcom
vap
need
identifi
implement
infectioncontrol
measur
mainli
crosstransmiss
may
need
improv
outcom
annal
intens
care
suppl
introduct
carbapenemas
respons
mani
therapeut
failur
addit
epidem
power
acquisit
type
resist
proteu
mirabili
natur
resist
tigecyclin
colistin
make
therapeut
option
even
restrict
aim
studi
defin
mechan
carbapenem
resist
p
mirabili
identifi
antibiot
resist
profil
strain
patient
method
studi
conduct
period
month
januari
june
strain
p
mirabili
isol
burn
patient
mic
carbapenem
perform
multiplex
realtim
pcr
perform
cepheid
genexpert
carbar
allow
detect
preval
carbapenemasegen
famili
blavim
blandm
blaimp
blakpc
result
studi
period
strain
p
mirabili
isol
rank
fifth
among
speci
isol
burn
patient
third
among
enterobacteriacea
mainli
found
cutan
sampl
blood
cultur
cathet
resist
rate
least
one
carbapenem
carbapenem
often
concern
imipen
case
strain
imipenem
affect
carbapenem
four
strain
resist
ertapenem
isol
sensit
meropenem
except
carbapenem
germ
express
high
level
resist
almost
antibiot
resist
fluoroquinolon
also
aminoglycosid
fosfomycin
resist
rate
strain
suscept
intermedi
cefepim
isol
sensit
intermedi
piperacillintazobactam
sensit
aztreonam
strain
sensit
temocillin
edta
test
posit
eleven
isol
hyperproduc
cephalosporinas
one
esbl
molecular
identif
show
sampl
test
blandm
gene
one
express
esbl
neg
conclus
presenc
carbapenemas
pmirabili
alarm
studi
ertapenem
best
sensit
detect
face
risk
therapeut
impass
prevent
measur
remain
best
solut
annal
intens
care
suppl
introduct
antibiot
resist
becom
major
public
health
problem
worldwid
current
drastic
increas
carbapenem
resist
gramneg
bacilli
crgnb
major
threat
fast
spread
rate
also
high
morbid
mortal
rate
patient
method
retrospect
studi
investig
epidemiolog
profil
prognosi
gramneg
bacilli
reduc
sensit
carbapenem
gnbrsc
among
patient
admit
intens
care
unit
militari
hospit
tuni
period
six
month
januaryjun
eucast
carbapenem
breakpoint
use
interpret
suscept
carbapenem
result
acinetobact
baumanii
isol
bacteri
speci
follow
pseudomona
aeruginosa
klebsiella
pneumonia
common
infect
ventil
associ
pneumonia
bacteremia
suppur
infect
urinari
tract
infect
pneumopathi
resist
gramneg
bacilli
carbapenem
associ
resist
antibiot
colistin
remain
activ
natur
sensit
organ
risk
factor
acquisit
infect
advanc
age
state
immunosuppress
patient
long
durat
hospitalis
prior
colonis
gnbrsc
special
previou
take
antibiot
last
month
mortal
within
day
infect
onset
multivari
analysi
predictor
inhospit
mortal
sepsisrel
organ
failur
assess
sofa
score
day
infect
p
inadequ
empir
antimicrobi
therapi
p
chronic
cardiac
failur
p
discuss
seri
epidemiolog
microbiolog
profil
gnbrsc
compar
litteratur
data
crgnb
screen
confirm
requir
combin
phenotyp
genotyp
test
increas
accuraci
detect
perform
seri
conclus
emerg
crgnb
call
rigor
applic
main
prevent
measur
reinforc
hygien
measur
strict
monitor
highli
resist
bacteria
adequ
sourc
control
appropri
use
antimicrobi
therapi
import
modifi
risk
factor
shown
surviv
benefit
popul
annal
intens
care
suppl
introduct
sepsi
defin
host
inflammatori
respons
lifethreaten
infect
potenti
lead
septic
shock
failur
organ
initi
infect
besid
antimicrobi
effect
antibiot
could
intrins
immunomodulatori
properti
endotheli
cell
abl
detect
danger
signal
pathogen
initi
innat
immun
respons
specif
condit
adapt
immun
aim
studi
highlight
effect
three
antibiot
class
endotheli
cell
immun
properti
sepsi
patient
method
human
microvascular
endotheli
cell
hmec
stimul
lipopolysaccharid
interferon
gamma
tumor
necrosi
factor
alpha
cytomix
h
administr
differ
antibiot
surfac
express
intercellular
adhes
molecul
programdeath
ligand
human
leukocyt
antigen
hla
class
hladr
determin
use
flow
cytometri
h
antibiot
administr
product
cytokin
interkeukin
il
hmec
determin
enzymelink
immunoabsorb
assay
elisa
quantit
polymeras
chain
reaction
qpcr
use
analyz
gapdh
control
hlaa
hladr
gene
express
result
compar
cytomix
alon
spiramycin
ug
ml
associ
cytomix
significantli
decreas
express
mean
fluoresc
intens
mfi
versu
p
hladr
mfi
versu
p
hmec
surfac
clarithromycin
erythromycin
also
significantli
decreas
express
hladr
qpcr
clarithromycin
significantli
decreas
hladr
gene
express
versu
hladr
fold
express
gapdh
p
gene
express
versu
fold
express
gapdh
p
compar
cytomix
figur
compar
cytomix
piperacillintazobactam
ug
ml
significantli
decreas
express
hmec
surfac
p
significantli
affect
hladr
express
vancomycin
chang
express
cd
cd
hladr
hmec
surfac
cytomix
stimul
product
hmec
significantli
modifi
antibiot
administr
macrolid
penicillin
glycopeptid
conclus
macrolid
penicillin
modul
express
hla
molecul
microvascular
endotheli
cell
surfac
use
cocultur
endotheli
cell
peripher
blood
mononuclear
cell
may
enlighten
pathophysiolog
implic
result
annal
intens
care
suppl
introduct
inflamm
endoplasm
reticulum
protein
fold
capac
surpass
lead
accumul
unfold
peptid
process
known
endoplasm
reticulum
stress
er
murin
model
sepsi
er
blocker
decreas
express
inflammatori
cytokin
reduc
organ
dysfunct
mortal
object
work
search
link
gene
express
er
organ
failur
patient
septic
shock
patient
method
conduct
prospect
studi
tertiari
care
hospit
includ
patient
admit
intens
care
unit
icu
septic
shock
blood
sampl
collect
day
icu
stay
extract
total
rna
quantit
pcr
perform
evalu
express
gene
code
key
element
er
code
chop
endotheliumrel
marker
main
object
correl
express
sequenti
organ
failur
assess
sofa
score
spearman
method
result
includ
patient
median
age
year
median
sapsii
median
length
stay
day
mortal
rate
correl
chop
express
sofa
score
howev
correl
sofa
score
express
observ
r
well
express
endotheli
aggress
marker
r
r
respect
chop
correl
express
express
follow
sofa
variat
r
conclus
studi
evalu
first
time
express
er
marker
patient
septic
shock
reveal
er
marker
might
partli
correl
sever
septic
shock
endotheli
dysfunct
annal
intens
care
suppl
introduct
widespread
recognit
critic
ill
character
state
immunosuppress
led
develop
nutrit
support
product
intervent
design
enhanc
host
immun
respons
immun
modul
diet
imd
contain
nutrient
display
immunoregul
properti
arginin
conceptu
appeal
data
individu
trial
sever
metaanalys
fail
produc
convinc
result
differ
studi
found
earli
enter
administr
larginin
patient
icu
increas
ornithin
synthesi
suggest
preferenti
use
arginas
pathway
citrullin
synthesi
bare
stimul
immun
function
unaffect
recent
data
suggest
citrullin
supplement
may
effici
increas
arginin
avail
product
arginin
supplement
hypothesi
supplement
citrullin
effici
arginin
increas
system
arginin
avail
decreas
postsepsi
immunosuppress
patient
method
use
mice
perform
cecal
ligat
punctur
clp
day
mice
sacrif
perform
cardiac
punctur
monitor
immun
function
especi
associ
impair
outcom
nosocomi
infect
acquisit
lymphocyt
apoptosi
mdsc
regulatori
tcell
second
set
experi
perform
secondari
infect
pneumonia
day
clp
sever
pulmonari
infect
assess
use
bronchoalveolar
lavag
histolog
analysi
note
spleen
kidney
harvest
evalu
bacteri
dissemin
experi
perform
differ
group
mice
citrullin
g
kg
j
arginin
g
kg
j
isonitrogen
placebo
diet
five
day
follow
clp
continu
variabl
repres
mean
sd
compar
use
student
test
p
indic
statist
signific
differ
result
citrullin
supplement
associ
diminish
proport
apoptot
lymphocyt
lower
recruit
regulatori
tcell
observ
trend
toward
hypoargininemia
correct
higher
citrullinemia
citrullin
group
assess
mrsa
pneumonia
sever
show
reduc
bacteri
load
bal
citrullin
fit
mice
bacteri
dissemin
also
significantli
lower
group
conclus
enter
administr
citrullin
associ
less
pronounc
post
septic
immunoparalysi
diminish
suscept
secondari
infect
murin
two
hit
model
sepsi
annal
intens
care
suppl
introduct
communityacquir
pneumonia
widespread
diseas
signific
morbimort
pneumonia
rate
drop
childhood
remain
low
decad
rise
elderli
dogma
adapt
immun
build
immunolog
memori
recent
challeng
emerg
evid
indic
innat
immun
cell
display
longterm
chang
infect
alveolar
macrophag
tissueresid
lung
cell
play
crucial
role
innat
immun
current
understand
base
studi
conduct
anim
without
preexist
condit
hypothes
display
adapt
characterist
resolut
pneumonia
studi
describ
extent
chang
recoveri
lung
infect
mice
patient
method
mice
infect
intranas
left
bronchial
instil
streptococcu
pneumonia
sp
one
week
interv
infect
infect
selflimit
mice
studi
week
later
name
thereaft
veteran
control
mice
singlecel
suspens
gener
lung
assess
flow
cytometri
data
analyz
use
tradit
manual
gate
addit
unsupervis
comput
approach
tsne
use
dimens
reduct
data
analysi
sort
transcriptom
analysi
veteran
naiv
mice
subsequ
infect
lethal
dose
sp
without
deplet
induc
clodron
result
lungresid
myeloid
cell
popul
ident
veteran
mice
defin
manual
gate
howev
examin
tsnevisu
map
dataset
reveal
differ
one
cluster
correspond
identifi
multipl
subtl
chang
immunophenotyp
veteran
includ
decreas
siglecf
express
increas
mhcii
express
remodel
longlast
still
observ
month
post
infect
ii
region
local
observ
left
lung
mice
infect
left
bronchu
veteran
newli
infect
better
bacteri
clearanc
compar
howev
enhanc
protect
observ
veteran
mice
deplet
final
transcriptom
profil
demonstr
mark
differ
naiv
veteran
includ
immun
function
cell
cycl
metabol
conclus
remodel
reprogram
mild
selflimit
respiratori
infect
chang
longlast
compartment
associ
enhanc
lung
protect
determin
veteran
respond
differ
subsequ
infect
may
offer
new
mechan
understand
alter
adult
high
suscept
pneumonia
annal
intens
care
suppl
introduct
sepsi
induc
long
last
alter
transcript
program
lead
sepsisinduc
immun
suppress
sii
secondari
infect
death
shift
toward
repress
histon
modif
overexpress
histon
desacetylas
hdac
observ
patient
sii
shown
hdac
inhibit
trichostatin
tsa
reduc
mortal
improv
bacteri
clearanc
prevent
lymphocyt
apoptosi
relev
murin
model
sii
investig
epigenet
chang
induc
model
revers
tsa
perform
transcript
analysi
splenocyt
studi
acetyl
tcell
patient
method
use
model
sii
follow
polymicrobi
briefli
mice
treat
tsa
mg
kg
ip
ctl
ligat
punctur
clp
surviv
mice
underw
intratrach
instil
cfu
pseudomona
aeruginosa
day
clp
geneexpress
studi
microarray
experi
perform
use
affymetrix
clariom
mous
genomewid
array
rna
isol
isol
tcell
clp
day
identifi
differenti
express
gene
use
anova
gene
use
unadjust
pvalu
fold
chang
filter
select
differenti
express
gene
use
mean
center
data
perform
sampl
gene
classif
hierarch
cluster
use
spearman
correl
similar
measur
averag
ward
linkag
algorithm
diseas
function
repres
key
gene
identifi
use
ingenu
softwar
tcell
use
luminex
histon
ptm
multiplex
assay
evalu
effect
tsa
global
acetyl
focu
acetyl
mark
result
gene
differenti
express
clp
tsatreat
mice
clp
mice
day
clp
effect
pronounc
sepsi
gene
differenti
express
day
sepsi
tsa
upregul
gene
downregul
clp
downregul
gene
upregul
clp
gene
directli
involv
immun
respons
fig
modul
tsa
model
includ
tcell
apoptosi
tcell
express
gene
affect
gene
involv
cellular
movement
immun
cell
traffick
inflammatori
respons
antimicrobi
respons
cell
death
surviv
fig
panhiston
acetyl
significantli
increas
tcell
day
sepsi
conclus
treatment
tsa
significantli
alter
histon
acetyl
express
gene
involv
modul
cellular
function
link
sii
tcell
apoptosi
exhaust
annal
intens
care
suppl
introduct
sepsi
initi
complex
immun
respons
concomit
occurr
pro
antiinflammatori
reaction
lead
increas
suscept
secondari
infect
repres
signific
caus
mortal
morbid
although
observ
signific
decreas
sepsi
associ
mortal
last
decad
clinic
trial
adjuv
therapi
fail
demonstr
improv
mortal
despit
signific
effect
anim
studi
discrep
might
due
lack
recommend
preclin
sepsi
model
enhanc
translat
valu
sepsi
model
experiment
studi
guidelin
recent
publish
howev
data
regard
effect
recommend
aim
studi
demonstr
follow
newli
publish
minimum
qualiti
threshold
preclin
sepsi
studi
mous
model
cecal
ligat
punctur
clp
mimic
sepsi
induc
immunosuppress
worsen
secondari
infect
patient
method
mice
use
perform
clp
compar
control
group
sham
day
mice
sacrif
perform
cardiac
punctur
monitor
immun
function
especi
associ
impair
outcom
nosocomi
infect
acquisit
lymphocyt
apoptosi
mdsc
regulatori
tcell
blood
phenotyp
tlymphocyt
prolifer
index
second
group
mice
use
studi
sever
secondari
infect
mrsa
pneumonia
day
clp
sham
surgeri
h
later
sever
infect
assess
continu
variabl
repres
mean
sd
compar
use
student
test
p
indic
statist
signific
differ
result
found
signific
increas
gmdsc
mmdsc
regulatori
tcell
monocyt
neutrophil
recruit
clp
mice
also
observ
higher
concentr
apoptot
lymphocyt
diminish
lymphocyt
prolifer
index
group
mrsa
pneumonia
sever
clp
mice
bacteri
load
bal
mrsa
bacteremia
concentr
harvest
spleen
kidney
significantli
higher
sham
group
conclus
observ
newli
publish
guidelin
follow
clp
induc
immun
dysfunct
respons
sever
secondari
infect
standard
anim
model
sepsi
improv
translat
valu
refer
osuchowski
marcin
f
et
al
minimum
qualiti
threshold
preclin
sepsi
studi
mqtipss
shock
p
annal
intens
care
suppl
introduct
pneumonia
usual
present
forgotten
killer
ventilatorassoci
pneumonia
repres
frequent
nosocomi
infect
intens
care
unit
diagnosi
remain
problemat
earli
diagnosi
could
larg
improv
prognost
outcom
sever
clinic
radiolog
biolog
tool
develop
impov
speed
diagnost
perform
recent
lung
ultrasound
becam
tool
allow
estim
lung
morpholog
bedsid
purpos
studi
determin
sensibl
specif
perform
diagnosi
lung
ultrasound
alon
associ
bronchoalveolar
lavag
patient
method
monocent
prospect
studi
patient
suspect
ventilatorassoci
pneumonia
investig
diagnost
perform
lung
ultrasound
sensibl
specif
sign
ultrasound
pneumonia
subpleur
consolid
lobar
consolid
arboresc
linear
air
bronchogram
also
evalu
combin
lung
ultrasound
direct
examin
bronchoalveolar
lavag
result
preval
ventilatorassoci
pneumonia
two
group
patient
without
ventilatorassoci
pneumonia
similar
term
gener
characterist
signific
differ
two
group
occur
purul
secret
lobar
hemilobar
consolid
specif
subpleur
consolid
arboresc
linear
air
bronchogram
specif
posit
predict
valu
associ
lung
ultrasound
bronchoalveolar
lavag
specif
posit
predict
valu
conclus
lung
ultrasound
vailabl
tool
practic
bedhead
among
critic
patient
intens
care
unit
valid
altern
earli
reliabl
diagnosi
ventilatorassoci
pneumonia
could
also
allow
follow
evolut
treatment
annal
intens
care
suppl
introduct
french
guidelin
recommend
reach
amikacin
concentr
h
begin
infus
h
time
minim
inhibitori
concentr
mic
respons
bacterium
probabilist
therapi
mic
consid
mg
l
target
rare
achiev
icu
despit
mg
kg
recommend
dosag
aim
elabor
nomogram
guid
clinician
choos
right
first
amikacin
dose
icu
patient
septic
shock
patient
method
data
two
prospect
french
cohort
icu
patient
treat
amikacin
sepsi
analyz
two
pharmacokinet
model
one
parametr
one
nonparametr
built
use
popul
approach
softwar
respect
use
nonparametr
model
produc
dose
nomogram
montecarlo
simul
amikacin
amount
need
achiev
h
mic
h
x
mic
accord
model
covari
depict
result
analyz
observ
patient
median
simplifi
acut
physiolog
score
ii
ninetyfour
patient
requir
invas
mechan
ventil
patient
need
vasopressor
twocompart
pharmacokinet
model
total
bodi
weight
tbw
influenc
central
compart
volum
creatinin
clearanc
accord
chronic
kidney
diseas
epidemiolog
collabor
ckdepi
formula
chosen
nonparametr
parametr
model
adequ
describ
h
similar
perform
coeffici
correl
dose
nomogram
elabor
accord
patient
tbw
creatinin
clearanc
recommend
amikacin
dose
achiev
h
mg
l
rang
mg
mg
mg
kg
mg
kg
conclus
first
amikacin
dose
depend
patient
tbw
creatinin
clearanc
result
frequent
dose
mg
kg
extern
valid
nomogram
evalu
amikacin
toxic
high
dose
necessari
use
nomogram
clinic
practic
annal
intens
care
suppl
introduct
bronchiol
still
one
lead
caus
morbid
mortal
children
advanc
molecular
diagnosi
led
increas
test
singl
multivir
respiratori
infect
routin
clinic
practic
aim
studi
identifi
viral
identif
outcom
sever
bronchiol
requir
noninvas
ventil
niv
highflow
nasal
cannula
oxygen
hfnc
patient
method
review
case
bronchiol
requir
niv
hfnc
pediatr
intens
care
depart
organ
detect
nasopharyng
swab
panel
includ
multiplex
pcr
assay
respifind
data
collect
electron
medic
record
emr
princip
studi
outcom
rate
niv
failur
defin
rate
intub
secondari
outcom
length
hostpit
stay
length
ventil
mortal
result
case
bronchiol
treat
niv
center
period
studi
viral
identif
done
n
case
bronchiol
tabl
n
niv
n
hfnc
n
viral
bacteria
coinfect
significantli
suscept
get
intub
patient
intub
patient
group
without
bacteri
coinfect
p
n
coinfect
anoth
viru
signific
differ
found
studi
outcom
rhino
enteroviru
associ
longer
length
stay
especi
heart
diseas
larger
tempor
distribut
year
conclus
found
higher
rate
niv
failur
patient
viral
bacteria
coinfect
differ
viral
coinfect
addit
medic
background
type
viru
multipl
infect
especi
bacteri
lead
better
care
children
high
risk
complic
includ
risk
niv
failur
annal
intens
care
suppl
introduct
amikacin
efficaci
requir
cmax
mg
l
correspond
time
minim
inhibitori
concentr
mic
breakpoint
sensit
strain
reach
plasma
peak
target
mg
kg
amikacin
recommend
patient
alter
pharmacokinet
properti
lead
underdosag
critic
ill
adult
aim
assess
incid
predict
factor
cmax
mg
l
popul
critic
ill
children
patient
method
children
admit
picu
locat
within
two
french
tertiari
academ
pediatr
hospit
receiv
amikacin
dose
mg
kg
includ
retrospect
observ
studi
novemb
june
result
clinic
biolog
data
amikacin
dose
inform
plasma
concentr
record
target
cmax
mg
l
risk
factor
cmax
mg
l
identifi
univari
analysi
cmax
mg
l
mg
l
includ
patient
respect
none
cmax
mg
l
patient
measur
mic
achiev
pharmacokinet
pharmacodynam
ratio
risk
factor
cmax
mg
l
low
blood
urea
concentr
p
amikacin
prescript
base
admiss
weight
less
actual
weight
aki
occur
patient
amikacin
inject
relat
sever
sepsi
use
nephrotox
agent
trough
concentr
mg
l
patient
measur
cmin
conclus
despit
use
maxim
amikacin
dose
mg
kg
cmax
pharmacokinet
target
popul
none
suffer
amikacin
overexposur
dose
strategi
amikacin
optim
use
actual
weight
rather
dri
weight
maxim
dose
mg
kg
regard
high
preval
aki
maxim
dose
amikacin
concern
patient
alter
pharmacokinet
properti
trough
concentr
systemat
monitor
patient
receiv
high
dose
aminoglycosid
annal
intens
care
suppl
introduct
ptif
infant
bronchiol
never
determin
howev
data
import
consid
set
hfnc
effici
optim
settl
flow
equal
higher
patient
ptif
patient
method
prospect
physiolog
observ
studi
primari
outcom
ptif
measur
popul
mild
bronchiol
secondari
outcom
correl
ptif
respiratori
distress
score
silverman
score
modifi
wood
clinic
asthma
score
mwca
respiratori
rate
rr
inclus
criteria
infant
bronchiol
month
old
treat
hfnc
mild
sever
mwca
need
invas
noninvas
ventil
sign
parent
consent
studi
design
patient
evalu
icu
montpelli
spiromet
appli
record
consecut
spontan
respiratori
cycl
ptif
tidal
volum
tv
rr
record
clinic
evalu
respiratori
distress
score
rate
silverman
mwca
result
mean
ds
novemb
februari
patient
month
old
g
evalu
spirometr
measur
ptif
lmin
ptif
index
weight
lminkg
tvkg
mlkg
pearson
correl
ptif
weight
good
r
p
correl
ptif
ptifkg
silverman
score
r
p
mwca
r
p
rr
r
p
conclus
ptif
independ
clinic
sign
respiratori
distress
hfnc
use
situat
studi
suggest
set
flow
close
l
min
kg
whatev
sever
annal
intens
care
suppl
introduct
prone
posit
pp
strategi
wide
use
manag
sever
adult
pediatr
acut
respiratori
distress
syndrom
pard
refractori
pard
benefit
extracorpor
respiratori
membran
oxygen
ecmo
pp
prove
situat
object
studi
evalu
effect
pp
lung
recruit
pard
ecmo
also
compar
ecmo
versu
nonecmo
patient
patient
method
singlecent
observ
studi
perform
picu
trousseau
hospit
june
june
prone
posit
protocol
use
pp
prescrib
intensivist
durat
h
h
lung
recruit
assess
static
complianc
supin
posit
pp
result
twentyf
pard
patient
includ
children
treat
convent
mechan
ventil
treat
ecmo
associ
apneic
ventil
mean
age
month
weight
kg
pp
mean
mean
arteri
satur
mean
ventilatori
paramet
ecmo
differ
nonecmo
group
ecmo
group
plateau
pressur
vs
p
peep
vs
p
drive
pressur
vs
p
tidal
volum
vs
ml
kg
p
complianc
increas
group
tabl
index
pulmonari
complianc
significantli
lower
ecmo
nonecmo
patient
discuss
patient
present
moder
pard
follow
pp
adult
recommend
ecmo
group
drive
pressur
significantli
higher
nonecmo
group
due
apneic
ventil
high
peep
limit
plateau
pressur
pp
might
effect
strategi
pard
ecmo
due
absenc
maintain
lung
recruit
low
tidal
volum
ventil
result
confirm
larger
cohort
conclus
prone
posit
pediatr
ecmoard
could
insuffici
maintain
lung
recruit
long
time
annal
intens
care
suppl
introduct
data
exist
concern
multidrugresist
mdr
bacteri
carriag
impact
healthcar
associ
infect
hcai
paediatr
intens
care
unit
picu
object
studi
estim
preval
mdr
bacteri
carriag
picu
describ
epidemiolog
relat
hcai
patient
method
perform
monocentr
prospect
cohort
studi
tertiari
bedpicu
januari
decemb
pari
franc
result
among
patient
admit
studi
period
patient
extendedspectrum
produc
enterobacteriacea
esbl
carrier
patient
methicillinresist
staphylococcu
aureu
mrsa
carrier
respect
colon
admiss
median
preval
rate
per
year
major
hcai
incid
infect
per
patientday
hcai
occur
includ
ventilatorassoci
pneumonia
vap
central
lineassoci
bloodstream
infect
clabsi
catheterassoci
urinari
tract
infect
cauti
due
esbl
wherea
due
mrsa
occur
previous
identifi
carrier
differ
length
stay
mortal
hcai
due
esbl
versu
hcai
due
esbl
respect
day
versu
day
p
versu
p
conclus
preval
acquir
mdr
bacteri
carriag
low
picu
patient
develop
hcai
mrsa
esbl
previou
carriag
identifi
surveil
swab
find
enabl
limit
use
vancomycin
carbapenem
case
hcai
patient
know
colon
annal
intens
care
suppl
introduct
autom
pupillometri
ap
use
quantifi
pupil
light
reflex
plr
critic
ill
patient
howev
complex
sympathet
parasympathet
pathway
involv
plr
may
expand
use
ap
quantifi
phenomena
relat
nervou
system
regul
vascular
tone
region
blood
flow
patient
method
observ
ongo
studi
includ
critic
ill
patient
admit
intens
care
unit
exclus
criteria
ocular
diseas
intracrani
diseas
arrhythmia
extracorpor
membran
oxygen
supraaort
arteriopathi
quantit
pupillometri
perform
use
pupillomet
calcul
neurolog
pupil
index
npi
pupillari
contract
latenc
constrict
veloc
dilat
veloc
mean
valu
variabl
measur
eye
calcul
transcrani
doppler
dwl
germani
perform
inson
left
middl
cerebr
arteri
lmca
mhz
probe
lmca
blood
flow
veloc
fv
arteri
blood
pressur
bp
signal
simultan
record
correl
coeffici
bp
fv
mxa
calcul
use
matlab
mathwork
usa
impair
car
defin
mxa
result
studi
patient
median
age
year
median
apach
ii
score
admiss
includ
sepsi
median
npi
median
mxa
patient
alter
car
observ
signific
correl
mxa
npi
r
p
variabl
measur
ap
npi
significantli
lower
patient
alter
car
other
vs
p
npi
valu
auc
predict
alter
car
npi
sensit
specif
predict
alter
car
conclus
neurolog
pupil
index
measur
autom
pupillometri
allow
assess
cerebr
autoregul
critic
ill
patient
annal
intens
care
suppl
introduct
often
extern
ventricular
drainag
evd
set
limit
time
question
find
right
time
remov
leav
evd
longer
necessari
expos
complic
especi
infecti
one
hand
wrongli
remov
evd
expos
recurr
hydrocephalu
risk
set
new
evd
formal
recommend
wean
evd
object
studi
describ
compar
wean
method
perform
depart
patient
method
first
juli
june
edv
place
patient
edv
least
one
wean
test
two
differ
method
perform
depart
rapid
wean
rw
consist
clamp
evd
gradual
wean
gw
consist
gradual
increas
level
evd
clamp
brain
ct
scan
perform
clamp
h
clamp
remov
evd
quantit
valu
express
mean
sd
compar
student
test
qualit
valu
express
number
valu
compar
test
result
wean
test
perform
evd
rw
gw
descript
comparison
patient
evd
characterist
type
wean
shown
tabl
wean
failur
neurolog
symptom
confus
somnol
n
headach
n
coma
n
nausea
n
aphasia
n
elev
intracrani
pressur
icp
ventricular
dilat
ct
scan
cerebrospin
fluid
csf
relat
problem
hemorrhag
csf
csf
leak
scar
first
failur
evd
final
success
remov
case
averag
day
conclus
two
wean
method
seem
perform
condit
within
delay
failur
rate
similar
rapid
wean
significantli
reduc
durat
evd
averag
day
annal
intens
care
suppl
introduct
infect
frequent
complic
stroke
pneumonia
frequent
site
infect
associ
lower
surviv
impair
neurolog
outcom
studi
focus
intens
care
patient
show
highest
incid
pneumonia
heterogen
sever
select
patient
date
studi
focus
exclus
epidemiolog
prognost
impact
pneumonia
mechan
ventil
stroke
patient
furthermor
previou
studi
lack
adjust
earli
decis
forgo
lifesustain
treatment
dflst
signific
confound
patient
patient
method
conduct
retrospect
analysi
larg
prospect
multicent
databas
period
includ
adult
ischem
stroke
patient
admit
icu
requir
invas
mechan
ventil
icu
admiss
relat
occurr
pneumonia
icu
stay
mortal
investig
use
cox
proport
hazard
model
adjust
dflst
data
present
median
interquartil
rang
number
percentag
result
identifi
patient
age
year
male
gender
patient
icu
icu
admiss
glasgow
coma
scale
score
gc
simplifi
acut
physiolog
score
sap
score
patient
requir
vasopressor
case
renal
replac
therapi
case
dflst
occur
day
icu
admiss
patient
withhold
care
withdraw
care
observ
case
respect
surviv
day
month
one
year
respect
icu
stay
pneumonia
episod
occur
least
patient
pneumonia
caus
sepsi
septic
shock
definit
case
respect
adjust
occurr
pneumonia
icu
stay
associ
mortal
figur
conclus
cohort
mechan
ventil
patient
acut
ischem
stroke
pneumonia
frequent
complic
associ
mortal
impact
pneumonia
function
outcom
survivor
investig
studi
annal
intens
care
suppl
introduct
stroke
common
neurolog
condit
manag
progress
recent
year
morbid
mortal
remain
high
stroke
second
lead
caus
death
world
develop
countri
behind
cardiovascular
diseas
accord
estim
new
case
regist
year
algeria
death
first
caus
acquir
mental
physic
disabl
object
analyz
risk
factor
relat
stroke
evalu
manag
patient
method
retrospect
studi
cover
period
month
octob
januari
includ
patient
acut
neurolog
impair
admit
emerg
depart
evalu
criteria
nihss
score
glasgow
score
blood
pressur
reason
orient
result
collect
file
patient
admit
acut
neurolog
deficit
stroke
ischem
patient
admit
intens
care
note
predomin
male
averag
age
patient
arriv
sever
hour
onset
symptom
nihss
score
nihss
analysi
risk
factor
show
hta
ara
ii
diabet
atrial
fibril
arrhythmia
case
dyslipidemia
cardiovascular
histori
case
relationship
hta
nihss
score
presenc
arteri
hypertens
nihss
nihss
nihss
atrial
fibril
arrhythmia
relationship
nihss
score
presenc
atrial
fibril
arrhythmia
nihss
score
nihss
nihss
score
discuss
frequenc
risk
factor
occurr
stroke
similar
found
literatur
howev
manag
optim
conclus
stroke
major
public
health
problem
countri
studi
show
hypertens
frequent
associ
risk
factor
need
strengthen
screen
treatment
number
patient
admit
intens
care
reduc
thank
creation
neurovascular
unit
control
risk
factor
summari
improv
manag
patient
stroke
assess
need
evalu
shown
relationship
risk
factor
name
hypertens
atrial
fibril
arrhythmia
must
control
annal
intens
care
suppl
introduct
stroke
import
caus
morbid
mortal
sever
independ
factor
influenc
overal
surviv
prognost
valu
cardiac
troponin
electrocardiograph
sign
poorli
studi
aim
work
evalu
frequenc
troponin
elev
acut
phase
stroke
associ
electrocardiograph
sign
mortal
patient
method
record
ischem
stroke
collect
juli
march
amongst
patient
patient
receiv
troponin
includ
clinic
paraclin
data
also
collect
associ
elev
troponin
ng
ml
along
presenc
electr
sign
ischemia
mortal
studi
result
patient
includ
mean
age
year
sex
ratio
comorbid
domin
high
blood
pressur
follow
diabet
concept
coronari
insuffici
known
patient
troponin
posit
patient
known
histori
coronari
arteri
diseas
diagnosi
troponinposit
nstemi
associ
stroke
retain
three
patient
half
patient
posit
troponin
consist
ecg
chang
myocardi
ischemia
p
ci
electr
sign
mainli
subepicardi
ischemia
follow
subendocardi
lesion
acfa
present
patient
associ
posit
troponin
p
goe
occurr
haemorrhag
transform
p
overal
mortal
deceas
patient
posit
troponin
p
conclus
acut
phase
stroke
elev
troponin
occurr
electrocardiograph
chang
must
part
comprehens
diagnost
approach
well
approach
prevent
manag
comorbid
annal
intens
care
suppl
introduct
malign
cerebr
edema
follow
ischem
stroke
life
threaten
caus
inadequ
blood
flow
perfus
increas
intracrani
pressur
brain
shift
lead
herniat
syndrom
brain
death
multipl
random
clinic
trial
shown
decompress
hemicraniectomi
dhc
effect
reduc
mortal
morbid
object
studi
evalu
outcom
mortal
morbid
patient
malign
ischem
stroke
underw
dhc
patient
method
retrospect
collect
data
malign
ischem
stroke
patient
requir
dhc
april
juli
clinic
outcom
assess
use
modifi
rankin
scale
mr
result
fourteen
patient
includ
mean
age
year
sd
year
patient
older
year
sex
ratio
sapsii
admiss
averag
sd
point
median
glasgow
coma
scale
seven
stroke
occur
left
middl
cerebr
arteri
mca
territori
occur
right
mca
territori
one
stroke
occur
posterior
cerebr
arteri
territori
one
stroke
occur
anterior
cerebr
arteri
territori
mean
time
decompress
hemicraniectomi
day
median
modifi
rankin
scale
mr
month
mortal
conclus
although
dch
consid
livesav
procedur
decreas
mortal
mani
patient
suffer
wors
function
outcom
disabl
annal
intens
care
suppl
introduct
braininjuri
lead
factor
mortal
morbid
traumat
injuri
young
previous
healthi
patient
earli
evalu
prognosi
patient
necessari
determin
suitabl
medic
care
strategi
aim
studi
predict
mortal
outcom
brain
injur
popul
base
first
clinic
biolog
evalu
patient
method
conduct
eight
month
long
prospect
cohort
includ
patient
admit
univers
hospit
icu
moder
sever
traumat
brain
injuri
tbi
defin
glasgow
coma
scale
twelv
gc
outcom
evalu
incid
death
glasgow
outcom
scale
go
day
thirti
univari
multivari
analysi
use
determin
level
signific
result
studi
period
trauma
patient
admit
icu
moder
sever
tbi
includ
male
femal
patient
mean
age
mean
injuri
sever
score
iss
accord
analysi
mortal
rate
among
patient
sustain
moder
sever
tbi
averag
icu
lo
day
averag
ventil
day
day
use
multivari
logist
regress
model
initi
glucos
serum
level
p
pupil
respons
p
found
independ
risk
factor
mortal
linear
regress
model
also
identifi
glucos
level
predict
go
day
p
conclus
conclud
initi
glucos
level
independ
predictor
mortal
morbid
brain
injur
patient
hyperglycemia
could
consid
simpl
yet
valuabl
marker
ofbrain
injuri
present
upon
admiss
could
reflect
extensivebrain
damag
frequent
associ
mortal
bad
outcom
annal
intens
care
suppl
introduct
delirium
acut
brain
dysfunct
commonli
seen
critic
ill
patient
associ
poor
outcom
delirium
usual
underdiagnos
physician
due
lack
adequ
screen
tool
confus
assess
method
intens
care
unit
camicu
one
wide
use
screen
method
detect
icu
delirium
translat
languag
scale
howev
translat
valid
tunisian
arab
dialect
languag
aim
studi
translat
retransl
valid
tunisian
version
camicu
patient
method
permiss
eli
et
al
forward
backward
translat
tunisian
version
camicu
perform
accord
protocol
mapi
research
institut
includ
conceptu
analysi
forward
translat
two
translat
consensu
two
version
backward
translat
comparison
sourc
backward
translat
pilot
test
obtain
final
translat
version
valid
valid
interrat
reliabl
assess
tunisian
camicu
two
intensivist
independ
assess
delirium
icu
patient
result
compar
refer
evalu
done
psychiatrist
use
diagnost
statist
manual
mental
disord
v
dsmv
interrat
reliabl
calcul
use
kappa
statist
result
studi
period
octob
june
patient
evalu
two
intensivist
one
psychiatrist
expert
independ
base
dsmv
criteria
patient
develop
delirium
accord
tunisian
camicu
frequenc
delirium
consecut
first
evalu
intensivist
second
intensivist
tunisian
camicu
done
accept
interrat
reliabl
intensivist
intensivist
term
assess
delirium
kappa
p
sensit
two
intensivist
evalu
use
tunisian
camicu
intensivist
intensivist
specif
respect
conclus
tunisian
version
camicu
show
good
valid
reliabl
detect
delirium
critic
ill
patient
could
therefor
appliabl
tunisian
icu
appropri
train
annal
intens
care
suppl
introduct
puls
oximetri
noninvas
method
monitor
oxygen
satur
critic
ill
patient
studi
investig
accuraci
intens
care
unit
icu
aim
determin
differ
puls
oximet
oxygen
satur
arteri
oxygen
satur
critic
ill
patient
assess
influenc
specif
physiolog
factor
accuraci
patient
method
conduct
prospect
studi
juli
septemb
inclus
criteria
simultan
arteri
blood
ga
abg
valu
record
pair
collect
concomit
haemoglobin
temperatur
lactatemia
requir
vasoact
drug
bia
calcul
differ
consid
accept
rang
nonaccept
analys
accord
concomit
condit
result
studi
period
collect
pair
mean
bia
bia
accept
pair
nonaccept
other
compar
subgroup
patient
accord
bias
accept
shown
tabl
conclus
bia
critic
ill
patient
high
accuraci
significantli
impair
hemoglobin
gdl
nevertheless
independ
hemodynam
respiratori
statu
annal
intens
care
suppl
introduct
respiratori
failur
pregnanc
postpartum
period
uncommon
particular
situat
lack
literatur
concern
assess
manag
patient
choic
investig
treatment
may
affect
mother
fetu
aim
studi
studi
characterist
outcom
patient
admit
icu
patient
method
mono
centric
descript
retrospect
studi
data
pregnant
postpartum
patient
admit
icu
januari
august
review
collect
inform
regard
clinic
present
treatment
outcom
result
forti
patient
includ
studi
account
icu
admiss
twentyf
pregnant
postpartum
period
median
age
year
old
median
sever
score
apach
ii
sap
ii
median
gestat
age
week
thirtythre
patient
acut
respiratori
failur
time
admiss
rest
develop
later
stayth
lead
caus
respiratori
failur
pulmonari
infect
n
patient
diagnos
viral
pneumonia
patient
asthma
patient
pulmonari
embol
patient
pulmonari
edema
six
patient
septic
shock
time
admiss
seven
sever
ard
isol
eleven
patient
five
women
cpap
among
four
surviv
three
lost
babi
eleven
ventil
non
invas
ventil
niv
nine
women
surviv
three
lost
babi
invas
ventil
iv
among
five
deceas
seven
patient
prone
posit
pp
three
mother
three
babi
surviv
among
two
deliv
cesarian
invas
ventil
p
sedat
p
curaris
p
acut
kidney
failur
p
prolong
hospit
icu
p
significantli
increas
mortal
pregnant
patient
postpartum
period
median
durat
stay
icu
day
patient
n
left
icu
without
major
dysfunct
discuss
conclus
niv
tri
possibl
even
mild
adr
asthma
iv
sedat
avoid
possibl
pp
consid
sever
ard
annal
intens
care
suppl
introduct
chronic
obstruct
pulmonari
diseas
copd
one
lead
caus
morbid
mortal
among
chronic
diseas
cognit
dysfunct
exacerb
prognosi
affect
adher
qualiti
life
object
work
evalu
cognit
function
patient
follow
copd
determin
affect
area
well
predict
factor
attack
patient
method
transvers
studi
conduct
outpati
clinic
pneumolog
depart
la
rabta
mongi
slim
la
marsa
patient
respiratori
function
investig
sever
copd
assess
gold
classif
bode
index
cognit
function
assess
use
mini
mental
state
examin
mmse
questionnair
translat
dialect
arab
result
one
hundr
fifti
patient
collect
illiter
mean
age
year
mean
smoke
py
patient
cardiovascular
comorbid
frequent
exacerb
respiratori
function
investig
show
mean
cvf
mean
mean
mmhg
less
mmhg
mean
mmhg
greater
mmhg
case
fiftyfour
percent
patient
gold
averag
bode
index
four
cognit
dysfunct
found
case
among
educ
among
illiter
impair
cognit
function
correl
age
p
number
year
studi
p
frequenc
exacerb
p
lower
mmhg
p
greater
mmhg
p
bode
index
p
multivari
linear
regress
studi
found
correl
number
year
studi
p
rhythm
disord
p
mmhg
p
conclus
rate
cognit
impair
popul
assess
mmse
questionnair
lower
report
literatur
due
among
thing
differ
methodolog
level
school
select
popul
number
year
studi
rhythm
disord
frequenc
exacerb
factor
significantli
correl
cognit
impair
annal
intens
care
suppl
introduct
mannosebind
lectin
mbl
play
import
role
innat
immun
respons
aim
determin
whether
baselin
serum
level
mbl
admiss
icu
could
predict
mortal
icu
patient
infect
patient
method
prospect
observ
studi
perform
icu
patient
ard
due
viru
demograph
characterist
sever
indic
record
icu
admiss
mbl
assay
blood
drawn
diagnosi
outcom
compar
accord
mbl
level
result
express
median
interquartil
rang
result
mbl
level
studi
patient
median
age
year
sever
infect
median
admiss
sap
ii
sofa
score
respect
thirtyday
mortal
rate
n
mbl
significantli
higher
nonsurvivor
ng
ml
vs
survivor
ng
ml
p
mbl
cutoff
ng
ml
sensit
specif
mortal
auc
ci
analysi
demonstr
strong
associ
mbl
level
mortal
logrank
p
mbl
ng
ml
independ
associ
mortal
adjust
hr
ci
p
conclus
studi
show
baselin
mbl
ng
ml
associ
higher
mortal
icu
patient
sever
infect
annal
intens
care
suppl
introduct
recent
demonstr
conserv
protocol
oxygen
therapi
result
lower
icu
mortal
convent
therapi
devic
automat
adjust
oxygen
flow
base
patient
need
emerg
depart
associ
improv
oxygen
adher
guidelin
aim
studi
evalu
feasibl
wean
oxygen
follow
mechan
ventil
mv
patient
admit
tunisian
icu
patient
method
prospect
cohort
studi
includ
cohort
patient
admit
icu
june
septemb
requir
mv
niv
intub
record
free
gener
curv
h
acut
clinic
condit
control
assess
flow
rate
percentag
patient
less
l
min
end
record
consumpt
variat
time
target
time
sever
desatur
time
hyperoxia
target
statist
dichotom
paramet
express
percentag
wherea
continu
variabl
express
median
percentil
interquartil
rang
link
paramet
assess
wilcoxon
test
result
twenti
six
record
collect
patient
median
age
year
male
copd
hypertens
diabet
first
ventil
modal
admiss
niv
main
reason
icu
admiss
acut
respiratori
failur
de
novo
chronic
free
record
made
day
icu
admiss
median
durat
interpret
record
h
mean
target
set
tabl
summar
main
find
free
record
record
observ
decreas
flow
median
reduct
flow
l
per
hour
end
free
record
note
median
flow
flow
l
min
note
record
conclus
cohort
automat
titrat
free
associ
substanti
reduct
deliveri
record
patient
follow
mechan
ventil
mv
studi
need
assess
impact
patient
outcom
costeffect
annal
intens
care
suppl
introduct
withdraw
mechan
ventil
mv
crucial
moment
icu
stay
may
influenc
patient
outcom
fail
extub
associ
high
mortal
rate
rang
around
adopt
wean
protocol
prevent
extub
failur
aim
review
practic
wean
mv
icu
burn
patient
method
retrospect
studi
conduct
burn
center
tuni
april
decemb
includ
mechan
ventil
patient
undergon
wean
trial
exclud
earli
die
patient
h
categor
ventil
patient
three
group
accord
difficulti
wean
process
simpl
wean
includ
patient
succeed
first
wean
trial
difficult
wean
patient
fail
first
weanig
trial
requir
trial
day
achiev
success
wean
prolong
wean
patient
requir
day
wean
first
wean
trial
wean
criteria
peep
respiratori
ratetid
volum
myocardi
ischemia
need
minim
vasopressor
hemoglobin
gdl
demograph
clinic
outcom
data
patient
analys
result
period
studi
patient
admit
patient
intub
includ
mean
age
year
sexratio
averag
tbsa
includ
face
neck
patient
averag
durat
sedat
day
studi
patient
simpl
wean
trial
difficult
wean
trial
prolong
wean
trial
wean
mv
success
ca
fail
case
caus
extub
failur
esenti
nosocomi
pneumonia
n
icu
acquir
weak
n
studi
total
bodi
burn
surfac
area
associ
extub
failur
tbsa
success
wean
group
vs
fail
wean
group
p
conclus
result
suggest
incid
extub
failur
high
patient
due
essenti
extent
burn
includ
neck
face
region
refer
esteban
j
respir
crit
care
med
j
respir
crit
care
med
annal
intens
care
suppl
introduct
acut
dyspnea
common
symptom
encount
hospit
patient
emerg
room
clinic
present
sometim
atyp
especi
elderli
wide
varieti
etiolog
sometim
life
threaten
work
aim
establish
epidemiolog
etiolog
profil
patient
admit
emerg
room
identifi
prognost
factor
patient
method
retrospect
studi
includ
patient
hospit
observ
unit
acut
dyspnea
defin
breath
discomfort
develop
worsen
less
two
week
exclud
patient
admit
immedi
resuscit
unit
suffer
posttraumat
dyspnea
result
includ
patient
hospit
acut
dyspnea
account
admiss
median
age
patient
year
acut
respiratori
failur
main
clinic
present
patient
hypoxem
case
hypercapn
case
dyspnea
multifactori
patient
main
etiolog
acut
communityacquir
pneumonia
acut
heart
failur
decompens
chronic
obstruct
pulmonari
diseas
copd
noninvas
ventil
invas
ventil
respect
necessari
case
intrahospit
mortal
highli
increas
patient
age
year
alter
conscious
hemodynam
instabl
ig
ii
score
case
acidemia
hypoxemia
use
mechan
ventil
well
need
vasoact
drug
also
associ
higher
mortal
rate
predictor
ventilatori
support
polypnea
cycl
minut
copd
sign
respiratori
distress
blood
pressur
mm
hg
copd
predictor
readmiss
patient
acut
dyspnea
wherea
higher
age
patient
correl
longer
hospit
stay
conclus
acut
dyspnea
one
lead
caus
emerg
hospit
elderli
patient
mainli
caus
decompens
respiratori
cardiac
comorbid
age
main
prognost
factor
annal
intens
care
suppl
introduct
problem
relat
mechan
ventil
wean
common
intens
care
mani
factor
affect
wean
process
make
short
difficult
prolong
aim
studi
wean
condit
procedur
depart
patient
method
retrospect
cohort
studi
conduct
patient
admit
icu
first
januari
septemb
includ
patient
mechan
ventil
h
period
use
wean
definit
classifi
patient
group
wean
patient
never
experienc
separ
attempt
group
short
wean
first
separ
attempt
result
termin
wean
process
within
h
success
separ
earli
death
group
difficult
wean
wean
termin
day
less
week
first
separ
attempt
success
separ
death
group
prolong
wean
wean
still
termin
day
first
separ
attempt
success
death
result
studi
period
patient
includ
median
age
year
median
apach
ii
sofa
score
respect
six
median
rate
hemoglobin
mean
level
first
separ
attempt
respect
gdl
mmhg
first
separ
attempt
carri
essenti
spontan
ventil
test
median
delay
h
first
spontan
ventil
test
success
fulfil
patient
fifti
percent
patient
classifi
short
wean
distribut
differ
group
summer
tabl
ten
patient
requir
tracheostomi
median
durat
sedat
h
median
mechan
ventil
durat
stay
respect
day
overal
mortal
rate
conclus
first
separ
attempt
success
case
patient
delay
prolong
